{"idx": 0, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'GBA1' refers to the gene symbol and is correct in context but does not exactly match the gold standard 'glucocerebrosidase,' which specifies the enzyme. The supporting sentence mentions GBA1 and provides relevant information about its mutation complexity, but it does not directly address the deficiency of glucocerebrosidase as the cause of Gaucher's disease, which is central to the gold answer.\", \"match\": false}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher's disease (GD) results from a deficiency of the lysosomal enzyme glucocerebrosidase and, in very rare occasions, a deficiency of its activator, the saposin C.", "model_answer": "The gene mutated in Gaucher disease is GBA1.\n\nAnswer: GBA1", "model_support": "The supporting sentence is:\n\"The complexity of identification and characterization of mutations in the gene of glucocerebrosidase (GBA1)...\" \n\nThis sentence explicitly mentions GBA1 as the gene involved in Gaucher's disease.", "retries": 1}
{"idx": 1, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence from the context is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 2, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by explaining that interfering with phospholamban-SERCA2a interaction impacts muscle contractility, which indirectly highlights phospholamban's regulatory role. However, it is slightly less direct compared to the gold supporting sentence, which explicitly mentions the ablation of phospholamban rescuing heart failure phenotypes. This makes the model's supporting sentence somewhat less concise and specific.\", \"match\": true}", "gold_answer": "phospholamban", "gold_support": "The ablation of a muscle-specific sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) inhibitor, phospholamban, rescued the spectrum of phenotypes that resemble human heart failure.", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban.", "model_support": "The supporting sentence that identifies phospholamban as the main regulatory molecule of SERCA2A in cardiac muscle is:\n\n\"Inhibition of phospholamban-SERCA2a interaction via in vivo expression of a phospholamban point mutant dominantly activated the contractility of ventricular muscle cells.\"\n\nThis sentence demonstrates that phospholamban regulates SERCA2a's function, as interfering with their interaction affects muscle contractility.", "retries": 1}
{"idx": 3, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking SAMe to histone methylation (H3K27me3). However, it contains slight redundancy by mentioning gene silencing and ethanol feeding, which are not necessary to directly support the role of SAMe as the methyl donor. A more concise explanation focusing solely on SAMe's role in histone methylation would have warranted a full score.\",\n  \"match\": true\n}", "gold_answer": "S-adenosylmethionine", "gold_support": "S-adenosylmethionine (SAMe), the major methyl donor for DNA and histone methylation was fed with ethanol for 1month in order to modify the effects of ethanol on rat liver.", "model_answer": "The methyl donor of histone methyltransferases is S-adenosylmethionine (SAMe). \n\nAnswer: S-adenosylmethionine (SAMe)", "model_support": "The supporting sentence from the context is:\n\n\"Microarray analysis showed that SAMe feeding prevented most of the changes in gene expression induced by ethanol feeding, presumably by inducing H3K27me3 and gene silencing.\"\n\nThis sentence indicates that SAMe is responsible for inducing histone methylation (H3K27me3), confirming its role as the methyl donor for histone methyltransferases.", "retries": 1}
{"idx": 4, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (mentioning TIA) that are not explicitly required by the gold answer. The supporting sentence provided by the model repeats the answer rather than offering concise, direct evidence from the context. While relevant, it lacks specificity and clarity compared to the gold supporting sentence, which directly ties the ROSIER scale to stroke diagnosis.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for identifying stroke or transient ischaemic attack (TIA) in the emergency department.", "model_support": "The ROSIER scale is used for identifying stroke or transient ischaemic attack (TIA) in the emergency department.\n\nSupporting sentence: To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.", "retries": 1}
{"idx": 5, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively links the ZFHX1B gene to Mowat-Wilson syndrome without unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B. \n\nAnswer: ZFHX1B", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 6, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it includes the full name of the disease which is not required. The supporting sentence provided by the model repeats the answer but does not add new reasoning or context. However, the additional context from the 'supporting sentence' (inefficient repression of a retrogene) provides relevant support for the gold answer, albeit with slight redundancy. Overall, the logic is sound, but the repetition lowers the score slightly.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD). \n\n**Supporting sentence:**  \n\"FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.\"", "retries": 1}
{"idx": 7, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying the receptor as the calcitonin gene-related peptide (CGRP) receptor. The supporting sentence, though accurate, relies on external knowledge rather than directly quoting or closely paraphrasing the provided context, which leads to slight redundancy. Ideally, it should have used the concise and relevant information from the context about telcagepant being a CGRP receptor antagonist.\",\n  \"match\": true\n}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is an oral calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.", "model_answer": "The receptor targeted by telcagepant is the calcitonin gene-related peptide (CGRP) receptor. Telcagepant functions as a CGRP receptor antagonist, which helps in treating migraines by blocking the CGRP pathway involved in pain signaling.\n\nAnswer: Calcitonin gene-related peptide (CGRP) receptor", "model_support": "The context provided does not explicitly mention the receptor targeted by telcagepant. However, based on external knowledge, telcagepant is known to target the calcitonin gene-related peptide (CGRP) receptor as a CGRP receptor antagonist. This information is not directly supported by the provided context.\n\n**Answer:** The receptor targeted by telcagepant is the calcitonin gene-related peptide (CGRP) receptor. However, the context does not provide a supporting sentence for this answer.", "retries": 1}
{"idx": 8, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct but includes extra information ('enhances the immune system's ability...') that is not part of the gold standard, making it less concise. The supporting sentence does not directly cover the interaction with PD-1 as described in the gold supporting sentence and instead focuses on study objectives, which are not relevant to explaining what protein the antibodies target. Although the model answer matches the gold standard conceptually, the supporting sentence fails to logically support the key point.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "CT-011 is a humanized IgG1 monoclonal antibody that modulates the immune response through interaction with PD-1, a protein belonging to the B7 receptor family present on lymphocytes.", "model_answer": "The antibodies MK-3475 and CT-011 target the PD-1 (Programmed Death-1) protein. This targeting enhances the immune system's ability to recognize and attack cancer cells, making them effective in treating various malignancies.", "model_support": "Supporting sentence: The objectives of this phase I study were to assess the dose-limiting toxicities, to determine the maximum tolerated dose, and to study the pharmacokinetics of CT-011 administered once to patients with advanced hematologic malignancies.", "retries": 1}
{"idx": 9, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate, but it comes from a different source than the context provided, which slightly affects its relevance to this specific scenario. However, it still logically supports the answer with minimal redundancy.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence that identifies JTV519 as a derivative of the 1,4-benzothiazepine group is:\n\n\"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 10, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Xist RNA' is very close to the gold standard 'Xist', with only a minor addition of 'RNA', which does not detract from the core correctness. The supporting sentence provided by the model discusses the regulation and role of Xist RNA in X inactivation, which supports the answer but contains some redundancy when compared to the concise and direct gold supporting sentence. The logic is sound, but the supporting sentence could be more focused.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "This progress has largely revolved around the discovery of the X inactive specific transcript (Xist) gene, which is known now to represent the master switch locus regulating X inactivation.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist RNA.\n\nAnswer: Xist RNA", "model_support": "The supporting sentence is: \"The goals for the future are to understand the mechanism of Xist regulation which underlies the establishment of appropriate X inactivation patterns and to determine how Xist RNA participates in the process of propagating inactivation in cis.\"\n\nThis sentence indicates that Xist RNA is involved in the process of X-chromosome inactivation, supporting the answer that it is responsible.", "retries": 1}
{"idx": 11, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard (adenosylmethionine being the methyl donor). The supporting sentence provides relevant information about AdoMet as a methyl donor, but it indirectly references its role in plants rather than directly addressing histone methyltransferases. While it establishes the general role of AdoMet as a methyl donor, it contains slight redundancy and does not fully align with the specific evidence provided in the gold supporting sentence.\", \"match\": true}", "gold_answer": "adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "The methyl donor for histone methyltransferases is S-adenosyl methionine (SAM), also known as AdoMet.", "model_support": "The supporting sentence from the context that indirectly supports the answer is:\n\n\"Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).\"\n\nThis sentence establishes that AdoMet (S-adenosylmethionine) is a precursor to SMM, which is used as a methyl donor. While it doesn't explicitly mention histone methyltransferases, it supports the general role of AdoMet as a methyl donor in biological processes, including histone methylation.", "retries": 1}
{"idx": 12, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK') conceptually, though it is slightly more verbose by specifying 'the mutation in the XK gene' instead of just 'XK'. The supporting sentence contains relevant information and logically supports the answer, but it is somewhat lengthy and includes additional details about the molecular consequences, which are not necessary to directly support the answer. This makes it slightly redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "The mutation in the XK gene is associated with McLeod syndrome.", "model_support": "Supporting sentence: Molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK. This deletion caused a frameshift in translation, leading to a premature stop codon at the amino acid position 408. We conclude this single-base deletion causes defective Kx protein, which is responsible for the McLeod phenotype in this patient.", "retries": 1}
{"idx": 13, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and accurate but contains slight redundancy by mentioning 'genome instability,' which is related but not directly part of the gold supporting sentence's specific focus on DNA repair defects, hypersensitivity to crosslinking agents, and chromosomal aberrations.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "The disease is manifested by defects in DNA repair, hypersensitivity to DNA crosslinking agents, and a high degree of chromosomal aberrations.", "model_answer": "The disease is Fanconi anemia.", "model_support": "Supporting sentence: Fanconi anemia (FA) is an autosomal disorder that causes genome instability.", "retries": 1}
{"idx": 14, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about ibrutinib's effects in trials, but it is slightly more detailed than necessary, introducing specifics about dosages and combinations that are not essential to directly support the answer. The gold supporting sentence is more concise while still being highly relevant.\",\n  \"match\": true\n}", "gold_answer": "Ibrutinib", "gold_support": "Ibrutinib: a novel Bruton's tyrosine kinase inhibitor with outstanding responses in patients with chronic lymphocytic leukemia.", "model_answer": "The name of the Bruton's tyrosine kinase inhibitor used for the treatment of chronic lymphocytic leukemia is ibrutinib.", "model_support": "The supporting sentence is:  \n\"In phase I/II trials, ibrutinib 420 mg or 840 mg - given continuously as single agent or at a dose of 420 mg daily in combination with a monoclonal antibody or chemoimmunotherapy - has been associated with high response rates and durable clinical remissions.\"", "retries": 1}
{"idx": 15, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer, it still aligns well with the gold supporting sentence in clarity and relevance.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "p53 is well known as the 'guardian of the genome' for differentiated and neoplastic cells.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\n**Supporting sentence:**  \n\"p53 is well known as the 'guardian of the genome' for differentiated and neoplastic cells.\"", "retries": 1}
{"idx": 16, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer, it still aligns well with the gold supporting sentence in terms of relevance and conciseness.\",\n  \"match\": true\n}", "gold_answer": "acute ischemic stroke", "gold_support": "MR CLEAN, a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands: study protocol for a randomized controlled trial.", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke.", "model_support": "The MR CLEAN study investigated the treatment of acute ischemic stroke. \n\n**Supporting sentence:**  \n\"However, a beneficial effect of IAT on functional recovery in patients with acute ischemic stroke remains unproven.\"", "retries": 1}
{"idx": 17, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation for calsequestrin's role in calcium regulation, but it is slightly more verbose than necessary and does not explicitly mention its role as the 'main calcium buffer,' which is present in the gold supporting sentence.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin, the main calcium buffer in the sarcoplasmic reticulum, provides a pool of calcium for release through the RyR and acts as a luminal calcium sensor for the channel via its interactions with triadin and junctin.", "model_answer": "The main calcium binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The sentence that supports the answer is:\n\n\"The close relationship between altered expression and dysfunction of calsequestrin in several skeletal and cardiac disorders highlights the critical role that calsequestrin plays in maintaining Ca²⁺ homeostasis and regulation of muscle contraction.\"\n\nThis sentence emphasizes calsequestrin's crucial role in calcium homeostasis, indicating it is the main calcium binding protein in the sarcoplasmic reticulum.", "retries": 1}
{"idx": 18, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context (icatibant is mentioned, though incorrectly associated with DX-88). The supporting sentence states that the question cannot be answered based on the context, which is incorrect since DX-88 is clearly defined in the context as ecallantide. The supporting sentence does not cover the gold answer and adds incorrect reasoning.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "Several novel therapies have completed phase III trials in the US, including: (i) plasma-derived C1-INH replacement therapies (Berinert P and Cinryze); (ii) a recombinant C1-INH replacement therapy (conestat alfa; Rhucin); (iii) a kallikrein inhibitor (ecallantide [DX-88]); and (iv) a bradykinin-2-receptor antagonist (icatibant).", "model_answer": "DX-88 is the investigational name for Icatibant.", "model_support": "The question regarding DX-88 cannot be answered based on the provided context, as DX-88 is not mentioned. \n\nAnswer: The context does not provide information about DX-88.", "retries": 1}
{"idx": 19, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant information and directly ties the disease FSHD to the ectopic expression of DUX4, but it is slightly more verbose than necessary. The gold supporting sentence is more concise while still being clear and relevant.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).\n\nAnswer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).\n\n**Supporting sentence:**  \n\"FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.\"", "retries": 1}
{"idx": 20, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Dermatitis herpetiformis') and correctly describes the rash as papulovesicular, which is accurate. The supporting sentence is relevant and covers the answer but repeats some information (e.g., 'papulovesicular rash') that makes it slightly redundant. It could be more concise while still retaining clarity.\", \"match\": true}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis, presenting as a papulovesicular rash. \n\nAnswer: Dermatitis herpetiformis, characterized by a papulovesicular rash.", "model_support": "The supporting sentence from the context is:\n\n\"It presents as a papulovesicular rash and is often associated with enteropathy.\"\n\nThis sentence describes the typical rash associated with gluten as dermatitis herpetiformis, presenting as a papulovesicular rash.", "retries": 1}
{"idx": 21, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('growth hormone') but is present in the context. The supporting sentence is relevant as it correctly points out that the context discusses hyperinsulinism and does not explicitly mention a deficiency. However, it fails to cover the gold answer (growth hormone deficiency), which is mentioned in the context provided.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described.", "model_answer": "The question asks about a hormone deficiency implicated in Costello syndrome based on the provided context. The context discusses hyperinsulinemic hypoglycemia in two patients with Costello syndrome, managed with diazoxide to reduce insulin secretion. It does not mention any hormone deficiency but rather an excess of insulin.\n\nAnswer: The context does not mention a specific hormone deficiency in Costello syndrome. The issue described is hyperinsulinism, not a deficiency.", "model_support": "The context does not mention a specific hormone deficiency in Costello syndrome. Instead, it describes the condition as being associated with hyperinsulinism, characterized by excessive insulin secretion leading to hypoglycemia. The patients required treatment to manage this overproduction of insulin, but no hormone deficiency was noted.\n\n**Answer:** The context does not indicate a hormone deficiency in Costello syndrome. Instead, it highlights hyperinsulinism, where there is an excess of insulin production.", "retries": 1}
{"idx": 22, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and logically supports the answer by clearly stating the autosomal dominant mode of inheritance for Acromicric dysplasia. Although the context includes additional details, the model’s supporting sentence remains focused and accurate.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "AD has an autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).", "model_answer": "The mode of inheritance of Acromicric dysplasia is autosomal dominant.", "model_support": "The mode of inheritance for Acromicric dysplasia is autosomal dominant.\n\n**Supporting sentence:** \"We then identified mutations in ADAMTSL2 in the recessive form of GD and a hotspot of mutations in FBN1 in the dominant form of GD and in AD (exon 41-42, encoding TGFβ binding protein-like domain 5 (TB5) of FBN1).\"", "retries": 1}
{"idx": 23, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it focuses on post-translational modifications (SUMOylation and acetylation) rather than identifying phospholamban as the main regulatory molecule. While the supporting sentence is relevant and mentions post-translational modifications, it does not cover the gold answer (phospholamban) or the broader signaling cascade that includes it. The logic is reasonable but misses key information from the context.\",\n  \"match\": false\n}", "gold_answer": "phospholamban", "gold_support": "SERCA2a activity can be regulated at multiple levels of a signaling cascade comprised of phospholamban, protein phosphatase 1, inhibitor-1, and PKCα.", "model_answer": "The main regulatory mechanisms of SERCA2a function in the cardiac muscle involve post-translational modifications such as SUMOylation and acetylation. However, the specific molecules responsible for these modifications are not explicitly named in the provided context. Therefore, based on the information given, the main regulatory processes are associated with these modifications, but the exact regulatory molecules cannot be identified from the context.", "model_support": "The supporting sentence from the context is:\n\n\"SERCA2 activity is also regulated by post-translational modifications including SUMOylation and acetylation.\"\n\nThis sentence indicates that the main regulatory mechanisms involve these post-translational modifications but does not specify the exact molecules responsible for them.", "retries": 1}
{"idx": 24, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate and aligns well with the gold standard, as 'subclinical hypothyroidism' directly relates to thyroid abnormalities. However, the gold answer is more concise ('thyroid'), while the model provides additional detail ('subclinical hypothyroidism'). The supporting sentence is relevant and supports the answer, but it includes a statistic that isn't strictly necessary for the explanation, making it slightly redundant.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "The common hormone abnormality in Williams syndrome is **subclinical hypothyroidism**, characterized by elevated thyroid-stimulating hormone (TSH) levels with normal free thyroxine (fT4) levels.", "model_support": "Supporting sentence: \"None of our patients had overt hypothyroidism; 29 patients (31.5%) had subclinical hypothyroidism.\"", "retries": 1}
{"idx": 25, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('IL-1β'). The supporting sentence is relevant and explains how Gevokizumab interacts with IL-1β by reducing its binding affinity to IL-1RI, which aligns well with the context. However, it contains slight redundancy by reiterating the molecule targeted in the explanation, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by Gevokizumab is interleukin-1β (IL-1β). The drug inhibits IL-1β signaling by reducing its binding affinity to the IL-1 receptor type I (IL-1RI), thus modulating its activity. \n\nAnswer: Interleukin-1β (IL-1β)", "model_support": "The molecule targeted by Gevokizumab is interleukin-1β (IL-1β). The drug inhibits IL-1β signaling by reducing its binding affinity to the IL-1 receptor type I (IL-1RI), thus modulating its activity.\n\n**Supporting sentence:** \"Gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"", "retries": 1}
{"idx": 26, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, stating three TAp73 isoforms when the gold standard specifies seven. The supporting sentence acknowledges that the context does not provide the information and admits the lack of a relevant supporting sentence, which shows awareness of its limitations but still fails to match the gold standard or logically support the correct answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Three TAp73 isoforms (α, β, γ) have been identified in humans.", "model_support": "The context does not explicitly state the number of TAp73 isoforms identified in humans. However, based on general knowledge, there are three TAp73 isoforms: α, β, and γ. Since the context does not provide this information, the supporting sentence is not present in the provided text. \n\nAnswer: The context does not specify the number of TAp73 isoforms identified in humans.", "retries": 1}
{"idx": 27, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "Selenocysteine (Sec, U) insertion into proteins is directed by translational recoding of specific UGA codons located upstream of a stem-loop structure known as Sec insertion sequence (SECIS) element.", "model_answer": "The name of the stem loop present in the 3' end of genes encoding for selenoproteins is the SECIS element.\n\nAnswer: SECIS element", "model_support": "Supporting sentence: Both eukaryotic and bacterial SelL genes use single SECIS elements for insertion of two Sec.", "retries": 1}
{"idx": 28, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but contains more detail than necessary, including information about the study design and specific measurements, which are not directly required to support the answer. A more concise sentence aligning with the gold supporting sentence would have sufficed.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "The medication to be administered is naloxone.", "model_support": "Supporting sentence: A prospective, sequential, observational cohort study of 196 consecutive patients with suspected opioid overdose was conducted in an urban out-of-hospital setting, comparing time intervals from arrival at the patient's side to development of a respiratory rate > or =10 breaths/min, and durations of bag-valve-mask ventilation.", "retries": 1}
{"idx": 29, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('XK' is equivalent to 'The mutation associated with McLeod syndrome is in the XK gene'). The supporting sentence provided by the model is relevant and covers the answer but repeats the same information twice, introducing slight redundancy. However, the logic is clear and directly supports the answer.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We report a novel mutation in the XK gene (XK) in a Japanese patient with McLeod syndrome.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.", "model_support": "The mutation associated with McLeod syndrome is in the XK gene. \n\n**Supporting sentence:** Molecular analysis revealed a single-base (T) deletion at the nucleotide position 1095 in XK. This deletion caused a frameshift in translation, leading to a premature stop codon at the amino acid position 408.", "retries": 1}
{"idx": 30, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about the construction of LepChorionDB, but it contains slight redundancy by mentioning the use of pHMMs, which is not necessary to directly support the answer. The gold supporting sentence is more concise while still covering the essential point.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for identifying chorion proteins in Lepidopteran proteomes is LepChorionDB.\n\nAnswer: LepChorionDB", "model_support": "**Answer:** LepChorionDB\n\n**Supporting Sentence:**  \n\"A database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.\"", "retries": 1}
{"idx": 31, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard (FSHD), and the supporting sentence is relevant and covers the answer. However, the supporting sentence provided by the model repeats the answer without adding much additional reasoning or context from the background information. It is slightly redundant compared to the more detailed gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is facio-scapulo-humeral dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the DUX4 protein is facio-scapulo-humeral dystrophy (FSHD). \n\n**Supporting Sentence:**  \n\"Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.\"", "retries": 1}
{"idx": 32, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation, but it includes slight redundancy by restating the answer within the reasoning. The gold supporting sentence is more concise while retaining all necessary information.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**. This conclusion is supported by the context, which discusses the biosynthesis of medicarpin and its accumulation in response to elicitation, indicating its role as a key phytoalexin.\n\n**Supporting Sentence:**\n\"Surprisingly, the isoflavone-O-methyltransferase (IOMT), which is induced along with other enzymes involved in medicarpin biosynthesis...\"", "retries": 1}
{"idx": 33, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model incorrectly states that there is no supporting sentence in the context, the gold supporting sentence provided directly confirms the answer with clear and concise reasoning. The model's error regarding the supporting sentence does not detract from the correctness of the answer itself.\", \"match\": true}", "gold_answer": "ibrutinib", "gold_support": "Furthermore, we demonstrate that the Bruton's tyrosine kinase inhibitor ibrutinib or the PI3K inhibitor idelalisib block B-cell receptor induced activation of LCP1.", "model_answer": "The name of the Bruton's tyrosine kinase inhibitor used for treating chronic lymphocytic leukemia is ibrutinib. \n\nAnswer: Ibrutinib", "model_support": "The context provided does not contain any information about Bruton's tyrosine kinase inhibitors or ibrutinib. It focuses on Lymphocyte cytosolic protein 1 (LCP1) and its role in chronic lymphocytic leukemia (CLL). Therefore, there is no supporting sentence within the given context for the answer regarding ibrutinib.\n\n**Answer:** The context does not provide information about Bruton's tyrosine kinase inhibitors or ibrutinib.", "retries": 1}
{"idx": 34, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes 'transient ischaemic attack (TIA)' which is not part of the gold answer, making it slightly less precise. The supporting sentence provides relevant information about the ROSIER scale but mixes in details about sensitivity and specificity, which are not necessary for directly supporting the answer. This makes the sentence somewhat lengthy and less focused compared to the concise gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "Answer: Stroke or transient ischaemic attack (TIA)", "model_support": "The supporting sentence from the context is:\n\n\"The ROSIER had a sensitivity of 83% (95% CI 78 to 87) and specificity of 44% (95% CI 34 to 53), and the FAST had a sensitivity of 81% (95% CI 76 to 86) and a specificity of 39% (95% CI 30 to 48).\"\n\nThis sentence provides the sensitivity and specificity of the ROSIER scale, indicating its use in diagnosing stroke or TIA.", "retries": 1}
{"idx": 35, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer correctly identifies hypothyroidism as a characteristic hormone abnormality in Pendred syndrome, which aligns with the gold standard concept of 'thyroid' dysfunction. The supporting sentence is relevant and provides additional context about impaired iodide transport affecting thyroid hormone production, consistent with external medical knowledge. However, it is slightly more detailed than necessary and introduces specifics (T4, T3) not explicitly required by the gold answer. This makes the response slightly redundant but still logically sound.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "The characteristic hormone abnormality in Pendred syndrome is hypothyroidism, specifically a deficiency in thyroid hormones such as thyroxine (T4) and triiodothyronine (T3).", "model_support": "The context discusses Pendred syndrome (PS) and mentions evaluations of the thyroid gland, including measuring thyroid hormones, iodine organification, and imaging techniques. However, it does not explicitly state that hypothyroidism is a characteristic feature. The answer provided is based on general medical knowledge that Pendred syndrome is associated with hypothyroidism, particularly due to mutations in the SLC26A4 gene, which affects iodide transport in the thyroid. Therefore, while the context does not directly support the answer, it is accurate based on external medical understanding.\n\nAnswer: The characteristic hormone abnormality in Pendred syndrome is hypothyroidism, specifically a deficiency in thyroid hormones such as thyroxine (T4) and triiodothyronine (T3).\n\nSupporting Sentence (Inferred from context and external knowledge): Pendred syndrome is associated with hypothyroidism due to impaired iodide transport in the thyroid gland, affecting the production of T4 and T3.", "retries": 1}
{"idx": 36, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by referencing the role of CNEs in development. Although it does not include all details from the gold supporting sentence, it succinctly captures the key point about CNEs regulating development.\", \"match\": true}", "gold_answer": "development", "gold_support": "Much evidence suggests that CNEs are selectively constrained and not mutational cold-spots, and there is evidence that some CNEs play a role in the regulation of development.", "model_answer": "The process that Conserved noncoding elements (CNEs) mostly regulate is development.", "model_support": "The process that Conserved noncoding elements (CNEs) mostly regulate is development. \n\nSupporting sentence: \"some of which have been implicated in the regulation of crucially important processes, including development.\"", "retries": 1}
{"idx": 37, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX') in meaning, as it specifies 'Na(+)/Ca(2+) exchanger (NCX),' which is correct. However, it is slightly more verbose than necessary. The supporting sentence provided by the model is relevant and establishes that SEA0400 prevents SNP effects mediated through NCX, but it introduces some redundancy when compared to the gold supporting sentence, which directly links SEA0400 to its role as an NCX inhibitor in a concise manner.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na(+)/Ca(2+) exchanger (NCX).", "model_support": "The small molecule SEA0400 is an inhibitor of the Na(+)/Ca(2+) exchanger (NCX). \n\n**Supporting sentence:** \"These effects of SNP were prevented by SEA0400.\" \n\nThis sentence indicates that SEA0400 prevents the effects of SNP, which are mediated through NCX, thereby establishing SEA0400 as an NCX inhibitor.", "retries": 1}
{"idx": 38, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence is somewhat lengthy and mixes relevant and irrelevant content. While it correctly references gender differences, it unnecessarily elaborates on aspects like erythrocyte sedimentation rates and treatment, which are not directly tied to the prevalence of RA in women. The logic is reasonable but could be more concise by focusing solely on the numerical evidence provided in the context (i.e., '312 women and 126 men').\",\n  \"match\": true\n}", "gold_answer": "women", "gold_support": "RESULTS: We studied 312 women and 126 men with early RA.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "The context provided discusses a study on early rheumatoid arthritis (RA) and its expression in men and women. While the study does not explicitly state that RA is more common in women, it does mention that women had a longer duration of follow-up and higher erythrocyte sedimentation rates (ESR) at onset. However, it concludes that gender does not significantly influence the expression of RA. \n\nThe answer that RA is more common in women is based on general medical knowledge, as RA is indeed more prevalent among women. However, the provided context does not include data on the prevalence of RA between genders, only on its expression and treatment differences.\n\n**Answer:** Rheumatoid Arthritis is more common in women.\n\n**Supporting Sentence:** The context does not explicitly state that RA is more common in women, but it discusses gender differences in disease expression, which is related to prevalence.", "retries": 1}
{"idx": 39, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, explaining p53's role in maintaining genomic stability, which aligns with the nickname 'guardian of the genome.' However, it includes a slightly redundant explanation about general knowledge and an indirect quote from the context, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The context does not explicitly refer to p53 as \"the guardian of the genome.\" However, based on general knowledge, p53 is known by this nickname due to its role in maintaining genomic stability. The supporting sentence from the context is:\n\n\"Wild-type p53 mediates imperative functions such as regulation of the cell cycle and programmed cell death.\"\n\nThis sentence highlights p53's critical role in genome maintenance, which is why it is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 40, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard ('Factor Xa' vs 'xa'), but the supporting sentence provided by the model does not directly support the answer. The chosen sentence discusses the general potential of new compounds without specifically mentioning betrixaban or its role as a Factor Xa inhibitor. While the logic connecting betrixaban to Factor Xa inhibition is present in the context, the supporting sentence selected is somewhat generic and lacks specificity.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "The clotting factor inhibited by betrixaban is Factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is: \"These new compounds have the potential to complement heparins and fondaparinux for short-term anticoagulation and/or to replace VKA for long-term anticoagulation in most patients.\"\n\nAnswer: Factor Xa", "retries": 1}
{"idx": 41, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard, as 'assessing patients with suspected acute stroke' inherently pertains to stroke. However, the supporting sentence discusses sensitivity and specificity values rather than directly stating that ROSIER is used for stroke assessment. While relevant, it introduces additional details that are not necessary for answering the question, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for assessing patients with suspected acute stroke.", "model_support": "The supporting sentence is:\n\n\"The ROSIER had a sensitivity of 83% (95% CI 78 to 87) and specificity of 44% (95% CI 34 to 53), and the FAST had a sensitivity of 81% (95% CI 76 to 86) and a specificity of 39% (95% CI 30 to 48).\"\n\nThis sentence indicates that the ROSIER scale is used to assess patients with suspected acute stroke by evaluating its sensitivity and specificity.", "retries": 1}
{"idx": 42, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly by identifying the correct ion exchanger (Na(+)/Ca(2+) exchanger). The supporting sentence provided in the gold standard is concise, directly relevant, and explicitly ties SEA0400 to being an inhibitor of the NCX, which fully supports the answer. Although the model's supporting sentence claims there is no mention of SEA0400, this appears to be an oversight since the context does indeed include a clear reference to SEA0400 as an NCX inhibitor.\", \"match\": true}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "Concerning the role of NCX in NO cytotoxicity, we have found, using the specific inhibitor of NCX 2-[4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline (SEA0400), that NCX is involved in NO-induced cytotoxicity in cultured microglia, astrocytes, and neuronal cells.", "model_answer": "The small molecule SEA0400 is an inhibitor of the sodium-calcium exchanger (NCX).", "model_support": "The context does not mention the small molecule SEA0400, so there is no supporting sentence to indicate that SEA0400 is an inhibitor of the sodium-calcium exchanger (NCX). \n\nAnswer: There is no supporting sentence in the context regarding SEA0400 as an inhibitor of the NCX, as SEA0400 is not mentioned.", "retries": 1}
{"idx": 43, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, albeit with a more detailed description of the disease. The supporting sentence provided by the model is identical to its answer and, while accurate, does not offer additional context or logical reasoning that directly ties DUX4's ectopic expression to FSHD as effectively as the gold supporting sentence. It lacks mention of the epigenetic repression and repeats contraction elements that are central to the disease mechanism. However, it is still relevant and covers the core relationship between DUX4 and FSHD.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).\n\n**Supporting sentence:**\n\"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"", "retries": 1}
{"idx": 44, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. While the model supporting sentence is slightly shorter than the gold supporting sentence, it still captures the essential point that EAE is widely used for understanding MS, making it an excellent match.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE), a widely recognized animal model of multiple sclerosis (MS), is highly useful for studying inflammation, demyelination, and neurodegeneration in the central nervous system (CNS).", "model_answer": "The most widely used model for the study of multiple sclerosis (MS) is Experimental Autoimmune Encephalomyelitis (EAE).", "model_support": "The supporting sentence from the context is:\n\n\"EAE is a particularly useful animal model for understanding both the mechanisms of immune-mediated CNS pathology and also the progressive clinical course of MS.\"\n\nThis sentence directly supports the answer that Experimental Autoimmune Encephalomyelitis (EAE) is the most widely used model for studying multiple sclerosis (MS).", "retries": 1}
{"idx": 45, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'factor Xa' is correct and matches the gold standard 'xa'. However, the supporting sentence provided by the model does not logically support the answer. It discusses clinical trials (EXPERT, EXPLORE-Xa, APEX) but does not mention that betrixaban is a direct factor Xa inhibitor, which is critical to supporting the answer. The gold supporting sentence directly states that betrixaban is a factor Xa inhibitor, making it more appropriate.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "Supporting sentence: Betrixaban was tested in Phase II studies in orthopedic thromboprophylaxis (EXPERT) and atrial fibrillation (EXPLORE-Xa), and is being evaluated in a Phase III trial of extended thromboprophylaxis in medical patients (APEX).", "retries": 1}
{"idx": 46, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer '1,4-benzothiazepine' is correct and matches the gold standard 'benzothiazepine' with only a minor difference in specificity (the addition of '1,4-'). The supporting sentence provided by the model is relevant and directly supports the answer, citing that JTV519 is a derivative of 1,4-benzothiazepine. However, it introduces slight redundancy by referencing an external context not provided in the current prompt, making it slightly verbose. Overall, the logic is strong, but the additional explanation reduces conciseness.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence for the answer that JTV519 is a derivative of 1,4-benzothiazepine is not present in the second context provided. The second context discusses S107 as a 1,4-benzothiazepine derivative, not JTV519. Therefore, the supporting sentence is not available in the given context. However, in the first context, the supporting sentence was:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"\n\nThis sentence clearly states that JTV519 is a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 47, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically by linking FANCA to the SWI/SNF complex and specifying BRG1 as the interacting subunit.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1.\n\nAnswer: BRG1", "model_support": "The supporting sentence from the context is:\n\n\"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"\n\nThis indicates that FANCA interacts with the SWI/SNF complex, of which BRG1 is a subunit.", "retries": 1}
{"idx": 48, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and clearly explains that [18F]altanserin is used to evaluate 5-HT2A receptors, aligning well with the gold supporting sentence. There is no excessive content or redundancy.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors evaluated with [18F]altanserin are the 5-HT2A receptors. \n\nAnswer: 5-HT2A receptors", "model_support": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors. \n\n**Supporting sentence:**  \n\"Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.\"", "retries": 1}
{"idx": 49, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model acknowledges that no direct context was given to link LY450139 to Semagacestat, which aligns with the instructions since the actual gold supporting sentence comes directly from the context provided here. Therefore, the model correctly identifies the lack of explicit support within the stated context.\", \"match\": true}", "gold_answer": "Semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "The investigational name LY450139 refers to the drug Semagacestat.\n\nAnswer: Semagacestat", "model_support": "The context provided does not include information linking LY450139 to Semagacestat. Therefore, the supporting sentence is not present in the given context. \n\nAnswer: The supporting sentence is not available in the provided context.", "retries": 1}
{"idx": 50, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa') in meaning, though it is slightly more verbose by specifying 'factor Xa'. The supporting sentence provides relevant information and logically supports the answer by referencing the factor Xa decoy used with betrixaban. However, it is somewhat indirect and less concise compared to the gold supporting sentence, which directly states that betrixaban is a factor Xa inhibitor.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence indicates that betrixaban inhibits factor Xa, as it is being used alongside a factor Xa decoy.", "retries": 1}
{"idx": 51, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and matches the gold standard ('xa'), but the supporting sentence is somewhat misleading. It references indirect factor Xa inhibitors (e.g., fondaparinux), while betrixaban is actually a direct factor Xa inhibitor as per the gold supporting sentence. The logic connecting betrixaban to factor Xa inhibition is present but could be more precise by directly mentioning the correct category of factor Xa inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context that implies betrixaban inhibits factor Xa is:\n\n\"Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux.\"\n\nAlthough betrixaban is not explicitly mentioned, it is inferred that as an indirect factor Xa inhibitor, it targets factor Xa.", "retries": 1}
{"idx": 52, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides evidence that the antibody targets alpha-synuclein, but it contains slight redundancy by mentioning phosphorylated alpha-synuclein, which is not necessary for directly supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The supporting sentence is:  \n\"The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals...\"\n\nThis sentence indicates that the antibody used for immunostaining targets alpha-synuclein.", "retries": 1}
{"idx": 53, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The correct gene is 'aryl hydrocarbon receptor interacting protein,' but the model incorrectly identifies 'GPR101.' The supporting sentence acknowledges that the context does not mention GPR101, which is accurate, but it still fails to connect to the correct gene from the context. While the model recognizes its lack of support from the text, it provides an incorrect answer and no relevant supporting evidence for the gold answer.\",\n  \"match\": false\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "The mutation implicated in familial isolated pituitary adenoma (FIPA) is in the GPR101 gene.", "model_support": "The context does not explicitly mention the GPR101 gene or familial isolated pituitary adenoma (FIPA). However, based on general medical knowledge, mutations in the GPR101 gene are associated with FIPA. Since the context does not provide a supporting sentence for this information, it cannot be directly quoted from the given text. \n\n**Answer:** The mutation implicated in familial isolated pituitary adenoma (FIPA) is in the GPR101 gene. However, the context does not provide a supporting sentence for this information.", "retries": 1}
{"idx": 54, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('interleukin-5'). However, the supporting sentence chosen is not optimal. While it provides some context about eosinophilic inflammation, it does not directly mention Mepolizumab or its specific target, interleukin-5. The logic connecting the inflammation to IL-5 is reasonable but could be clearer and more concise by using the explicit sentence from the context that directly states Mepolizumab targets IL-5. The supporting sentence is somewhat indirect and mixes general background with relevant information.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or a 100-mg subcutaneous dose, or placebo every 4 weeks for 32 weeks.", "model_answer": "Mepolizumab targets Interleukin-5 (IL-5), a cytokine crucial for eosinophil function.", "model_support": "The supporting sentence from the context that implies Mepolizumab targets Interleukin-5 (IL-5) is:\n\n\"Some patients with severe asthma have frequent exacerbations associated with persistent eosinophilic inflammation despite continuous treatment with high-dose inhaled glucocorticoids with or without oral glucocorticoids.\"\n\nThis sentence highlights the presence of eosinophilic inflammation, which is managed by IL-5, leading to the inference that Mepolizumab targets IL-5.", "retries": 1}
{"idx": 55, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence mentions the five N-terminal isoforms, including TAp73, but does not provide evidence for the existence of seven TAp73 isoforms specifically. The logic used to derive '2' is unclear and likely incorrect, while the supporting sentence includes relevant information yet fails to cover the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is 2.", "model_support": "The context provided lists five N-terminal isoforms, including TAp73. Based on the information given, TAp73 is mentioned as one of the isoforms. However, the answer provided by the user states that there are two TAp73 isoforms identified in humans. The supporting sentence from the context is:\n\n\"the expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR\"\n\nThis sentence lists TAp73 as one of the five isoforms measured in the study. The answer indicating two TAp73 isoforms may be based on external knowledge not provided in the context.", "retries": 1}
{"idx": 56, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'), though it adds 'template' in parentheses, which is still correct but slightly redundant. The supporting sentence is relevant and supports the answer by connecting UV-induced repair to transcription-coupled repair; however, it does not explicitly mention the 'transcribed strand,' making it less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "Transcription-coupled repair (TCR) targets the transcribed (template) strand of the gene.", "model_support": "The supporting sentence from the context is:\n\n\"UV-enhanced reactivation of a UV-damaged reporter gene suggests transcription-coupled repair is UV-inducible in human cells.\"\n\nThis sentence supports the conclusion that transcription-coupled repair (TCR) targets the transcribed (template) strand of the gene, as it highlights the role of TCR in repairing UV-damaged genes during transcription.", "retries": 1}
{"idx": 57, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK'), but it is slightly more verbose by specifying 'the XK gene' instead of just 'XK'. The supporting sentence provided by the model is relevant and covers the answer correctly, though it repeats the same information in a less concise manner compared to the gold supporting sentence. The model supporting sentence does not provide additional reasoning or context that the gold supporting sentence offers (e.g., details about the absence of XK protein and hematological characteristics). Overall, the logic is sound, but there is some redundancy.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.", "model_support": "The mutation associated with McLeod syndrome is the XK gene. \n\nSupporting sentence: \"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\"", "retries": 1}
{"idx": 58, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but lacks specificity and does not fully cover the gold supporting sentence's detailed explanation of PBT2 being tested in a Phase IIa clinical trial for Alzheimer's disease. It is slightly too general and misses key details about the drug's mechanism and trial context.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "PBT2 has been tested for Alzheimer's disease.", "model_support": "Supporting sentence: Drug development based on the metals hypothesis of Alzheimer's disease.", "retries": 1}
{"idx": 59, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically supports the answer by specifying that [18F]altanserin evaluates 5-HT2A receptors. Minor extra details in the context do not detract from the strong logical connection.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are 5-HT2A receptors. \n\nAnswer: 5-HT2A receptors", "model_support": "The receptors that can be evaluated with [18F]altanserin are 5-HT2A receptors.\n\n**Supporting sentence:**  \n\"In cortical brain regions with a high density of 5-HT2A receptors, the outcome parameter (binding potential, BP1) showed high reproducibility...\"", "retries": 1}
{"idx": 60, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard with a slightly more detailed explanation of PCSK9's function, which is acceptable. The supporting sentence provided by the model is relevant but does not directly cover the gold answer as it focuses on clinical trial outcomes rather than the mechanism of Evolocumab's action on PCSK9. The gold supporting sentence provides a clearer connection to the enzyme being targeted.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab and alirocumab are fully human monoclonal antibodies inhibiting the proprotein convertase subtilisin/kexin type 9 (PCSK9) that binds to hepatic LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "Evolocumab targets the enzyme Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9). By inhibiting PCSK9, Evolocumab prevents the enzyme from binding to LDL receptors, thereby increasing the number of LDL receptors available to remove LDL cholesterol from the blood, effectively lowering LDL levels.", "model_support": "The enzyme targeted by Evolocumab is **Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)**.\n\n**Supporting sentence:**  \n\"Phase II (for evolocumab and alirocumab) and III (for evolocumab) trials show that PCSK9 inhibitors are equally well tolerated, with adverse events mainly limited to mild-to-moderate nasopharyngitis, injection-site pain, arthralgia and back pain.\"", "retries": 1}
{"idx": 61, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions iron deficiency, which is relevant and present in the context, but it does not exactly match the gold standard 'iron'. The supporting sentence provided by the model incorrectly states that there is no supporting sentence in the context, while the gold supporting sentence shows that the context indeed mentions iron deficiency. Thus, the supporting sentence fails to cover the gold answer.\", \"match\": false}", "gold_answer": "iron", "gold_support": "The syndrome is increasingly often diagnosed, particularly in association with iron deficiency, during pregnancy, in chronic renal failure and in patients with peripheral neuropathy.", "model_answer": "The deficiency associated with restless leg syndrome is iron deficiency.", "model_support": "The context does not provide a supporting sentence for the answer regarding iron deficiency as the cause of restless leg syndrome. The provided information discusses symptoms, treatments, and mentions that the cause is unknown but sometimes familial. It does not reference any deficiencies, including iron deficiency. \n\nAnswer: The context does not mention iron deficiency as a cause of restless leg syndrome. Therefore, no supporting sentence is available from the given context.", "retries": 1}
{"idx": 62, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('stroke') in meaning, though it is more detailed. The supporting sentence is relevant and directly supports the answer by emphasizing the effectiveness of the ROSIER scale in differentiating stroke from mimics, but it includes slightly more detail than necessary for a concise explanation.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for identifying acute stroke in the emergency room by differentiating it from stroke mimics.", "model_support": "The supporting sentence from the context is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 63, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'BCR-ABL' matches the gold standard 'Bcr-Abl' with a minor formatting difference, which is acceptable. The supporting sentence provided by the model is relevant but contains redundancy and does not directly state the link between the Philadelphia chromosome and Bcr-Abl as clearly as the gold supporting sentence. It discusses disease persistence and resistance, which is tangential to the specific question about Imatinib's target. However, it still supports the idea of tyrosine kinase inhibitors targeting BCR-ABL in CML.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) arises as a consequence of a chromosomal translocation giving rise to the Philadelphia chromosome and Bcr-Abl oncogene.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The supporting sentence is: \"However, the success of tyrosine kinase inhibitors, as rationally designed first-line therapies, has been tempered by problems of disease persistence and resistance.\" This sentence implies the use of tyrosine kinase inhibitors, such as Imatinib, targeting the BCR-ABL kinase in CML.", "retries": 1}
{"idx": 64, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer 'BCR-ABL tyrosine kinase' is very close to the gold standard 'BCR-ABL,' with only minor additional wording ('tyrosine kinase') that does not detract from correctness. The supporting sentence, however, discusses the introduction and impact of imatinib but does not directly mention the Philadelphia chromosome or BCR-ABL1 fusion gene as the specific target, making it less precise than the gold supporting sentence. It contains relevant information but has slight redundancy and lacks direct logical coverage of the gold answer.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) originates from a hematopoietic stem cell carrying the Philadelphia (Ph) chromosome and oncogenic BCR-ABL1 fusion gene.", "model_answer": "The target of Imatinib (Gleevec) is the BCR-ABL tyrosine kinase.\n\nAnswer: BCR-ABL tyrosine kinase", "model_support": "Supporting sentence: The first tyrosine-kinase inhibitor (TKI) imatinib was introduced to clinical practice 10 years ago, and it radically improved the outcome of CML patients.", "retries": 1}
{"idx": 65, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by including 'factor'. The supporting sentence provides relevant information but includes additional details about a factor Xa decoy and reversal agents, which are not necessary to directly support the answer. This makes the supporting sentence somewhat redundant, though it still logically implies that betrixaban inhibits factor Xa.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" This implies that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 66, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise and directly relevant, clearly stating that BACH1 is a repressor. Although the additional sentence provided in the evaluation contrasts BACH1 with Nrf2, it does not detract from the clarity or correctness of the model's own supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1, one of the most inducible phase 2 proteins.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor. \n\n**Supporting Sentence:**  \n\"On the other hand, the transactivator Nrf2 binds and up-regulates the ARE-governed gene expression.\" This sentence contrasts BACH1's role as a repressor with Nrf2's role as an activator.", "retries": 1}
{"idx": 67, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning. Although it repeats the answer itself, this does not detract from its relevance or correctness.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\nSupporting sentence: The amyloidogenic fragment 61-95 amino acids of alpha-synuclein is the non-Abeta component of senile plaque amyloid in Alzheimer disease.", "retries": 1}
{"idx": 68, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('ticks') is correct in general but does not match the gold standard ('Ixodes ricinus'), which provides the specific species of the vector. The supporting sentence mentions that Louping ill virus is tick-borne, which is relevant but does not specify the exact vector species (Ixodes ricinus) as required by the gold answer. Therefore, while the answer is present in the context, it lacks the specificity needed and the supporting sentence does not fully cover the gold answer.\", \"match\": false}", "gold_answer": "Ixodes ricinus", "gold_support": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.", "model_answer": "The vector of Louping ill virus is ticks.", "model_support": "The supporting sentence from the context that identifies ticks as the vector of Louping ill virus is:\n\n**\"We used Susceptible Infected Recovered (SIR) models parameterized for the tick-borne louping ill virus (LIV) system.\"**\n\nThis sentence explicitly states that Louping ill virus is tick-borne, confirming ticks as the vector.", "retries": 1}
{"idx": 69, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on the exclusion of APOBEC3B from chromatin during mitosis rather than its nuclear localization after mitosis.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "The APOBEC3B protein is predominantly cytoplasmic, as it is excluded from chromatin throughout mitosis, indicating it does not localize to the nucleus.\n\n**Supporting Sentence:**\n\"APOBEC3B, APOBEC3D, APOBEC3F and APOBEC3G are excluded from chromatin throughout mitosis.\"", "retries": 1}
{"idx": 70, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate, but it does not directly quote the key information from the context that explicitly states 'anti-interleukin-5 monoclonal antibody,' which would have made it more precise. Instead, it indirectly supports the answer by discussing the targeting of eosinophils, which is a downstream effect of IL-5 inhibition. Slight redundancy exists in mentioning the study without directly focusing on the molecule.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "We conducted an international, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of an anti-interleukin-5 monoclonal antibody, mepolizumab, in patients with the hypereosinophilic syndrome.", "model_answer": "Mepolizumab targets interleukin-5 (IL-5). \n\nAnswer: Interleukin-5 (IL-5)", "model_support": "The molecule targeted by Mepolizumab is interleukin-5 (IL-5). \n\nSupporting sentence: \"Our study shows that treatment with mepolizumab, an agent designed to target eosinophils, can result in corticosteroid-sparing for patients negative for FIP1L1-PDGFRA who have the hypereosinophilic syndrome.\"", "retries": 1}
{"idx": 71, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "methyl-CpG-binding protein 2 (Mecp2)", "gold_support": "The last decade has seen the identification of the disease-causing gene, methyl-CpG-binding protein 2 (Mecp2) and the development of mouse models that phenocopy many aspects of the human syndrome, including breathing dysfunction.", "model_answer": "The methyl-CpG-binding protein associated with Rett syndrome when mutated is **MeCP2**.", "model_support": "Supporting sentence: \"Recent studies have begun to characterize the breathing phenotype of Mecp2 mutant mice...\"", "retries": 1}
{"idx": 72, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is a direct repetition of the answer, which lacks additional context or reasoning. The gold supporting sentence offers more detailed and logical information about why dermatitis herpetiformis is associated with gluten sensitivity. Despite this, the model's supporting sentence is still relevant and aligns with the gold answer.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "The typical rash associated with gluten sensitivity is dermatitis herpetiformis.", "model_support": "The typical rash associated with gluten sensitivity is dermatitis herpetiformis.\n\nSupporting sentence: \"Dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.\"", "retries": 1}
{"idx": 73, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides correct information about flumazenil's use in benzodiazepine overdose, but it includes additional details about continuous infusion that are not strictly necessary to support the answer, making it slightly more verbose than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "Flumazenil is the drug used as an antidote in benzodiazepine overdose.", "model_support": "Supporting sentence: Bolus doses of flumazenil are usually adequate to achieve reversal; however, when medical conditions may lead to a prolonged half-life of the benzodiazepine involved, continuous infusion may be warranted.", "retries": 1}
{"idx": 74, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes extra details ('and transient ischaemic attack (TIA)') that are not part of the gold answer. The supporting sentence is somewhat lengthy and mixes relevant content with additional context, such as mentioning sensitivity and specificity, which are not directly necessary for supporting the answer. However, it still logically connects the ROSIER scale to stroke identification.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for the identification and diagnosis of stroke and transient ischaemic attack (TIA) in emergency department settings.", "model_support": "The supporting sentence that indicates the ROSIER scale is used for identifying and diagnosing stroke and TIA is:\n\n\"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"\n\nThis sentence directly links the ROSIER scale to its application in diagnosing stroke in emergency settings.", "retries": 1}
{"idx": 75, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, correctly identifying 'PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9)' as the enzyme targeted by Evolocumab. The supporting sentence provides relevant information and explains the mechanism of action of Evolocumab, but it contains slight redundancy by repeating the answer within the supporting sentence itself. Additionally, while the context explicitly mentions PCSK9, the model incorrectly states that the context does not mention it, which slightly weakens the clarity of reasoning.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "BACKGROUND: Evolocumab, a monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), significantly reduced low-density lipoprotein (LDL) cholesterol levels in phase 2 studies.", "model_answer": "The enzyme targeted by Evolocumab is PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9).", "model_support": "The enzyme targeted by Evolocumab is PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9). This conclusion is based on the understanding of Evolocumab's mechanism of action, which involves inhibiting PCSK9 to reduce LDL cholesterol levels, even though the context does not explicitly mention PCSK9.\n\nSupporting sentence: The context does not explicitly mention PCSK9, but based on known pharmacological information, Evolocumab is a PCSK9 inhibitor.", "retries": 1}
{"idx": 76, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant, does not directly explain why dermatitis herpetiformis is the correct answer. It mentions the distinction between LAD and dermatitis herpetiformis but lacks the explicit reasoning about gluten dependency found in the gold supporting sentence.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "This contrasts to the situation in dermatitis herpetiformis, where both the rash and the enteropathy are gluten dependent.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "Supporting sentence: These data add further to the evidence that LAD and dermatitis herpetiformis are separate entities.", "retries": 1}
{"idx": 77, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"\n\nThis sentence explicitly states that JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.", "retries": 1}
{"idx": 78, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by discussing DNMT1-mediated maintenance DNA methylation, but it contains slight redundancy compared to the gold supporting sentence, which directly highlights DNMT1's role as the 'major maintenance DNA methyltransferase.'\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DNMT1, the major maintenance DNA methyltransferase in animals, helps to regulate gene expression, genome imprinting, and X-chromosome inactivation.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is **DNMT1**.", "model_support": "Supporting sentence: Structural and biochemical data establish how a combination of active and autoinhibitory mechanisms ensures the high fidelity of DNMT1-mediated maintenance DNA methylation.", "retries": 1}
{"idx": 79, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Dnmt1'), though it includes the full name 'DNA methyltransferase 1 (Dnmt1)', which is acceptable but slightly more verbose than necessary. The supporting sentence is relevant and covers the answer, but does not directly quote the most concise and direct evidence from the context ('DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining the methylation marks through cell division'). Instead, it refers to manipulation of Dnmt1, which is indirectly related but less precise.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining the methylation marks through cell division.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (Dnmt1).\n\nAnswer: DNA methyltransferase 1 (Dnmt1)", "model_support": "The supporting sentence from the context is: \"Manipulation of these enzymes, especially Dnmt1, provides a means to alter DNA methylation levels.\" This indicates that Dnmt1 is involved in the maintenance of DNA methylation.\n\n**Answer:** DNA methyltransferase 1 (Dnmt1) is the enzyme involved in the maintenance of DNA (cytosine-5-)-methylation.", "retries": 1}
{"idx": 80, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context for medicarpin being the major phytoalexin in alfalfa, but it contains slight redundancy by discussing the methylation process in more detail than necessary. The gold supporting sentence is more concise while still covering the essential information.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence that identifies medicarpin as the major phytoalexin in alfalfa is:\n\n\"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\"\n\nThis sentence indicates that medicarpin is a significant compound in alfalfa, synthesized through the methylation process, aligning with its role as a phytoalexin.", "retries": 1}
{"idx": 81, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'BCR-ABL protein' is correct and aligns with the gold standard 'bcr-abl', though it uses a slightly different but equivalent term. The supporting sentence highlights Imatinib's effectiveness in achieving complete cytogenetic response (CCR), which indirectly supports the targeting of BCR-ABL. However, it does not explicitly mention BCR-ABL or its role as the target of Imatinib, making it less direct compared to the gold supporting sentence. The logic is sound, but there is slight redundancy in discussing CCR without explicitly linking it to BCR-ABL.\", \"match\": true}", "gold_answer": "bcr-abl", "gold_support": "Imatinib mesylate (Glivec) is a selective inhibitor of bcr-abl tyrosine kinase, the product of the Philadelphia chromosome, which is the hallmark of chronic myeloid leukaemia (CML).", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL protein.", "model_support": "The supporting sentence from the context that identifies the BCR-ABL protein as the target of Imatinib (Gleevec) is:\n\n\"With imatinib, complete cytogenetic response (CCR) can be achieved in over 70% of newly diagnosed patients with CML.\"\n\nThis sentence highlights the effectiveness of Imatinib in achieving CCR, which is linked to its targeting of the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 82, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' being shorthand for 'factor Xa'). The supporting sentence in the model is incorrect as it states there is no supporting sentence in the context, while the gold supporting sentence provides accurate information that directly supports the answer. However, the model's answer itself is correct and aligns with the gold answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban, so there is no supporting sentence for the claim that betrixaban inhibits factor Xa. The context only discusses apixaban and rivaroxaban as examples of factor Xa inhibitors.", "retries": 1}
{"idx": 83, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Na+/Ca2+ exchanger (NCX1),' is very close to the gold standard 'NCX,' as NCX1 is a specific isoform of the Na+/Ca2+ exchanger (NCX). The supporting sentence provided is relevant and demonstrates the functional role of SEA0400 in reducing retinal damage, indirectly supporting its action on the NCX. However, it does not explicitly mention that SEA0400 is a selective NCX inhibitor, which would have made the reasoning more direct and aligned with the gold supporting sentence. Thus, while accurate, the supporting sentence could be more precise.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca2+ exchanger NCX1.\n\nAnswer: Na+/Ca2+ exchanger (NCX1)", "model_support": "Supporting sentence: SEA0400 at 3 and 10 mg/kg significantly reduced NMDA- or high intraocular pressure-induced retinal cell damage in mice.", "retries": 1}
{"idx": 84, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and provides clear reasoning by linking [18F]altanserin to the evaluation of 5-HT2A receptors. Although it references additional details (pig cortex and cerebellum), this does not detract from the strong logical connection to the gold answer.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Imaging the cerebral serotonin 2A (5-HT2A ) receptors with positron emission tomography (PET) has been carried out in humans with [(11) C]MDL 100907 and [(18) F]altanserin.", "model_answer": "The [18F]altanserin can be used to evaluate the 5-HT2A receptors. \n\nAnswer: 5-HT2A receptors", "model_support": "The supporting sentence from the context is:\n\n\"5-HT2A receptor binding in pig cortex and cerebellum was investigated by autoradiography with [(3) H]MDL 100907, [(18) F]MH.MZ, and [(18) F]altanserin.\"\n\nThis sentence indicates that [18F]altanserin, along with [(18) F]MH.MZ, was used to evaluate 5-HT2A receptor binding in pig cortex and cerebellum.", "retries": 1}
{"idx": 85, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa') in essence, as 'factor Xa' is a direct and accurate expansion of the abbreviation. The supporting sentence provides relevant information about factor Xa inhibitors and correctly places betrixaban within this class. However, it includes slight redundancy by mentioning general knowledge not directly provided in the context, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context discusses direct factor Xa inhibitors, a class of drugs used for stroke prevention in atrial fibrillation. While betrixaban is not explicitly mentioned, it is known to belong to this class. Therefore, based on the context and general knowledge, betrixaban inhibits factor Xa.\n\n**Answer:** Betrixaban inhibits factor Xa.  \n**Supporting Statement:** \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...\"", "retries": 1}
{"idx": 86, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically. The model's supporting sentence clearly identifies Gevokizumab as an IL-1β-neutralizing antibody, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "The drug Gevokizumab targets interleukin-1 beta (IL-1β).\n\nAnswer: Interleukin-1 beta (IL-1β)", "model_support": "The supporting sentence from the context is: \"This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.\" \n\nThis sentence confirms that Gevokizumab targets interleukin-1 beta (IL-1β), as it is described as an IL-1β-neutralizing antibody.", "retries": 1}
{"idx": 87, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking NF1 to neurofibromatosis type 1, but it does not explicitly mention the mutation or deletion aspect as clearly as the gold supporting sentence. It focuses more on association rather than directly addressing the genetic cause of the disease, leading to slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis 1 gene (NF1 ) fulfills the criteria of a tumor suppressor gene and is deleted or mutated heterozygously in patients with NF1.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.\n\nAnswer: The NF1 gene.", "model_support": "The supporting sentence from the context is:\n\n\"Neurofibromatosis type 1 (NF1) is strongly associated with the development of pilocytic astrocytoma (PA), frequently appearing as optic glioma.\"\n\nThis sentence indicates that NF1 is the gene involved in neurofibromatosis type 1, confirming that the NF1 gene is the one mutated in this condition.", "retries": 1}
{"idx": 88, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct but slightly more detailed than the gold standard ('Stroke'), which reduces conciseness. The supporting sentence provides relevant information and logically supports the answer, though it indirectly references the context of stroke identification rather than explicitly stating the ROSIER scale's use for diagnosing stroke. It contains minor redundancy by mentioning 'suspected stroke' instead of directly aligning with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for identifying stroke or transient ischaemic attack (TIA) in emergency settings.", "model_support": "The sentence that supports the answer is:\n\n\"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"\n\nThis sentence indicates that the study aims to evaluate scales like ROSIER for diagnosing stroke or TIA, thus linking ROSIER to its use in identifying these conditions in emergency settings.", "retries": 1}
{"idx": 89, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('naloxone') in meaning, though it is slightly more verbose by including 'should be administered.' The supporting sentence provides relevant information and logically supports the answer, but it contains slight redundancy by elaborating on how naloxone was administered in both routes. The gold supporting sentence is more concise while still being sufficient.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "Naloxone should be administered when managing patients with suspected acute opioid overdose.", "model_support": "The supporting sentence from the context that indicates which medication should be administered when managing patients with suspected acute opioid overdose is:\n\n\"Naloxone was administered either i.v. (n = 74) or s.q. (n = 122), for respiratory depression of <10 breaths/min.\"\n\nThis sentence clearly states that naloxone is the medication used in both administration routes to manage respiratory depression caused by opioid overdose.", "retries": 1}
{"idx": 90, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'XIST RNA' is very close to the gold standard 'XIST', though it includes 'RNA', which is not explicitly required in the gold answer. The supporting sentence provided by the model is incorrect because it states that there is no supporting sentence in the context, while the gold supporting sentence directly references XIST and its role in X-inactivation. Despite this, the logic connecting XIST to the process is strong and accurate based on general knowledge, hence a score of 4.\", \"match\": true}", "gold_answer": "XIST", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "The transcript responsible for X-chromosome inactivation is XIST RNA.", "model_support": "The context does not explicitly mention XIST RNA as the transcript responsible for X-chromosome inactivation. Therefore, there is no supporting sentence within the provided context for the answer that XIST RNA is responsible for X-chromosome inactivation.\n\n**Answer:**  \nThe context does not provide a supporting sentence for the claim that XIST RNA is the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 91, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SECIS') in essence, though it includes an additional descriptor ('The stem-loop structure present in the 3' end of genes encoding for selenoproteins is called'). The supporting sentence provides relevant context and confirms the presence of the SECIS element as a stem-loop structure in the 3'UTR. However, it introduces slight redundancy by discussing alternative splicing and variant transcripts, which are not necessary to directly support the answer. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Cotranslational incorporation of Sec into SelS depends on the recoding of the UGA codon, which requires a Selenocysteine Insertion Sequence (SECIS) element in the 3'UTR of the transcript.", "model_answer": "The stem-loop structure present in the 3' end of genes encoding for selenoproteins is called the SECIS element.", "model_support": "The supporting sentence is:  \n\"The human SelS gene encodes two transcripts (variants 1 and 2), which differ in their 3'UTR sequences due to an alternative splicing event that removes the SECIS element from the variant 1 transcript.\"  \n\nThis sentence confirms that the SECIS element is a stem-loop structure present in the 3'UTR of genes encoding selenoproteins, specifically in the case of the SelS gene.", "retries": 1}
{"idx": 92, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "The enzyme inhibited by Orteronel is CYP17A1.", "model_support": "The enzyme inhibited by Orteronel is **CYP17A1**.\n\n**Supporting sentence:**  \n\"In summary, orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity, suggesting that orteronel might be effective for hormone-dependent breast cancers and estrogen-dependent diseases.\"", "retries": 1}
{"idx": 93, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate, but it is slightly less comprehensive than the gold supporting sentence. While it correctly mentions alpha-synuclein immunoreactivity, it refers to rare neuronal soma rather than directly referencing Lewy bodies or dystrophic neurites as in the gold sentence. This makes it somewhat less ideal despite being correct.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein. \n\n**Supporting sentence:** \"Rare neuronal soma in PD brain were immunoreactive for alpha-synuclein.\"", "retries": 1}
{"idx": 94, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('BCR-ABL') in identifying the tyrosine kinase targeted by Imatinib. However, the supporting sentence is missing from the provided context, and while the model correctly explains the role of BCR-ABL and Imatinib based on general knowledge, this information is not explicitly present in the given text. The gold supporting sentence directly references the relevant sentence from the context, which the model failed to utilize. Thus, there is slight redundancy in the explanation without leveraging the concise supporting evidence available.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib mesylate is a tyrosine kinase inhibitor with high affinity for the BCR-ABL fusion protein expressed by the hematopoietic cells in chronic myelogenous leukemia (CML).", "model_answer": "Imatinib targets the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia. This kinase is responsible for the uncontrolled cell growth seen in the disease, and Imatinib inhibits its activity to treat the condition.", "model_support": "The supporting sentence for the answer is not present in the provided context. The context discusses the use of Imatinib in treating CML but does not explicitly mention that it targets the BCR-ABL tyrosine kinase. The answer is accurate based on general knowledge, but the context does not include the specific information about the kinase target.\n\n**Answer:** The supporting sentence is not present in the context provided. However, it is established that Imatinib targets the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 95, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning imaging features that help determine underlying celiac disease, which is not directly necessary to support the answer. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "celiac disease", "gold_support": "Retrospective chart review was performed to detect associated disease processes, such as celiac disease.", "model_answer": "Small bowel lymphoma is commonly associated with celiac disease.", "model_support": "The supporting sentence from the context is:\n\n\"identifying a number of key features that may help the interpreting radiologist in suggesting the underlying histologic subtype and whether the presence of underlying celiac disease is likely.\"\n\nThis sentence indicates that small bowel lymphoma is associated with celiac disease, as it suggests that imaging features can help determine the likelihood of underlying celiac disease.", "retries": 1}
{"idx": 96, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK') in essence by correctly identifying the XK gene, though it is slightly more verbose. The supporting sentence provided by the model is relevant and discusses phenotypic variability associated with the deletion in the XK gene, but it does not directly mention the specific deletion or provide as clear a connection to the genetic mutation as the gold supporting sentence does. Thus, while logical and related, it contains some redundancy and lacks precision compared to the ideal gold support.\", \"match\": true}", "gold_answer": "XK", "gold_support": "Molecular genetic analysis revealed a small deletion in the XK gene (938-942delCTCTA), which has been already described in a North American patient of Anglo-Saxon descent and a Japanese family, presenting with seizures, muscle atrophy or chorea yet absence of psychiatric features.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.\n\nAnswer: The XK gene mutation is associated with McLeod syndrome.", "model_support": "Supporting sentence: These findings argue against a founder effect and indicate a profound phenotypic variability associated with the 938-942delCTCTA deletion.\n\nAnswer: The mutation associated with McLeod syndrome is in the XK gene.", "retries": 1}
{"idx": 97, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to mention the seven TAp73 isoforms and instead focuses only on the five N-terminal isoforms, leading to an incorrect conclusion.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context identifies five N-terminal isoforms of p73, including TAp73. Specifically, TAp73 is listed as one distinct isoform among the five. Therefore, only one TAp73 isoform has been identified in humans based on the provided information.\n\nAnswer: 1", "model_support": "The context identifies five N-terminal isoforms of p73, including TAp73. Specifically, TAp73 is listed as one distinct isoform among the five. Therefore, only one TAp73 isoform has been identified in humans based on the provided information.\n\nAnswer: 1\n\nSupporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "retries": 1}
{"idx": 98, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that ZFHX1B mutations are responsible for Mowat-Wilson syndrome, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B.", "model_support": "Supporting sentence: Nonsense mutations of the ZFHX1B gene in two Japanese girls with Mowat-Wilson syndrome.", "retries": 1}
{"idx": 99, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Na+/Ca²⁺ exchanger (NCX1),' is very close to the gold standard 'NCX,' but it specifies the isoform NCX1 rather than the general term NCX. The supporting sentence provided by the model is relevant and supports the idea that SEA0400 inhibits NCX1, but it focuses on the reduction of retinal damage without directly mentioning that SEA0400 is a selective NCX inhibitor, which would have made it more precise. Therefore, while accurate, it contains slight redundancy and lacks full alignment with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca²⁺ exchanger, specifically NCX1.\n\nAnswer: Na+/Ca²⁺ exchanger (NCX1)", "model_support": "The supporting sentence is: \"SEA0400 at 3 and 10 mg/kg significantly reduced NMDA- or high intraocular pressure-induced retinal cell damage in mice.\" This indicates that SEA0400 reduces cell damage associated with NCX1 activity, suggesting it inhibits NCX1.", "retries": 1}
{"idx": 100, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'). The supporting sentence is relevant and aligns with the gold supporting sentence, but it is slightly less detailed compared to the gold version. While it captures the essence of TCR targeting the transcribed strand, it omits mention of GGR for contrast, which makes it less comprehensive than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) acts solely on the transcribed strand of expressed genes, while global genomic repair (GGR) is responsible for the ubiquitous repair of the genome.", "model_answer": "The gene strand targeted by Transcription-Coupled Repair (TCR) is the transcribed strand. TCR is responsible for maintaining the integrity of the transcribed strands of genes, ensuring that any lesions or damage on these strands are repaired efficiently to prevent interference with transcription and potential mutations.", "model_support": "The supporting sentence from the context is:\n\n\"TCR, responsible for maintenance of transcribed strands.\"", "retries": 1}
{"idx": 101, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate and aligns with the gold standard, specifying the serotonin 5-HT2A receptor. However, the supporting sentence, while relevant, includes information about test-retest variability and development of the radiotracer, which is not directly necessary to support the specific answer about the 5-HT2A receptor. The supporting sentence could be more concise to focus solely on the correlation between [18F]altanserin binding and 5-HT2A receptors.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the serotonin 5-HT2A receptors.", "model_support": "The supporting sentence is:\n\n\"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"", "retries": 1}
{"idx": 102, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'acute stroke' is slightly more specific than the gold standard 'stroke,' but it still matches the intended meaning. The supporting sentence is relevant and supports the answer well, though it paraphrases rather than directly quoting the gold supporting sentence, making it slightly less concise.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for acute stroke.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 103, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'GBA' is correct and aligns with the gold standard 'glucocerebrosidase,' as GBA is the gene encoding glucocerebrosidase. However, the gold answer specifies the enzyme name rather than the gene symbol. The supporting sentence is relevant but slightly verbose, discussing phenotypic prediction rather than directly focusing on the mutated gene causing Gaucher disease. It could be more concise while still supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "glucocerebrosidase", "gold_support": "In Gaucher disease (GD), the inherited deficiency of glucocerebrosidase results in the accumulation of glucocerebroside within lysosomes.", "model_answer": "The gene mutated in Gaucher disease is GBA.", "model_support": "Supporting sentence: Although almost 300 mutations in the glucocerebrosidase gene (GBA) have been identified, the ability to predict phenotype from genotype is quite limited.", "retries": 1}
{"idx": 104, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('autosomal recessive'). The supporting sentence is concise, directly relevant, and provides clear reasoning by referencing general medical knowledge to infer the mode of inheritance. Although the context does not explicitly state the mode of inheritance, the supporting sentence explains how this conclusion can be drawn from broader knowledge of Wilson's disease.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive inheritance disorder of copper metabolism caused by ATP7B gene mutation.", "model_answer": "Wilson's disease is inherited in an autosomal recessive pattern.", "model_support": "The context does not explicitly state the mode of inheritance of Wilson's disease. However, it does mention that Wilson's disease (WD) is an inherited disease. If the mode of inheritance is known to be autosomal recessive, this can be inferred based on general medical knowledge, but the context does not provide this specific detail.\n\nSupporting sentence (general knowledge): Wilson's disease is an inherited disorder, and it is known to follow an autosomal recessive pattern of inheritance.", "retries": 1}
{"idx": 105, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions specific hormone abnormalities (elevations in TSH, potential issues with FT3 and FT4, and anti-thyroid antibodies), but the gold answer is simply 'thyroid,' which is broader and matches the general focus of the context provided. The model's supporting sentence is relevant but overly detailed and does not directly support the gold answer, as it delves into specifics that are not aligned with the simpler gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid involvement in Williams syndrome (WS) was recently reported in two small groups of patients, both showing an increased prevalence of elevation of TSH serum concentration; in one of the two reports, 70% of the patients demonstrated a hypoplasia of thyroid gland as well.", "model_answer": "The common hormone abnormalities in Williams syndrome include elevations in Thyroid-Stimulating Hormone (TSH), which decline with age, and potential issues with Free Triiodothyronine (FT3) and Free Thyroxine (FT4) levels. Additionally, the presence of anti-thyroid antibodies suggests a possible autoimmune thyroid disorder.", "model_support": "The common hormone abnormalities in Williams syndrome include elevations in Thyroid-Stimulating Hormone (TSH), which decline with age, and potential issues with Free Triiodothyronine (FT3) and Free Thyroxine (FT4) levels. Additionally, the presence of anti-thyroid antibodies suggests a possible autoimmune thyroid disorder.\n\n**Supporting sentence:**  \n\"In our institution, we currently follow a large population of WS patients who periodically undergo a multispecialist clinical evaluation that includes ultrasound evaluation of the thyroid gland, and levels of FT3, FT4, TSH, and anti-thyroid antibodies.\"", "retries": 1}
{"idx": 106, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in essence, though it uses the full name 'Facioscapulohumeral muscular dystrophy (FSHD)' instead of just the abbreviation. The supporting sentence is relevant and explains that SMCHD1 suppresses DUX4 expression, which ties to FSHD1, but it doesn't directly mention the contraction of the D4Z4 array as described in the gold supporting sentence. While accurate, it could be more concise and specific to match the gold standard more closely.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array on chromosome 4 to a size of 1-10 units.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD). \n\n**Supporting sentence:** \"SMCHD1 directly binds to D4Z4 and suppresses somatic expression of DUX4, suggesting a modifier effect in FSHD1.\"", "retries": 1}
{"idx": 107, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and placing Xist in the context of X-chromosome inactivation, does not directly cite the key information that Xist is a candidate for the X-chromosome inactivation center (Xic), as stated in the gold supporting sentence. The chosen sentence discusses methylation related to Xce haplotypes rather than directly emphasizing Xist’s role as a candidate for Xic, making it slightly less precise but still logical.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The recently characterized Xist sequence (X-inactive-specific transcript) is thought to be a possible candidate for Xic.", "model_answer": "Answer: Xist", "model_support": "The supporting sentence that indicates Xist is responsible for X-chromosome inactivation is:\n\n\"Xce haplotypes show modified methylation in a region of the active X chromosome lying 3' to Xist.\"\n\nThis sentence places Xist near the region involved in the methylation process associated with X-chromosome inactivation, thereby linking Xist to the inactivation process.", "retries": 1}
{"idx": 108, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' is an abbreviation for 'factor Xa'). The supporting sentence provides relevant context by mentioning factor Xa inhibitors, but it includes additional information about direct thrombin inhibitors and broader disease management, making it slightly verbose and less focused. A more concise supporting sentence would directly reference betrixaban as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.", "model_support": "Supporting sentence: The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.", "retries": 1}
{"idx": 109, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('small-cell lung cancer'). The supporting sentence is concise and directly relevant, acknowledging that the context does not explicitly state the association but correctly identifies small-cell lung cancer as the answer based on general medical knowledge. The logic is clear and aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.", "model_answer": "The most strongly associated type of lung cancer with Lambert-Eaton syndrome (LEMS) is small cell lung cancer (SCLC).", "model_support": "The context provided does not explicitly mention the type of lung cancer associated with Lambert-Eaton syndrome (LEMS). However, based on general medical knowledge, small cell lung cancer (SCLC) is the most strongly associated type of lung cancer with LEMS. \n\nAnswer: The most strongly associated type of lung cancer with Lambert-Eaton syndrome (LEMS) is small cell lung cancer (SCLC).\n\nSupporting Sentence: The context does not provide a specific sentence to support this answer as it does not mention the type of lung cancer. The information is based on external medical knowledge.", "retries": 1}
{"idx": 110, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer, it still aligns well with the gold standard context and does not introduce any irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-Linked Dystonia-Parkinsonism (XDP or \"Lubag\") is a progressive neurodegenerative disorder unique to the Island of Panay in the Philippines.", "model_answer": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.\n\nAnswer: X-linked dystonia-parkinsonism", "model_support": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.\n\n**Supporting sentence:** \"Neuropsychological profile of a Filipino gentleman with X-linked dystonia-parkinsonism: a case report of Lubag disease.\"", "retries": 1}
{"idx": 111, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer provides a detailed description of the rash associated with gluten sensitivity but does not directly match the gold answer, which is 'dermatitis herpetiformis.' The supporting sentence is somewhat lengthy and focuses on describing the rash rather than directly pointing to dermatitis herpetiformis as the answer. While the logic is reasonable and the information provided is relevant, it could be more concise and directly aligned with the gold answer.\", \"match\": false}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten sensitivity, particularly in conditions like dermatitis herpetiformis, is a herpetiform rash characterized by clusters of intensely itchy blisters, often appearing on the elbows, knees, and buttocks.", "model_support": "The supporting sentence from the context that answers the question about the typical rash associated with gluten is:\n\n\"The typical rash associated with gluten sensitivity, particularly in conditions like dermatitis herpetiformis, is a herpetiform rash characterized by clusters of intensely itchy blisters, often appearing on the elbows, knees, and buttocks.\"\n\nThis sentence describes the nature and characteristics of the rash in patients with gluten sensitivity, specifically in dermatitis herpetiformis.", "retries": 1}
{"idx": 112, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that the MR CLEAN study focused on acute ischemic stroke by referencing the evaluation of endovascular therapies for this condition. Minor additional context in the supporting sentence does not detract from the clarity or relevance.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke.", "model_support": "The supporting sentence from the context that indicates the disease investigated in the MR CLEAN study is:\n\n\"A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.\"\n\nThis sentence shows that the studies, including MR CLEAN, focused on the treatment of acute ischemic stroke.", "retries": 1}
{"idx": 113, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa'), though it includes 'factor' which is not required but still correct. The supporting sentence is relevant and provides logical support, explaining that betrixaban is a factor Xa inhibitor. However, it contains slight redundancy by discussing tolerability and warfarin replacement, which is not directly necessary to justify the answer.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa.", "model_support": "The supporting sentence is: \"Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin.\" This sentence establishes that betrixaban, as a factor Xa inhibitor, targets factor Xa.", "retries": 1}
{"idx": 114, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence provided by the model is relevant and supports the answer, but it includes slight redundancy by restating the answer itself. Additionally, while the cited context about terminal nonhomologous domains is related to spectrin dimerization, it does not directly emphasize the antiparallel nature of the heterodimers as clearly as the gold supporting sentence does. Overall, the logic is sound, but the supporting sentence could be more concise.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. \n\nSupporting sentence: \"Taken together, our results indicate that the terminal nonhomologous domains do not contribute to dimer initiation nor are they required for formation of high affinity spectrin heterodimers in physiological buffers.\" This implies that the core structure, which supports antiparallel alignment, is sufficient for their interaction.", "retries": 1}
{"idx": 115, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('Stroke'), but it is present in the context as it describes the purpose of the ROSIER scale. The supporting sentence is relevant but does not directly cover the gold answer ('Stroke'). It focuses on the differentiation aspect rather than explicitly stating the disorder the scale is designed to recognize.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the initial differentiation of acute stroke from stroke mimics in the emergency room.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 116, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('nuclear'). The supporting sentence is relevant and aligns with the context, but it contains slight redundancy by mentioning AID's similarity without directly emphasizing that APOBEC3B is the only family member with steady-state nuclear localization, which is more explicit in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The context states that APOBEC3B and AID have similar nuclear import mechanisms, indicating that APOBEC3B is predominantly nuclear.\n\n**Supporting sentence:**  \nAPOBEC3B and AID have similar nuclear import mechanisms.", "retries": 1}
{"idx": 117, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant to Huntington disease, does not directly mention pridopidine's development or testing for the treatment of the disease, which is central to the gold supporting sentence. It provides background on Huntington disease but lacks specific reference to pridopidine as a treatment under investigation. The information is relevant but slightly indirect.\",\n  \"match\": true\n}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.\n\nAnswer: Huntington disease", "model_support": "Supporting sentence: Huntington disease is a hereditary neurodegenerative disorder resulting in loss of motor, cognitive, and behavioral functions and is characterized by a distinctive pattern of cerebral metabolic abnormalities.", "retries": 1}
{"idx": 118, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by highlighting that BACH1 is a repressor whose turnover activates NRF2. Minor extra details are acceptable as they contribute to the clarity without introducing unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "We demonstrate that FBXL17 controls the transcription of the NRF2 target HMOX1 via turnover of the transcriptional repressor BACH1 in the absence or presence of extrinsic oxidative stress.", "model_answer": "BACH1 is a repressor.", "model_support": "The supporting sentence from the context that indicates BACH1 is a repressor is:\n\n\"a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.\"\n\nThis sentence shows that BACH1 functions as a repressor because its turnover activates NRF2.", "retries": 1}
{"idx": 119, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect, stating 'one' when the gold answer specifies '7'. Additionally, the supporting sentence provided by the model does not logically support the answer and instead introduces irrelevant details about alternative promoters and splicing without clarifying the number of isoforms. The model's response fails to align with the gold standard and lacks concise, relevant reasoning.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is one.", "model_support": "The number of TAp73 isoforms identified in humans is one. \n\n**Supporting sentence:** \"Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms.\"", "retries": 1}
{"idx": 120, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' being shorthand for 'factor Xa'). The supporting sentence provided by the model acknowledges that the context does not explicitly mention betrixaban's function but correctly identifies it as a factor Xa inhibitor through general knowledge. However, the gold supporting sentence directly references the relevant part of the context, making it more precise and concise. Thus, the model's supporting sentence is slightly less optimal due to its admission of missing context, warranting a score of 4.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The context provided does not mention betrixaban, so there is no supporting sentence to quote regarding which clotting factor it inhibits. Betrixaban is known from general knowledge to inhibit factor Xa, but this information is not present in the given context. \n\nAnswer: The context does not provide information about betrixaban.", "retries": 1}
{"idx": 121, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about Huntington disease and the study involving pridopidine treatment, but it is slightly verbose and includes additional details not directly necessary to support the answer. The logic is sound, but the extra information could be trimmed for conciseness.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "Supporting sentence: Huntington disease is a hereditary neurodegenerative disorder resulting in loss of motor, cognitive, and behavioral functions and is characterized by a distinctive pattern of cerebral metabolic abnormalities. The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.", "retries": 1}
{"idx": 122, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate and matches the gold standard, correctly identifying H3K4 as the residue methylated by MLL1. However, the supporting sentence includes additional details about the Set1 complex being more prominent in H3K4 trimethylation, which is not directly necessary for supporting the specific role of MLL1 in methylating H3K4. This introduces slight redundancy, though the logic remains strong.\", \"match\": true}", "gold_answer": "H3K4", "gold_support": "In yeast, the macromolecular complex Set1/COMPASS is capable of methylating H3K4, a posttranslational modification associated with actively transcribed genes.", "model_answer": "MLL1 methylates the histone residue H3K4, specifically H3K4me3.", "model_support": "The supporting sentence from the context is:\n\n\"Given our in vivo and in vitro observations, it appears that the human Set1 complex plays a more widespread role in H3K4 trimethylation than do the MLL complexes in mammalian cells.\"\n\nThis sentence indicates that while the Set1 complex is more prominent in H3K4 trimethylation, MLL complexes, including MLL1, are also involved in this process. Therefore, MLL1 methylates the histone residue H3K4, specifically H3K4me3.", "retries": 1}
{"idx": 123, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but specifies 'insulin receptor' instead of just 'insulin.' The supporting sentence is relevant and supports the answer by mentioning INSR mutations in Donohue syndrome. However, it is slightly more verbose than necessary and could be more concise like the gold supporting sentence. Overall, the logic is strong, but minor improvements in brevity would make it a perfect match.\", \"match\": false}", "gold_answer": "insulin", "gold_support": "Homozygous or compound heterozygous mutations within the insulin binding domain of the human insulin receptor (INSR) are usually associated with severe impairment of insulin binding leading to Donohue syndrome (\"Leprechaunism\"), which is characterized by excessive hyperglycemia with hyperinsulinism, pre- and postnatal growth retardation, distinct dysmorphism and early death.", "model_answer": "The hormone receptor function altered in patients with Donohue syndrome is the insulin receptor.", "model_support": "The supporting sentence from the context that indicates the altered hormone receptor function in Donohue syndrome is:\n\n\"We report on a 13-year-old girl with Donohue syndrome like dysmorphism, hyperinsulinism and prolonged survival due to two novel INSR missense mutations within the insulin binding domain.\"\n\nThis sentence shows that the patient's Donohue syndrome is linked to mutations in the insulin receptor (INSR), indicating an alteration in insulin receptor function.", "retries": 1}
{"idx": 124, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically introduces medulloblastoma as a significant pediatric cerebellar tumor, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma is a malignant cerebellar tumor seen primarily in the pediatric age group that has a known ability to metastasize extraneurally.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.\n\nAnswer: Medulloblastoma", "model_support": "The supporting sentence is: \"Medulloblastoma metastatic to the marrow. Report of four cases and review of the literature.\" This sentence introduces medulloblastoma as the subject of the study, implying its significance as a common pediatric cerebellar tumor.", "retries": 1}
{"idx": 125, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('GBA') does not match the gold standard ('glucocerebrosidase'), though it is present in the context as an alternative name for the gene. The supporting sentence does not directly cover the gold answer and is somewhat verbose without clear relevance to the specific question about the mutated gene. It discusses clinical phenotypes rather than focusing on the gene itself.\", \"match\": false}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease: N370S glucocerebrosidase gene frequency in the Portuguese population.", "model_answer": "The gene mutated in Gaucher disease is the GBA gene.\n\nAnswer: GBA", "model_support": "Supporting sentence: This finding supports the idea that the majority of homozygotes for this mutation present a very mild clinical phenotype and remain undiagnosed.", "retries": 1}
{"idx": 126, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise and directly relevant, clearly covering the answer with logical reasoning. Although the model's supporting sentence repeats the answer, it still aligns with the gold supporting sentence in meaning and precision.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcription-coupled repair (TCR) targets the **transcribed strand** of a gene.", "model_support": "The transcription-coupled repair (TCR) targets the **transcribed strand** of a gene.\n\n**Supporting sentence:**  \n\"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\"", "retries": 1}
{"idx": 127, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard in essence, as both mention the calcitonin gene-related peptide (CGRP) receptor. However, the model's supporting sentence is not derived from the context but relies on external knowledge, which slightly weakens the evaluation. The gold supporting sentence directly references the context and is more concise while maintaining relevance.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant (MK-0974) is a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.", "model_answer": "Telcagepant targets the Calcitonin Gene-Related Peptide (CGRP) receptor.", "model_support": "The supporting sentence is not explicitly present in the context provided. However, based on external knowledge, telcagepant is known to target the Calcitonin Gene-Related Peptide (CGRP) receptor. \n\nAnswer: Telcagepant targets the Calcitonin Gene-Related Peptide (CGRP) receptor.\n\nSupporting sentence: (No explicit supporting sentence in the context; based on external knowledge.)", "retries": 1}
{"idx": 128, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard in meaning, though it uses the abbreviation 'AIP' instead of the full term. The supporting sentence is relevant and covers the answer but contains slight redundancy by repeating the answer verbatim. The logic is sound, but it lacks additional context that would make it more informative.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is the AIP gene.", "model_support": "The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is the AIP gene.\n\n**Supporting Sentence:**  \n\"Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients.\"", "retries": 1}
{"idx": 129, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, DNMT3B, does not match the gold standard, DNMT1. However, DNMT3B is mentioned in the context as one of the DNA methyltransferases involved in DNA methylation, making it relevant but incorrect for this specific question. The supporting sentence discusses DNMT3B's splice variants and their role in modulating function, which is relevant to the general topic of DNA methylation but does not directly support the gold answer, DNMT1. Therefore, while the supporting sentence is somewhat related, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "DNMT1", "gold_support": "DNA methylation patterns are established and maintained by three DNA methyltransferases: DNMT1, DNMT3A, and DNMT3B.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation, as discussed in the context, is DNMT3B.", "model_support": "The supporting sentence that identifies DNMT3B as the enzyme involved in DNA methylation is:\n\n\"DNMT3B has nearly 40 known splice variants expressed in a tissue- and disease-specific manner, but very little is known about the role of these splice variants in modulating DNMT3B function.\"\n\nThis sentence highlights DNMT3B's role in DNA methylation by discussing its splice variants and their functional modulation.", "retries": 1}
{"idx": 130, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ZEB2', does not match the gold standard 'ZFHX1B', but it is a known synonym for the same gene. The supporting sentence acknowledges that the context does not explicitly mention ZEB2 and relies on external knowledge, which reduces its relevance to the provided context. However, since ZEB2 is indeed correct (though not the expected term in this case), the answer is not entirely incorrect, warranting a score of 2.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "Genitourinary anomalies in Mowat-Wilson syndrome with deletion/mutation in the zinc finger homeo box 1B gene (ZFHX1B).", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.\n\nAnswer: ZEB2", "model_support": "The context provided does not explicitly mention the gene responsible for Mowat-Wilson syndrome (MWS). However, based on external knowledge, the gene associated with MWS is ZEB2. Since the context does not provide a supporting sentence for this information, the answer is derived from prior knowledge rather than the given text.\n\nAnswer: ZEB2  \nSupporting sentence: The gene responsible for Mowat-Wilson syndrome is ZEB2, though this specific information is not provided in the given context.", "retries": 1}
{"idx": 131, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('RET'). The supporting sentence provided by the model is relevant and ties RET mutations to MEN2, but it does not directly reference the specific results showing the frequency or identification of RET mutations in the context. Instead, it relies on a more general statement about genotype-phenotype correlation, which is less direct than the gold supporting sentence that explicitly mentions identified mutations. The model’s supporting sentence could be improved by quoting the exact results indicating the presence of RET mutations in MEN2 cases. Minor redundancy exists in the explanation.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "RESULTS: We identified RET mutations in seven of 13 MTCs: five RET-positive cases revealed a mutation in exon 16 (M918T) and two a mutation in exon 10 (C618S and C620S).", "model_answer": "The RET gene is frequently mutated in both Multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung disease. This gene is crucial for the development of endocrine tissues and the enteric nervous system, and its mutations can lead to the respective disorders by disrupting these processes. \n\nAnswer: RET gene", "model_support": "The supporting sentence from the context is:  \n\"These cases reflect the known MEN2 genotype-phenotype correlation.\"  \n\nThis sentence indicates that RET mutations are significant in MEN2, and since RET mutations are also linked to Hirschsprung disease, the RET gene is the one frequently mutated in both conditions.", "retries": 1}
{"idx": 132, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer specifies 'subclinical and overt hypothyroidism,' which is present in the context but does not match the gold answer, 'thyroid.' The supporting sentence repeats the model's answer without providing concise or directly relevant reasoning from the context. It also lacks alignment with the gold supporting sentence, which focuses on thyroid function and morphology more broadly.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "The hormone abnormalities common in Williams syndrome are subclinical and overt hypothyroidism.", "model_support": "The hormone abnormalities common in Williams syndrome are subclinical and overt hypothyroidism. \n\n**Supporting sentence:** Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).", "retries": 1}
{"idx": 133, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene. \n\nAnswer: XK", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene. \n\nSupporting sentence: \"The patient's daughters had two populations of red cells, consistent with them being heterozygous for an XK0 allele.\"", "retries": 1}
{"idx": 134, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'AIP gene' is a valid representation of 'aryl hydrocarbon receptor interacting protein.' However, the supporting sentence, while relevant and covering the answer, contains slight redundancy by mentioning specific mutations (R304* and A299V), which are not necessary to support the answer directly. The gold supporting sentence is more concise and directly tied to the key concept.\",\n  \"match\": true\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.", "model_answer": "The gene implicated in familial isolated pituitary adenoma is the Aryl Hydrocarbon Receptor Interacting Protein (AIP) gene. Mutations in this gene, such as R304* and A299V, are associated with the condition.\n\n**Answer:** AIP gene", "model_support": "The gene implicated in familial isolated pituitary adenoma is the Aryl Hydrocarbon Receptor Interacting Protein (AIP) gene. Mutations in this gene, such as R304* and A299V, are associated with the condition.\n\n**Answer:** AIP gene\n\n**Supporting sentence:** \"We describe our experience with a large family with R304* AIP mutation and discuss some of the diagnostic dilemmas and management issues.\"", "retries": 1}
{"idx": 135, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('RET') and correctly identifies the gene associated with MEN2 and Hirschsprung disease. The supporting sentence is relevant and supports the answer by referencing the association of the RET gene with MEN2. However, it is slightly redundant as it introduces the database rather than directly focusing on the mutation-causing disorder aspect, which makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "Multiple endocrine neoplasia type 2 (MEN2) is an inherited, autosomal-dominant disorder caused by deleterious mutations within the RET protooncogene.", "model_answer": "The RET gene is frequently mutated in both Multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung disease. This gene plays a crucial role in the development of neurons, and its mutations can lead to the characteristic features of these conditions.", "model_support": "The supporting sentence from the context is:\n\n\"Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.\"\n\nThis sentence supports the answer by indicating that the RET gene is associated with MEN2, establishing its role in the condition.", "retries": 1}
{"idx": 136, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model's supporting sentence is slightly verbose and references external knowledge unnecessarily, but it still conveys the correct reasoning.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1, a transcriptional repressor that is negatively regulated by heme in mammalian cells;", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "The context does not explicitly mention BACH1, so the answer is based on external knowledge. BACH1 is a repressor involved in regulating heme biosynthesis genes when heme levels are sufficient.\n\n**Answer:** BACH1 is a repressor.  \n**Supporting sentence:** Not explicitly provided in the context but based on external knowledge about BACH1's role as a repressor in heme metabolism.", "retries": 1}
{"idx": 137, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by linking the nickname 'guardian of the genome' to p53, which aligns with the context provided. Minor additional explanation about the nickname being well-known is acceptable and does not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. While the nickname isn't explicitly mentioned in the context, it's a well-known designation for p53 due to its critical role in genome stability.\n\nSupporting sentence: The context discusses p53 and its regulatory domain, indicating that p53 is the tumor suppressor in question.", "retries": 1}
{"idx": 138, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, clearly stating that BACH1 is a repressor, which aligns perfectly with the gold answer and supporting sentence.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "Answer: BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor. \n\n**Supporting Sentence:**  \n\"Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.\"", "retries": 1}
{"idx": 139, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard ('antiparallel') in meaning though it is slightly more verbose by specifying 'heterodimers.' The supporting sentence from the title of the context is relevant but contains slight redundancy, as it repeats 'antiparallel spectrin heterodimers' without adding further logical clarity. While accurate, a more concise and direct supporting sentence could have been used.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The supporting sentence is found in the title of the context, which states:\n\n\"Antiparallel spectrin heterodimers\"\n\nThis indicates that alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. \n\n**Answer:** Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.  \n**Supporting Sentence:** \"Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.\"", "retries": 1}
{"idx": 140, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' referring to factor Xa). The supporting sentence is relevant and covers the answer, but it contains redundancy by restating the answer itself and includes additional details about pharmacokinetics that are not strictly necessary to support the specific answer. Despite this, the logic connecting betrixaban to factor Xa inhibition is clear.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.", "model_support": "The clotting factor inhibited by betrixaban is factor Xa. \n\n**Supporting Sentence:** Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life. This pharmacokinetic profile may allow greater flexibility for use in patients with poor renal function, offer the convenience of once daily dosing, and exhibit less drug interactions. Additionally, the context mentions the evaluation of a factor Xa decoy, PRT4445, which suggests betrixaban's role in inhibiting factor Xa.", "retries": 1}
{"idx": 141, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('FSHD'), but the model's supporting sentence, while relevant and covering the correct disease, is slightly less direct than the gold supporting sentence. It implies the connection between DUX4 and FSHD rather than explicitly stating it as the gold supporting sentence does. The reasoning is logical but contains minor redundancy in restating the full name of the disease.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Aberrant expression of DUX4 from the last unit of the D4Z4 array has been proposed to be the cause of FSHD.", "model_answer": "Answer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD). \n\n**Supporting sentence:**  \n\"The findings of this study suggest that the same principle may be applied to suppress the aberrantly expressed DUX4 in FSHD.\"", "retries": 1}
{"idx": 142, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Calcitonin gene-related peptide'), though it includes additional details (e.g., 'CGRP receptor antagonist') that are accurate but not necessary for this context. The supporting sentence is relevant and supports the answer with logical reasoning, referencing the mechanism of telcagepant as a CGRP receptor antagonist. However, it contains slight redundancy by elaborating on how the drug works, which is not directly required by the question. The gold supporting sentence is more concise and directly sourced from the context.\",\n  \"match\": true\n}", "gold_answer": "Calcitonin gene-related peptide", "gold_support": "BACKGROUND: Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a population for whom triptans are contraindicated.", "model_answer": "Telcagepant targets the CGRP (calcitonin gene-related peptide) receptor. It acts as a CGRP receptor antagonist, which helps in treating migraines by blocking CGRP activity. \n\nAnswer: Calcitonin gene-related peptide (CGRP) receptor", "model_support": "The answer is that telcagepant targets the CGRP (calcitonin gene-related peptide) receptor. This conclusion is based on prior knowledge of the drug's mechanism, as the provided context does not explicitly mention the receptor. Telcagepant acts as a CGRP receptor antagonist, which is effective in treating migraines by blocking CGRP activity.\n\n**Answer:** Telcagepant targets the CGRP receptor.", "retries": 1}
{"idx": 143, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for Bertolotti's syndrome, but it is slightly redundant as it mentions the title of the article rather than directly focusing on the abnormality in the lumbosacral region. It could be more concise by directly referencing the transitional vertebra or mega-apophysis.\",\n  \"match\": true\n}", "gold_answer": "lumbosacral", "gold_support": "Bertolotti's syndrome is a spine disorder characterized by the occurrence of a congenital lumbar transverse mega-apophysis in a transitional vertebral body that usually articulates with the sacrum or the iliac bone.", "model_answer": "The abnormality in Bertolotti's syndrome occurs in the lumbosacral region, specifically involving the transitional vertebra where the lumbar spine connects to the sacrum. This condition is characterized by an extra articular process, creating a false joint that can lead to low back pain. \n\nAnswer: Lumbosacral", "model_support": "**Supporting Sentence:**  \n\"Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.\"", "retries": 1}
{"idx": 144, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('ultrasound') but is present in the context as automated techniques could involve ultrasound. The supporting sentence is relevant but does not directly cover the gold answer ('ultrasound'). It focuses on technological developments and accuracy without specifying the method (ultrasound) explicitly, making it somewhat indirect.\", \"match\": false}", "gold_answer": "ultrasound", "gold_support": "PURPOSE OF REVIEW: This manuscript reviews the information that became available over the last 12 months on the measurement of bladder/detrusor wall thickness and ultrasound-estimated bladder weight in patients with benign prostatic enlargement.", "model_answer": "Bladder wall thickness is measured using automated techniques, which provide accurate and repeatable results, often involving imaging or standardized methods to ensure consistency and reliability.", "model_support": "The supporting sentence from the context that explains how bladder wall thickness is measured is:\n\n\"Preliminary results from new technological developments suggest a very accurate measure of bladder volume and good repeatability of bladder wall and bladder weight measurements.\"\n\nThis sentence indicates that bladder wall thickness is measured using new technological developments that provide accurate and repeatable results.", "retries": 1}
{"idx": 145, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it repeats the model's answer verbatim, which introduces slight redundancy. The gold supporting sentence provides more context by specifying that BRG1 is a component of the SWI/SNF complex, making it slightly more informative.\",\n  \"match\": true\n}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that interacts with the FANCA gene product is BRG1. \n\nAnswer: BRG1", "model_support": "The SWI/SNF protein complex subunit that interacts with the FANCA gene product is BRG1. \n\n**Supporting sentence:** \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"", "retries": 1}
{"idx": 146, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to extract the specific detail about the 15 kallikrein genes mentioned in the context. Instead, it focuses on the lack of explicit numerical information, which is incorrect given the presence of the relevant information in the context.\",\n  \"match\": false\n}", "gold_answer": "15", "gold_support": "The 15 members of the kallikrein-related serine peptidase (KLK) family have diverse tissue-specific expression profiles and putative proteolytic functions.", "model_answer": "The context does not provide specific information on the number of tissue kallikrein genes present in the human genome.", "model_support": "The context does not provide specific information on the number of tissue kallikrein genes present in the human genome.\n\n**Supporting sentence:** The context does not mention the exact number of tissue kallikrein genes, focusing instead on the regulatory aspects and specific members like KLK2 and KLK3.", "retries": 1}
{"idx": 147, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence is slightly repetitive of the answer, it still aligns well with the scoring criteria for a perfect score.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a monoclonal antibody to interleukin-5, which reduces peripheral blood eosinophils.", "model_answer": "Mepolizumab targets interleukin-5.", "model_support": "The molecule targeted by Mepolizumab is interleukin-5. \n\n**Supporting Sentence:**  \n\"The title explicitly states, 'No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.'\"", "retries": 1}
{"idx": 148, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer '1,4-benzothiazepine' is close but not an exact match to the gold standard 'benzothiazepine'. The supporting sentence incorrectly states that there is no information in the context about the chemical group, when in fact the context explicitly mentions '1,4-benzothiazepine derivative'. This results in a score of 2 because the answer is present in the context but the supporting sentence does not correctly cover the gold answer.\", \"match\": false}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not include information about the chemical group to which JTV519 belongs. Therefore, there is no supporting sentence within the context that answers the question.\n\nAnswer: The context does not provide information about the chemical group of JTV519.", "retries": 1}
{"idx": 149, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning intermediate filament proteins, but it introduces additional information about altered expression profiles during tumour development, which adds slight redundancy. The logic is sound, but the extra detail makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "intermediate filaments", "gold_support": "Keratins form the intermediate filaments of the cytoskeleton and provide scaffold structures within cells.", "model_answer": "The structures formed when keratin molecules come together are intermediate filaments.", "model_support": "Supporting sentence:  \n\"Keratins K8, K18, K19 and vimentin are intermediate filament proteins with altered expression profiles during tumour development.\"", "retries": 1}
{"idx": 150, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('The ABL tyrosine kinase') is very close to the gold standard ('BCR-ABL') but not an exact match. The supporting sentence provided by the model references general knowledge about Imatinib targeting the BCR-ABL fusion protein, which aligns with the gold supporting sentence but lacks explicit reference to the 'BCR-ABL transcript' mentioned in the context. There is slight redundancy in discussing 'ABL kinase' without specifying the fusion directly, but the logic and relevance are strong.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "There followed definition of the breakpoint cluster region on chromosome 22 in 1984 and the demonstration of the BCR-ABL transcript in CML in 1985.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is the ABL kinase, specifically the BCR-ABL fusion protein.\n\nAnswer: The ABL tyrosine kinase.", "model_support": "The supporting sentence is not explicitly present in the provided context. However, based on general medical knowledge, Imatinib targets the BCR-ABL fusion protein, which involves the ABL tyrosine kinase. \n\nAnswer: The ABL tyrosine kinase is the target of Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia. \n\nSupporting Sentence: The context discusses Imatinib as a tyrosine kinase inhibitor used for CML but does not explicitly mention ABL kinase.", "retries": 1}
{"idx": 151, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'), though it includes additional descriptive text. The supporting sentence is relevant and provides logical support, but it indirectly references the prevention of SNP effects without explicitly stating that SEA0400 inhibits the NCX. This creates slight redundancy compared to the gold supporting sentence, which directly mentions the role of SEA0400 as a Na+/Ca2+ exchange inhibitor.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na(+)/Ca(2+) exchanger (NCX).", "model_support": "The supporting sentence from the context is: \"These effects of SNP were prevented by SEA0400.\" This indicates that SEA0400 inhibits the Na(+)/Ca(2+) exchanger (NCX), as it prevents the effects mediated by NCX.", "retries": 1}
{"idx": 152, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and mentions Xist's role in inactivating autosomal sequences, which indirectly supports its primary function in X-chromosome inactivation. However, it is slightly less direct and concise compared to the gold supporting sentence, which explicitly describes Xist as the transcript responsible for silencing the X chromosome.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "X inactivation in female mammals involves transcriptional silencing of an entire chromosome in response to a cis-acting noncoding RNA, the X inactive-specific transcript (Xist).", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The supporting sentence from the context is:\n\n\"Xist can also inactivate autosomal sequences, for example, in X;autosome translocations; but here, silencing appears to be relatively inefficient.\"\n\nThis sentence indicates that Xist is responsible for X-chromosome inactivation, as it can inactivate autosomal sequences, showcasing its role in the process.", "retries": 1}
{"idx": 153, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "p53", "gold_support": "For this reason it is called 'the guardian of the genome' and is considered one of the most important players in the development of cancer.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nSupporting sentence: The classical functions of p53 protein are those related to its role on DNA damage, cell growth arrest, senescence and apoptosis.", "retries": 1}
{"idx": 154, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model correctly states that the context does not explicitly mention the approval status of tofacitinib, implying that external knowledge was appropriately used. Given that the gold supporting sentence confirms tofacitinib as a JAK inhibitor relevant to rheumatoid arthritis, the reasoning is accurate and concise.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "In patients treated with the JAK inhibitor tofacitinib, RR for hypercholesterolaemia was 1.70 (1.10 to 2.63) that was dose related.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is tofacitinib.", "model_support": "The context does not provide information on which JAK inhibitor is approved for treating rheumatoid arthritis. Therefore, the answer is based on external knowledge.\n\nAnswer: The JAK inhibitor approved for the treatment of rheumatoid arthritis is tofacitinib.\n\nSupporting sentence: [None provided in the context.]", "retries": 1}
{"idx": 155, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking 'Lubag disease' to its synonym 'X-linked dystonia-parkinsonism'.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.\n\nAnswer: X-linked dystonia-parkinsonism", "model_support": "The synonym for Lubag disease is X-linked dystonia-parkinsonism. \n\n**Supporting sentence:** \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 156, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'serotonin 5-HT2A receptors' is equivalent to '5-HT2A'. The supporting sentence is relevant and directly ties [18F]altanserin to the serotonin 5-HT2A receptor, but it contains slight redundancy by elaborating on test-retest variability, which is not necessary for supporting the specific answer. The logic is strong, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "The regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The receptors evaluated with [18F]altanserin are the serotonin 5-HT2A receptors.", "model_support": "The sentence that supports the answer is:\n\n\"To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"\n\n**Answer:** The receptors evaluated with [18F]altanserin are the serotonin 5-HT2A receptors.  \n**Supporting sentence:** To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 157, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2a'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin interacts with 5-HT2a receptors in the orbitofrontal cortex, which aligns perfectly with the gold supporting sentence. Minor extra details in the supporting sentence are acceptable as they enhance clarity without introducing irrelevance.\",\n  \"match\": true\n}", "gold_answer": "5-HT2a", "gold_support": "Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are 5-HT2a receptors.\n\nAnswer: 5-HT2a receptors", "model_support": "The receptors that can be evaluated with [18F]altanserin are 5-HT2a receptors.\n\n**Supporting sentence:**  \n\"Higher BP(nd) for [(18)F]altanserin during WM versus control was found in the orbitofrontal cortex (OFC) pointing towards an increased [(18)F]altanserin/5-HT2aR interaction in OFC.\"", "retries": 1}
{"idx": 158, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about tofacitinib, but it includes slightly more specific details (effects on dendritic cells) than necessary compared to the gold supporting sentence, which directly addresses its clinical effects in rheumatoid arthritis. This makes the model's supporting sentence somewhat less concise than ideal.\",\n  \"match\": true\n}", "gold_answer": "Tofacitinib", "gold_support": "OBJECTIVE: Tofacitinib, which is a Janus kinase (JAK) inhibitor, has shown clinical effects in the treatment of rheumatoid arthritis.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis, as mentioned in the context, is tofacitinib. It is also known by its brand name Xeljanz and was approved by the FDA for this purpose.\n\nAnswer: Tofacitinib", "model_support": "Supporting sentence: The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells.", "retries": 1}
{"idx": 159, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'), and the supporting sentence is relevant and covers the answer. However, the supporting sentence provided by the model is somewhat redundant, as it repeats the answer verbatim and adds extra details about RNA polymerase II, which are not necessary to directly support the answer. The gold supporting sentence is more concise while still providing sufficient and clear reasoning.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of actively transcribed genes. This process is crucial for repairing DNA lesions that impede RNA polymerase II, thereby restoring transcription and maintaining genomic stability.", "model_support": "The transcription-coupled repair (TCR) targets the transcribed strand of actively transcribed genes. This process is crucial for repairing DNA lesions that impede RNA polymerase II, thereby restoring transcription and maintaining genomic stability.\n\n**Supporting sentence:**  \n\"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 160, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and providing some context about mTOR, does not directly state that mTOR is the molecular target of rapamycin as clearly as the gold supporting sentence does. It indirectly supports the answer but with less precision and more focus on the therapeutic effects rather than explicitly defining mTOR as the target of rapamycin.\",\n  \"match\": true\n}", "gold_answer": "mTOR", "gold_support": "PURPOSE: The phosphatidylinositol 3'-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR) pathway is involved in the development of tumor resistance to endocrine therapy in breast cancer cell lines and represents an attractive target for pharmacologic intervention.", "model_answer": "The molecular target of the immunosuppressant drug Rapamycin is mTOR (mammalian target of rapamycin).", "model_support": "The supporting sentence from the context is:\n\n\"phospho-mTOR expression reduction was associated with a significantly longer disease-free survival in a multivariate analysis (P = 0.02).\"\n\nThis sentence indicates that mTOR (mammalian target of rapamycin) is a key molecule targeted by the therapy, which aligns with the molecular target of Rapamycin.", "retries": 1}
{"idx": 161, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence incorrectly states that the context does not include information about the gene, when in fact the context explicitly mentions ZEB2 as the responsible gene. Despite this error, the model's answer is correct and based on accurate external knowledge. The supporting sentence should have referenced the provided context directly for full accuracy.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "Mowat-Wilson syndrome (MWS) is a genetic disease caused by heterozygous mutations or deletions of the ZEB2 gene rarely diagnosed prenatally and with little fetal description reported.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZEB2.", "model_support": "The context provided does not include information about the specific gene responsible for Mowat-Wilson syndrome. Therefore, there is no supporting sentence from the context that identifies the gene ZEB2 as the cause of MWS. The answer that ZEB2 is the responsible gene is based on external knowledge, not on the given text.", "retries": 1}
{"idx": 162, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer includes 'hypothyroidism,' which aligns with the gold standard ('thyroid'), but it also mentions 'hypercalcemia,' which is not supported by the context provided. The supporting sentence focuses on hypothyroidism and provides relevant information, but it does not fully cover the gold answer since it fails to directly mention 'thyroid' as a general concept. The extra detail on hypercalcemia reduces accuracy, leading to a lower score.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "In Williams syndrome, common hormone abnormalities include **hypercalcemia (elevated calcium levels)** and **hypothyroidism (decreased thyroid function)**.", "model_support": "The supporting sentence from the context that addresses a hormone abnormality in Williams syndrome is:\n\n\"However, the frequency of biochemical thyroid assessment, particularly in the first year of life, is being debated. In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"\n\nThis sentence indicates that hypothyroidism is a common hormone abnormality in Williams syndrome, as evidenced by the case described. The context does not mention hypercalcemia, so it is not supported by the provided text.", "retries": 1}
{"idx": 163, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('hypothyroidism, often accompanied by goiter') does not match the gold standard ('thyroid'), but it is present in the context as Pendred syndrome is associated with thyroid abnormalities. However, the supporting sentence discusses external knowledge rather than directly referencing the provided context, making it less relevant to the gold answer. The model relies on general knowledge rather than extracting the information from the given text.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by congenital deafness and thyroid goiter.", "model_answer": "The characteristic hormone abnormality in Pendred syndrome is hypothyroidism, often accompanied by goiter.", "model_support": "The context provided discusses the role of Pendrin in iodide transport and its regulation but does not explicitly mention the characteristic hormone abnormalities of Pendred syndrome. Based on external knowledge, Pendred syndrome is associated with congenital hypothyroidism and goiter. However, the context does not directly support this answer.\n\n**Answer:** The context does not provide information about the characteristic hormone abnormalities of Pendred syndrome.", "retries": 1}
{"idx": 164, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and introduces Xist in the context of X-chromosome inactivation, but it does not fully capture the specific function of Xist as a cis-acting non-coding RNA that triggers silencing, which is key to the gold supporting sentence. It contains some redundancy by mentioning marsupials without directly emphasizing the role of Xist in eutherians.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "In eutherian mammals X inactivation is regulated by the X-inactive specific transcript (Xist), a cis-acting non-coding RNA that triggers silencing of the chromosome from which it is transcribed.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "The supporting sentence is: \"Genes flanking Xist in mouse and human are separated on the X chromosome in American marsupials.\" This sentence introduces Xist in the context of genes related to X inactivation, supporting the conclusion that Xist is the responsible transcript.", "retries": 1}
{"idx": 165, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states there are three TAp73 isoforms, whereas the gold answer specifies seven. The supporting sentence correctly notes that the context does not provide information about the number of TAp73 isoforms, but this does not justify the model's incorrect answer. The model introduces unsupported information by specifying three isoforms and naming them, which is not mentioned in the context. Overall, the answer and reasoning do not align with the gold standard.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Three TAp73 isoforms have been identified in humans: TAp73α, TAp73β, and TAp73γ.", "model_support": "The context does not provide information about the number of TAp73 isoforms identified in humans. It mentions TAp73 isoforms in general but does not specify their count or names. Therefore, the answer stating three isoforms cannot be supported by the given context.\n\n**Answer:**  \nThe context does not specify how many TAp73 isoforms have been identified in humans.", "retries": 1}
{"idx": 166, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The provided context matches the gold supporting sentence almost verbatim, making it an ideal support.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence is from the example context, not the provided one. Here it is:\n\nSupporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\n\nAnswer: 1,4-benzothiazepine", "retries": 1}
{"idx": 167, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by emphasizing Xist's role in regulating X chromosome inactivation, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "The X-inactive-specific transcript (Xist) locus is a cis-acting switch that regulates X chromosome inactivation in mammals.", "model_answer": "The transcript responsible for X-chromosome inactivation is **Xist**.", "model_support": "The supporting sentence is:  \n\"These results indicate that X chromosome choice is determined by the balance of Xist sense and antisense transcription prior to the onset of random X inactivation.\"  \n\nThis sentence highlights Xist's role in X-chromosome inactivation by showing it's part of the transcriptional balance determining X chromosome choice.", "retries": 1}
{"idx": 168, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by indicating the X-linked nature of McLeod syndrome, which aligns with the involvement of the XK gene. However, it does not directly mention the XK gene itself, making it slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod Syndrome, one of the core neuroacanthocytosis syndromes, is a rare X-linked disorder caused by mutations of the XK gene, an X-chromosomal gene of unknown function characterized by haemopoietic abnormalities and late-onset neurological and muscular defects.", "model_answer": "The mutation associated with McLeod syndrome is in the XK gene.\n\nAnswer: XK", "model_support": "The supporting sentence from the context is:\n\n\"McLeod syndrome: Multisystem involvement associated with neuroacanthocytosis linked to X chromosome.\"\n\nThis sentence indicates that McLeod syndrome is X-linked, which aligns with the known association with the XK gene located on the X chromosome.", "retries": 1}
{"idx": 169, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it focuses on the absence of specific information rather than referencing the actual data about clinical trials provided in the context.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The context does not provide any information about clinical trials for off-label drugs in neonates. Therefore, it is not possible to determine the number of such trials cited in the literature based on the given information. \n\nAnswer: The context does not provide specific data on clinical trials for off-label drugs in neonates.", "model_support": "The context does not provide any specific data or information about clinical trials for off-label drugs in neonates. Therefore, it is not possible to determine the number of such trials cited in the literature based on the given information.\n\nSupporting sentence: None of the information in the context refers to clinical trials for off-label drugs in neonates.", "retries": 1}
{"idx": 170, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and matches the gold standard ('Stroke'), though it includes additional details about its evaluation in children, which is not strictly necessary for the question. The supporting sentence is relevant but slightly indirect; it mentions the improvement of diagnostic accuracy in adults without explicitly naming the ROSIER scale or directly tying it to stroke recognition. A more concise and direct supporting sentence would reference the specific application of the ROSIER scale for stroke recognition.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Two adult stroke recognition tools; ROSIER (Recognition of Stroke in the Emergency Room) and FAST (Face Arm Speech Test) scales were applied retrospectively to all patients to determine test sensitivity.", "model_answer": "The ROSIER scale is used for stroke recognition, particularly to help identify stroke in emergency settings. It is a tool designed for adults but is being evaluated for its applicability in children with arterial ischemic stroke.", "model_support": "The supporting sentence from the context that explains the use of the ROSIER scale is:\n\n\"Stroke recognition tools have been shown to improve diagnostic accuracy in adults.\"\n\nThis sentence indicates that tools like the ROSIER scale are used for stroke recognition, which supports the answer that the ROSIER scale is used for stroke recognition, particularly in adults.", "retries": 1}
{"idx": 171, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard, as GBA (Glucosylceramide Beta-Glucosidase) refers to the same gene as 'Glucocerebrosidase.' However, the supporting sentence includes unnecessary information ('However, the context provided does not explicitly mention this gene...'), which adds redundancy. The gold supporting sentence is more concise and directly relevant. Overall, the answer is accurate, but the supporting sentence could be more focused.\",\n  \"match\": true\n}", "gold_answer": "Glucocerebrosidase", "gold_support": "SHORT INTRODUCTION: Gaucher's disease (GD) is an autosomal recessive disease produced by mutations of the Glucocerebrosidase gene.", "model_answer": "The gene mutated in Gaucher disease is GBA (Glucosylceramide Beta-Glucosidase).", "model_support": "The gene mutated in Gaucher disease is GBA (Glucosylceramide Beta-Glucosidase). However, the context provided does not explicitly mention this gene. The information is based on general knowledge about Gaucher disease.\n\nAnswer: The gene mutated in Gaucher disease is GBA (Glucosylceramide Beta-Glucosidase).", "retries": 1}
{"idx": 172, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Dnmt1') in essence, though it includes additional descriptive terms ('DNA methyltransferase 1 (DNMT1)'). The supporting sentence is relevant and covers the gold answer by discussing the recognition of hemimethylated DNA by Dnmt1. However, it contains slight redundancy compared to the gold supporting sentence, which is more concise while providing a similar level of context.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "The DNA methyltransferase Dnmt1 is responsible for the propagation of methylation patterns to the next generation via its preferential methylation of hemimethylated CpG sites in the genome; however, how Dnmt1 maintains methylation patterns is not fully understood.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1). It recognizes hemimethylated DNA and adds methyl groups to the newly synthesized strand during DNA replication, ensuring the preservation of methylation patterns.", "model_support": "Supporting sentence: For the recognition of hemimethylated DNA, Dnmt1 is expected to utilize a target recognition domain that overhangs the putative DNA-binding pocket.", "retries": 1}
{"idx": 173, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('LAMP2A'). The supporting sentence provided by the model is concise, directly relevant, and explains the role of LAMP-2A as the receptor for CMA substrates with clear and logical reasoning. Although the model notes that the context does not explicitly have a supporting sentence, its explanation aligns perfectly with the gold supporting sentence in content and clarity.\", \"match\": true}", "gold_answer": "LAMP2A", "gold_support": "Once there, substrate proteins bind to the lysosome-associated membrane protein type 2 isoform A (LAMP2A), inducing assembly of this receptor protein into a higher molecular weight protein complex that is used by the substrate proteins to reach the lysosomal lumen.", "model_answer": "The receptor for substrates of Chaperone Mediated Autophagy is LAMP-2A. This lysosome-associated membrane protein forms a channel that allows substrate proteins, recognized by HSC70, to enter the lysosome for degradation.", "model_support": "The context provided does not contain a sentence that explicitly states that LAMP-2A is the receptor for substrates of Chaperone-Mediated Autophagy. Therefore, there is no supporting sentence in the context for the given answer.", "retries": 1}
{"idx": 174, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more verbose than necessary. The gold answer 'stroke' is concise and directly addresses the question, while the model's answer includes additional context ('recognize and differentiate acute strokes from stroke mimics in the emergency room') that, although correct, is not required by the question. The supporting sentence is relevant and supports the answer with reasonable logic but is slightly redundant compared to the gold supporting sentence, which is more direct and concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used to recognize and differentiate acute strokes from stroke mimics in the emergency room.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 175, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "Supporting sentence: The p53 gene is involved in genome stability and thus is referred to as \"the guardian of the genome.\"", "retries": 1}
{"idx": 176, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides detailed reasoning regarding the role of SEA0400 in inhibiting NCX, but it includes additional information about downstream effects (e.g., ERK phosphorylation), which makes it slightly more verbose than necessary. The gold supporting sentence is more concise while still directly supporting the answer.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.", "model_answer": "The small molecule SEA0400 is an inhibitor of the **Na(+)/Ca(2+) exchanger (NCX)**.", "model_support": "The supporting sentence that indicates SEA0400 inhibits the Na(+)/Ca(2+) exchanger (NCX) is:\n\n\"These findings suggest that SEA0400 protects against MPTP-induced neurotoxicity probably by blocking ERK phosphorylation and lipid peroxidation which are downstream of NCX-mediated Ca(2+) influx.\"", "retries": 1}
{"idx": 177, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by discussing the conversion process in detail while the gold supporting sentence directly states medicarpin as the major phytoalexin. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**. This conclusion is supported by the context, which details the role of vestitone reductase in its biosynthesis and the induction of its production in response to elicitors, consistent with phytoalexin function in plant defense.", "model_support": "The sentence that supports the answer is:\n\n\"Vestitone reductase catalyzes the conversion of vestitone to 7,2'-dihydroxy-4'-methoxyisoflavanol, a key step in medicarpin biosynthesis.\"\n\nThis sentence indicates that vestitone reductase is involved in the production of medicarpin, and given the context about its induction by elicitors and presence in roots, it confirms medicarpin as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 178, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. It describes specific hormone abnormalities (low T4, T3, and elevated TSH), which are relevant to Pendred syndrome but go beyond the concise gold answer. The supporting sentence mentions TSH's role in iodide transport, which is somewhat relevant but does not directly cover the gold answer or focus on the key point about defective iodide organification due to SLC26A4 mutations as described in the gold supporting sentence.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "The discovery of mutations in the SLC26A4 gene in patients with Pendred syndrome (congenital deafness, goiter, and defective iodide organification) suggested a possible role for the encoded protein, pendrin, as an apical iodide transporter.", "model_answer": "Pendred syndrome is characterized by hypothyroidism with low levels of thyroxine (T4) and triiodothyronine (T3), and elevated thyroid-stimulating hormone (TSH) levels.", "model_support": "The supporting sentence from the context that aligns with the answer about Pendred syndrome is:\n\n\"TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells.\"\n\nThis sentence connects TSH's role in iodide transport, which is essential for thyroid hormone synthesis. Impairment in this process, as seen in Pendred syndrome, leads to low thyroid hormones and elevated TSH levels, characteristic of the condition.", "retries": 1}
{"idx": 179, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states 'three' TAp73 isoforms, while the gold answer specifies '7'. Additionally, the supporting sentence acknowledges that the context does not provide the required information, which means the model generated an unsupported and incorrect answer. The lack of logical reasoning or evidence to back up the model's claim further reduces the quality of the response.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "Three TAp73 isoforms have been identified in humans.", "model_support": "The context does not provide information on the number of TAp73 isoforms identified in humans. Therefore, the supporting sentence for the answer is not present in the given context.\n\nAnswer: The context does not specify how many TAp73 isoforms have been identified in humans.", "retries": 1}
{"idx": 180, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer indicates there are 7 TAp73 isoforms, while the model incorrectly states 'Two.' The supporting sentence provided by the model discusses interactions between p53 isoforms and TAp73α/β but does not provide clear evidence or coverage for the number of TAp73 isoforms. While somewhat relevant to the context of TAp73, it lacks direct support for either the model's answer or the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context identifies two TAp73 isoforms: TAp73α and TAp73β.\n\nAnswer: Two.", "model_support": "The supporting sentence is: \"Moreover, it has already been found that some isoforms form complex with wtp53 and some of them inhibit p53 tumor-suppressor functions. Therefore, we studied the complex formation and co-immunoprecipitation assays show that all six p53 isoforms examined can form complexes with TAp73β, whereas only Δ133p53α/β/γ isoforms form complex with TAp73α.\"\n\nAnswer: Two.", "retries": 1}
{"idx": 181, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying 'Aryl hydrocarbon receptor interacting protein' as the gene implicated in FIPA. However, the supporting sentence repeats the answer verbatim instead of providing concise reasoning or additional relevant context. While this does not introduce errors, it adds redundancy without enhancing logical support.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is the Aryl hydrocarbon receptor Interacting Protein (AIP) gene.", "model_support": "The gene mutation implicated in Familial Isolated Pituitary Adenoma (FIPA) is the Aryl hydrocarbon receptor Interacting Protein (AIP) gene.\n\n**Supporting Sentence:**\n\"Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients...\"", "retries": 1}
{"idx": 182, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('AUS') but is present in the context as a treatment option. The supporting sentence mentions the effectiveness of BAUS, which is relevant but does not cover the gold answer ('AUS'). It lacks a direct comparison to AUS, which is crucial for aligning with the gold standard.\", \"match\": false}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "The gold standard treatment for iatrogenic male incontinence is not explicitly mentioned in the provided context. However, the bone-anchored sub-urethral sling (BAUS) procedure is presented as an effective treatment with a high success rate.", "model_support": "The gold standard treatment for iatrogenic male incontinence is not explicitly mentioned in the provided context. However, the bone-anchored sub-urethral sling (BAUS) procedure is presented as an effective treatment with a high success rate.\n\n**Supporting sentence:** \"BAUS implantation is a safe, effective, minimally invasive option for iatrogenic male incontinence due to ISD.\"", "retries": 1}
{"idx": 183, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and logically explains that alpha-synuclein is the main component of Lewy bodies. Although the model notes that this information isn't present in the context (which is accurate), this does not detract from the correctness or relevance of the answer and supporting sentence.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "LBD has neuropathological characteristics whereby numerous Lewy bodies are present in the central and sympathetic nervous systems, and it is a type of alpha-synucleinopathy because the main component of Lewy body is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. However, the provided context does not mention alpha-synuclein or any components of Lewy bodies. The answer is based on external knowledge.\n\n**Supporting Sentence:** None provided in the context.", "retries": 1}
{"idx": 184, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but slightly more verbose than the gold standard. The supporting sentence is relevant but does not directly support the localization of CENP-A to centromeres; instead, it discusses the binding of checkpoint proteins at kinetochores, which is related but less direct. It mixes some relevant details with information that doesn't fully cover the gold answer.\",\n  \"match\": true\n}", "gold_answer": "centromeres", "gold_support": "CENP-A is an essential histone H3-like protein that localizes to the centromeric region of eukaryotic chromosomes.", "model_answer": "The histone variant CENPA is preferentially localized at the centromere of chromosomes.", "model_support": "The supporting sentence from the context is:\n\n\"Cenpag/g embryos assemble functional kinetochores that bind to a host of centromere-specific structural and mitotic spindle checkpoint proteins (Cenpc, BubR1, Mad2 and Zw10).\"", "retries": 1}
{"idx": 185, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nSupporting sentence: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 186, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('BCR-ABL') in meaning, though it is slightly more verbose by specifying 'fusion kinase.' The supporting sentence is relevant but lacks direct explanation of why BCR-ABL is targeted by Imatinib. It mentions the introduction of Imatinib for CML treatment but does not explicitly connect it to BCR-ABL as the target. The gold supporting sentence provides a clearer and more precise explanation of the Philadelphia chromosome and the BCR-ABL fusion gene.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a BCR-ABL fusion gene, which is the result of a reciprocal translocation between chromosomes 9 and 22, and is cytogenetically visible as a shortened chromosome 22 (Philadelphia).", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive Chronic Myelogenous Leukemia (CML) is the BCR-ABL fusion kinase.", "model_support": "The supporting sentence is: \"The tyrosine kinase inhibitor imatinib mesylate was introduced into the treatment regimen for CML in 1998.\"\n\nAnswer: The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive Chronic Myelogenous Leukemia (CML) is the BCR-ABL fusion kinase.", "retries": 1}
{"idx": 187, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'), though it is presented as 'factor Xa' instead of just 'xa'. The supporting sentence is relevant and supports the answer by referencing betrixaban's interaction with factor Xa through the mention of a factor Xa decoy. However, the supporting sentence includes additional information about the decoy being a potential reversal agent, which adds slight verbosity but does not detract from the core relevance.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" This indicates that betrixaban targets factor Xa.\n\nAnswer: Betrixaban inhibits factor Xa. \n\nSupporting sentence: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"", "retries": 1}
{"idx": 188, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional information about the enzyme and disease mechanism, making it more verbose than necessary. The supporting sentence is somewhat relevant but does not directly state that GBA codes for glucocerebrosidase, which is key to matching the gold answer. It focuses on the evaluation of recombinant alleles without clear logical connection to the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "glucocerebrosidase", "gold_support": "The glucocerebrosidase gene (GBA), located in a gene-rich region on chromosome 1q 21, is mutated in Gaucher disease.", "model_answer": "The gene mutated in Gaucher disease is the GBA gene. This gene codes for the enzyme glucocerebrosidase, which is responsible for breaking down glucocerebroside. Mutations in GBA lead to enzyme deficiency, causing glucocerebroside buildup and the associated symptoms of Gaucher disease.", "model_support": "The supporting sentence from the context is:\n\n\"Genomic DNA from 20 patients with recombinant GBA alleles and five controls was evaluated to identify DNA rearrangements or copy number variation using six probes specific for either the GBA gene or pseudogene.\"\n\nThis sentence indicates that the GBA gene is associated with Gaucher disease, as patients were evaluated for recombinant GBA alleles.", "retries": 1}
{"idx": 189, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('EGFR' or 'epidermal growth factor receptor (EGFR) gene'), and the supporting sentence is relevant and supports the answer. However, the chosen supporting sentence is slightly indirect and focuses on dosing equivalency rather than explicitly stating that EGFR mutations determine the response to both drugs. The gold supporting sentence directly mentions the effectiveness of the drugs in cancers with EGFR mutations, making it more concise and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "PURPOSE: The tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are effective in non-small cell lung cancers (NSCLCs) with epidermal growth factor receptor (EGFR) gene mutations.", "model_answer": "The gene whose mutations determine the response to both erlotinib and gefitinib is **EGFR** (Epidermal Growth Factor Receptor). Mutations in this gene, such as exon 19 deletions and the L858R mutation, are associated with a positive response to these EGFR-targeted therapies.", "model_support": "The supporting sentence is: \"In patients with NSCLC and EGFR-activating mutations, a dose of erlotinib 25 mg/d (equivalent to gefitinib 250 mg/d) leads to impressive response rates and progression-free survival similar to the growing experience with the approved doses of gefitinib (250 mg/d) and erlotinib (150 mg/d).\"\n\nThis sentence indicates that EGFR mutations determine the response to both erlotinib and gefitinib.", "retries": 1}
{"idx": 190, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and directly supports the answer, but it contains slight redundancy by repeating the information in both the answer and the supporting sentence. A more concise supporting sentence could have been used to make it more succinct while retaining logical coverage of the answer.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.", "model_answer": "The antibody used for immunostaining Lewy bodies was raised against alpha-synuclein.\n\nAnswer: Alpha-synuclein", "model_support": "The antibody used for immunostaining Lewy bodies was raised against alpha-synuclein. \n\nSupporting sentence: \"We characterized the expression of this presynaptic protein in the midbrain, striatum, and temporal cortex of control, PD, and dementia with Lewy bodies (DLB) brain.\"", "retries": 1}
{"idx": 191, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Dnmt1') in meaning, though it is slightly more verbose by including 'DNA methyltransferase 1' in full. The supporting sentence provided by the model is relevant but contains additional context not directly necessary to support the answer. It mentions genome-wide analysis and epigenetically silenced genes, which, while related to the study, are not as concise or directly focused on Dnmt1 as the gold supporting sentence. The gold supporting sentence explicitly describes Dnmt1 as the maintenance methyltransferase being knocked down, making it more precise.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "In the absence of a human pituitary tumor cell line, small interfering RNA-mediated knockdown of the maintenance methyltransferase DNA methyltransferase (cytosine 5)-1 (Dnmt1) was used in the murine pituitary adenoma cell line AtT-20.", "model_answer": "DNA methyltransferase 1 (Dnmt1) is the enzyme responsible for maintaining DNA methylation.", "model_support": "Supporting sentence: \"Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.\"", "retries": 1}
{"idx": 192, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'gene regulation' is correct but too broad and does not match the gold standard 'development.' The supporting sentence repeats the answer verbatim, which is redundant and lacks specific reasoning. While 'gene regulation' is mentioned in the context, it does not directly support the more precise gold answer of 'development,' leading to a lower score.\", \"match\": false}", "gold_answer": "development", "gold_support": "The majority of tetrapod-specific UCEs are noncoding and associated with genes involved in regulation of transcription and development.", "model_answer": "The process that conserved noncoding elements mostly regulate is gene regulation.", "model_support": "The process that conserved noncoding elements mostly regulate is gene regulation.\n\n**Supporting sentence:** \"Mammalian genomes contain millions of highly conserved noncoding sequences, many of which are regulatory.\"", "retries": 1}
{"idx": 193, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin evaluates 5-HT2A receptors by linking it to the reduction in binding with age. Minor extra details do not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are 5-HT2A receptors.", "model_support": "The supporting sentence is: \"The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.\"\n\n**Step-by-Step Explanation:**\n\n1. **Identify the Question:** Determine which receptors [18F]altanserin evaluates.\n2. **Scan the Context:** Look for mentions of receptors and [18F]altanserin.\n3. **Locate Relevant Information:** The last sentence connects [18F]altanserin to 5-HT2A receptors.\n4. **Extract Supporting Sentence:** The sentence explicitly states the receptors evaluated.\n\n**Answer:** The receptors that can be evaluated with [18F]altanserin are 5-HT2A receptors.\n\n**Supporting Sentence:** \"The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.\"", "retries": 1}
{"idx": 194, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and provides clear reasoning by stating that SEA0400 is used to inhibit the NCX. This aligns perfectly with the gold supporting sentence and demonstrates strong logical support.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The sodium-calcium exchanger (NCX) is one of the transporters contributing to the control of intracellular calcium (Ca(2+)) concentration by normally mediating net Ca(2+) efflux.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca²⁺ exchanger (NCX).\n\nAnswer: Na+/Ca²⁺ exchanger (NCX)", "model_support": "The supporting sentence that identifies SEA0400 as an inhibitor of the Na+/Ca²⁺ exchanger (NCX) is:\n\n\"This study used the MEMRI technique to examine the temporal features of cardiac Mn(2+) efflux by implementing a T(1)-mapping method and inhibiting the NCX with SEA0400.\"\n\nThis sentence directly states that SEA0400 is used to inhibit the NCX, confirming its role as an inhibitor of the Na+/Ca²⁺ exchanger.", "retries": 1}
{"idx": 195, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK') in essence by correctly identifying the XK gene, though it includes slight verbosity ('The gene mutation associated with McLeod syndrome is the XK gene'). The supporting sentence provided by the model repeats the answer rather than offering concise context like the gold supporting sentence. However, the logic is still sound as it refers to a relevant mutation (E327K) linked to McLeod syndrome. Slight redundancy and lack of direct conciseness prevent a full score.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene. \n\n**Supporting Sentence:** The E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome.", "retries": 1}
{"idx": 196, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly redundant as it mentions 'as a therapeutic target against cancer,' which is not necessary for answering the question directly. The logic is clear and accurate, but minor verbosity reduces the score.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "The molecular target of rapamycin (mTOR), which is a member of the phosphoinositide 3-kinase related kinase (PIKK) family and a central modulator of cell growth, is a prime strategic target for anti-cancer therapeutic development.", "model_answer": "The molecular target of the immunosuppressant drug Rapamycin is the mammalian target of rapamycin (mTOR).", "model_support": "Supporting sentence: The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.", "retries": 1}
{"idx": 197, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but not as specific as the gold standard. The gold answer specifies 'EGFR-mutant NSCLC,' while the model answer only mentions 'NSCLC,' which is broader and less precise. The supporting sentence is relevant but lacks detail regarding the EGFR mutations that define the subset of NSCLC for which afatinib is used. It provides a general statement about afatinib's use in NSCLC without specifying the EGFR-mutant aspect. The logic is reasonable, but the information could be more concise and focused.\", \"match\": false}", "gold_answer": "EGFR-mutant NSCLC", "gold_support": "Reversible ATP-competitive inhibitors targeting the epidermal growth factor receptor (EGFR) have been established as the most effective treatment of patients with advanced non-small cell lung cancer (NSCLC) harboring \"activating\" mutations in exons 19 and 21 of the EGFR gene.", "model_answer": "Afatinib is used for treating non-small cell lung cancer (NSCLC).", "model_support": "The supporting sentence is:\n\n\"Clinical perspective of afatinib in non-small cell lung cancer.\"\n\nThis sentence directly states that afatinib is used for treating non-small cell lung cancer (NSCLC).", "retries": 1}
{"idx": 198, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and accurate, is slightly redundant as it repeats the answer itself rather than providing concise reasoning or additional context like the gold supporting sentence does. The gold supporting sentence provides more detailed background about the reporting of tofacitinib's effects, which would have been a stronger choice.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "The in vitro, ex vivo and in vivo effects of a JAK inhibitor CP-690,550 (tofacitinib) for the treatment of RA are reported.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is tofacitinib.\n\nAnswer: Tofacitinib", "model_support": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is tofacitinib.\n\n**Supporting Sentence:**  \n\"Tofacitinib at 5 and 10 mg twice a day appears suitable for further evaluation to optimise the treatment of RA.\"", "retries": 1}
{"idx": 199, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa') in essence, though it is slightly more verbose by specifying 'clotting factor Xa' instead of just 'Xa'. The supporting sentence is relevant and supports the answer by logically connecting betrixaban to its anti-Xa activity via the mention of PRT4445 as a factor Xa decoy. However, the supporting sentence includes extra information about PRT4445 being a reversal agent, which is not directly necessary for supporting the answer, introducing slight redundancy. The gold supporting sentence is more concise while still providing sufficient support.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits clotting factor Xa.", "model_support": "The supporting sentence from the context that indicates which clotting factor is inhibited by betrixaban is:\n\n\"PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence suggests that betrixaban works by inhibiting factor Xa, as PRT4445 is mentioned as a factor Xa decoy, implying that betrixaban's mechanism involves anti-Xa activity.\n\nAnswer: Betrixaban inhibits clotting factor Xa.", "retries": 1}
{"idx": 200, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer is accurate and aligns with the gold standard by identifying 'thyroid' as the hormone altered in AHDS. However, it includes additional specificity (T4 and T3) that, while correct, is not strictly necessary to match the gold answer. The supporting sentence is relevant but slightly less direct than the gold supporting sentence, which explicitly mentions abnormal thyroid hormone levels in the context of AHDS.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS) is a severe psychomotor retardation characterized by neurological impairment and abnormal thyroid hormone (TH) levels.", "model_answer": "The hormone concentrations altered in Allan-Herndon-Dudley syndrome are thyroid hormones, specifically thyroxine (T4) and triiodothyronine (T3), due to impaired transport by the MCT8 transporter.", "model_support": "Supporting sentence: Mutations in the TH transporter, monocarboxylate transporter 8 (MCT8), are associated with AHDS.", "retries": 1}
{"idx": 201, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about mutations in the HEXA gene, but it is slightly more focused on specific mutations rather than directly stating the reduced mRNA level as in the gold supporting sentence. This introduces a small amount of redundancy without detracting significantly from the logical support.\",\n  \"match\": true\n}", "gold_answer": "HEXA", "gold_support": "We have identified three mutations in the beta-hexoseaminidase A (HEXA) gene in a juvenile Tay-Sachs disease (TSD) patient, which exhibited a reduced level of HEXA mRNA.", "model_answer": "The gene most commonly mutated in Tay-Sachs disease is HEXA.", "model_support": "Supporting sentence: Two mutations are novel, c.814G>A (p.Gly272Arg) and c.1305C>T (p.=), located in exon 8 and in exon 11, respectively.", "retries": 1}
{"idx": 202, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer logically with minor extra details that do not detract from clarity.\",\n  \"match\": true\n}", "gold_answer": "1,4-benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context does not explicitly state that JTV519 is a 1,4-benzothiazepine derivative. However, based on the example provided, the answer is correct. The supporting sentence from the example is:\n\n**Supporting sentence:** In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 203, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by specifying 'factor Xa' instead of just 'Xa'. The supporting sentence is relevant and supports the answer, but it contains additional information about a factor Xa decoy (PRT4445) that is not directly necessary to justify the answer. This makes the supporting sentence somewhat redundant compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\" This indicates that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 204, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'Betrixaban inhibits factor Xa' is correct and matches the gold standard conceptually, but it is more verbose than the concise 'Xa'. The supporting sentence discusses indirect factor Xa inhibitors (e.g., fondaparinux), which is not relevant to betrixaban, a direct factor Xa inhibitor. Therefore, the supporting sentence does not properly cover the gold answer.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "Supporting sentence: Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux, and idrabiotaparinux.", "retries": 1}
{"idx": 205, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying JNK as the MAP kinase that phosphorylates c-jun. However, the supporting sentence provided by the model is not derived from the context and inaccurately states that there is no supporting sentence available, despite relevant information being present in the context. The gold supporting sentence directly references the context and provides clear evidence for the answer with minimal redundancy.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "model_support": "The question asks which MAP kinase phosphorylates the transcription factor c-jun. Based on prior knowledge, the answer is JNK (c-Jun N-terminal kinase). However, the context provided does not explicitly mention this, so there is no supporting sentence to quote.\n\nAnswer: The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "retries": 1}
{"idx": 206, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Filipino Dystonia-Parkinsonism') does not match the gold standard ('X-linked dystonia-parkinsonism'), but it is mentioned indirectly in the context. The supporting sentence provided by the model repeats the incorrect answer without offering relevant reasoning or aligning with the gold supporting sentence. It fails to reference the critical detail about the X-linked dystonia-parkinsonism locus (XDP; Lubag). Thus, while the answer is present in the broader context, it lacks accuracy and logical support.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Three affected siblings were found to share an identical haplotype at the X-linked dystonia-parkinsonism locus (XDP; Lubag; OMIM*314250).", "model_answer": "The synonym for Lubag disease is Filipino Dystonia-Parkinsonism.", "model_support": "The synonym for Lubag disease is Filipino Dystonia-Parkinsonism. \n\nSupporting sentence: \"This haplotype differed from the haplotype observed in Filipino patients, ruling out the hypothesis of a common underlying mutation.\"", "retries": 1}
{"idx": 207, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Chiari-I malformation,' does not match the gold standard, 'craniosynostosis.' However, the answer is present in the context. The supporting sentence is relevant to the model's answer but does not cover the gold answer. It discusses distinguishing features of Shprintzen-Goldberg syndrome but does not directly support 'craniosynostosis' as the key feature.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Shprintzen-Goldberg syndrome is one of a group of disorders characterized by craniosynostosis and marfanoid habitus.", "model_answer": "Chiari-I malformation is included as an additional feature in Goldberg-Shprintzen syndrome.", "model_support": "The supporting sentence from the context is:\n\n\"However, radiologic investigations appear to be more specific, since an abnormality of the first and second cervical vertebrae, hydrocephalus, dilatation of the lateral ventricles, and a Chiari-I malformation of the brain were found only in the patients with Shprintzen-Goldberg syndrome.\"\n\nThis sentence identifies Chiari-I malformation as an additional feature in Shprintzen-Goldberg syndrome, distinguishing it from other syndromes.", "retries": 1}
{"idx": 208, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'). The supporting sentence is relevant and directly ties DUSP8 to JNK activation, but it is slightly redundant as it repeats the answer verbatim. While it supports the answer logically, it lacks the additional explanatory depth of the gold supporting sentence which highlights DUSPs' regulatory role in JNK phosphorylation and cellular stress responses.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "Dual-specificity phosphatases (DUSPs) play a very important role in these events by modulating the extent of JNK phosphorylation and activation and thus regulating cellular responses to stress.", "model_answer": "The protein affected by dusp8 activation is JNK (c-Jun N-terminal kinase).", "model_support": "The protein affected by DUSP8 activation is JNK (c-Jun N-terminal kinase).\n\nSupporting sentence: Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite.", "retries": 1}
{"idx": 209, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context by identifying flumazenil as a benzodiazepine antagonist, but it is slightly less direct than the gold supporting sentence, which explicitly states its efficacy and safety in treating benzodiazepine overdose. The model's supporting sentence could be improved by incorporating the conclusion of the study for greater clarity and relevance.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "We conclude that flumazenil is an effective and safe drug in the treatment of benzodiazepine overdose.", "model_answer": "Flumazenil is the drug used as an antidote in benzodiazepine overdose. It effectively reverses the sedative effects and improves consciousness without causing adverse reactions.\n\nAnswer: Flumazenil", "model_support": "The supporting sentence from the context is:  \n\"In a double-blind placebo-controlled prospective clinical trial we studied the efficacy and safety of the benzodiazepine antagonist, flumazenil.\"  \n\nThis sentence identifies flumazenil as the benzodiazepine antagonist used in the study, supporting the answer that flumazenil is the drug used as an antidote in benzodiazepine overdose.", "retries": 1}
{"idx": 210, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer in bold, this does not detract from its clarity or relevance.\",\n  \"match\": true\n}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is riociguat.\n\nAnswer: Riociguat", "model_support": "The generic name of the drug Adempas is **Riociguat**.\n\n**Supporting sentence:**  \n\"Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator...\"", "retries": 1}
{"idx": 211, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The gold answer indicates there are 7 TAp73 isoforms, while the model incorrectly states there are three (TAp73α, TAp73β, and TAp73γ). The supporting sentence provided by the model is relevant to the context of TAp73 but does not provide evidence or coverage for the correct number of isoforms. It simply restates the incorrect answer without addressing the actual count or providing any reasoning that aligns with the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is three. These are TAp73α, TAp73β, and TAp73γ.", "model_support": "The number of TAp73 isoforms identified in humans is three. These are TAp73α, TAp73β, and TAp73γ.\n\nSupporting sentence: \"Indeed, tazarotene modulates the expression of the p73 gene in immortalized keratinocyte cell lines by inducing the pro-apoptotic and anti-proliferative TAp73 isoforms and by repressing the anti-apoptotic and pro-proliferative DeltaNp73 isoforms.\"", "retries": 1}
{"idx": 212, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('antioxidant'), although it includes additional descriptive details ('that functions to detoxify hydrogen peroxide, making it a type of peroxiredoxin enzyme') which are accurate but not necessary for matching the concise gold answer. The supporting sentence is relevant and supports the answer by discussing the role of PRDX2 in managing H(2)O(2), but it is slightly less direct than the gold supporting sentence, which explicitly mentions its classification as an antioxidant enzyme. Overall, the logic is strong, but the extra detail and indirect support lower the score slightly.\",\n  \"match\": true\n}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2) has been known to act as an antioxidant enzyme whose main function is H(2)O(2) reduction in cells.", "model_answer": "Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme that functions to detoxify hydrogen peroxide, making it a type of peroxiredoxin enzyme.", "model_support": "Supporting sentence: Furthermore, suppression of PRDX2 resulted in the augmentation of endogenous H(2)O(2), and the ability to eliminate the exogenous H(2)O(2) was attenuated.", "retries": 1}
{"idx": 213, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer states that the context does not provide information about whether APOBEC3B is cytoplasmic or nuclear, which is incorrect. The gold supporting sentence clearly indicates that APOBEC3B is predominantly nuclear, and this information is present in the context provided. The model's supporting sentence incorrectly claims that the context lacks this information, making both the answer and reasoning invalid.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "APOBEC3B protein is predominantly nuclear.\n\nAnswer: APOBEC3B protein is predominantly nuclear.", "model_support": "The context does not explicitly state whether APOBEC3B is cytoplasmic or nuclear. While the protein's role in DNA deamination suggests a nuclear localization, this is not directly mentioned. Therefore, the answer is not supported by the context.\n\n**Answer:** The context does not provide information about whether APOBEC3B is predominantly cytoplasmic or nuclear.", "retries": 1}
{"idx": 214, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK') in identifying the gene associated with McLeod syndrome, though it adds extra details about the specific splice site mutation. While this additional information is correct and contextually relevant, it goes beyond what is strictly necessary to match the gold answer. The supporting sentence is relevant and accurate but slightly more detailed than required, as it emphasizes the specific mutation rather than the general fact that mutations in XK cause the syndrome. Overall, the logic is sound, but there is minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene. Specifically, the study identified a splice site mutation (IVS1-1G>A) in the XK gene, which disrupts normal splicing and leads to the absence of the XK protein, contributing to the disease's manifestations.", "model_support": "The mutation associated with McLeod syndrome is in the XK gene. The supporting sentence is:\n\n\"A novel XK splice site mutation (IVS1-1G>A) has been identified in a McLeod patient who has developed hematologic, neuromuscular, and neurologic symptoms.\"\n\nThis sentence identifies the specific XK mutation and its role in the disease.", "retries": 1}
{"idx": 215, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('globus pallidus internus'), and the supporting sentence is relevant and covers the answer. However, the model's supporting sentence repeats the answer verbatim, which introduces slight redundancy. The logic is strong, but a more concise explanation could have been provided.\",\n  \"match\": true\n}", "gold_answer": "globus pallidus internus", "gold_support": "Bilateral pallidal deep brain stimulation (BP-DBS) of the globus pallidus internus (GPi) is an effective treatment for primary dystonia, but the effect of this reversible surgical procedure on dystonia-choreoathetosis CP, which is a subtype of secondary dystonia, is unknown.", "model_answer": "The neurostimulation targets the globus pallidus internus (GPi) for the treatment of dystonia.", "model_support": "The neurostimulation targets the globus pallidus internus (GPi) for the treatment of dystonia.\n\nSupporting sentence: \"Little improvement was seen when the neurostimulation diffused to adjacent structures (mainly to the globus pallidus externus [GPe]).\" This indicates that the primary target was the GPi, as diffusion to the GPe did not provide significant benefits.", "retries": 1}
{"idx": 216, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'matriptase,' does not match the gold standard, 'LEKTI.' However, 'matriptase' is mentioned in the context as a contributing factor in the disease mechanism. The supporting sentence focuses on matriptase's role in initiating the syndrome but does not cover the gold answer (LEKTI) or its critical role as the etiological origin of Netherton syndrome. Thus, while relevant, it fails to directly support the correct answer.\",\n  \"match\": false\n}", "gold_answer": "LEKTI", "gold_support": "Deficiency in the serine protease inhibitor LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.", "model_answer": "The protein causing Netherton syndrome is matriptase.", "model_support": "The protein causing Netherton syndrome is matriptase, as indicated by the supporting sentence:\n\n\"Here we show that the membrane protease matriptase initiates Netherton syndrome in a LEKTI-deficient mouse model by premature activation of a pro-kallikrein cascade.\"", "retries": 1}
{"idx": 217, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, Gαq, does not match the gold standard, Rac1, but Gαq is a known G protein involved in cellular processes, making it relevant though incorrect in this context. The supporting sentence is based on prior knowledge and does not cover the gold answer or directly reference the provided context. Thus, while the answer is present in the broader biological context, it fails to align with the specific information given in the passage.\", \"match\": false}", "gold_answer": "Rac1", "gold_support": "We demonstrated the utility of this system with LAD constructs that can recruit the small G-protein Rac1 to the plasma membrane and induce the local formation of lamellipodia in response to focal illumination.", "model_answer": "The G protein essential for the formation and function of lamellipodia is Gαq.", "model_support": "The supporting sentence for the answer is not present in the provided context. The answer is based on prior knowledge that Gαq is essential for lamellipodia formation, particularly through its role in activating phospholipase C, which affects the actin cytoskeleton. \n\n**Answer:** The G protein essential for the formation and function of lamellipodia is Gαq. \n\n**Supporting Sentence:** (Not provided in the context; based on prior knowledge) Gαq activates downstream effectors like phospholipase C, influencing cell signaling and cytoskeletal rearrangements necessary for lamellipodia formation.", "retries": 1}
{"idx": 218, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant and accurate information about Clostridium botulinum, including its association with sausage and anaerobic environments, which aligns well with the context. However, it is slightly redundant as it repeats the answer within the supporting sentence, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "An epidemiological investigation and laboratory detection studies showed that sausage contaminated by type A Clostridium botulinum caused this outbreak of food poisoning.", "model_answer": "The most known bacterium responsible for botulism, often referred to as sausage poisoning, is **Clostridium botulinum**. This bacterium thrives in anaerobic environments, such as those found in processed meats like sausages, and produces a potent toxin that causes the disease.", "model_support": "The most known bacterium responsible for botulism, often referred to as sausage poisoning, is **Clostridium botulinum**. This bacterium thrives in anaerobic environments, such as those found in processed meats like sausages, and produces a potent toxin that causes the disease.\n\n**Supporting Explanation:**\nWhile the context does not explicitly name Clostridium botulinum, it mentions an outbreak of foodborne botulism linked to contaminated sausage. This association with sausage and the nature of the disease (botulism) strongly implies the involvement of Clostridium botulinum, which is well-known for causing botulism in such scenarios.", "retries": 1}
{"idx": 219, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('iron') but is present in the context. The supporting sentence is relevant but does not directly cover the gold answer, as it focuses on the absence of explicit information in the context rather than extracting the relevant detail about iron deficiency. The logic is reasonable but misses the key point.\", \"match\": false}", "gold_answer": "iron", "gold_support": "RLS may also be secondary to a number of conditions including iron deficiency, pregnancy and end-stage renal failure and, perhaps, neuropathy.", "model_answer": "The context provided does not specify a particular deficiency that causes restless leg syndrome (RLS). While RLS is often associated with iron deficiency in general medical knowledge, this information is not included in the given context. Therefore, based on the provided context, the cause of RLS as a deficiency is not mentioned.", "model_support": "The context provided does not specify a particular deficiency that causes restless leg syndrome (RLS). While RLS is often associated with iron deficiency in general medical knowledge, this information is not included in the given context. Therefore, based on the provided context, the cause of RLS as a deficiency is not mentioned.", "retries": 1}
{"idx": 220, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'), though it uses a slightly more verbose form ('Sodium-Calcium Exchanger (NCX)'). The supporting sentence is relevant and provides logical backing for the answer, but it is somewhat indirect and includes additional experimental details not strictly necessary to support the answer. It could be more concise, like the gold supporting sentence.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Sodium-Calcium Exchanger (NCX).", "model_support": "The supporting sentence is:\n\n\"Thus, we examined the effect of SEA0400 on NCX currents and I/R induced intracellular Ca2+ overload in mouse ventricular myocytes using patch clamp techniques and fluorescence measurements.\"\n\nThis sentence indicates that SEA0400 was tested for its effect on NCX currents, supporting the conclusion that it inhibits the Sodium-Calcium Exchanger (NCX).", "retries": 1}
{"idx": 221, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it is slightly more verbose by specifying 'diagnosing strokes' instead of just 'stroke'. The supporting sentence provided by the model repeats the answer without adding further relevant context, making it somewhat redundant. However, it still logically supports the answer. The gold supporting sentence is more concise and directly ties the ROSIER scale to stroke assessment, making it a stronger choice.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for diagnosing strokes.", "model_support": "The ROSIER scale is used for diagnosing strokes.\n\nSupporting sentence: Emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 222, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model notes that the context does not explicitly state the inheritance pattern, this aligns with the instructions to use general medical knowledge if needed. The gold supporting sentence is slightly more detailed, but the model's supporting explanation is appropriate and accurate.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "The mode of inheritance of Facioscapulohumeral muscular dystrophy (FSHD) is autosomal dominant.", "model_support": "The mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD) is autosomal dominant. However, the provided context does not explicitly state this. The closest relevant information is the mention of a genetic test identifying a deletion, but it does not specify the inheritance pattern. Therefore, the answer is based on general medical knowledge rather than the given context.\n\nSupporting sentence: (Not explicitly provided in the context)", "retries": 1}
{"idx": 223, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides context for the answer, but it includes additional details about the study's aim that are not directly necessary to support the answer, introducing slight redundancy.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "Supporting sentence: The aim of this study was to assess the morphology and distribution of alpha-synuclein immunoreactivity in cases of dementia with Lewy bodies (DLB), and to compare alpha-synuclein with ubiquitin immunostaining.", "retries": 1}
{"idx": 224, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, PTEN is mentioned in the context as a 'new guardian of the genome', making it relevant but incorrect for this specific question. The supporting sentence refers to PTEN as a 'new guardian of the genome', which supports the model's answer but does not cover the gold answer ('p53'). Therefore, while the answer and supporting sentence are relevant to the context, they do not align with the gold standard.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is PTEN.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is PTEN. \n\n**Supporting sentence:** \"Thus, we propose that PTEN is a new guardian of the genome.\"", "retries": 1}
{"idx": 225, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by linking pridopidine to its testing in Huntington disease.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for treatment of Huntington disease.", "model_support": "The supporting sentence from the context is:\n\n\"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.\"", "retries": 1}
{"idx": 226, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('XK gene' is equivalent to 'XK'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking the XK gene mutation to McLeod syndrome. Minor extra details in the supporting sentence are acceptable as they do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The mutation in the XK gene is associated with McLeod syndrome. \n\nAnswer: XK gene", "model_support": "The supporting sentence from the context is:\n\n\"McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.\"\n\nThis sentence directly indicates that the XK gene mutation is associated with McLeod syndrome.", "retries": 1}
{"idx": 227, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states there is only one TAp73 isoform identified in humans, whereas the gold answer specifies seven. The supporting sentence mentions five N-terminal isoforms but does not provide evidence for the model's claim of only one TAp73 isoform, and it fails to address the correct number of isoforms. The reasoning is flawed, and the support is irrelevant to the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is one.", "model_support": "The supporting sentence from the context is:\n\n\"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.\"\n\nThis sentence indicates that TAp73 is one of the five N-terminal isoforms measured, confirming that only one TAp73 isoform was identified in the study.", "retries": 1}
{"idx": 228, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence in the model is incorrect as it states there is no information in the context, whereas the context clearly provides the relevant sentence. However, since the answer is correct and aligns perfectly with the gold standard, the score remains high based on the answer alone.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Wilson's disease is a rare genetic disorder of copper metabolism with autosomal recessive inheritance.", "model_answer": "The mode of inheritance of Wilson's disease is autosomal recessive.", "model_support": "The context provided does not contain any information about the mode of inheritance of Wilson's disease. Therefore, there is no supporting sentence in the context to answer the question.", "retries": 1}
{"idx": 229, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it repeats the answer verbatim without providing additional reasoning or context. Despite this, it is still relevant and supports the answer logically.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β).", "model_support": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β).\n\n**Supporting Sentence:**\n\"Canakinumab is known to neutralize IL-1β by competing for binding to IL-1R and therefore blocking signaling by the antigen:antibody complex.\"\n\nThis sentence indicates that canakinumab targets IL-1β, and the context further explains that both canakinumab and gevokizumab are studied in relation to IL-1β, confirming that Gevokizumab also targets the same molecule.", "retries": 1}
{"idx": 230, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('autosomal dominant') in meaning, though it includes additional details about the mutations. The supporting sentence is relevant and provides logical support by describing genetic linkage and mutations tied to the disease; however, it contains slight redundancy with extra details about specific families and mutations, which are not strictly necessary to justify the inheritance pattern.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner, primarily through specific gene mutations involving nucleotide repeat expansions.", "model_support": "The supporting sentence is: \"Multiple families, predominantly of German descent and with clinically variable presentation that included proximal myotonic myopathy (PROMM) and type 2 DM (DM2) but without the DM1 mutation, showed linkage to the 3q21 region and were recently shown to segregate a (CCTG)(n) expansion mutation in intron 1 of ZNF9.\"\n\nThis sentence indicates that the disease is linked to specific chromosomal regions and mutations, suggesting an autosomal dominant inheritance pattern, as it refers to families showing linkage and the presence of a specific mutation causing the disease.", "retries": 1}
{"idx": 231, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'factor Xa'). The supporting sentence is relevant and correctly explains that betrixaban is a direct factor Xa inhibitor. However, it contains slight redundancy by discussing the broader class of factor Xa inhibitors rather than focusing solely on betrixaban as the gold supporting sentence does. This makes it less concise but still logical.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "The drug betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\"\n\nThis sentence indicates that betrixaban, as a direct factor Xa inhibitor, targets factor Xa for inhibition.", "retries": 1}
{"idx": 232, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('antiparallel'), but the supporting sentence does not effectively utilize the provided context. Instead, it incorrectly states that there is no supporting sentence in the context, despite the gold supporting sentence being present and clearly relevant. The model answer itself is well-reasoned and explains the biological importance of the antiparallel arrangement, but the evaluation of the context is flawed. This results in a score of 3 for mixing correct reasoning with an incorrect assessment of the context.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Mapping the stress-dependent labeling kinetics of α- and β-spectrin by LC-MS/MS identifies Cys in these antiparallel chains that are either force-enhanced or force-independent in labeling, with structural analyses indicating the force-enhanced sites are sequestered either in spectrin's triple-helical domains or in interactions with actin or ankyrin.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. This arrangement is crucial for the formation of the spectrin-actin network, which provides mechanical support and flexibility to the cell membrane, particularly in red blood cells. The antiparallel orientation allows the tetramer to distribute stress effectively and maintain the cell's shape under various conditions.", "model_support": "The context provided does not explicitly state that alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. Therefore, there is no supporting sentence within the given context for this answer. The assertion about the antiparallel arrangement may be based on general biological knowledge rather than the specific details provided in the context.", "retries": 1}
{"idx": 233, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (NF1), but the supporting sentence is slightly redundant as it repeats the answer verbatim. While the provided context about Nf1 and Trp53 mutation is relevant, it does not directly cover the specific relationship between NF1 mutations and neurofibromatosis type I as comprehensively as the gold supporting sentence. Some minor verbosity exists, but the logic is still sound.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Humans with mutations in NF1 develop neurofibromatosis type I (NF1) and have increased risk of optic gliomas, astrocytomas and glioblastomas.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.", "model_support": "The gene mutated in type 1 neurofibromatosis is the NF1 gene. \n\n**Supporting sentence:** \"We present here a mouse model of astrocytomas involving mutation of two tumour-suppressor genes, Nf1 and Trp53.\"", "retries": 1}
{"idx": 234, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by emphasizing DNMT1's role in the DNA damage response, which indirectly ties to its function in maintaining DNA methylation. However, the supporting sentence includes slight redundancy by mentioning the broader context of DNA damage response machinery, which is not directly necessary for justifying the answer.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "We and others have shown that DNA methyltransferase 1 (DNMT1), the maintenance methyltransferase, contributes to the cellular response to DNA damage, yet DNMT1's exact role in this process remains unclear.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The supporting sentence from the context is:\n\n\"Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery.\"\n\nThis sentence highlights DNMT1's role in the DNA damage response, which is part of its broader function in maintaining DNA methylation.", "retries": 1}
{"idx": 235, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically covers the answer by clearly linking [18F]altanserin to the evaluation of 5-HT2A serotonin receptors.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The [18F]altanserin can be used to evaluate the **5-HT2A serotonin receptors** in the brain.", "model_support": "The supporting sentence is:\n\n\"The test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.\"\n\nThis sentence clearly indicates that [18F]altanserin is used to evaluate the 5-HT2A serotonin receptors in the brain.", "retries": 1}
{"idx": 236, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning by referencing p53's role as a tumor suppressor, which aligns with its widely recognized title of 'guardian of the genome.'\", \"match\": true}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**. \n\nSupporting sentence: While the context does not explicitly mention the nickname, it refers to p53's role as a tumor suppressor and its importance in inhibiting tumorigenesis, which aligns with its widely recognized title.", "retries": 1}
{"idx": 237, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly less direct compared to the gold supporting sentence, which explicitly mentions the co-administration of L-DOPA and benserazide in specific dosages. The model's supporting sentence captures the key idea but does not include the explicit detail about the combination treatment being administered subcutaneously.\", \"match\": true}", "gold_answer": "L-DOPA", "gold_support": "They were injected subcutaneously (s.c.) with L-DOPA methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-DOPA/benserazide) alone or in combination with (-)-OSU6162 (1.0, 3.0, 6.0 or 10 mg/kg, s.c.).", "model_answer": "Benserazide is typically co-administered with L-DOPA. This combination helps to increase dopamine levels in the brain by reducing the breakdown of L-DOPA in the body, thereby improving symptoms in Parkinson's disease patients. \n\nAnswer: L-DOPA", "model_support": "The supporting sentence from the context is:\n\n\"L-DOPA/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\"\n\nThis sentence indicates that benserazide is co-administered with L-DOPA, as they are used together to manage symptoms in Parkinson's disease.", "retries": 1}
{"idx": 238, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains slight redundancy by repeating the answer itself as part of the supporting sentence. The logic is strong, but the repetition prevents it from being perfectly concise.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.\n\n**Supporting sentence:** \"Labeling studies with [(14)C]phenylalanine indicated that afrormosin conjugates were the major de novo synthesized isoflavonoid products in unelicited cells. During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.\"\n\nThis sentence supports the conclusion that medicarpin is the major phytoalexin, particularly under elicitation conditions.", "retries": 1}
{"idx": 239, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('calcineurin'). The supporting sentence is concise, directly relevant, and logically explains the role of calcineurin in NFAT activation by mentioning its dephosphorylation requirement for NFAT nuclear localization. There is no redundancy or excessive content.\",\n  \"match\": true\n}", "gold_answer": "calcineurin", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Calcineurin (CaN) is the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors.", "model_support": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors is Calcineurin (CaN). \n\n**Supporting Sentence:** \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 240, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the truncating ZFHX1B mutations found in patients with the characteristic phenotype of Mowat-Wilson syndrome.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "\"Mowat-Wilson\" syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZFHX1B. \n\n**Supporting sentence:** Direct sequencing demonstrated truncating ZFHX1B mutations in all four patients with the characteristic facial phenotype, but not in the patient with syndromic Hirschsprung disease without the distinct facial appearance.", "retries": 1}
{"idx": 241, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') and is correct. The supporting sentence provided by the model is relevant and supports the answer with logical reasoning, but it contains slight redundancy by elaborating on both DUX4 and PITX1, while the gold supporting sentence focuses more concisely on DUX4 alone. This makes the model's supporting sentence slightly more verbose than necessary.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is **Facioscapulohumeral muscular dystrophy (FSHD)**.", "model_support": "The supporting sentence that links the ectopic expression of DUX4 protein to Facioscapulohumeral muscular dystrophy (FSHD) is:\n\n\"Our results suggest that up-regulation of both DUX4 and PITX1 in FSHD muscles may play critical roles in the molecular mechanisms of the disease.\"\n\nThis sentence directly connects the increased expression of DUX4 with FSHD, indicating its role in the disease's molecular mechanisms.", "retries": 1}
{"idx": 242, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('nuclear'). The supporting sentence provided by the model is relevant and accurate but slightly redundant compared to the gold supporting sentence. While it correctly explains the nuclear import mechanism, it does not directly emphasize that A3B is the only family member with steady-state nuclear localization, which is a key point in the gold supporting sentence. Overall, the logic is strong, but the model's sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The APOBEC3B protein is predominantly nuclear. \n\n**Supporting Sentence:**  \n\"A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID (activation-induced cytosine deaminase).\"", "retries": 1}
{"idx": 243, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'betrixaban inhibits factor Xa' is correct and aligns with the gold standard 'Xa'. However, it is slightly more verbose than necessary. The supporting sentence provides relevant information but includes details about the study’s objectives, which are not directly required to support the answer, introducing slight redundancy. Despite this, the logic connecting betrixaban to being a factor Xa inhibitor is clear.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors.\"\n\nThis sentence confirms that betrixaban, along with rivaroxaban, apixaban, and edoxaban, is a direct factor Xa inhibitor.", "retries": 1}
{"idx": 244, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly addresses the role of phospholamban as a regulator of SERCA2a, but it contains slight redundancy by repeating the answer verbatim. The logic is strong, but the inclusion of extra wording makes it less concise than the ideal.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban (PLN), the reversible inhibitor of the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA2a), is a key regulator of myocyte Ca(2+) cycling with a significant role in heart failure.", "model_answer": "Phospholamban is the main regulatory molecule of SERCA2a function in cardiac muscle.", "model_support": "The main regulatory molecule of SERCA2a function in cardiac muscle is phospholamban. \n\n**Supporting sentence:**  \n\"SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.\"", "retries": 1}
{"idx": 245, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer, but it is slightly more verbose than necessary. While it covers the importance of BTK inhibition and mentions ibrutinib, it includes additional details about the TCL1 mouse model that are not essential to directly support the answer. The gold supporting sentence is more concise while still being clear and relevant.\",\n  \"match\": true\n}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "The name of the Bruton's tyrosine kinase inhibitor used for treating chronic lymphocytic leukemia is ibrutinib.", "model_support": "The supporting sentence is: \"Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL, demonstrating that BTK is a critical kinase for CLL development and expansion and thus an important target of ibrutinib.\"", "retries": 1}
{"idx": 246, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'hypothyroidism' is very close to the gold standard 'thyroid,' as hypothyroidism directly relates to thyroid abnormalities. However, it does not match the gold answer exactly. The supporting sentence is relevant and supports the answer with a specific example of congenital hypothyroidism in Williams syndrome, though it includes slightly more detail than necessary. The logic is sound, but the answer could be more concise to fully match the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "The common hormone abnormality in Williams syndrome is hypothyroidism.", "model_support": "The supporting sentence that indicates hypothyroidism is a common hormone abnormality in Williams syndrome is:\n\n\"In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"", "retries": 1}
{"idx": 247, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking DH to gluten exposure as described in the context. Minor extra details are present but do not detract from the strong logic.\",\n  \"match\": true\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is a chronic papulovesicular immune-mediated disorder associated with gluten-sensitive enteropathy.", "model_answer": "The typical rash associated with gluten is Dermatitis herpetiformis. \n\nAnswer: Dermatitis herpetiformis", "model_support": "The typical rash associated with gluten is dermatitis herpetiformis (DH), as indicated by the context which discusses the onset of DH in patients with celiac disease after gluten exposure. \n\nSupporting sentence: \"We report eight cases in which DH appeared many years after celiac disease (CD) in child.\"", "retries": 1}
{"idx": 248, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why ibrutinib is the correct answer by referencing its role in inhibiting BTK kinase activity in CLL. Minor additional context from the model's supporting sentence does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "ibrutinib", "gold_support": "Bruton's tyrosine kinase (BTK) shows constitutive activity in CLL and is the target of irreversible inhibition by ibrutinib, an orally bioavailable kinase inhibitor that has shown outstanding activity in CLL.", "model_answer": "Ibrutinib is the Bruton's tyrosine kinase inhibitor used for treating chronic lymphocytic leukemia.\n\nAnswer: Ibrutinib", "model_support": "The supporting sentence from the context is:\n\n\"Inhibition of BTK kinase activity through either targeted genetic inactivation or ibrutinib in the TCL1 mouse significantly delays the development of CLL...\"\n\nThis sentence directly mentions ibrutinib as the Bruton's tyrosine kinase inhibitor used for treating chronic lymphocytic leukemia.", "retries": 1}
{"idx": 249, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly by identifying DNMT1 as the enzyme involved in maintaining DNA (cytosine-5-)-methylation. The supporting sentence is concise, directly relevant, and logically explains the role of DNMT1 in the maintenance of DNA methylation patterns based on both the context provided and general biological knowledge.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "We propose a new model that suggests that the maintenance of DNA methylation relies not only on the recognition of hemimethylated DNA by DNA methyltransferase 1 (DNMT1) but also on the localization of the DNMT3A and DNMT3B enzymes to specific chromatin regions that contain methylated DNA.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1).", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1). \n\n**Supporting sentence:** While the context does not explicitly name the enzyme, it discusses the process of maintaining DNA methylation patterns during cell division. Based on established biological knowledge, DNMT1 is the enzyme responsible for this maintenance.", "retries": 1}
{"idx": 250, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context, as Pendred syndrome involves thyroid hormone abnormalities. However, the supporting sentence discusses thyroid enlargement and L-thyroxine therapy, which is relevant but does not directly cover the gold answer ('thyroid'). The explanation of low T3, T4, and elevated TSH is correct but goes beyond the gold answer's simplicity. The supporting sentence is relevant but lacks direct alignment with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroidectomy in a patient with multinodular dyshormonogenetic goitre--a case of Pendred syndrome confirmed by mutations in the PDS/SLC26A4 gene.", "model_answer": "Pendred syndrome is characterized by low levels of thyroid hormones, specifically triiodothyronine (T3) and thyroxine (T4), accompanied by elevated thyroid-stimulating hormone (TSH) levels. \n\nAnswer: Low levels of triiodothyronine (T3) and thyroxine (T4) with elevated thyroid-stimulating hormone (TSH).", "model_support": "The supporting sentence from the context is:\n\n\"A small diffuse thyroid enlargement developed during infancy and although substitution therapy with L-thyroxine was adequate, it progressed and underwent multinodular transformation.\"\n\nThis sentence indicates that the patient required substitution therapy with L-thyroxine, which is a treatment for low thyroid hormone levels, supporting the presence of low T3 and T4 with elevated TSH.", "retries": 1}
{"idx": 251, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, '17,20-lyase,' does not match the gold standard 'CYP17A1.' While '17,20-lyase' is related to the activity of CYP17A1 and mentioned in the context, it is not the correct enzyme name. The supporting sentence discusses reduced androgen synthesis but fails to directly mention CYP17A1 as the specific enzyme inhibited by Orteronel. It provides relevant information about androgen suppression but does not cover the gold answer adequately.\", \"match\": false}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Orteronel inhibits the enzyme 17,20-lyase, which is involved in the synthesis of androgens in the adrenal glands. This inhibition helps reduce overall androgen levels, making it effective in treating prostate cancer. \n\nAnswer: 17,20-lyase", "model_support": "The enzyme inhibited by Orteronel is 17,20-lyase. \n\n**Supporting sentence:** \"Orteronel treatment leads to reduced prostate-specific antigen levels, a marker of prostate cancer tumor burden, and more complete suppression of androgen synthesis than conventional androgen deprivation therapies that act in the testes alone.\" \n\nThis indicates that Orteronel suppresses androgen synthesis beyond the testes, likely targeting 17,20-lyase in the adrenal glands to reduce androgen levels.", "retries": 1}
{"idx": 252, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context that bortezomib is used to treat multiple myeloma, but it includes additional details about the treatment cycles and patient numbers, which are not necessary to directly support the answer. This makes it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, indicated for multiple myeloma (MM) treatment, is available in 3.5-mg vials, a quantity higher than the average dose commonly prescribed.", "model_answer": "Velcade (bortezomib) is mainly used to treat multiple myeloma.", "model_support": "The supporting sentence that links Velcade (bortezomib) to the treatment of multiple myeloma is:\n\n\"Thirty-five patients (mean body surface area of 1.73 m(2)) received 509 infusions in 131 cycles of treatment (average of 3.77 cycles per patient).\"\n\nThis sentence refers to patients with MM (multiple myeloma) being treated with bortezomib, confirming its use for this disease.", "retries": 1}
{"idx": 253, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning the identification of BCR-ABL as a key development in CML treatment, but it is slightly redundant because it does not directly explain the role of BCR-ABL or its connection to Imatinib as clearly as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a hematopoietic stem cell cancer driven by the BCR-ABL fusion protein that arises from the translocation of chromosomes 9 and 22.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "**Supporting Sentence:**  \n\"The discovery of the Ph and, subsequently, the identification of BCr-ABL revolutionized the treatment of CML.\"  \n\nThis sentence supports the answer by indicating that BCr-ABL is the target of Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 254, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'lingual dystonia,' does not match the gold standard 'X-linked dystonia-parkinsonism.' However, the term 'lingual dystonia' is mentioned in the context, albeit as a symptom rather than a synonym for lubag disease. The supporting sentence refers to lingual dystonia but does not logically support it as a synonym for lubag disease. It discusses a treatment for lingual dystonia, which is irrelevant to providing a synonym. Thus, while partially relevant, the model answer and supporting sentence do not align with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The synonym for \"lubag disease\" is lingual dystonia.", "model_support": "The synonym for \"lubag disease\" is lingual dystonia, as indicated by the context. \n\nSupporting sentence: Botulinum toxin injection for severe lingual dystonia was successful.", "retries": 1}
{"idx": 255, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model, although identical to the answer, is concise, directly relevant, and aligns with the logical reasoning found in the context. It effectively conveys the connection between gluten and dermatitis herpetiformis without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "BACKGROUND: Dermatitis herpetiformis (DH) is a specific dermatological manifestation of coeliac disease and 80% of DH patients have gluten sensitive enteropathy manifested by crypt hyperplasia and villous atrophy.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "The typical rash associated with gluten is dermatitis herpetiformis.\n\nSupporting sentence: \n\"Metalloelastase (MMP-12) was abundantly expressed by subepithelial macrophages in both coeliac intestine and spontaneous and induced DH rash.\"", "retries": 1}
{"idx": 256, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the topic but fails to cover the gold answer directly. It speculates about a cytoplasmic role without referencing the explicit statement in the context that APOBEC3B is predominantly nuclear. The logic is weakened by the lack of direct support for the correct answer.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "The context provided does not explicitly state whether the APOBEC3B protein is predominantly cytoplasmic or nuclear. However, it does suggest that APOBEC3B and APOBEC3F provide a preintegration barrier to L1 retrotransposition, which might imply a cytoplasmic role. This is speculative, as the context does not confirm the localization directly. Therefore, based on the information given, we cannot definitively determine the predominant localization of APOBEC3B.", "retries": 1}
{"idx": 257, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although identical to the model's answer, is concise, directly relevant, and logically covers the answer by clearly stating the disease investigated in the MR CLEAN study. There is no excessive verbosity or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The disease investigated in the MR CLEAN study is acute ischemic stroke.", "model_support": "The disease investigated in the MR CLEAN study is acute ischemic stroke. \n\nSupporting sentence: The disease investigated in the MR CLEAN study is acute ischemic stroke.", "retries": 1}
{"idx": 258, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Betrixaban inhibits factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the answer, but it is slightly verbose and contains extra information about a reversal agent (PRT4445), which is not directly necessary to support the answer. A more concise supporting sentence could have been chosen, such as the title itself ('Evaluation of the oral direct factor Xa inhibitor - betrixaban').\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context that indicates betrixaban inhibits factor Xa is:\n\n\"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence supports the answer because it associates betrixaban with anti-Xa activity, implying that it inhibits factor Xa. The mention of a reversal agent for anti-Xa agents further confirms that betrixaban targets factor Xa.", "retries": 1}
{"idx": 259, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'PD-1' as the protein targeted by the antibodies. The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that the antibodies target the PD-1 protein. Although it repeats the answer verbatim, this is acceptable since the logic is strong and there is no excessive or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "The antibodies MK-3475 and CT-011 target the **PD-1** protein.", "model_support": "The antibodies MK-3475 and CT-011 target the PD-1 protein.\n\nSupporting sentence: \"In summary, we demonstrate that PD-1 expression is increased in T cells of patients with active myeloma, and that CT-011 enhances activated T-cell responses after DC/tumor fusion stimulation.\"", "retries": 1}
{"idx": 260, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'FGFR3' matches the gold standard 'fibroblast growth factor receptor 3 (FGFR3)' in meaning, though it is a shortened form. The supporting sentence provided by the model is relevant and concise, directly linking FGFR3 to Achondroplasia. However, it lacks the specific detail about the mutation (N540K) mentioned in the gold supporting sentence, which slightly reduces its comprehensiveness. Overall, the logic is strong, but minor details are missing.\",\n  \"match\": true\n}", "gold_answer": "fibroblast growth factor receptor 3 (FGFR3)", "gold_support": "These phenotypic findings were later confirmed by the presence of fibroblast growth factor receptor 3 (FGFR3) gene mutation N540K.", "model_answer": "The gene mutation associated with Achondroplasia is FGFR3.\n\nAnswer: FGFR3", "model_support": "The mutation associated with Achondroplasia is in the FGFR3 gene.\n\n**Supporting Sentence:**  \n\"Hypochondroplasia due to FGFR3 gene mutation (N540K) and mosaic form of Down syndrome in the same patient.\"", "retries": 1}
{"idx": 261, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'). However, the supporting sentence is somewhat redundant because it unnecessarily states that the context does not explicitly mention the answer, which is incorrect since the gold supporting sentence directly provides this information from the text. Despite this, the supporting sentence still correctly identifies JNK as the kinase responsible for c-Jun phosphorylation based on general knowledge, making it relevant but slightly verbose.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "An in vitro kinase assay revealed that the resultant c-Jun phosphorylation was primarily mediated via activated c-Jun N-terminal protein kinase (JNK).", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "model_support": "The context provided does not explicitly mention which MAP kinase phosphorylates c-jun. Therefore, it is not possible to identify a supporting sentence from the given text. However, based on general knowledge, JNK (c-Jun N-terminal kinase) is a MAP kinase known to phosphorylate c-jun.", "retries": 1}
{"idx": 262, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('stroke'), though it is more verbose than necessary. The supporting sentence is relevant and supports the answer by specifying that the ROSIER scale is used as a stroke recognition tool in the prehospital setting, but it includes slight redundancy (e.g., 'emergency physicians prospectively used'). Overall, the logic is strong, but a more concise explanation could have been provided.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for diagnosing stroke in emergency settings, particularly in the prehospital environment to aid in recognizing stroke symptoms accurately.", "model_support": "The supporting sentence is:  \n\"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"\n\nThis sentence directly indicates that the ROSIER scale is utilized by emergency physicians in the prehospital setting for recognizing stroke symptoms, aligning with the answer provided.", "retries": 1}
{"idx": 263, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking the NF1 gene to neurofibromatosis type 1, but it introduces additional information about the gene being a candidate tumor suppressor for sporadic insulinomas, which adds slight redundancy. The core logic is strong, but this extra detail makes the sentence less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "It is well known that patients with von Recklinghausen syndrome (NF-1) (OMIM 162200) carrying NF1 germline mutations are predisposed to endocrine tumors including pheochromocytomas and duodenal somatostatinomas.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.\n\nAnswer: NF1", "model_support": "The supporting sentence that identifies the gene mutated in type 1 neurofibromatosis is:\n\n\"Furthermore, the NF1 gene must be considered as a candidate tumor suppressor gene for sporadic insulinomas and probably other pancreatic endocrine tumors.\"\n\nThis sentence directly links the NF1 gene to the syndrome and its role in the development of tumors, confirming that the NF1 gene is the one mutated in neurofibromatosis type 1.", "retries": 1}
{"idx": 264, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('thiol peroxidase enzyme') is more specific than the gold answer ('antioxidant'), which is present in the context but does not fully align with the gold standard. The supporting sentence correctly identifies PRDX2 as an antioxidant enzyme but adds unnecessary details about thiol peroxidase and general function, making it less concise and somewhat redundant.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "Here, we offer the first evidence that an antioxidant enzyme has a key role in this transition.", "model_answer": "Peroxiredoxin-2 (PRDX2) is a thiol peroxidase enzyme. It functions within the cell's antioxidant defense system by reducing peroxides using a conserved cysteine residue, which is regenerated by thioredoxin. This activity helps protect the cell from oxidative damage.", "model_support": "The context provided does not explicitly state the type of enzyme that peroxiredoxin-2 (PRDX2) is. However, based on general knowledge, PRDX2 is a thiol peroxidase enzyme involved in antioxidant defense by reducing peroxides. \n\n**Answer:** The context does not explicitly identify the type of enzyme PRDX2 is. However, from general knowledge, PRDX2 is a thiol peroxidase enzyme.", "retries": 1}
{"idx": 265, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively highlights that the study's objective was to investigate metabolic changes in Huntington disease patients before and after pridopidine treatment, which aligns perfectly with the gold answer.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "The supporting sentence from the context is:\n\n\"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"\n\nThis sentence directly indicates that Pridopidine was tested for the treatment of Huntington disease.", "retries": 1}
{"idx": 266, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the competition with the methyl group donor S-Adenosyl methionine.\", \"match\": true}", "gold_answer": "S-Adenosyl methionine", "gold_support": "To investigate if tumor growth is dependent on the enzymatic activity of Ezh2, we developed a potent and selective small molecule inhibitor, EI1, which inhibits the enzymatic activity of Ezh2 through direct binding to the enzyme and competing with the methyl group donor S-Adenosyl methionine.", "model_answer": "The methyl donor for histone methyltransferases is S-adenosyl methionine (SAM).\n\nAnswer: S-adenosyl methionine (SAM)", "model_support": "The context provided does not include information about S-adenosyl methionine (SAM) being the methyl donor for histone methyltransferases. Therefore, there is no supporting sentence from the context to answer the question.\n\nAnswer: The context does not provide information about the methyl donor for histone methyltransferases.", "retries": 1}
{"idx": 267, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('cerebral hemiatrophy') but is present in the context. It lists features like hemiplegia, microcephaly, and intellectual disability, which are associated with the syndrome but do not directly address the characteristic feature identified in the gold answer. The supporting sentence mentions relevant details (spastic hemiplegia, microcephaly, developmental delay), but it does not cover the gold answer ('cerebral hemiatrophy') as the primary diagnostic feature observed on CT. Therefore, while the content is somewhat related, it misses the key diagnostic hallmark.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic features of Dyke-Davidoff-Masson syndrome are hemiplegia, microcephaly, and intellectual disability.", "model_support": "The characteristic features of Dyke-Davidoff-Masson syndrome, as described in the context, include spastic hemiplegia, microcephaly, and developmental delay, which can be indicative of intellectual disability. These features are highlighted in the supporting sentence:\n\n\"A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains.\"\n\n**Answer:** The characteristic features of Dyke-Davidoff-Masson syndrome are spastic hemiplegia, microcephaly, and developmental delay (intellectual disability).", "retries": 1}
{"idx": 268, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context mentions 'transcriptionally active TAp73 isoforms' in plural, which implies there are multiple TAp73 isoforms, yet the model incorrectly concludes there is only one. Additionally, the supporting sentence provided by the model is overly verbose and does not directly support the correct answer. It focuses on describing the two types of p73 isoforms (TAp73 and DeltaNp73) rather than addressing how many TAp73 isoforms exist.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context identifies two isoforms of p73: TAp73 and DeltaNp73. Specifically, TAp73 is one isoform, and DeltaNp73 is another. Therefore, the number of TAp73 isoforms identified is one.\n\nAnswer: One.", "model_support": "The context identifies two isoforms of p73: TAp73 and DeltaNp73. Specifically, TAp73 is one isoform, and DeltaNp73 is another. Therefore, the number of TAp73 isoforms identified is one.\n\nSupporting sentence: \"Transcription from two different promoters on the p73 gene results in generation of transcriptionally active TAp73 isoforms and dominant negative DeltaNp73 isoforms with opposing pro- and anti-apoptotic functions.\"", "retries": 1}
{"idx": 269, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('repressor'). The supporting sentence is concise, directly relevant, and logically explains that BACH1 acts as a repressor by referencing its role in HO-1 regulation. This aligns well with the gold supporting sentence without introducing unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "BTB and CNC homolog 1 (Bach1) is a transcriptional repressor of heme oxygenase-1 (HO-1).", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor based on its role in the feedback regulation of HO-1 expression, where its absence leads to increased HO-1 levels and reduced intestinal injury.\n\n**Supporting sentence:**  \n\"It plays an important role in the feedback regulation of HO-1 expression, which protects cells from various insults including oxidative stress and inflammatory cytokines.\"", "retries": 1}
{"idx": 270, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer correctly identifies BACH1 as a repressor, matching the gold standard. The supporting sentence provides relevant and accurate information about BACH1's role in repressing transcription and its interaction with heme levels, which supports the answer well. However, it is slightly verbose compared to the concise gold supporting sentence, which directly states BACH1's function as a repressor without additional mechanistic details.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "The transcriptional regulator BACH1 is a repressor. It inhibits the transcription of the alpha-globin gene, particularly when heme levels are low, by binding to the NA site in the HS-40 enhancer. The presence of heme reduces Bach1's repressive activity and promotes its nuclear export, thereby allowing gene expression to proceed.", "model_support": "The transcriptional regulator BACH1 is a repressor. It inhibits the transcription of the alpha-globin gene, particularly when heme levels are low, by binding to the NA site in the HS-40 enhancer. The presence of heme reduces Bach1's repressive activity and promotes its nuclear export, thereby allowing gene expression to proceed.", "retries": 1}
{"idx": 271, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that Clostridium botulinum is responsible for botulism by referencing the context provided. Although the model supporting sentence includes a bit more detail about foodborne illness, this does not detract from the clarity or correctness of the explanation.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "BACKGROUND: Botulism is a serious neuroparalytic disease caused by toxins of Clostridium botulinum.", "model_answer": "Clostridium botulinum", "model_support": "The most known bacterium responsible for botulism is Clostridium botulinum. While the provided context does not explicitly mention the bacterium, it discusses botulism and the botulinum toxin, which is produced by Clostridium botulinum. This bacterium is well-known for causing botulism, including cases of foodborne illness often linked to improperly preserved foods, hence the term \"sausage-poisoning.\"\n\n**Supporting Sentence:** The context discusses the botulinum toxin and its role in botulism, implying the involvement of Clostridium botulinum, the bacterium that produces this toxin.", "retries": 1}
{"idx": 272, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise and directly relevant, logically covering the answer by identifying ZEB2 as the gene responsible for Mowat-Wilson syndrome. Although the gold supporting sentence provides additional detail about haploinsufficiency and mutations, the model's supporting sentence is still correct and sufficient.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZEB2.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZEB2.\n\nSupporting sentence: \"This report, the first such analysis in North American patients, adds to the growing list of both novel pathogenic mutations associated with MWS, as well as other variants in the ZEB2 gene.\"", "retries": 1}
{"idx": 273, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context for Clostridium botulinum being associated with botulism, but it contains slight redundancy by mentioning a diagnostic method (PCR) that is not directly necessary to support the answer. The logic is strong, but the additional details about PCR make it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease in animals is mainly caused by toxins produced by Clostridium botulinum strains belonging to group III, although outbreaks due to toxins produced by group I and II organisms have been recognized.", "model_answer": "The most well-known bacterium responsible for botulism is **Clostridium botulinum**.", "model_support": "The supporting sentence that identifies Clostridium botulinum as the bacterium responsible for botulism is:\n\n\"In this article we report the development and in-house validation of a new multiplex real-time PCR for detecting and typing the neurotoxin genes found in C. botulinum group III organisms.\"\n\nThis sentence directly mentions Clostridium botulinum in the context of developing a diagnostic method for botulism, thereby supporting the answer.", "retries": 1}
{"idx": 274, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about nestin-positive cells, but it includes slightly more detail about the cultivation conditions than necessary, making it somewhat redundant compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "Only a minority of stem cells expressed nestin, a marker for neural precursor cells.", "model_answer": "The intermediate filament protein used as a non-specific marker for neuronal precursor cells in the subventricular zone is nestin.\n\nAnswer: Nestin", "model_support": "Supporting sentence: Cultivation in serum-free medium supplemented with specific growth factors resulted in a markedly higher percentage of nestin-positive cells.", "retries": 1}
{"idx": 275, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that alpha-synuclein is the main component of Lewy bodies. The logic is strong without excessive content.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\n**Supporting Sentence:**  \n\"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies. Accumulation of ubiquitylated synphilin-1 leads to massive formation of inclusion bodies, which resemble Lewy bodies by their ability to recruit alpha-synuclein.\"", "retries": 1}
{"idx": 276, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'icatibant,' does not match the gold standard 'ecallantide.' However, icatibant is a drug used in similar contexts, so it is present in the broader context of treatments for hereditary angioedema. The supporting sentence mentions the effectiveness of DX-88 but does not provide any specific information to directly support the incorrect answer or clarify the relationship between DX-88 and ecallantide. Therefore, while relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "ecallantide", "gold_support": "DX-88 (ecallantide), a 60-amino acid recombinant protein discovered through phage display technology, is a highly specific, potent inhibitor of human plasma kallikrein that has been used successfully in the treatment of patients experiencing acute HAE attacks.", "model_answer": "DX-88 is the investigational name of the drug icatibant.", "model_support": "The supporting sentence from the context is:\n\n\"After administration of DX-88, 80 mg intravenously, abdominal pain and nausea resolved within 30 min.\"\n\nThis sentence supports the answer by indicating the use and effectiveness of DX-88 in treating the patient, aligning with the known fact that DX-88 is the investigational name of icatibant.", "retries": 1}
{"idx": 277, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is not directly relevant to the answer and lacks the key information about LY450139 being semagacestat. The gold supporting sentence explicitly states the relationship between LY450139 and semagacestat, making it more appropriate and concise.\",\n  \"match\": true\n}", "gold_answer": "semagacestat", "gold_support": "The γ-secretase inhibitor LY450139 (semagacestat) lowers plasma Aβ(1-40) and Aβ(1-42) in a dose-dependent manner but has no clear effect on the CSF level of these isoforms.", "model_answer": "The investigational name of LY450139 is semagacestat.", "model_support": "The supporting sentence is: \"9 dogs were treated with a single dose of the γ-secretase modulator E2012, the γ-secretase inhibitor LY450139, or vehicle...\"", "retries": 1}
{"idx": 278, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that cysteine mutations are central to CADASIL syndrome by referencing the context's emphasis on loss or gain of cysteine residues. This aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "cysteine", "gold_support": "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited cerebrovascular disease due to mutations involving loss or gain of a cysteine residue in the NOTCH3 gene.", "model_answer": "Cysteine.", "model_support": "The amino acid residue that appears mutated in most cases of CADASIL syndrome is cysteine. This is supported by the context's focus on mutations leading to the loss or gain of a cysteine residue, indicating their significance in the disease.\n\n**Supporting Sentence:**  \n\"Moreover genetic variants different from loss or gain of a cysteine residue are identified and presented.\"", "retries": 1}
{"idx": 279, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('p53'). However, the supporting sentence provided by the model is not as direct or concise as the gold supporting sentence. While it correctly identifies p53 and provides context about its role in genomic studies, it does not explicitly mention the key reasoning that p53 is called 'the guardian of the genome' because it controls apoptosis and cell cycle arrest. The model's supporting sentence introduces additional information about the study without clearly emphasizing the defining feature of p53 from the context.\",\n  \"match\": true\n}", "gold_answer": "di", "gold_support": "The p53 gene has been referred to as 'the guardian of the genome' because it controls apoptosis and cell cycle arrest.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\n**Supporting sentence:** \"The purpose of this study was to evaluate the association of p53 codon 72 genetic polymorphism and the p53 immunohistochemistry with Helicobacter pylori-associated gastroduodenal diseases, including gastric cancer.\"\n\nThis sentence supports the answer by mentioning p53, which is known as the \"guardian of the genome\" for its role in maintaining genomic stability and preventing cancer.", "retries": 1}
{"idx": 280, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in essence, as 'factor Xa' is equivalent to 'xa'. The supporting sentence provided by the model is relevant and supports the answer by indicating that betrixaban belongs to the class of direct factor Xa inhibitors. However, the supporting sentence is slightly redundant because it only broadly refers to the class of drugs without directly referencing the specific mechanism of action for betrixaban. A more concise and direct supporting sentence would have been preferred.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation.\"\n\nThis sentence establishes that betrixaban, as part of the class of direct factor Xa inhibitors, targets factor Xa, supporting the answer that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 281, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by citing the exact phrase from the context that explains why p53 is referred to as 'the guardian of the genome.'\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**. \n\n**Answer:** p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.\n\n**Supporting Sentence:**  \n\"This is the first report that demonstrates the mechanism of action of the MAR-binding protein SMAR1 in modulating the activity of p53, often referred to as the 'guardian of the genome.'\"", "retries": 1}
{"idx": 282, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard, but the supporting sentence is incorrect and does not cover the gold answer. The provided supporting sentence discusses macroautophagy, which is not relevant to the KFERQ motif or chaperone-mediated autophagy (CMA).\", \"match\": true}", "gold_answer": "chaperone-mediated autophagy (CMA)", "gold_support": "Macroautophagy is followed by chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes through the LAMP-2A (Lysosome-associated membrane protein type 2A) receptor.", "model_answer": "The autophagy pathway triggered by the KFERQ motif of cytosolic proteins is chaperone-mediated autophagy (CMA).", "model_support": "Supporting sentence: The first response of autophagy is macroautophagy, which sequesters cytoplasm including organelles inside double-membraned autophagosome vesicles that fuse with lysosomes to degrade and recycle the contents.", "retries": 1}
{"idx": 283, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence relies on external general knowledge rather than directly citing relevant information from the context, which contains an explicit statement about TCR preferentially repairing the transcribed strand. While the logic is sound and the explanation clear, the supporting sentence could have been more concise by directly referencing the provided context.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "It has been previously shown that disruption of RAD26 in yeast strain W303-1B results in a strain that is deficient in transcription-coupled repair (TCR), the preferential repair of the transcribed strand of an expressed gene over the non-transcribed strand and the rest of the genome.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the **transcribed strand**.", "model_support": "The supporting sentence for the answer that transcription-coupled repair (TCR) targets the transcribed strand is not explicitly provided in the given context. However, based on general knowledge, TCR is known to repair damage primarily on the transcribed strand as transcription machinery can detect and repair lesions during transcription. The context discusses the role of Rad26 in chromatin remodeling and its impact on TCR, but it does not specify the strand targeted by TCR.\n\nAnswer: The gene strand targeted by transcription-coupled repair (TCR) is the **transcribed strand**.\n\nSupporting sentence: While the context does not explicitly state this, it is generally understood that TCR repairs damage on the transcribed strand, as transcription machinery can detect and repair lesions during transcription.", "retries": 1}
{"idx": 284, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'SERCA2a', is very close to the gold standard 'SERCA2', as SERCA2a is a specific isoform of the SERCA2 gene and is correct in the context of the heart. The supporting sentence is relevant and directly identifies SERCA2a as the main calcium pump in the heart, aligning well with the gold supporting sentence. However, the model answer could be considered slightly more specific than necessary since 'SERCA2' would have sufficed as a broader term covering all isoforms. The supporting sentence also contains a minor redundancy by specifying 'mainly represented,' which adds slight verbosity. Overall, it logically supports the answer.\", \"match\": true}", "gold_answer": "SERCA2", "gold_support": "During diastole, muscle relaxation occurs as Ca2+ is again removed from cytosol, predominantly by accumulation into SR via the action of SERCA2a.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA2a.", "model_support": "The supporting sentence from the context is:\n\n\"SERCA is mainly represented by the SERCA2a isoform in the heart.\"\n\nThis sentence directly identifies SERCA2a as the main calcium pump of the sarcoplasmic reticulum in the heart.", "retries": 1}
{"idx": 285, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer ('NF1 gene') matches the gold standard ('NF1'), though it includes 'gene,' which is slightly more verbose than necessary. The supporting sentence repeats the answer but does not provide additional reasoning or context to support the claim, making it less informative compared to the gold supporting sentence. However, it still aligns with the correct information and is relevant.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "The NF1 gene codes for a protein called \"neurofibromin.\" It possesses a region that shares a high homology with the family of GTPase-activating proteins, which are negative regulators of RAS function and thereby control cell growth and differentiation.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.", "model_support": "The gene mutated in type 1 neurofibromatosis is the NF1 gene. \n\n**Step-by-Step Explanation:**\n\n1. **Understanding the Context:** The context discusses the NF1 gene's role in neurofibromatosis. It refers to a double-hit model where both copies of the NF1 gene are inactivated, contributing to tumor development.\n\n2. **Identifying Key Information:** The text explicitly states that the NF1 gene is a tumor-suppressor gene and that mutations in both copies are associated with neurofibromas.\n\n3. **Connecting to Neurofibromatosis Type 1:** Neurofibromatosis type 1 (NF1) is directly linked to mutations in the NF1 gene, as indicated by the study's findings and the discussed genetic model.\n\n**Answer:** The NF1 gene is the gene mutated in type 1 neurofibromatosis.", "retries": 1}
{"idx": 286, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by explaining that all three complexes, including the one corresponding to MLL1, are H3K4 methyltransferases. However, it introduces slight redundancy by mentioning Drosophila specifics that are not directly required for supporting the answer about MLL1.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Methylation of histone H3 lysine 4 (H3K4) in Saccharomyces cerevisiae is implemented by Set1/COMPASS, which was originally purified based on the similarity of yeast Set1 to human MLL1 and Drosophila melanogaster Trithorax (Trx).", "model_answer": "The histone residue methylated by MLL1 is H3K4.", "model_support": "The supporting sentence is: \"all three complexes in Drosophila are H3K4 methyltransferases; however, dSet1/COMPASS is the major monoubiquitination-dependent H3K4 di- and trimethylase in Drosophila.\" This indicates that MLL1, corresponding to Trx, methylates H3K4.", "retries": 1}
{"idx": 287, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard ('p16INK4a' vs. 'p16INK4'), with only a minor discrepancy in formatting (omission of 'a'). However, the supporting sentence does not directly support the answer as it mentions the lack of correlation between Bmi-1 and p16INK4a, which could confuse the reader. The logic behind the regulation could have been better supported by more relevant information from the context.\", \"match\": true}", "gold_answer": "p16INK4", "gold_support": "Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.", "model_answer": "The cyclin-dependent kinase inhibitor regulated by Bmi-1 is **p16INK4a**.", "model_support": "The supporting sentence from the context is: \"however, there was no correlation between expression of Bmi-1 and p16INK4a, p14ARF, or h-TERT.\"\n\nDespite this, the answer provided is p16INK4a, which is a cyclin-dependent kinase inhibitor regulated by Bmi-1. This suggests that while the context indicates no correlation in expression levels in this specific study, Bmi-1 is generally known to regulate p16INK4a, possibly through other mechanisms not addressed in the study. \n\n**Answer:** The cyclin-dependent kinase inhibitor regulated by Bmi-1 is **p16INK4a**. \n\n**Supporting sentence:** \"however, there was no correlation between expression of Bmi-1 and p16INK4a, p14ARF, or h-TERT.\"", "retries": 1}
{"idx": 288, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly, correctly identifying Semagacestat as the drug corresponding to LY450139. However, the supporting sentence includes extra information about discontinuation and adverse effects, which, while accurate, is not directly mentioned in the context provided. The gold supporting sentence is more concise and directly relevant to the answer.\",\n  \"match\": true\n}", "gold_answer": "Semagacestat", "gold_support": "The outcomes of the clinical trials of the γ-secretase inhibitor Semagacestat (LY-450139) and the γ-secretase modulator (GSM) Tarenflurbil were disappointing, but may not represent the end of the γ-secretase era.", "model_answer": "LY450139 is the investigational name for Semagacestat, a γ-secretase modulator that was being developed as a potential treatment for Alzheimer's disease. However, it was discontinued due to adverse effects, including an increased risk of skin cancer.", "model_support": "The context provided does not mention LY450139 or Semagacestat. Therefore, based on the given text, I cannot identify LY450139 as the investigational name for any specific drug. However, from external knowledge, LY450139 is known as Semagacestat, a γ-secretase modulator that was discontinued due to adverse effects.", "retries": 1}
{"idx": 289, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, though it includes 'recessive' which is not strictly necessary for synonymy. The supporting sentence provided by the model is a direct repetition of its answer, which is relevant but slightly redundant compared to the more detailed and logical gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Despite recessive inheritance, X-linked dystonia-parkinsonism (Lubag disease) has also been described in women presenting with a late-onset isolated parkinsonian syndrome.", "model_answer": "The synonym of the lubag disease is X-linked recessive dystonia-parkinsonism.", "model_support": "The synonym of the lubag disease is X-linked recessive dystonia-parkinsonism. \n\nSupporting sentence: \"Woman with x-linked recessive dystonia-parkinsonism: clue to the epidemiology of parkinsonism in Filipino women?\"", "retries": 1}
{"idx": 290, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('antiparallel'). The supporting sentence provided by the model is concise, directly relevant, and clearly supports the answer by stating that alpha-spectrin and beta-spectrin form antiparallel heterodimers. This aligns well with the gold supporting sentence, maintaining clarity and logical reasoning.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.\n\nSupporting sentence: R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.", "retries": 1}
{"idx": 291, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Betrixaban inhibits factor Xa' is accurate and aligns with the gold standard 'Xa'. However, the supporting sentence chosen by the model is not the most concise or direct evidence for the answer. The gold supporting sentence 'Evaluation of the oral direct factor Xa inhibitor - betrixaban' directly states that betrixaban is a factor Xa inhibitor, making it more suitable. The model's supporting sentence introduces additional context about a factor Xa decoy, which, while relevant, adds unnecessary information and slightly reduces clarity and conciseness.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence that indicates betrixaban inhibits factor Xa is:\n\n\"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence implies that betrixaban targets factor Xa, as it is discussed alongside a factor Xa decoy, suggesting its role in inhibiting factor Xa.", "retries": 1}
{"idx": 292, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' in essence, as it correctly identifies the broader chemical group with additional specificity. The supporting sentence, though not from the provided context, is relevant and directly supports the answer by confirming JTV519 as a 1,4-benzothiazepine derivative. However, the use of an external source for the supporting sentence introduces slight redundancy, as the context already provides a concise and sufficient statement ('Protective effect of JTV519, a new 1,4-benzothiazepine derivative').\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence for the answer that JTV519 is a 1,4-benzothiazepine derivative is not explicitly present in the provided context. However, based on prior knowledge from another context, the sentence is:\n\n\"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 293, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Zfhx1b' matches the gold standard 'ZFHX1B' in substance, as they refer to the same gene with minor formatting differences (case sensitivity). The supporting sentence is relevant and covers the answer logically, though it does not explicitly mention the connection to human Mowat-Wilson syndrome as comprehensively as the gold supporting sentence. It focuses on the mouse model without emphasizing the broader clinical context, making it slightly less ideal but still valid.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is Zfhx1b.\n\n**Answer:** Zfhx1b", "model_support": "The gene responsible for Mowat-Wilson syndrome is Zfhx1b.\n\n**Supporting sentence:** Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.", "retries": 1}
{"idx": 294, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('alpha-synuclein' vs. 'Alpha-synuclein'). The supporting sentence is relevant and provides a logical explanation of alpha-synuclein's role in Lewy body formation, supported by the context. However, it includes slight redundancy in mentioning beta-synuclein's regulatory role, which adds verbosity without being necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein (AS) is the main component of Lewy bodies and its aggregation is a key event in the pathogenesis of PD.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. This conclusion is supported by the context, which discusses the role of beta-synuclein in inhibiting alpha-synuclein aggregation and regulating its functionality, thereby highlighting alpha-synuclein's central role in Lewy body formation. \n\n**Answer:**  \nThe main component of Lewy bodies is alpha-synuclein.", "retries": 1}
{"idx": 295, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. The gold answer specifies 7 isoforms, while the model incorrectly states there are only two (TAp73α and TAp73β). However, the supporting sentence acknowledges that the context does not provide specific information about the number of TAp73 isoforms, which aligns with the fact that the model's answer is based on external knowledge rather than the given context. The supporting sentence is relevant but fails to cover the gold answer, resulting in a score of 2.\", \"match\": false}", "gold_answer": "7", "gold_support": "The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "model_answer": "The number of TAp73 isoforms identified in humans is two: TAp73α and TAp73β.", "model_support": "The context does not provide specific information about the number of TAp73 isoforms identified in humans. It mentions TAp73, DeltaNp73, and DeltaN'p73 being upregulated but does not specify the number of TAp73 isoforms. The answer provided refers to external knowledge about TAp73α and TAp73β, which is not supported by the given context.\n\n**Answer:** The context does not provide a supporting sentence for the number of TAp73 isoforms identified in humans. The information about two isoforms is based on external knowledge not present in the context.", "retries": 1}
{"idx": 296, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer matches the gold standard ('flumazenil') but is more verbose than necessary. The supporting sentence provided by the model incorrectly states that there is no supporting sentence in the context, while the context does contain a relevant sentence mentioning flumazenil as a treatment for benzodiazepine intoxication. Therefore, the supporting sentence evaluation is incorrect.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15-1788).", "model_answer": "The antidote for benzodiazepine overdose is flumazenil, which acts as a GABA receptor antagonist to reverse the effects of benzodiazepines.", "model_support": "The context provided does not contain a supporting sentence for the answer. The given context discusses criteria of efficacy related to sedation and orientation but does not mention flumazenil or its use as an antidote. Therefore, there is no supporting sentence in the provided context to confirm the answer.\n\nAnswer: There is no supporting sentence in the context provided that mentions flumazenil or its use as an antidote for benzodiazepine overdose.", "retries": 1}
{"idx": 297, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by explaining the role of isoflavone reductase in medicarpin biosynthesis, but it includes slightly more detail about the enzyme than necessary, making it somewhat redundant compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence is: \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\" This sentence indicates that IFR is crucial for the production of medicarpin, identifying it as the major phytoalexin in alfalfa. \n\n**Answer:** The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**. \n\n**Supporting Sentence:** \"Isoflavone reductase (IFR), the penultimate enzyme in medicarpin biosynthesis, is responsible for introducing one of two chiral centers in (-)-medicarpin.\"", "retries": 1}
{"idx": 298, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Telcagepant targets the CGRP receptor' is essentially correct and aligns with the gold standard 'calcitonin gene-related peptide,' as both refer to the same receptor. However, the gold answer uses the full term rather than the abbreviation. The supporting sentence provides accurate information about telcagepant being a CGRP receptor antagonist but includes additional details about its function in preventing blood vessel dilation, which, while correct, are not directly necessary to support the answer. This makes the supporting sentence slightly more verbose than needed.\", \"match\": true}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.", "model_answer": "Telcagepant targets the CGRP receptor.", "model_support": "The receptor targeted by telcagepant is the CGRP receptor. Although the context provided does not explicitly state this, it is known from pharmacology studies that telcagepant functions as a CGRP receptor antagonist, which prevents the dilation of blood vessels associated with migraines. \n\n**Answer:** Telcagepant targets the CGRP receptor.", "retries": 1}
{"idx": 299, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'DNA methyltransferase 1 (Dnmt1)' is a correct and equivalent identification of the enzyme. However, the supporting sentence provided by the model is somewhat redundant because it repeats the same information as the answer without adding further context or reasoning. The gold supporting sentence provides richer detail about the role of Dnmt1 in maintaining methylation patterns, making it more informative and logically supportive.\",\n  \"match\": true\n}", "gold_answer": "Dnmt1", "gold_support": "The maintenance methylation of hemimethylated CpG sites by the DNA methyltransferase Dnmt1 is the molecular basis of the inheritance of DNA methylation patterns.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (Dnmt1).", "model_support": "The enzyme involved in maintaining DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (Dnmt1). \n\n**Supporting Sentence:**  \n\"Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.\"", "retries": 1}
{"idx": 300, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard in essence, mentioning α-synuclein as the main component. However, it includes additional details about modifications (phosphorylation, ubiquitination, nitration), which are not strictly necessary for answering the question but remain factually accurate. The supporting sentence provides relevant information from the context and supports the answer logically, though it repeats some of the extra detail present in the answer. The gold supporting sentence is more concise, hence a score of 4.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "The main component of Lewy bodies is α-synuclein, which is modified through phosphorylation, ubiquitination, and nitration.", "model_support": "The main component of Lewy bodies is α-synuclein, which undergoes modifications such as phosphorylation, ubiquitination, and nitration. \n\n**Supporting sentence:**  \n\"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.\"", "retries": 1}
{"idx": 301, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer. While the context mentions multiple isoforms (TAp73 alpha and Delta Np73 alpha), the model incorrectly concludes that only one TAp73 isoform exists, missing the broader array of isoforms implied by 'an array of p73 proteins.'\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans, as per the context provided, is one. Specifically, TAp73 alpha is the identified isoform.", "model_support": "The context identifies one TAp73 isoform in humans, specifically TAp73 alpha.\n\n**Supporting Sentence:**  \n\"p73, the first p53 gene homologue, encodes an array of p73 proteins including p73 alpha full-length (TAp73 alpha) and amino-truncated isoforms (Delta Np73 alpha), two proteins with opposite biological functions.\"", "retries": 1}
{"idx": 302, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as both specify 'the transcribed strand.' However, the supporting sentence provided by the model is a direct repetition of the answer, which lacks additional context or logical reasoning. The gold supporting sentence provides more comprehensive information about TCR targeting the transcribed strand within the framework of NER subpathways. Despite this, the model's supporting sentence from the context is relevant and aligns with the gold answer, though it is less detailed.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of the gene.", "model_support": "The transcription-coupled repair (TCR) targets the transcribed strand of the gene.\n\n**Supporting sentence:**  \n\"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"", "retries": 1}
{"idx": 303, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'ZEB2', is correct but does not exactly match the gold standard 'ZFHX1B'. However, ZEB2 is an alternative name for ZFHX1B, making the answer valid within the context. The supporting sentence repeats the answer without additional reasoning or direct relevance to the gold supporting sentence. It lacks the contextual details provided in the gold standard (e.g., haploinsufficiency, chromosome 2). Slight redundancy exists, but the logic connecting the gene to the syndrome is sound.\",\n  \"match\": false\n}", "gold_answer": "ZFHX1B", "gold_support": "Haploinsufficiency of a gene termed ZFHX1B (also known as SIP1) on chromosome 2 is responsible for this condition, and clinical genetic testing for MWS recently became available.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is **ZEB2**.", "model_support": "The gene responsible for Mowat-Wilson syndrome is **ZEB2**. \n\nSupporting sentence (implied from external knowledge): Mowat-Wilson syndrome is caused by mutations in the ZEB2 gene, which is involved in the development of various tissues and organs.", "retries": 1}
{"idx": 304, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard, as CYP17A1 is the enzyme inhibited by Orteronel. However, the supporting sentence provided by the model is a direct repetition of the answer, which lacks explanatory depth. While it is relevant, it does not offer the detailed reasoning seen in the gold supporting sentence, which explains the role of CYP17A1 and its activities. The model's supporting sentence could be more informative rather than just restating the answer.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "The enzyme inhibited by Orteronel is 17,20-lyase (CYP17A1).", "model_support": "The enzyme inhibited by Orteronel is 17,20-lyase (CYP17A1).\n\n**Supporting sentence:** \"Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.\"", "retries": 1}
{"idx": 305, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**. \n\n**Answer:** p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.\n\n**Answer:** p53\n\n**Supporting sentence:** \"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"", "retries": 1}
{"idx": 306, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer 'Iron deficiency' matches the gold standard 'iron' in essence, though it is slightly more verbose. The supporting sentence is relevant and covers the answer, but it introduces additional context (e.g., cystic fibrosis and chronic hemoptysis) that, while accurate, is not necessary to explain the core relationship between iron deficiency and restless leg syndrome. This makes it somewhat redundant compared to the gold supporting sentence, which is more concise and directly tied to the gold answer.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are considered to be a continuum of a neurological sleep disorder associated with abnormal iron metabolism or deficiency.", "model_answer": "The deficiency causing restless leg syndrome in this case is iron deficiency. \n\nAnswer: Iron deficiency", "model_support": "Supporting sentence: \"I describe a case of RLS and PLMD in a cystic fibrosis patient with iron deficiency from chronic hemoptysis.\"", "retries": 1}
{"idx": 307, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about the drug's function and development stage are acceptable as they do not detract from the clarity or correctness of the response.\", \"match\": true}", "gold_answer": "semagacestat", "gold_support": "ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).", "model_answer": "The investigational name LY450139 refers to the drug Semagacestat. \n\nAnswer: Semagacestat", "model_support": "The supporting sentence is: \"Semagacestat (LY450139) is a novel γ-secretase inhibitor currently in late-stage development by Eli Lilly and Company as a potential treatment for Alzheimer's disease (AD).\"", "retries": 1}
{"idx": 308, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as it correctly identifies SERCA (Sarco/Endoplasmic Reticulum Calcium ATPase) as the main calcium pump. However, the supporting sentence is slightly redundant because it merely mentions 'modulation' of the Ca(2+)-ATPase without directly emphasizing its role as the primary calcium pump. While relevant, it could be more concise and explicit like the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is the Ca²⁺-ATPase, commonly referred to as SERCA (Sarco/Endoplasmic Reticulum Calcium ATPase). This enzyme is responsible for actively transporting calcium ions into the SR, playing a crucial role in muscle relaxation and calcium regulation.", "model_support": "The supporting sentence from the context is:\n\n\"Modulation of rabbit muscle sarcoplasmic reticulum Ca(2+)-ATPase activity by novel quercetin derivatives.\"\n\nThis sentence directly identifies Ca(2+)-ATPase as the main calcium pump of the sarcoplasmic reticulum, which is also known as SERCA.", "retries": 1}
{"idx": 309, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, as 'SECIS element' is a valid expansion of the gold answer 'SECIS.' The supporting sentence chosen by the model is relevant but does not directly cover the gold answer or provide details about the SECIS element itself. It focuses on the investigation of selenocysteine insertion rather than explicitly mentioning the identification or function of the SECIS elements in the 3' UTR. Therefore, while the answer is correct and the sentence is relevant, it lacks specificity and direct logical support for the gold answer.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "Two functional SECIS elements were identified in the 3' untranslated region of the rat selenoprotein P mRNA, with predicted stem-loops and critical nucleotides similar to those in the SECIS elements in the type I iodothyronine 5' deiodinase (5'DI) and glutathione peroxidase selenoprotein mRNAs.", "model_answer": "The stem loop present in the 3' end of genes encoding for selenoproteins is called the SECIS element.\n\nAnswer: SECIS element", "model_support": "The supporting sentence is:  \n\"We investigated the requirements for selenocysteine insertion at single or multiple UGA codons in eukaryotic selenoproteins.\"", "retries": 1}
{"idx": 310, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard (XK gene vs. XK), though it is slightly more verbose by including 'gene.' The supporting sentence provided by the model is relevant but does not directly reference the specific mutation or details from the context, unlike the gold supporting sentence which explicitly mentions the missense mutation in exon 3. The model's supporting sentence is less precise and lacks the specificity of the gold supporting sentence, leading to a score of 4.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.\n\nAnswer: XK gene", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene. \n\n**Supporting sentence:** McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.", "retries": 1}
{"idx": 311, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'myelosuppression,' does not match the gold standard, 'cardiotoxicity.' Myelosuppression is mentioned in the context as a dose-limiting toxicity, but it is not identified as the major adverse effect of Adriamycin. The supporting sentence mentions myelosuppression but fails to cover the gold answer, cardiotoxicity, which is described in the context as a major and serious adverse effect. The supporting sentence is relevant but does not align with the gold standard.\", \"match\": false}", "gold_answer": "Cardiotoxicity", "gold_support": "Cardiotoxicity is a major adverse effect of the anthracycline antibiotics and can be acute or chronic; in the acute setting, electrocardiographic abnormalities may be seen, including ST-T elevations and arrhythmias, but chronic cardiotoxicity represents a serious adverse effect that may be lethal due to the development of irreversible, cumulative dose-dependent, congestive cardiomyopathy.", "model_answer": "The major adverse effect of Adriamycin (doxorubicin) is myelosuppression, characterized by neutropenia and leucopenia.", "model_support": "The major adverse effect of Adriamycin (doxorubicin) is myelosuppression, characterized by neutropenia and leucopenia. \n\n**Supporting sentence:**  \n\"Myelosuppression, predominantly neutropenia and leucopenia, is the dose-limiting toxicity; in addition to this, mucositis, nausea, vomiting and alopecia are frequent, whereas hepatopathy, characterised by elevated bilirubin concentrations, occurs less frequently.\"", "retries": 1}
{"idx": 312, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly establishes the connection between DX-88 and ecallantide through logical reasoning. Although the model supporting sentence includes additional details about ecallantide's function, these do not detract from the clarity or correctness of the response.\",\n  \"match\": true\n}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies.", "model_answer": "The investigational name DX-88 refers to the drug ecallantide.\n\nAnswer: ecallantide", "model_support": "The supporting sentence in the context that identifies ecallantide as the drug referred to by the investigational name DX-88 is:\n\n\"Ecallantide, a novel plasma kallikrein inhibitor, inhibits production of bradykinin, the key mediator of these angioedema attacks.\"\n\nThis sentence establishes ecallantide as the drug being discussed, which is known by the investigational name DX-88.", "retries": 1}
{"idx": 313, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'), though it adds slight extra detail by specifying 'c-Jun N-terminal kinase.' The supporting sentence provides relevant information but includes redundancy and verbosity, mentioning general knowledge instead of focusing directly on the context. It could be more concise by removing phrases like 'based on general knowledge' and focusing on the relevance of JNK in the provided context. Overall, the logic is sound, but there is room for brevity.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "The expressions of Bcl-2, Bax, caspase-3, extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal protein kinases (JNK), and p38 were evaluated by Western blot.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "model_support": "The question asks which MAP kinase phosphorylates the transcription factor c-jun. The answer provided is JNK (c-Jun N-terminal kinase). \n\nThe context discusses the involvement of MAP kinase pathways in apoptosis but does not explicitly mention JNK or c-jun. However, based on general knowledge, JNK is known to phosphorylate c-jun. \n\nAnswer: The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase). \n\nSupporting explanation: While the context does not explicitly name JNK, it is a known fact that JNK is responsible for phosphorylating c-jun.", "retries": 1}
{"idx": 314, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and clearly identifies SEA0400 as an inhibitor of the Na+/Ca2+ exchanger (NCX), which logically supports the answer. There is no excessive content or redundancy.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "Using SEA0400, a potent and selective inhibitor of the Na+-Ca2+ exchanger (NCX), we examined whether NCX is involved in nitric oxide (NO)-induced disturbance of endoplasmic reticulum (ER) Ca2+ homeostasis followed by apoptosis in cultured rat microglia.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX).", "model_support": "The supporting sentence from the context is:\n\n**\"SEA0400, a specific inhibitor of the Na+-Ca2+ exchanger, attenuates sodium nitroprusside-induced apoptosis in cultured rat microglia.\"**\n\nThis sentence directly identifies SEA0400 as an inhibitor of the Na+/Ca2+ exchanger.", "retries": 1}
{"idx": 315, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes a statement about the context not mentioning nestin, which introduces slight redundancy. Despite this, the logic is clear and directly supports the answer.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "In the subventricular zone, this effect was exerted selectively on a precursor subpopulation expressing nestin but not neuronal or glial cell-specific proteins.", "model_answer": "The intermediate filament protein nestin is commonly used as a non-specific marker for neuronal precursor cells in the subventricular zone.\n\nAnswer: Nestin", "model_support": "The question asks for an intermediate filament protein used as a non-specific marker for neuronal precursor cells in the subventricular zone. Based on general knowledge, nestin is commonly used for this purpose. However, the provided context does not mention nestin or any other specific proteins related to this function. Therefore, the answer is based on external knowledge rather than the given context.\n\n**Answer:** Nestin is commonly used as a non-specific marker for neuronal precursor cells in the subventricular zone, though this information is not supported by the provided context.", "retries": 1}
{"idx": 316, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'antioxidant enzyme,' aligns with the gold standard 'antioxidant,' though it includes extra detail ('enzyme') not explicitly required. The supporting sentence is relevant and supports the answer by identifying PRDX2 as an Srx-dependent modified enzyme, which ties into its role in the antioxidant system. However, the supporting sentence could be slightly more concise, as it introduces minor redundancy when mentioning Srx dependency.\",\n  \"match\": true\n}", "gold_answer": "antioxidant", "gold_support": "The aim of this study was to examine gonadotropin regulation of antioxidant enzyme sulfiredoxin (Srx) and peroxiredoxin 2 (PRDX2) expressions and modification during the ovulatory process in rats.", "model_answer": "Peroxiredoxin 2 (PRDX2) is an antioxidant enzyme that functions to detoxify hydrogen peroxide, playing a role in maintaining cellular redox balance.", "model_support": "The enzyme peroxiredoxin 2 (PRDX2) is identified as an Srx-dependent modified enzyme, indicating its role in the antioxidant system. \n\n**Supporting Sentence:**  \n\"Gene expression of PRDX2, identified as an Srx-dependent modified enzyme, was stimulated by gonadotropins.\"", "retries": 1}
{"idx": 317, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly ('Fungi'). However, the supporting sentence, while relevant and introducing the analysis comparing Microsporidia with Fungi, is slightly indirect and does not explicitly state the phylogenetic relationship. It contains minor redundancy by referencing the software rather than focusing on the key evidence of the relationship. A more concise and direct supporting sentence would have been 'Phylogenetic analysis indicates a relationship between the Microsporidia and the Fungi.'\", \"match\": true}", "gold_answer": "Fungi", "gold_support": "Phylogenetic analysis indicates a relationship between the Microsporidia and the Fungi.", "model_answer": "Microsporidia belong to the kingdom Fungi.", "model_support": "The supporting sentence from the context is:\n\n\"New evidence on the relationship between Microsporidia and Fungi: a genome-wide analysis by DarkHorse software.\"\n\nThis sentence introduces the analysis comparing Microsporidia and Fungi, suggesting their classification within the kingdom Fungi.", "retries": 1}
{"idx": 318, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly mentions that pridopidine was tested in the context of Huntington disease, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "**Supporting Sentence:**\n\"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.\"", "retries": 1}
{"idx": 319, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer 'antiparallel' matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer by discussing the pairing of motifs in a manner consistent with an antiparallel arrangement. However, it includes slightly more detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "The spectrin heterodimer is formed by the antiparallel lateral association of an alpha and a beta subunit, each of which comprises largely a series of homologous triple-helical motifs.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The supporting sentence from the context is:\n\n\"complementary long range electrostatic interactions on the AB faces of the triple-helical motifs in the dimer nucleation site initiate the correct pairing of motifs, i.e. alpha21-beta1 and alpha20-beta2.\"\n\nThis sentence indicates that the motifs pair in a way that suggests an antiparallel arrangement, as alpha21 pairs with beta1 and alpha20 pairs with beta2, which is a reverse order.", "retries": 1}
{"idx": 320, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence is irrelevant and overly verbose, failing to logically support the gold answer. The context clearly provides the correct synonym in parentheses, which the model missed.\", \"match\": false}", "gold_answer": "X-linked dystonia-Parkinsonism", "gold_support": "Adductor laryngeal breathing dystonia in a patient with lubag (X-linked dystonia-Parkinsonism syndrome).", "model_answer": "The synonym of the lubag disease is lingual dystonia.", "model_support": "The term \"lubag disease\" is not mentioned in the provided context. Therefore, it is not possible to confirm a synonym for \"lubag disease\" based on the given information.", "retries": 1}
{"idx": 321, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and logically supports the answer by referencing the examination of SEA0400's effect on NCX currents. Minor additional details about the methods used (patch clamp techniques and fluorescence measurements) are acceptable as they do not detract from the clarity or accuracy of the support.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "SEA0400, a novel Na+/Ca2+ exchanger inhibitor, reduces calcium overload induced by ischemia and reperfusion in mouse ventricular myocytes.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Sodium-Calcium Exchanger (NCX), an ion antiporter/exchanger.\n\n**Answer:** Sodium-Calcium Exchanger (NCX)", "model_support": "**Supporting Sentence:**  \n\"Thus, we examined the effect of SEA0400 on NCX currents and I/R induced intracellular Ca2+ overload in mouse ventricular myocytes using patch clamp techniques and fluorescence measurements.\"\n\nThis sentence directly indicates that SEA0400 was tested for its effect on NCX currents, supporting the conclusion that it inhibits the Sodium-Calcium Exchanger (NCX).", "retries": 1}
{"idx": 322, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin is used to evaluate serotonin 5-HT2A receptors. There is no redundancy or unnecessary content.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the serotonin 5-HT2A receptors. \n\nAnswer: 5-HT2A receptors", "model_support": "The receptors that can be evaluated with [18F]altanserin are the serotonin 5-HT2A receptors.\n\nSupporting sentence: To this end, the regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.", "retries": 1}
{"idx": 323, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context. The supporting sentence repeats the model's answer verbatim and is overly verbose when contrasted with the gold supporting sentence, which directly explains the genetic cause of Pendred syndrome. While the information about normal TSH levels and iodine organification is relevant to the condition, it does not align with the specific gold answer or its supporting explanation.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Biallelic mutations of SLC26A4 (encoding pendrin) cause Pendred syndrome (PS), an autosomal recessive genetic disorder with deafness and goiter.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are normal serum thyrotropin (TSH) levels and normal iodine organification.", "model_support": "The characteristic hormone abnormalities in Pendred syndrome are normal serum thyrotropin (TSH) levels and normal iodine organification. \n\n**Supporting Sentence:**  \n\"The mechanism underlying the development of the goiter is unknown. Here, we report clinical and molecular findings of a patient with PS. This 27-year-old woman was born to nonconsanguineous healthy parents. She was seen at our hospital due to hearing loss at age 3 years, and subsequently developed goiter at age 10 years. Thyroidal iodine uptake was also increased during goiter progression ((123)I uptake at 24 hr: 20.2% at age 17 years; 69.4% at age 24 years; reference, 8-40), while serum thyrotropin (TSH) levels and iodine organification (examined by the perchrolate or thiocyanate discharge test) remained normal.\"", "retries": 1}
{"idx": 324, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly supports the answer by identifying EWS/FLI1 as the fusion protein involved in Ewing sarcoma. However, it contains slight redundancy by mentioning the regulation of EYA3 and its effects on cell survival and chemoresistance, which are not necessary to justify the specific answer about the fusion protein.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "The fusion protein involved in the development of Ewing sarcoma is EWS/FLI1.", "model_support": "The supporting sentence from the context is: \n\n\"EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.\"\n\nThis sentence directly identifies EWS/FLI1 as the fusion protein involved in the development of Ewing sarcoma.", "retries": 1}
{"idx": 325, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Stroke'). The supporting sentence is concise, directly relevant, and logically explains that the ROSIER scale is used as a stroke recognition tool in the prehospital setting. It aligns well with the gold supporting sentence while maintaining clarity and brevity.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for recognizing or diagnosing stroke in the prehospital setting. It helps emergency physicians identify stroke or transient ischemic attack in suspected patients before they reach the hospital.\n\nAnswer: Stroke", "model_support": "The supporting sentence is:\n\n\"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"\n\nThis sentence directly states that the ROSIER scale is used for recognizing stroke in the prehospital setting by emergency physicians.", "retries": 1}
{"idx": 326, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides information that ties medicarpin to its role in alfalfa, but it includes some additional details about transcript levels in roots and root nodules, which are not strictly necessary to support the answer. This makes it slightly more verbose than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized by way of the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence is: \"In healthy alfalfa plants, the highest levels of transcripts were detected in roots and root nodules, consistent with the synthesis of medicarpin and its conjugate in these tissues.\" This indicates that medicarpin is synthesized in the roots and root nodules, which are typical sites for phytoalexin production, thus confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 327, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Acute stroke,' is very close to the gold standard 'stroke' and is correct in context. The supporting sentence is relevant and directly addresses the use of the ROSIER scale for differentiating acute stroke in the ER, which aligns well with the gold supporting sentence. However, the supporting sentence contains slight redundancy by specifying 'from other conditions with similar symptoms,' which is implied but not necessary for full accuracy.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke in the emergency room setting. It helps differentiate stroke from other conditions with similar symptoms, improving the accuracy of referrals to the stroke team. \n\nAnswer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 328, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The supporting sentence from the context is:\n\n\"Among many genetic lesions, mutational inactivation of p53 tumor suppressor, the 'guardian of the genome,' is the most frequent event found in 50% of human cancers.\"\n\nThis sentence directly refers to p53 as \"the guardian of the genome,\" confirming the answer.", "retries": 1}
{"idx": 329, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Rheumatoid Arthritis is more common in women') does not match the gold standard ('women'), as it is a complete sentence rather than a concise response. However, the information provided in the model's answer is correct based on general medical knowledge, though it is not explicitly supported by the context given. The supporting sentence acknowledges that the context does not provide prevalence data but introduces external knowledge instead. While relevant, the supporting sentence is somewhat verbose and does not directly reference the specific gender distribution presented in the results section of the context (n=67 men vs. n=225 women), which could have offered stronger support.\", \"match\": false}", "gold_answer": "women", "gold_support": "RESULTS: At baseline, men (n = 67) and women (n = 225) had similar disease activity and radiographic damage; men, however, had significantly worse erosion, while women had worse joint space narrowing.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "The context provided does not explicitly address the prevalence of Rheumatoid Arthritis (RA) in men versus women. It focuses on a study examining gender differences in disease progression and treatment responses in a specific cohort of early RA patients. Therefore, while it is known from general medical knowledge that RA is more common in women, this information is not supported by the given context.\n\n**Answer:** The context does not provide information on whether Rheumatoid Arthritis is more common in men or women.", "retries": 1}
{"idx": 330, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is slightly more detailed than the gold standard but still correct and relevant. It mentions congenital hypothyroidism, which directly relates to thyroid abnormalities, matching the gold answer conceptually. The supporting sentence is relevant and provides useful context about the need for regular thyroid assessments in Williams syndrome, although it is somewhat verbose compared to the concise gold supporting sentence. Overall, the logic is sound, but the additional details lower the score slightly.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Hormone abnormalities common in Williams syndrome include congenital hypothyroidism, as evidenced by the case described where the individual had low thyroid function and required treatment with L-thyroxine. Regular thyroid assessments are recommended for individuals with Williams syndrome.", "model_support": "The supporting sentence from the context is:\n\n\"Therefore, the possibility of congenital hypothyroidism should always be taken into consideration too and, even if congenital hypothyroidism neonatal screening is negative, thyroid (morphology and function) evaluation should be regularly assessed when the diagnosis is made and, thereafter, every year in the first years of life.\"", "retries": 1}
{"idx": 331, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer with logical reasoning, but it includes additional details about Hsp70's interaction with CHIP and its role in ubiquitination, which slightly increases verbosity without being strictly necessary to support the answer.\", \"match\": true}", "gold_answer": "Hsp70", "gold_support": "Inhibition of Hsp90 upregulated the expression of Hsp70 and Hsp70-bound Nox2, 5 and promoted degradation.", "model_answer": "Hsp70 is found to be upregulated during Hsp90 inhibition.", "model_support": "The heat shock protein Hsp70 is found to be upregulated during Hsp90 inhibition. This is supported by the context which explains that silencing Hsp70 prevents the degradation of Nox5 caused by Hsp90 inhibitors, indicating that Hsp70 becomes more active in this scenario. Hsp70 works with CHIP to promote the ubiquitination and degradation of Nox proteins, thereby reducing reactive oxygen species production.\n\n**Answer:** Hsp70 is upregulated during Hsp90 inhibition.", "retries": 1}
{"idx": 332, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('peroxidase enzyme') does not match the gold standard ('antioxidant'), but it is a correct description based on external knowledge. The supporting sentence acknowledges that the context does not provide relevant information, which is accurate, but this leads to a failure to identify the gold supporting sentence within the context. Therefore, while the model's supporting statement is technically correct in noting the lack of context, it misses the opportunity to directly cite the available gold supporting sentence.\", \"match\": false}", "gold_answer": "antioxidant", "gold_support": "Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, was the most upregulated while tribbles homolog 3 (TRB3), a pro-apoptotic protein, was the most downregulated, implying a beneficial effect of lithium on neuronal cells.", "model_answer": "Peroxiredoxin 2 (PRDX2) is a peroxidase enzyme. It plays a role in antioxidant defense by catalyzing the reduction of peroxides, such as hydrogen peroxide, into water, thereby protecting cells from oxidative stress.", "model_support": "The context provided does not contain any information about peroxiredoxin 2 (PRDX2). Therefore, there is no supporting sentence in the context that can be quoted to answer the question. The information about PRDX2 being a peroxidase enzyme is not derived from the given context but is external knowledge.\n\n**Answer:** The context does not provide information about peroxiredoxin 2 (PRDX2).", "retries": 1}
{"idx": 333, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('Inhibitor 1') by identifying the correct protein, though it includes additional details about phosphorylation sites which are not strictly necessary for answering the question. The supporting sentence is relevant and explains the activation mechanism of Inhibitor 1, but it contains slight redundancy by repeating the model answer verbatim. Despite this, the logic is clear and directly supports the answer.\", \"match\": true}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.", "model_answer": "The main inhibitor of protein phosphatase 1 (PP1) is inhibitor 1 (I-1), which is activated through phosphorylation at Thr(35) and Ser(67).", "model_support": "The main inhibitor of protein phosphatase 1 (PP1) is inhibitor 1 (I-1), which is activated through phosphorylation at Thr(35) and Ser(67).\n\n**Supporting Sentence:**  \n\"Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. Nonphosphorylated I-1 is inactive, whereas phosphorylated I-1 is a potent PP1 inhibitor.\"", "retries": 1}
{"idx": 334, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is not the most concise or directly relevant to the question about Lewy bodies. While it mentions alpha-synuclein, it refers to multiple system atrophy rather than Parkinson's disease or Lewy body dementia, which are more directly tied to the gold supporting sentence. The chosen supporting sentence from the context should have been more specific to Lewy bodies in Parkinson's disease or Lewy body dementia for a perfect score.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\n**Supporting sentence:**  \n\"In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.\"", "retries": 1}
{"idx": 335, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is more verbose and explanatory rather than directly matching 'Stroke.' The supporting sentence is somewhat lengthy and contains additional information about improving referrals, which is relevant but not necessary to support the gold answer. While the logic is reasonable and connects to stroke recognition, it could be more concise to directly align with the gold standard.\", \"match\": false}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing and differentiating acute stroke from stroke mimics in the emergency room setting. It enhances the accuracy of stroke diagnosis and appropriate referrals to the stroke team.", "model_support": "Supporting sentence:  \n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER. Introduction of the instrument improved the appropriateness of referrals to the stroke team.\"", "retries": 1}
{"idx": 336, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it provides the full name instead of the abbreviation. The supporting sentence from the model is relevant but slightly redundant as it repeats the answer verbatim without adding new reasoning or context. The gold supporting sentence directly explains the association between FSHD and DUX4 aberrant production, making it more informative.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is Facioscapulohumeral muscular dystrophy (FSHD). \n\nAnswer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "The disease associated with the ectopic expression of the DUX4 protein is Facioscapulohumeral muscular dystrophy (FSHD). \n\nSupporting sentence: \"These studies offer insight into the autonomous distribution of muscle weakness that is characteristic of FSHD.\"", "retries": 1}
{"idx": 337, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant, is slightly redundant as it repeats the answer itself rather than providing additional context or reasoning from the given background information. A more concise and informative supporting sentence would have been preferred.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Phenomenology of \"Lubag\" or X-linked dystonia-parkinsonism.", "model_answer": "The synonym for Lubag disease is X-linked Dystonia-Parkinsonism.", "model_support": "The synonym for Lubag disease is X-linked Dystonia-Parkinsonism. \n\n**Supporting Sentence:** \"We present cinematographic material of 11 cases of Lubag carrying the XDP haplotypes...\"", "retries": 1}
{"idx": 338, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although identical to the answer, is concise and directly relevant, capturing the essential fact that BACH1 acts as a repressor. While it could have included more context, it still logically supports the answer without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a mammalian transcriptional repressor of HO-1.", "model_answer": "The transcriptional regulator BACH1 is a repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor.\n\nSupporting sentence: \"ZnMP produces profound post-transcriptional down-regulation of Bach1 protein levels and transcriptional up-regulation of HO-1.\"", "retries": 1}
{"idx": 339, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying 'XK' as the gene associated with McLeod syndrome. The supporting sentence is concise, directly relevant, and covers the answer logically by clearly linking the mutation to the XK gene in the context of McLeod syndrome.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "A spontaneous novel XK gene mutation in a patient with McLeod syndrome.", "model_answer": "The gene associated with McLeod syndrome is **XK**.", "model_support": "The mutation associated with McLeod syndrome is in the **XK** gene. \n\n**Supporting sentence:** \"This point mutation creates an in-frame stop codon (W314X), and predicts a truncated XK protein of 313 amino acids, compared with 444 amino acids in the normal XK protein.\"", "retries": 1}
{"idx": 340, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, although identical to the answer, is concise and directly relevant, covering the answer with clear and logical reasoning. Minor redundancy is acceptable as the logic remains strong.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.", "model_support": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.\n\n**Supporting sentence:** \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 341, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), but the supporting sentence is missing. While the context does contain relevant information that could have been used as a supporting sentence, the model failed to extract it. The correct supporting sentence should have been something like 'Recently developed anticoagulants include... factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.' Therefore, although the answer is correct, the lack of a supporting sentence reduces the score.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban, so there is no supporting sentence available.\n\nAnswer: The context does not provide information about betrixaban.", "retries": 1}
{"idx": 342, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating the synonym relationship between 'lubag' disease and X-linked dystonia-parkinsonism. Minor extra details are acceptable as the logic is strong and there is no excessive content.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "X-linked dystonia-parkinsonism (XDP) or \"lubag\" is an X-linked recessive disorder that afflicts Filipino men, and rarely, women.", "model_answer": "X-linked dystonia-parkinsonism", "model_support": "The synonym for \"lubag\" disease is X-linked dystonia-parkinsonism. \n\nSupporting sentence: \"Phenotypic and molecular analyses of X-linked dystonia-parkinsonism (\"lubag\") in women.\"", "retries": 1}
{"idx": 343, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, identifying SERCA as the main calcium pump. The supporting sentence is relevant and correctly identifies SERCA as the calcium pump in the sarcoplasmic reticulum, but it includes additional information about Seipin's interaction with SERCA, which is not necessary to answer the question directly. This makes the supporting sentence slightly redundant compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "SERCA", "gold_support": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is the sarco/endoplasmic reticulum calcium-ATPase (SERCA).", "model_support": "The supporting sentence from the context is:\n\n\"Seipin physically interacts with the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) in both Drosophila and man.\"\n\nThis sentence identifies SERCA as the calcium pump in the sarcoplasmic reticulum, confirming it as the main pump.", "retries": 1}
{"idx": 344, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('repressor'), but it is more verbose than necessary. The supporting sentence repeats the answer and adds extra details that, while relevant, make it slightly redundant compared to the concise gold supporting sentence. However, the logic is clear and accurately reflects the context.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naive to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "BACH1 is a transcriptional repressor. It inhibits the transcription factor NRF2 from binding to ARE-like enhancers until it is inactivated during oxidative stress, allowing NRF2 to activate gene expression.", "model_support": "BACH1 is a transcriptional repressor. It inhibits the transcription factor NRF2 from binding to ARE-like enhancers until it is inactivated during oxidative stress, allowing NRF2 to activate gene expression.\n\n**Supporting sentence:** \"In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.\"", "retries": 1}
{"idx": 345, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('fungi') semantically, though it is slightly more verbose by specifying 'Kingdom Fungi.' The supporting sentence is relevant and provides context about microsporidia being debated within the fungal tree of life, which indirectly supports their classification in the fungi kingdom. However, it does not directly reference the key phylogenomic evidence provided in the gold supporting sentence, making it somewhat less precise and slightly redundant.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Microsporidia belong to the Kingdom Fungi according to their current classification.", "model_support": "The supporting sentence that indicates microsporidia belong to the Kingdom Fungi is: \"However, the specific position of microsporidia within the fungal tree of life is still debated.\" This sentence implies their classification within the Fungi kingdom by discussing their placement within the fungal tree.", "retries": 1}
{"idx": 346, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is concise and aligns well with the gold standard, capturing the autoimmune hypothesis. However, it does not mention the role of an environmental trigger or genetic susceptibility, which are key details in the gold answer. The supporting sentence is relevant and supports the answer but lacks specificity regarding the environmental trigger and genetic factors, making it slightly less comprehensive than the gold supporting sentence.\", \"match\": true}", "gold_answer": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "gold_support": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility.", "model_answer": "The reason for narcolepsy cases after H1N1 vaccination is hypothesized to be autoimmune, though specific mechanisms have not been identified.", "model_support": "Supporting sentence: The pathological explanation of this association and narcolepsy is likely to be autoimmune, although supportive evidence is lacking.", "retries": 1}
{"idx": 347, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('XK') in meaning by specifying the XK gene. However, it is slightly more verbose than necessary. The supporting sentence provides relevant information but includes additional details about variants in mood disorder and schizophrenia subjects, making it somewhat redundant compared to the gold supporting sentence, which directly states the role of XK in McLeod syndrome.\", \"match\": true}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "The gene mutation associated with McLeod syndrome is in the XK gene.", "model_support": "Supporting sentence: We identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.", "retries": 1}
{"idx": 348, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer ('Na⁺/Ca²⁺ exchanger') is very close to the gold standard ('NCX'), as NCX stands for Na⁺/Ca²⁺ exchanger. However, it does not match exactly, resulting in a minor discrepancy. The supporting sentence is somewhat problematic because it discusses PPADS rather than SEA0400, which is the molecule mentioned in the question. Although the sentence provided relates to NCX inhibition, it does not directly support the specific role of SEA0400, leading to a score that reflects partial accuracy and relevance.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "The small molecule SEA0400 is an inhibitor of the **Na⁺/Ca²⁺ exchanger**.", "model_support": "The supporting sentence from the context regarding the inhibitor of the Na+/Ca²+ exchanger is about PPADS, not SEA0400. Here is the relevant sentence:\n\n\"PPADS, a P2X receptor antagonist, acts as a NCX(REV) inhibitor in guinea pig tracheal myocytes.\"\n\nSince SEA0400 is not mentioned in the context, there is no supporting sentence for it. It appears SEA0400 might be another inhibitor not discussed in this text.", "retries": 1}
{"idx": 349, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model supporting sentence repeats the answer verbatim, it still aligns well with the gold supporting sentence in clarity and relevance.\",\n  \"match\": true\n}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "\"Lubag\" or X-linked dystonia-parkinsonism (XDP) is a genetic syndrome afflicting Filipino men.", "model_answer": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.\n\nAnswer: X-linked dystonia-parkinsonism", "model_support": "The synonym for \"Lubag\" disease is X-linked dystonia-parkinsonism.\n\n**Supporting sentence:**  \n\"First case of X-linked dystonia-parkinsonism ('Lubag')...\"", "retries": 1}
{"idx": 350, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('centromeres') in meaning, though it is slightly more verbose ('centromere region of chromosomes'). The supporting sentence provided by the model refers to general knowledge rather than directly citing the context. However, the gold supporting sentence from the context provides clear and direct evidence for the localization of CENPA at centromeres. The model could have used this specific sentence for stronger support. Overall, the logic is sound but contains minor redundancy and does not fully leverage the given context.\",\n  \"match\": true\n}", "gold_answer": "centromeres", "gold_support": "CENPA is a member of the histone H3-like proteins and is thought to replace histone H3 in centromeric nucleosomes.", "model_answer": "CENPA is preferentially localized to the centromere region of chromosomes.", "model_support": "The context does not explicitly state where the histone variant CENPA is preferentially localized. However, based on general knowledge, CENPA is known to be localized to the centromere region of chromosomes. \n\nSupporting sentence: **CENPC is a DNA-binding protein that is located at the inner kinetochore plate of active mammalian centromeres.** (Note: This sentence refers to CENPC, not CENPA, but it provides context about centromere localization in general.)", "retries": 1}
{"idx": 351, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly supports the answer, but it repeats the same information as the answer without additional context or reasoning, making it slightly redundant. The gold supporting sentence provides more comprehensive context about the function of the enzyme, which would have been ideal.\",\n  \"match\": true\n}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Evolocumab (AMG145) is a monoclonal antibody inhibiting the proprotein convertase subtilisin/kexin type 9 that binds to the liver LDL receptor and prevents it from normal recycling by targeting it for degradation.", "model_answer": "The enzyme targeted by Evolocumab is proprotein convertase subtilisin/kexin type 9 (PCSK9).", "model_support": "The enzyme targeted by Evolocumab is proprotein convertase subtilisin/kexin type 9 (PCSK9).\n\nSupporting sentence: Evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9.", "retries": 1}
{"idx": 352, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while slightly repetitive by directly quoting the answer, is concise and directly relevant, covering the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\nSupporting sentence: In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.", "retries": 1}
{"idx": 353, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('nuclear'), but the supporting sentence includes unnecessary generalizations and lacks direct conciseness. While it correctly references the nuclear localization of APOBEC3B based on general biological knowledge, it adds extra reasoning about the context not specifying the localization, which slightly dilutes the clarity and focus. The gold supporting sentence is more direct and explicitly tied to evidence from the context.\",\n  \"match\": true\n}", "gold_answer": "nuclear", "gold_support": "Endogenous APOBEC3B protein is predominantly nuclear and the only detectable source of DNA C-to-U editing activity in breast cancer cell-line extracts.", "model_answer": "APOBEC3B protein is predominantly nuclear.", "model_support": "The context does not explicitly state whether the APOBEC3B protein is predominantly cytoplasmic or nuclear. While the text discusses the protein's enzymatic activity and its role in mutations, it does not provide specific information about its cellular localization. Therefore, based solely on the provided context, we cannot definitively determine whether APOBEC3B is cytoplasmic or nuclear. However, it is known from general biological knowledge that APOBEC3B functions in the nucleus, where it catalyzes DNA deamination. \n\n**Answer:** The context does not specify the predominant localization of APOBEC3B. However, based on general knowledge, APOBEC3B is predominantly nuclear as it functions in DNA deamination within the nucleus.", "retries": 1}
{"idx": 354, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is redundant, as it repeats the answer itself rather than offering concise background information from the context. The gold supporting sentence is more succinct and directly relevant, making the model's supporting sentence slightly less optimal despite being correct.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis, as indicated by the context, is tofacitinib.", "model_support": "The JAK inhibitor approved for the treatment of rheumatoid arthritis, as indicated by the context, is tofacitinib.\n\n**Supporting sentence:** \"The preclinical pharmacokinetic (PK)/pharmacodynamic (PD) profile of tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).\"", "retries": 1}
{"idx": 355, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer. It focuses on the lack of explicit information rather than leveraging the comparison made in the context that directly states APOBEC3B is predominantly nuclear.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "The context does not provide explicit information about the predominant localization of APOBEC3B. It focuses on APOBEC3G's cytoplasmic localization and the factors influencing it. Therefore, based on the given information, we cannot definitively determine whether APOBEC3B is predominantly cytoplasmic or nuclear.", "model_support": "The context does not explicitly state whether APOBEC3B is predominantly cytoplasmic or nuclear. The focus is on APOBEC3G's cytoplasmic localization and the regions influencing it. Therefore, based on the provided information, we cannot definitively determine the predominant localization of APOBEC3B.\n\nSupporting sentence: The context does not provide explicit information about the predominant localization of APOBEC3B. It focuses on APOBEC3G's cytoplasmic localization and the factors influencing it. Therefore, based on the given information, we cannot definitively determine whether APOBEC3B is predominantly cytoplasmic or nuclear.", "retries": 1}
{"idx": 356, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NF1'), though it is slightly more verbose by including 'The gene mutated in type 1 neurofibromatosis is the'. The supporting sentence chosen by the model is relevant but does not provide detailed reasoning or context about the NF1 gene being a tumor suppressor or its role in downregulating N-ras, unlike the gold supporting sentence. While correct, the model's supporting sentence repeats the answer without adding substantial explanatory information, making it somewhat redundant.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) gene is a tumor suppressor gene, and the NF1 gene product, neurofibromin, can downregulate the N-ras gene.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.", "model_support": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.\n\n**Supporting sentence:**  \n\"Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.\"", "retries": 1}
{"idx": 357, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'), and the supporting sentence correctly identifies JNK as the kinase responsible for phosphorylating c-jun based on prior knowledge. However, the supporting sentence is slightly verbose and indirectly references the context without explicitly highlighting the direct mention of JNK in the gold supporting sentence. It introduces additional details about ERK and p38 pathways that are not necessary for supporting the specific answer.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "It also reduced the expressions of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and increases the expressions of reversion-inducing cysteine-rich protein with kazal motifs (RECK), as well as tissue inhibitor of metalloproteinase (TIMP) via inhibiting STAT3 by activating the mitogen-activated protein (MAP) kinases (the c-Jun N-terminal kinase (JNK), the p38 and extracellular signal-regulated kinase (ERK)) in A549 cells treated with RY10-4.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal Kinase).", "model_support": "The supporting sentence for the answer that JNK phosphorylates c-jun is implied by the discussion of MAP kinase pathways in the context, even though JNK is not explicitly mentioned. The context states:\n\n\"Treatment with RY10-4 inhibited the expression of pro-caspase-3, pro-caspase-9, Bcl-2 as well as phosphorylation of signal transducer and activator of transcription-3 (p-STAT3). Moreover, the cytotoxic effect of RY10-4 was induction of apoptosis in A549 cells by enhancing production of reactive oxygen species (ROS). Taken together, the observations suggested that RY10-4 had affected Bcl-2 family members, caspases, MMPs, TIMPs expressions and ROS production via inhibiting STAT3 activities through ERK and p38 pathways in A549 cells.\"\n\nWhile the context discusses ERK and p38 pathways, it doesn't explicitly mention JNK. However, based on prior knowledge, JNK is known to phosphorylate c-jun, making it the correct answer.", "retries": 1}
{"idx": 358, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel') in meaning, as it correctly identifies that alpha-spectrin and beta-spectrin form antiparallel heterodimers. However, the supporting sentence repeats the answer rather than offering concise explanatory context from the provided background information. The gold supporting sentence is more informative, explaining that the basic unit of spectrin is an antiparallel heterodimer. Despite this, the model's supporting sentence is still relevant but lacks additional clarity or detail.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.\n\n**Supporting sentence:**  \n\"R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.\"", "retries": 1}
{"idx": 359, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation of the role of calcineurin in the Ca²+/calcineurin/NFAT pathway. However, it includes additional details about the SCID syndrome which, while related, are not necessary to directly support the answer, making it slightly verbose.\", \"match\": true}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "Calcineurin is the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors.", "model_support": "The supporting sentence from the context is:\n\n\"The importance of the Ca²+/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca²+ entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence.\"\n\nThis sentence highlights the role of calcineurin in the Ca²+/calcineurin/NFAT pathway, which is crucial for activating NFAT transcription factors.", "retries": 1}
{"idx": 360, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('repressor'). However, the supporting sentence provided by the model is a direct repetition of the answer rather than an explanation or evidence from the context. The gold supporting sentence is more detailed and directly explains BACH1's role as a repressor in the relevant biological mechanism. While the model's answer is correct, its supporting sentence lacks depth and reasoning compared to the gold standard, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "The transcriptional regulator BACH1 is a repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor.\n\n**Supporting sentence:**  \n\"We conclude that BACH1 is a bona fide Nrf2 target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.\"", "retries": 1}
{"idx": 361, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ZEB2', does not match the gold standard 'ZFHX1B', but it is a known synonym for the same gene. However, since the question asks specifically for the gene name used in the context, the answer does not fully align with the provided text. The supporting sentence is incorrect as it states that the context does not mention the gene, when in fact the gold supporting sentence shows that ZFHX1B is explicitly mentioned in association with Mowat-Wilson syndrome.\", \"match\": false}", "gold_answer": "ZFHX1B", "gold_support": "A missense mutation in the ZFHX1B gene associated with an atypical Mowat-Wilson syndrome phenotype.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.", "model_support": "The context provided does not mention the gene responsible for Mowat-Wilson syndrome. Therefore, the supporting sentence cannot be identified from the given text.", "retries": 1}
{"idx": 362, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that BACH1 is a transcriptional repressor by referencing its inactivation being necessary for NRF2-mediated gene induction. This aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "In contrast, the transcriptional repressor BACH1 binds ARE-like enhancers in cells naïve to oxidative stress and antagonizes NRF2 binding until it becomes inactivated by pro-oxidants.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "Supporting sentence: \"Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1.\"", "retries": 1}
{"idx": 363, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly explains that tofacitinib is approved for treating rheumatoid arthritis, aligning perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib: The First Janus Kinase (JAK) inhibitor for the treatment of rheumatoid arthritis.", "model_answer": "Tofacitinib is the JAK inhibitor approved for the treatment of rheumatoid arthritis, as indicated by the context.\n\nAnswer: Tofacitinib", "model_support": "The supporting sentence from the context is:\n\n\"Tofacitinib is an oral treatment option for RA patients who have inadequate response or intolerance to methotrexate.\"\n\nThis sentence indicates that tofacitinib is approved for treating rheumatoid arthritis, specifically for patients who do not respond adequately to methotrexate.", "retries": 1}
{"idx": 364, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Epidermal growth factor,' does not match the gold standard, 'EGFRvIII.' However, the answer is related to the context because EGFRvIII is a mutant form of the epidermal growth factor receptor (EGFR). The supporting sentence mentions EGFRvIII but does not directly explain that rindopepimut is an analog of EGFRvIII, making the support incomplete and somewhat indirect.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Answer: Epidermal growth factor.", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 365, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer 'BCR-ABL' is very close to the gold standard 'Bcr-Abl,' with only a minor difference in formatting (uppercase vs. camel case). However, the supporting sentence chosen by the model is suboptimal. While it mentions Bcr-Abl tyrosine kinase inhibitors, it does not directly state that Imatinib targets Bcr-Abl and instead focuses on second-generation inhibitors, which is less relevant. The logic connecting the answer to the supporting sentence could be stronger and more concise.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib is an inhibitor of the Bcr-Abl tyrosine kinase; however, resistance is common.", "model_answer": "Imatinib (Gleevec) targets the BCR-ABL tyrosine kinase, which is the product of the Philadelphia chromosome translocation and is responsible for the uncontrolled cell growth in Philadelphia-chromosome positive chronic myelogenous leukemia.\n\nAnswer: BCR-ABL", "model_support": "The supporting sentence is:\n\n\"Following the approval of the second-generation Bcr-Abl tyrosine kinase inhibitors (TKIs).\"\n\nThis sentence indicates that Imatinib is a tyrosine kinase inhibitor targeting Bcr-Abl, aligning with the answer that Imatinib targets the BCR-ABL tyrosine kinase.", "retries": 1}
{"idx": 366, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly (both indicate 'IL-17A' or 'interleukin-17A'). The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning. It appropriately references the blockade of IL-17A by secukinumab, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "interleukin-17A", "gold_support": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.", "model_answer": "The molecule targeted by the monoclonal antibody Secukinumab is IL-17A.\n\nAnswer: IL-17A", "model_support": "The molecule targeted by the monoclonal antibody Secukinumab is IL-17A.\n\n**Supporting sentence:**  \n\"Blockade of IL-17A by secukinumab does not appear to interfere with efficacy of influenza and meningococcal vaccinations, as assessed by the achievement of protective antibody levels.\"", "retries": 1}
{"idx": 367, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides useful context about LepChorionDB being a tool for studying chorion proteins, but it contains slight redundancy by mentioning future studies and annotators, which is not directly necessary to support the answer.\", \"match\": true}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for the identification of chorion proteins in Lepidopteran proteomes is LepChorionDB.\n\nAnswer: LepChorionDB", "model_support": "The supporting sentence from the context is:\n\n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators...\"\n\nThis sentence highlights that LepChorionDB is a tool designed for studying and identifying chorion proteins, directly answering the question about the available database.", "retries": 1}
{"idx": 368, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but incorrectly states that the context does not explicitly mention NOTCH3, which it does. The supporting sentence includes slight redundancy by repeating the answer, but overall reasoning is logical.\", \"match\": true}", "gold_answer": "NOTCH3 gene", "gold_support": "OBJECTIVE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease of the brain caused by mutations in the NOTCH3 gene.", "model_answer": "The gene involved in CADASIL is NOTCH3.", "model_support": "The gene involved in CADASIL is NOTCH3. However, the provided context does not explicitly mention the NOTCH3 gene. The answer is correct based on prior knowledge, but the supporting sentence is not present in the given context.", "retries": 1}
{"idx": 369, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by explaining DNMT1's role in DNA methylation maintenance, but it includes additional details about UHRF2's inability to recruit DNMT1, which makes it slightly more verbose than necessary. The core logic is strong, but the extra content reduces conciseness.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "S phase-dependent interaction with DNMT1 dictates the role of UHRF1 but not UHRF2 in DNA methylation maintenance.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The supporting sentence from the context that identifies DNMT1 as the enzyme involved in maintaining DNA methylation is:\n\n\"UHRF2 is not able to rescue the DNA methylation defect in Uhrf1 null mouse embryonic stem cells. This can be attributed to the inability for UHRF2 to recruit DNMT1 to replication foci during S phase of the cell cycle.\"\n\nThis sentence highlights DNMT1's crucial role in DNA methylation maintenance, particularly during the S phase of the cell cycle, as UHRF2's inability to recruit DNMT1 leads to a methylation defect.", "retries": 1}
{"idx": 370, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('multiple') in meaning, though it is more verbose. The supporting sentence from the model provides accurate and relevant information about the three origins of replication (O1, O2, O3), which supports the answer. However, the gold supporting sentence is more concise and directly addresses the presence of multiple origins without unnecessary details, making the model's supporting sentence slightly redundant.\",\n  \"match\": true\n}", "gold_answer": "multiple", "gold_support": "However, because some archaeal genomes contain multiple origins of replication, bias in gene dosage caused by delayed replication should be minimized and hence the substitution rate of genes should associate less with chromosome position.", "model_answer": "Archaeal genomes, as exemplified by Sulfolobus islandicus, contain multiple origins of replication. In this study, three origins (O1, O2, O3) were identified, with replication timing influencing gene evolution and expression. This indicates that archaeal genomes can have multiple origins. \n\nAnswer: Archaeal genomes contain multiple origins of replication.", "model_support": "The supporting sentence from the context that indicates archaeal genomes contain multiple origins of replication is:\n\n\"Ortholog families were grouped by their consensus position and designated by their proximity to one of the three origins (O1, O2, O3).\"\n\nThis sentence clearly states that Sulfolobus islandicus, an archaeon, has three origins of replication, demonstrating that archaeal genomes can contain multiple origins.", "retries": 1}
{"idx": 371, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. It correctly identifies that defects in transporters are involved, but it fails to specify MCT8 as required by the gold answer. The supporting sentence mentions 'cell transporters' but does not directly reference MCT8 or fully cover the gold answer, making it relevant yet incomplete.\", \"match\": false}", "gold_answer": "MCT8", "gold_support": "One, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8;", "model_answer": "The context discusses genetic defects in hormone receptors, cell transporters, and deiodination as causes of thyroid hormone resistance. While it mentions that defects can occur in transporters, it does not specify which particular transporter is implicated. Therefore, the specific transporter is not named in the context, but the category of transporters is identified as being involved in the syndrome.\n\nAnswer: The specific thyroid hormone transporter implicated is not named in the context, but defects in cell transporters are identified as a cause of resistance syndrome.", "model_support": "The supporting sentence from the context is: \"genetic defects in hormone receptors, cell transporters and deiodination.\" This sentence indicates that defects in cell transporters are implicated in thyroid hormone resistance syndrome, but it does not specify which particular transporter is involved.", "retries": 1}
{"idx": 372, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and supports the answer by indicating that betrixaban is an oral factor Xa inhibitor. However, it contains slight redundancy by mentioning warfarin, which is not directly necessary for supporting the specific answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Two direct factor Xa inhibitors are emerging from phase II trials (betrixaban and YM150) and three are being evaluated in phase III trials (apixaban, edoxaban, and rivaroxaban) for the prevention of stroke and systemic emboli in patients with atrial fibrillation.", "model_answer": "Answer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Oral direct factor Xa inhibitors are potentially well tolerated and effective replacements for warfarin.\"\n\nThis sentence indicates that betrixaban, being an oral factor Xa inhibitor, inhibits factor Xa.", "retries": 1}
{"idx": 373, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'AIP' is an accepted abbreviation for 'aryl hydrocarbon receptor interacting protein.' The supporting sentence is relevant and provides correct information about AIP mutations being germline and linked to familial predisposition. However, it includes additional details (e.g., specific mutation R304Q) that are not necessary to directly support the answer, making it slightly redundant compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The aryl hydrocarbon receptor interacting protein (AIP) gene has a major role in the pathogenesis of familial isolated pituitary adenoma.", "model_answer": "The gene implicated in familial isolated pituitary adenoma is the Aryl Hydrocarbon Receptor Interacting Protein (AIP) gene.\n\nAnswer: AIP", "model_support": "The supporting sentence from the context that implicates the AIP gene in familial conditions, including familial isolated pituitary adenoma (FIPA), is:\n\n\"A somatic AIP mutation, substitution of arginine with glutamine at codon 304 (R304Q), was identified in 2 of 132 tumors. The mutation was germline in both cases despite the nonfamilial presentation.\"\n\nThis sentence highlights that the AIP mutation is germline, indicating an inherited predisposition, which is relevant to familial conditions such as FIPA.", "retries": 1}
{"idx": 374, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody.", "model_answer": "The molecule targeted by Gevokizumab is interleukin-1 beta (IL-1β).\n\nAnswer: interleukin-1 beta (IL-1β)", "model_support": "The supporting sentence from the context is: \"This novel IL-1β-neutralizing antibody improved glycemia, possibly via restored insulin production and action, and reduced inflammation in patients with type 2 diabetes.\"", "retries": 1}
{"idx": 375, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly verbose compared to the gold supporting sentence. The model's supporting sentence provides additional experimental details that are not necessary for answering the question directly, but it still logically supports the answer.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Novel NF1 gene mutation in a Japanese patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.\n\nAnswer: NF1", "model_support": "The supporting sentence is: \"we used the polymerase chain reaction (PCR) and DNA sequencing analysis to characterize the NF1 gene in a 53-year-old Japanese patient with NF1 who suffered from neurofibroma, pheochromocytoma, and gastrointestinal stromal tumor (GIST).\"", "retries": 1}
{"idx": 376, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is missing in the model's output but could have been extracted concisely from the context provided. The gold supporting sentence directly references betrixaban as a factor Xa inhibitor, which would have been ideal for the model to include.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The context provided does not mention betrixaban, making it impossible to identify a supporting sentence for the answer that betrixaban inhibits factor Xa within the given text.", "retries": 1}
{"idx": 377, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('JNK'), but it is slightly more verbose by including 'c-Jun N-terminal kinase' in parentheses. The supporting sentence identifies JNK as a MAP kinase and implies its role in phosphorylating c-jun, though it does not explicitly state this function. It provides relevant context with minor redundancy but still supports the answer logically.\", \"match\": true}", "gold_answer": "JNK", "gold_support": "JNK phosphorylates and regulates the activity of transcription factors other than c-Jun, including ATF2, Elk-1, p53 and c-Myc and non-transcription factors, such as members of the Bcl-2 family.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "model_support": "The supporting sentence from the context is:\n\n\"The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein kinase (MAPK) family...\"\n\nThis sentence identifies JNK as a MAP kinase, which is responsible for phosphorylating c-jun.", "retries": 1}
{"idx": 378, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is slightly more detailed than the gold standard but still accurate and directly related to it. The supporting sentence provides relevant context, though it includes minor extra details that could be more concise. Overall, the logic is sound, and the information supports the answer well.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for stroke recognition in the prehospital setting.", "model_support": "The supporting sentence is: \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"\n\n**Answer:** The ROSIER scale is used for stroke recognition in the prehospital setting.", "retries": 1}
{"idx": 379, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and pointing to medulloblastoma, does not fully capture the specific detail that medulloblastoma is the most common pediatric cerebellar tumor. It mentions p18Ink4c as a tumor suppressor but lacks explicit mention of medulloblastoma being the most common, which is present in the gold supporting sentence. The logic is sound, but the sentence could be more directly aligned with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "The supporting sentence is: \"The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.\" This sentence explicitly names medulloblastoma, indicating it is the tumor being discussed, and thus supports the answer that it is the most common pediatric cerebellar tumor.\n\n**Answer:** The most common type of pediatric cerebellar tumor is medulloblastoma.  \n**Supporting sentence:** \"The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.\"", "retries": 1}
{"idx": 380, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is close to the gold standard but includes additional details ('predominantly affects males and involves left hemisphere') that are not strictly necessary to define the characteristic feature of the syndrome, which is simply 'cerebral hemiatrophy.' The supporting sentence provides relevant information about male gender and left side involvement but is somewhat verbose and mixes specific study findings with the general characteristic of the disease. Logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "Left hemisphere and male sex dominance of cerebral hemiatrophy (Dyke-Davidoff-Masson Syndrome).", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is that it predominantly affects males and involves left hemisphere cerebral hemiatrophy.", "model_support": "Supporting sentence: We conclude that male gender and left side involvement are frequent in cerebral hemiatrophy disease.", "retries": 1}
{"idx": 381, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('S-adenosylmethionine') with a minor variation in formatting (SAM vs. S-adenosylmethionine), which is acceptable. The supporting sentence is relevant and supports the answer by referencing AdoMet (SAM) as a methyl donor, but it includes additional information about SMM synthesis that slightly complicates the explanation, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "S-adenosylmethionine", "gold_support": "AtHMT-1 and -2 both utilize l-SMM or (S,S)-AdoMet as a methyl donor in vitro and have higher affinities for SMM.", "model_answer": "The methyl donor for histone methyltransferases is **S-adenosyl methionine (SAM)**.", "model_support": "The supporting sentence from the context that indicates S-adenosyl methionine (SAM) is the methyl donor for histone methyltransferases is:\n\n\"Plants synthesize S-methylmethionine (SMM) from S-adenosylmethionine (AdoMet), and methionine (Met) by a unique reaction and, like other organisms, use SMM as a methyl donor for Met synthesis from homocysteine (Hcy).\"\n\nThis sentence highlights the role of AdoMet (SAM) in the synthesis of SMM, supporting the general understanding that SAM serves as the methyl donor in various methylation processes, including those involving histone methyltransferases.", "retries": 1}
{"idx": 382, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard in meaning, as 'acetylation, specifically on lysine residues' is equivalent to 'acetylated lysines'. The supporting sentence provides relevant information and logically supports the answer by explaining that bromodomains bind to acetylated lysine residues. However, it contains slight redundancy by reiterating the answer within the supporting sentence itself, which could be more concise.\", \"match\": true}", "gold_answer": "acetylated lysines", "gold_support": "Double bromodomain proteins bind to acetylated lysines in histones, bringing associated histone modification and nucleosome remodeling activity to chromatin.", "model_answer": "The histone modification recognized by the bromodomain is acetylation, specifically on lysine residues.", "model_support": "The histone modification recognized by the bromodomain is acetylation, specifically on lysine residues. Bromodomains are known to bind to acetylated lysine residues on histones, which plays a role in regulating chromatin structure and gene expression.\n\n**Supporting Sentence:** The context discusses bromodomain proteins being critical in controlling gene expression by altering chromatin status, which is a process influenced by histone acetylation. Although the context doesn't explicitly mention acetylation, the role of bromodomains in chromatin regulation strongly implies their recognition of this modification.", "retries": 1}
{"idx": 383, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and matches the gold standard ('xa' refers to Factor Xa). However, the supporting sentence provided by the model is problematic. While it correctly identifies that betrixaban inhibits Factor Xa, it unnecessarily states that the context does not explicitly mention betrixaban or its target, leading to verbosity and a lack of direct relevance to the immediate context. The gold supporting sentence provides sufficient indirect support by referencing FXa inhibitors in the market, which could logically include betrixaban. Thus, the model's supporting sentence mixes clarity with unnecessary elaboration, making it less concise than ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not explicitly mention betrixaban or its specific target. Therefore, I cannot quote a supporting sentence from the context to answer the question. However, based on general knowledge, betrixaban is known to inhibit Factor Xa. If you would like me to provide this information, please let me know, and I can confirm it based on external knowledge.", "retries": 1}
{"idx": 384, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'formononetin,' does not match the gold standard, 'medicarpin.' However, formononetin is mentioned in the context as a related compound. The supporting sentence discusses the possible role of an enzyme in the synthesis of formononetin but does not directly support the gold answer, as it does not mention medicarpin or its role as the major phytoalexin.\", \"match\": false}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.", "model_support": "The supporting sentence is: \"The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.\"\n\n**Answer:** The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.  \n**Supporting Sentence:** The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.", "retries": 1}
{"idx": 385, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard. However, the supporting sentence is somewhat redundant because it references external knowledge rather than directly using the context provided. The gold supporting sentence is more concise and directly relevant to the context. Despite this, the model's reasoning is logical and correctly ties bortezomib to multiple myeloma.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "INTRODUCTION: Over the past decade, the novel agents thalidomide, lenalidomide, and bortezomib have emerged as effective treatment in patients with multiple myeloma (MM).", "model_answer": "Velcade (bortezomib) is mainly used for treating multiple myeloma.", "model_support": "The context provided does not mention Velcade (bortezomib). Therefore, there is no supporting sentence from the given context that answers the question. However, based on external knowledge, Velcade is primarily used for treating multiple myeloma.\n\nAnswer: Velcade (bortezomib) is mainly used for treating multiple myeloma. \n\nSupporting Explanation: While the context does not explicitly mention Velcade, it discusses the treatment of multiple myeloma with other agents. Velcade, as a known treatment for multiple myeloma, is inferred from external knowledge.", "retries": 1}
{"idx": 386, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, '17,20-lyase,' does not match the gold standard 'CYP17A1,' but is present in the context as a component of CYP17A1. The supporting sentence is relevant and accurate but does not fully cover the gold answer, which specifies CYP17A1 as the enzyme responsible for extra-gonadal androgen synthesis. The logic connects to the correct enzyme activity but misses the broader enzymatic complex that the gold answer emphasizes.\",\n  \"match\": false\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "Orteronel inhibits the enzyme 17,20-lyase, which is part of the CYP17A1 enzyme complex. This inhibition effectively suppresses androgen production, making it a valuable therapeutic option for conditions like castration-resistant prostate cancer (CRPC).\n\n**Answer:** The enzyme inhibited by Orteronel is 17,20-lyase.", "model_support": "The enzyme inhibited by Orteronel is 17,20-lyase, which is part of the CYP17A1 enzyme complex.\n\n**Supporting Sentence:**  \n\"Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.\"", "retries": 1}
{"idx": 387, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions specific hormone abnormalities (low T4 and T3) leading to hypothyroidism, which is relevant but does not directly match the gold answer 'thyroid.' The supporting sentence discusses congenital hypothyroidism broadly and its consequences, which is somewhat related but does not specifically cover the gold answer or its supporting context about gene defects associated with Pendred syndrome. The connection between the model's answer and the gold standard is weak, and the supporting sentence lacks precision.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are low levels of thyroxine (T4) and triiodothyronine (T3), leading to hypothyroidism.", "model_support": "The supporting sentence from the context is: \"Congenital hypothyroidism is the most common neonatal metabolic disorder and results in severe neurodevelopmental impairment and infertility if untreated.\" This sentence highlights the consequences of untreated congenital hypothyroidism, which includes the characteristic hormone abnormalities of low T4 and T3 levels, leading to hypothyroidism, as seen in Pendred syndrome.", "retries": 1}
{"idx": 388, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('the transcribed strand'), though it is more verbose than necessary. The supporting sentence, while relevant, is lengthy and includes additional details about DNA-PKcs and its interaction with other proteins, which are not directly required to support the answer. The logic is reasonable but could be more concise by focusing solely on the preferential repair of the transcribed strand.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "TCR can preferentially remove the bulky DNA lesions located at the transcribed strand of a transcriptional active gene more rapidly than those at the untranscribed strand or overall genomic DNA.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of genes to ensure efficient repair of DNA lesions that interfere with transcription, thereby maintaining genome integrity and transcriptional fidelity.", "model_support": "**Answer:** The transcription-coupled repair (TCR) targets the transcribed strand of genes to ensure efficient repair of DNA lesions that interfere with transcription, thereby maintaining genome integrity and transcriptional fidelity.\n\n**Supporting Sentence:** \"Our data suggest that DNA-PKcs plays a role in the TCR pathway of UV-damaged DNA. One possible mechanistic hypothesis is that DNA-PKcs may function through associating with CyclinT2/CDK9 (P-TEFb) to modulate the activity of RNA Pol II, which has already been identified as a key molecule recognizing and initializing TCR.\"\n\nThis sentence supports the conclusion that TCR targets the transcribed strand by highlighting the role of DNA-PKcs in interacting with components involved in transcription elongation, thereby facilitating repair on the transcribed strand.", "retries": 1}
{"idx": 389, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard, as 'BCR-ABL tyrosine kinase' is an accurate description of the target. However, it includes slight verbosity ('tyrosine kinase') not present in the gold answer ('BCR-ABL'). The supporting sentence provides relevant information about Imatinib's mechanism but does not directly mention the fusion gene BCR-ABL or its origin from the Philadelphia chromosome, which would make it more concise and precise. Overall, the logic is sound, but minor redundancy and lack of specificity lower the score.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase.", "model_support": "The supporting sentence is: \"Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.\" This sentence indicates that Imatinib targets the BCR-ABL tyrosine kinase, which is crucial in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 390, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning that aligns with the context and gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "This family showed typical features of this syndrome with QT prolongation, torsades de pointes ventricular tachycardia, sudden death and an autosomal dominant inheritance pattern.", "model_answer": "The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant.", "model_support": "The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant, as it is a type of congenital long QT syndrome typically inherited in this pattern. \n\n**Supporting sentence:** The context mentions a family with Romano-Ward syndrome, which is consistent with an autosomal dominant inheritance pattern.", "retries": 1}
{"idx": 391, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'CaMKII (Calcium/Calmodulin-Dependent Protein Kinase II),' is essentially correct and matches the gold standard 'CaM kinase II,' as both refer to the same enzyme. However, the supporting sentence provided by the model does not directly come from the context and includes information (RyR2-Ser(2814) phosphorylation) that is not mentioned in the given context, making it less precise. The gold supporting sentence is more directly tied to the context of the question. The model's supporting sentence is relevant but contains slight redundancy and unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "CaM kinase II", "gold_support": "NE-induced MAP kinase and cPLA2 activation was also inhibited in cells treated with a CaM kinase II inhibitor, KN-93, or with CaM kinase II antisense oligonucleotide.", "model_answer": "KN-93 inhibits CaMKII (Calcium/Calmodulin-Dependent Protein Kinase II).", "model_support": "Supporting sentence: Contribution of Ca²⁺ -/calmodulin-dependent kinase II (CaMKII) was assessed by KN-93 and Western blot (RyR2-Ser(2814) phosphorylation).", "retries": 1}
{"idx": 392, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (CYP17A1), though it is slightly more verbose by adding 'which is involved in androgen biosynthesis.' The supporting sentence refers to external knowledge rather than directly quoting the context provided, but it aligns with the gold supporting sentence in meaning. It is relevant and covers the answer, albeit with a minor reliance on non-contextual information, which prevents a perfect score.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel inhibits the 17,20 lyase activity of the enzyme CYP17A1, which is important for androgen synthesis in the testes, adrenal glands and prostate cancer cells.", "model_answer": "Orteronel inhibits the enzyme CYP17A1, which is involved in androgen biosynthesis.", "model_support": "The context provided does not explicitly mention the specific enzyme inhibited by Orteronel. However, based on external knowledge, Orteronel is known to inhibit CYP17A1, an enzyme involved in androgen biosynthesis. \n\nAnswer: Orteronel inhibits the enzyme CYP17A1, which is involved in androgen biosynthesis. \n\nSupporting Sentence: The context does not provide a direct supporting sentence for this answer.", "retries": 1}
{"idx": 393, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by linking the McLeod phenotype to the XK gene mutation. Minor extra details are acceptable as they do not detract from the clarity or correctness of the response.\", \"match\": true}", "gold_answer": "XK", "gold_support": "McLeod syndrome: life-long neuropsychiatric disorder due to a novel mutation of the XK gene.", "model_answer": "The gene associated with McLeod syndrome is the XK gene.\n\nAnswer: XK", "model_support": "The McLeod phenotype in the context indicates a mutation in the XK gene, which is associated with McLeod syndrome.\n\n**Answer:** XK\n\n**Supporting sentence:** \"Investigation results included... the McLeod phenotype.\"", "retries": 1}
{"idx": 394, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying that the study's objective was to investigate metabolic changes in Huntington disease patients before and after pridopidine treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "The supporting sentence from the context that answers the question is:\n\n\"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"", "retries": 1}
{"idx": 395, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('growth hormone') but is present in the context as a secondary detail ('cortisol deficiency'). The supporting sentence mentions cortisol deficiency, which is relevant to the context but does not cover the gold answer. The model fails to identify the primary hormone deficiency (growth hormone) highlighted in the gold supporting sentence.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "We describe an 18-month-old boy with Costello syndrome (CS) with proven partial growth hormone (GH) deficiency and hypoglycemic episodes.", "model_answer": "The hormone deficiency implicated in Costello syndrome is cortisol deficiency.", "model_support": "The hormone deficiency implicated in Costello syndrome is cortisol deficiency. \n\nSupporting sentence: \"The hypoglycemia is deemed to be due to cortisol deficiency.\"", "retries": 1}
{"idx": 396, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('small-cell lung cancer'), and the supporting sentence provides relevant information about the association between SCLC and Lambert-Eaton syndrome. However, the supporting sentence is slightly indirect and does not explicitly mention that SCLC cells express the antigens responsible for LES, as stated in the gold supporting sentence. The logical connection is present but could be more explicit.\",\n  \"match\": true\n}", "gold_answer": "small-cell lung cancer", "gold_support": "Human small-cell lung cancer (SCLC) cells are believed to express the antigens responsible for the production of pathological antibodies in the Lambert-Eaton syndrome (LES), a Ca2+ channel disorder in which quantal transmitter release from the motor nerve terminal is impaired.", "model_answer": "The type of lung cancer most strongly associated with Lambert-Eaton syndrome is small cell lung cancer (SCLC).", "model_support": "The supporting sentence is: \"The expression of P-type Ca2+ channels in the SCLC cells and the reactivity of LES IgG with these channels support the hypothesis that P-type Ca2+ channels in these cancer cells may trigger the autoantibody production in this disorder.\" This indicates a strong association between SCLC and LES.", "retries": 1}
{"idx": 397, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('hemiatrophy of one side of the body') does not match the gold standard ('cerebral hemiatrophy'), although it is related and mentioned in the context. The supporting sentence repeats the model's answer but does not directly cover the gold answer ('cerebral hemiatrophy'). While relevant, the supporting sentence lacks precision and clarity in linking to the correct term from the gold standard.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "MRI brain revealed characteristic features diagnostic of congenital type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is hemiatrophy of one side of the body.", "model_support": "The characteristic feature of Dyke-Davidoff-Masson syndrome is hemiatrophy of one side of the body.\n\n**Supporting sentence:**  \n\"A 15-year-old female presented with seizures, right-sided hemiparesis, hemiatrophy of the right side of the body and mental retardation.\"", "retries": 1}
{"idx": 398, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by stating 'factor Xa' instead of just 'Xa'. The supporting sentence is relevant and supports the answer by discussing a factor Xa decoy in relation to betrixaban, but it contains some redundancy and unnecessary detail about PRT4445 being evaluated as a reversal agent. This makes the reasoning slightly less concise than ideal, but still logical and correct.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence indicates that PRT4445, a factor Xa decoy, is being evaluated to reverse the effects of betrixaban, implying that betrixaban inhibits factor Xa. Therefore, betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 399, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states APOBEC3B is predominantly cytoplasmic, while the gold answer specifies that APOBEC3B is nuclear. Additionally, the supporting sentence provided by the model is irrelevant to the gold answer, as it discusses APOBEC3G's cytoplasmic localization rather than addressing APOBEC3B's nuclear localization.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "To define the domains of APOBEC3G that determine cytoplasmic localization, comparisons were made with APOBEC3B, which is predominantly nuclear.", "model_answer": "APOBEC3B is predominantly cytoplasmic.", "model_support": "APOBEC3B is predominantly cytoplasmic.\n\n**Supporting Sentence:** APOBEC3G localizes predominantly to the cytoplasm of cells, which is consistent with a model wherein cytosolic APOBEC3G packages into assembling virions, where it exerts its antiviral effect by deaminating viral cDNA cytosines during reverse transcription.", "retries": 1}
{"idx": 400, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is redundant and verbose compared to the gold supporting sentence. While it does mention ZEB2 and relates to the context of Mowat-Wilson syndrome, it includes unnecessary details about specific mutations and patient cases rather than focusing on the key information that all typical cases result from haploinsufficiency of ZEB2. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.\n\nAnswer: ZEB2", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZEB2.\n\n**Supporting sentence:**  \n\"Here we report on the results of comprehensive molecular testing for 27 patients testing positive for MWS. Twenty-one patients had a nonsense, frameshift, or splice site mutation identified by sequencing; 14 of which localized to exon 8 and 17 of which are novel. Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\"", "retries": 1}
{"idx": 401, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('5-HT2A'), though it includes 'receptors,' which is implied but not strictly necessary. The supporting sentence provides relevant information and demonstrates logical support for the answer, but it is unnecessarily long and contains details that are tangential to the core explanation. A more concise extraction from the context could have been used to directly support the evaluation of 5-HT2A receptors.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The [18F]altanserin is used to evaluate 5-HT2A receptors.\n\nAnswer: 5-HT2A receptors", "model_support": "The supporting sentence is:\n\n\"PURPOSE:  PROCEDURES: Ten Sprague Dawley rats underwent 180 min PET scans with arterial blood sampling. Reference tissue methods were evaluated on the basis of invasive kinetic models with metabolite-corrected arterial input functions. In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.\"\n\nThis sentence indicates that [18F]altanserin is used to evaluate 5-HT2A receptors.", "retries": 1}
{"idx": 402, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('Stroke'), though it is slightly more descriptive than necessary. The supporting sentence is relevant and provides good context for the ROSIER scale's purpose, but it includes additional details that, while informative, are not essential to directly supporting the answer. This makes it somewhat redundant compared to the gold supporting sentence, which is more concise.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for assessing and recognizing stroke in emergency room settings.", "model_support": "Supporting sentence: A seven-item (total score from -2 to +5) stroke recognition instrument was constructed on the basis of clinical history (loss of consciousness, convulsive fits) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect).", "retries": 1}
{"idx": 403, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('Na(+)/Ca(2+) exchanger (NCX)') is correct and matches the gold standard ('NCX'), but the supporting sentence provided by the model does not logically support the answer. The chosen sentence discusses the effects of SEA0400 on reducing arrhythmias but does not explicitly state that SEA0400 is an inhibitor of NCX, which is crucial for supporting the answer. The gold supporting sentence directly identifies SEA0400 as an NCX inhibitor, making it more relevant and concise.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "SEA0400 (1 μM), a pharmacological inhibitor of NCX, significantly shortened the MAP duration (P < .01) and reduced dispersion (P < .05).", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na(+)/Ca(2+) exchanger (NCX).\n\nAnswer: Na(+)/Ca(2+) exchanger (NCX)", "model_support": "The supporting sentence from the context that identifies SEA0400 as an inhibitor of the Na(+)/Ca(2+) exchanger (NCX) is:\n\n\"It suppressed EAD in 6 of 13 sotalol-treated failing hearts and in 9 of 10 veratridine-treated failing hearts, leading to a reduction in VT (60% in sotalol-treated failing hearts and 83% in veratridine-treated failing hearts).\"\n\nThis sentence indicates the effect of SEA0400, which is used as the NCX inhibitor in the study.", "retries": 1}
{"idx": 404, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard ('S-adenosylmethionine') and provides a correct, slightly more detailed explanation by including the alternative name 'SAM' and its role in biochemical processes. The supporting sentence is relevant but contains some redundancy. It discusses AdoMet's role in plants and the SMM cycle, which indirectly supports the answer but includes extra information not directly tied to histone methyltransferases. A more concise sentence focusing solely on AdoMet as the methyl donor would have warranted a full score.\",\n  \"match\": true\n}", "gold_answer": "S-adenosylmethionine", "gold_support": "Angiosperms synthesize S-methylmethionine (SMM) from methionine (Met) and S-adenosylmethionine (AdoMet) in a unique reaction catalyzed by Met S-methyltransferase (MMT).", "model_answer": "The methyl donor for histone methyltransferases is S-adenosylmethionine (SAM), also known as AdoMet. This compound is crucial for transferring methyl groups in various biochemical processes, including histone methylation.", "model_support": "The supporting sentence from the context is:\n\n\"Because plants lack the negative feedback loops that regulate AdoMet pool size in other eukaryotes, the SMM cycle may be the main mechanism whereby plants achieve short-term control of AdoMet level.\"\n\nThis sentence highlights the role of S-adenosylmethionine (AdoMet) in biochemical processes, including its role as a methyl donor, which is crucial for histone methyltransferases.", "retries": 1}
{"idx": 405, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('XK') when considering acceptable variations (e.g., 'XK gene' vs. 'XK'). However, the supporting sentence is slightly redundant because it repeats the answer verbatim instead of providing additional context or logical reasoning as seen in the gold supporting sentence. Despite this, the supporting sentence still aligns with the gold standard by referencing the XK gene mutation.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The McLeod syndrome is an X-linked disorder caused by mutations of the XK gene encoding the XK protein.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.\n\nAnswer: XK gene", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene.\n\n**Supporting sentence:**  \n\"We describe a family with a novel point mutation in the XK gene...\"", "retries": 1}
{"idx": 406, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and logically explains that betrixaban is one of the new oral anticoagulants targeting factor Xa. There are no unnecessary details, and the reasoning is clear.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.\"\n\nThis sentence supports the answer by indicating that oral anticoagulants, including betrixaban, target factor Xa.", "retries": 1}
{"idx": 407, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SET domain'). The supporting sentence is relevant and covers the answer, but it introduces slight redundancy by elaborating on the catalytic activity, which is not necessary for directly supporting the answer. The gold supporting sentence is more concise and directly ties the SET domain to the identity of the protein in question.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Data base analysis indicates that human Set1A protein shares 39% identity with an uncharacterized SET domain protein, KIAA1076, hereafter denoted Set1B.", "model_answer": "The characteristic domain of histone methyltransferases is the SET domain. This catalytic domain is responsible for the methyltransferase activity, enabling the transfer of methyl groups to histone proteins, specifically at sites like H3-K4 in the case of Set1A and Set1B complexes.", "model_support": "The characteristic domain of histone methyltransferases is the SET domain, which is responsible for their catalytic activity. \n\n**Supporting sentence:** \"A 123-amino acid fragment upstream of the Set1A SET domain is necessary for interaction with CFP1, Ash2, Rbbp5, and Wdr5.\"", "retries": 1}
{"idx": 408, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate reasoning, mentioning that MLL1 targets H3K4 based on general biological knowledge. However, it introduces slight redundancy by referencing 'general knowledge' instead of directly citing the context provided, which includes evidence about H3K4 methylation during MDR1 activation.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "It has also been shown that MDR1 activation is accompanied by increased methylation on lysine 4 of histone H3 (H3K4).", "model_answer": "The histone residue methylated by MLL1 is H3K4.\n\nAnswer: H3K4", "model_support": "The histone residue methylated by MLL1 is H3K4. This conclusion is based on the general knowledge that MLL1 functions as a histone methyltransferase targeting the H3K4 residue, which is associated with gene activation.\n\n**Answer:** H3K4\n\n**Supporting Information:** While the context does not explicitly state the histone residue, it is known from general biological knowledge that MLL1 methylates H3K4.", "retries": 1}
{"idx": 409, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but more verbose than the gold standard. The supporting sentence provided by the model is a restatement of the answer rather than an extraction from the context, which makes it less relevant and not as concise as the gold supporting sentence. The logic is reasonable, but the supporting sentence could be more directly tied to the evidence in the context.\", \"match\": true}", "gold_answer": "mTOR", "gold_support": "L-Leucine also increased the levels of phosphorylated molecular target of rapamycin (mTOR) and two of its targets, ribosomal protein S6 kinase (p70S6K), and 4E binding protein 1 (4E-BP1); furthermore, rapamycin (an mTOR inhibitor) blocked all of the mitogenic effects of L-leucine.", "model_answer": "The molecular target of the immunosuppressant drug Rapamycin is the mTOR (mammalian target of rapamycin) pathway.", "model_support": "The molecular target of the immunosuppressant drug Rapamycin is the mTOR (mammalian target of rapamycin) pathway.\n\nSupporting sentence: In conclusion, L-leucine stimulated DNA synthesis and promoted cell cycle progression in primary cultured chicken hepatocytes through PKC, ERK1/2, PI3K/Akt, and mTOR.", "retries": 1}
{"idx": 410, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is more detailed than necessary. The gold answer simply states 'thyroid,' which implies abnormalities related to thyroid function, while the model specifies hypothyroidism and impaired hormone production, which is a reasonable elaboration but not exactly matching the concise nature of the gold answer. The supporting sentence provided by the model is somewhat relevant but does not directly cover the gold answer or supporting sentence as effectively as it could. It adds reasoning about thyroid dysfunction but lacks the direct connection to Pendred syndrome's characteristic features mentioned in the gold supporting sentence. Overall, the logic is reasonable but could be more concise.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome (PS) is an autosomal recessive disease that is characterized by congenital sensorineural hearing loss, goiter, and a partial iodine organification defect.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome involve thyroid dysfunction, specifically issues related to thyroid hormone production and regulation, such as hypothyroidism.", "model_support": "The characteristic hormone abnormalities in Pendred syndrome are related to the thyroid, specifically issues such as hypothyroidism due to impaired thyroid hormone production.\n\n**Supporting Sentence:**  \n\"The mild thyroid dysfunction in these patients suggests that PS should be considered in all patients with congenital or early-onset hearing impairment.\"", "retries": 1}
{"idx": 411, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NF1') in meaning, though it is slightly more verbose by specifying 'the NF1 gene.' The supporting sentence provided by the model repeats the answer and does not offer additional logical reasoning or context. However, the gold supporting sentence provides more direct evidence from the text. The model's supporting sentence could be improved by citing a sentence that explicitly mentions the detection of pathogenic mutations in the NF1 gene for confirmation.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.", "model_support": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.\n\n**Supporting Sentence:**  \n\"Because of their co-localization with the tumor suppressor protein neurofibromin, which is mutated in NF1, mitochondria were particular attractive candidates for investigation.\"", "retries": 1}
{"idx": 412, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Hypothyroidism,' is very close to the gold standard 'thyroid,' but it is slightly more specific than required. The supporting sentence provides relevant information about congenital hypothyroidism and thyroid hypoplasia, which aligns with the context of the gold answer. However, it is somewhat verbose and includes debated aspects like the frequency of biochemical assessment, which detracts from conciseness. Overall, the logic is reasonable but could be more focused.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Hypothyroidism is a common hormonal abnormality in Williams syndrome.", "model_support": "Supporting sentence: However, the frequency of biochemical thyroid assessment, particularly in the first year of life, is being debated. In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.", "retries": 1}
{"idx": 413, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Betrixaban inhibits factor Xa,' is correct and aligns with the gold answer ('xa'). However, the supporting sentence provided by the model is unnecessarily lengthy and includes pharmacokinetic details that are not directly relevant to the specific question about which clotting factor is inhibited. While it does eventually mention a factor Xa decoy in conjunction with betrixaban, this is an indirect way of supporting the answer. The gold supporting sentence is much more concise and directly mentions 'factor Xa inhibitor,' making it more effective.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life.\"\n\nAdditionally, the context mentions that betrixaban is being evaluated in conjunction with a factor Xa decoy, PRT4445, which suggests that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 414, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by highlighting the presence of multiple selenocysteine residues, although it references the zebrafish selenoprotein P with 17 residues rather than directly quoting the human-specific detail from the gold supporting sentence. This introduces slight redundancy but still provides logical support.\",\n  \"match\": true\n}", "gold_answer": "selenoprotein P", "gold_support": "Whereas most selenoproteins contain a single selenocysteine residue, the human, bovine and rodent selenoprotein P genes encode proteins containing 10-12 selenocysteines.", "model_answer": "The human selenoprotein that contains several Se-Cys residues is selenoprotein P. \n\nAnswer: Selenoprotein P", "model_support": "The supporting sentence is: \"Sequencing of the cDNA revealed the presence of 17 selenocysteine codons, the highest number reported in any protein.\" This indicates that selenoprotein P, including its human counterpart, contains multiple Se-Cys residues.", "retries": 1}
{"idx": 415, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context about JTV519's function, which aligns well with the gold supporting sentence without introducing irrelevant information.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "K201 (JTV519) is a 1,4-benzothiazepine derivative that exhibits a strong cardioprotective action and acts as a multiple-channel blocker, including as a K+ channel blocker.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 416, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('cerebral hemiatrophy') but is present in the context as a feature of the syndrome. The supporting sentence repeats the model's answer without covering the gold answer or providing concise reasoning directly tied to 'cerebral hemiatrophy.' Therefore, while relevant, it does not fully support the gold standard.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The purpose of this study was to retrospectively evaluate the cognitive and electroclinical characteristics of right cerebral hemiatrophy (Dyke-Davidoff-Masson syndrome [DDMS]).", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is impairment in visuospatial functions, particularly affecting spatial processing and orientation discrimination.", "model_support": "The characteristic feature of Dyke-Davidoff-Masson syndrome is impairment in visuospatial functions, particularly affecting spatial processing and orientation discrimination. \n\nSupporting sentence: \"Neuropsychological assessments demonstrated consistent impairments in tasks that have a spatial component (spatial processing and orientation discrimination), whereas attention, executive functions, and verbal memory domains were variably impaired.\"", "retries": 1}
{"idx": 417, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and covering the role of DNMT1 in DNA methylation, does not directly reference the specific mutation or its effect on Snrpn imprinting as the gold supporting sentence does. It provides general information about DNMT1 being essential for spermatogenesis but lacks the specificity and direct logical connection to the mutation context provided in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DNA methyltransferase 1 (Dnmt1) mutation affects Snrpn imprinting in the mouse male germ line.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.\n\n**Supporting sentence:** DNA methylation and DNA methyltransferases are essential for spermatogenesis.", "retries": 1}
{"idx": 418, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer (1,4-benzothiazepine) matches the gold standard (benzothiazepine) with only a minor difference in specificity. The supporting sentence is missing in the model output, but the correct information could have been extracted from the context provided. The gold supporting sentence directly supports the answer and is concise, though the model failed to provide it.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence for the answer is not present in the provided context. The context does not mention the chemical group that JTV519 is a derivative of. \n\nAnswer: The supporting sentence is not present in the context.", "retries": 1}
{"idx": 419, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with a minor difference in specificity (adding '1,4-' which is technically correct but not required by the gold standard). The supporting sentence is relevant and accurate, referencing JTV519 as a 1,4-benzothiazepine derivative. However, it includes an unnecessary statement about the context not containing explicit confirmation, which adds redundancy. This makes the supporting sentence slightly verbose but still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "The cardioprotective effects of a new 1,4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The supporting sentence that identifies JTV519 as a 1,4-benzothiazepine derivative is not present in the provided context. Therefore, within this context, there is no explicit statement confirming the chemical group of JTV519. However, based on prior knowledge from the example provided, JTV519 is known to be a derivative of the 1,4-benzothiazepine group.", "retries": 1}
{"idx": 420, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is incorrect because it states that no specific sentence in the context provides the answer, whereas the gold supporting sentence clearly does. However, since the instructions prioritize rating based on the answer and the logic of the supporting sentence, the answer is correct, and the reasoning could be seen as an issue of identifying the sentence rather than logical relevance. Thus, it receives a perfect score.\", \"match\": true}", "gold_answer": "15", "gold_support": "Novel kallikrein genes were cloned recently, and it was shown that the human kallikrein family contains 15 genes tandemly aligned on chromosomal locus 19q13.3-q13.4.", "model_answer": "The human genome contains 15 tissue kallikrein genes.", "model_support": "The context provided does not contain a specific sentence that states the number of tissue kallikrein genes in the human genome. Therefore, the supporting sentence cannot be identified from the given text. \n\nAnswer: The context does not provide information about the number of tissue kallikrein genes in the human genome.", "retries": 1}
{"idx": 421, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, Dnmt3b, does not match the gold standard, which is Dnmt1. However, Dnmt3b is mentioned in the context as having a role in maintaining methylation for certain genes, making it relevant but incorrect in this specific case. The supporting sentence provided by the model repeats the answer without offering additional reasoning or clarity. The gold supporting sentence clearly explains that Dnmt1 is responsible for maintenance methylation during DNA replication, which the model fails to capture.\", \"match\": false}", "gold_answer": "Dnmt1", "gold_support": "It is generally accepted that DNA methyltransferases carry out specific and non-overlapping functions, Dnmt3a and Dnmt3b being responsible for the establishment of methylation around the time of implantation and Dnmt1 ensuring that methylation is faithfully copied to daughter cells via what has come to be known as \"maintenance methylation.\"", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation, particularly for certain germ line genes in somatic cells, is **Dnmt3b**.", "model_support": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation, particularly for certain germ line genes in somatic cells, is **Dnmt3b**.\n\n**Supporting sentence:** \"We propose here observations in support of the hypothesis that the maintenance of methylation and subsequent silencing of a handful of germ line genes requires Dnmt3b but not Dnmt1.\"", "retries": 1}
{"idx": 422, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but includes additional information ('transient ischaemic attack') which is not part of the gold standard ('stroke'). The supporting sentence is relevant but somewhat lengthy and mixes context with diagnostic scales rather than directly focusing on the ROSIER scale's purpose. While logical, it could be more concise.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for identifying stroke and transient ischaemic attack (TIA) in the emergency department.", "model_support": "The supporting sentence is:  \n\"Clinical scores for the identification of stroke and transient ischaemic attack in the emergency department: a cross-sectional study.\"", "retries": 1}
{"idx": 423, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it includes additional context about the prehospital setting, which is not strictly necessary for answering the question. The supporting sentence is relevant and directly ties the ROSIER scale to stroke recognition in the prehospital setting, but it contains slight redundancy by specifying 'emergency physicians' and 'suspected patients,' which adds minor verbosity.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for recognizing stroke in the prehospital setting.", "model_support": "The supporting sentence is:\n\n\"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 424, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('alpha-synuclein'). The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning additional details like the identification of the alpha-synuclein gene on chromosome 4q, which is not directly required to explain the answer. The logic is clear and accurate, but a more concise statement would improve it.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Distinctive histopathology was revealed with alpha-synuclein immunostaining, including pleomorphic Lewy bodies, synuclein-positive glial inclusions and widespread, severe neuritic dystrophy.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.", "model_support": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein, as indicated by the context that highlights alpha-synuclein as a component of Lewy bodies and the immunoreactivity of the antibodies against it.\n\n**Supporting sentence:**  \n\"The identification of the alpha-synuclein gene on chromosome 4q as a locus for familial Lewy-body parkinsonism and of alpha-synuclein as a component of Lewy bodies has heralded a new era in the study of Parkinson's disease.\"", "retries": 1}
{"idx": 425, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that pridopidine was tested for Huntington disease, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.\n\nAnswer: Huntington disease", "model_support": "The supporting sentence from the context is:\n\n\"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"\n\nThis sentence directly indicates that pridopidine was tested for the treatment of Huntington disease.", "retries": 1}
{"idx": 426, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer is correct and matches the gold standard (factor Xa). However, the supporting sentence provided by the model is somewhat indirect and refers to indirect factor Xa inhibitors rather than explicitly mentioning that betrixaban is a direct factor Xa inhibitor. The chosen supporting sentence introduces some confusion by referencing indirect inhibitors instead of directly supporting the answer with the relevant sentence from the context. The logic is reasonable but could be more precise.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux.\"\n\nAlthough betrixaban is not explicitly listed, it is known to be an indirect factor Xa inhibitor, fitting into the category described in the context.", "retries": 1}
{"idx": 427, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard ('IL-1β'). The supporting sentence is relevant and supports the answer by explaining that gevokizumab decreases IL-1β's binding affinity to its receptor, which aligns with the context. However, it contains minor redundancy by specifying details about both IL-1RI and IL-1 receptor type II, which slightly exceeds what is needed for concise support.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is Interleukin-1β (IL-1β). The drug inhibits IL-1β by reducing its binding affinity to the IL-1 receptor type I (IL-1RI), thereby modulating IL-1β signaling.\n\nAnswer: Interleukin-1β (IL-1β)", "model_support": "The molecule targeted by the drug Gevokizumab is Interleukin-1β (IL-1β). The supporting sentence from the context is:\n\n\"Gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"", "retries": 1}
{"idx": 428, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'autologous epidural blood patch' is a correct and specific description of the treatment. The supporting sentence provides relevant information about the treatment but includes additional details (e.g., volume of blood, complications) that are not directly necessary to support the answer. While logical, it could be more concise to align better with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients (e.g. age < 50 years, post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch.", "model_answer": "The definitive treatment for low-pressure headache is the autologous epidural blood patch.", "model_support": "The definitive treatment for low-pressure headache is the autologous epidural blood patch. This treatment involves injecting the patient's own blood into the epidural space to patch the leak and restore cerebrospinal fluid (CSF) pressure. \n\nSupporting sentence: \"The optimum volume of blood has been shown to be 12-20 ml for adult patients. Complications of autologous epidural blood patch are rare.\"", "retries": 1}
{"idx": 429, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning that supports the answer by emphasizing the role of Bcr-Abl in CML.\", \"match\": true}", "gold_answer": "Bcr-Abl", "gold_support": "Imatinib mesylate is a new drug that can inhibit the tyrosine kinase activity of Bcr-Abl, the receptors for platelet-derived growth factor receptor(PDGF) and stem cell factor, or c-kit.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia chromosome-positive chronic myelogenous leukemia is **Bcr-Abl**.", "model_support": "The supporting sentence from the context is:\n\n\"The expression of Bcr-Abl tyrosine kinase has been shown to be necessary and sufficient for the transformed phenotype of CML cells.\"\n\nThis sentence highlights that the Bcr-Abl tyrosine kinase is central to the disease process in Chronic Myeloid Leukemia (CML), making it the target for Imatinib (Gleevec), a tyrosine kinase inhibitor.", "retries": 1}
{"idx": 430, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'GPR101', does not match the gold standard, 'aryl hydrocarbon receptor interacting protein'. However, the supporting sentence correctly identifies that the context does not explicitly mention the gene but attempts to provide external knowledge. The issue is that this external knowledge is incorrect in this case, as GPR101 is not mentioned in the context or associated with familial isolated pituitary adenoma in the provided information. Thus, while the attempt to introduce external knowledge is relevant, the answer itself is incorrect based on both the context and gold standard.\",\n  \"match\": false\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "To date, the number of molecular genetic factors unequivocally linked to pituitary tumours can be counted on the fingers of one hand: (1) GNAS1 activation in acromegaly; (2) the MENIN and p27Kip1 (CDKN1B) mutations associated with multiple endocrine neoplasia type 1; (3) mutations of PRKA1RA with loss of 17q22-24 in Carney complex, and (4) aryl hydrocarbon receptor interacting protein gene mutations in 15% of familial isolated pituitary adenomas and 50% of familial isolated acromegaly.", "model_answer": "The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is GPR101.", "model_support": "The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is GPR101. However, the supporting sentence for this answer is not explicitly provided in the given context. Based on external knowledge, GPR101 mutations are associated with FIPA. \n\nAnswer: The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is GPR101. \n\nSupporting sentence: While not explicitly mentioned in the context, GPR101 mutations are known to be associated with FIPA.", "retries": 1}
{"idx": 431, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'growth hormone (GH) deficiency' is effectively equivalent to 'Growth hormone' in this context. The supporting sentence is relevant and covers the answer, but it includes some redundancy by mentioning successful treatment, which is not necessary to directly support the answer. The logic is clear but could be more concise.\", \"match\": true}", "gold_answer": "Growth hormone", "gold_support": "Growth hormone deficiency in Costello syndrome.", "model_answer": "The hormone deficiency implicated in Costello syndrome is growth hormone (GH) deficiency.", "model_support": "The supporting sentence from the context is: \"To our knowledge, these are the only patients with Costello syndrome who have been successfully treated for GH deficiency.\" This indicates that growth hormone (GH) deficiency is implicated in Costello syndrome.\n\nAnswer: The hormone deficiency implicated in Costello syndrome is growth hormone (GH) deficiency.", "retries": 1}
{"idx": 432, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The answer '3' matches the gold standard 'three'. However, the supporting sentence is not relevant to the question and does not cover the gold answer. The chosen supporting sentence discusses compound activity against RSV, which is unrelated to the number of genera in the Flaviviridae family. A more appropriate supporting sentence would have been the one mentioning the three genera explicitly.\",\n  \"match\": true\n}", "gold_answer": "three", "gold_support": "Within a project aimed at discovering new Flaviviridae inhibitors, new variously substituted 2-phenylbenzimidazoles were synthesized and evaluated in cell-based assays for cytotoxicity and antiviral activity against viruses representatives of the three genera of the Flaviviridae family, i.e.: Pestivirus (BVDV), Flavivirus (YFV) and Hepacivirus (HCV).", "model_answer": "The Flaviviridae family comprises three genera: Flavivirus, Pestivirus, and Hepacivirus.\n\nAnswer: 3", "model_support": "The supporting sentence from the context is:\n\n\"Interestingly, 35 was moderately active also against RSV (EC(50) = 25 μM).\"", "retries": 1}
{"idx": 433, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by specifying the deletion of the ZEB2 gene as the cause of Mowat-Wilson syndrome.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "Individuals with Mowat-Wilson syndrome (MWS; OMIM#235730) have characteristic facial features, a variety of congenital anomalies such as Hirschsprung disease, and intellectual disabilities caused by mutation or deletion of ZEB2 gene.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZEB2. \n\n**Supporting Sentence:**  \n\"High resolution microarray analysis revealed 0.9 Mb deletion of 2q22.3 involving two genes: ZEB2 and GTDC1.\"", "retries": 1}
{"idx": 434, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SERCA'), and the supporting sentence is relevant, but it contains slight redundancy. The chosen supporting sentence discusses the modulation of SERCA rather than directly stating its role as the calcium pump, which makes it less precise compared to the gold supporting sentence. However, the logic connecting the answer to the context is still strong.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is the SERCA (Sarcoplasmic Reticulum Calcium ATPase) pump.", "model_support": "The supporting sentence from the context is:\n\n\"Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvment.\"\n\nThis sentence identifies SERCA as the calcium pump in the sarcoplasmic reticulum, supporting the answer that SERCA is the main calcium pump.", "retries": 1}
{"idx": 435, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer, but it indirectly implies the interaction through the SWI/SNF complex without explicitly mentioning BRG1 as the specific subunit, leading to slight redundancy. The gold supporting sentence is more direct in stating the association between FANCA and BRG1.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1.\n\nAnswer: BRG1", "model_support": "The supporting sentence is: \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\" Since BRG1 is a subunit of the SWI/SNF complex, this implies that FANCA interacts with BRG1.\n\n**Answer:**  \nSupporting sentence: \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"", "retries": 1}
{"idx": 436, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence includes information about resistance mechanisms (mutations or increased BCR-ABL expression), which is not directly necessary to support the answer. While it is relevant and provides additional context, it introduces slight redundancy compared to the gold supporting sentence, which is more concise and directly explains Imatinib's mechanism of action on BCR-ABL.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Imatinib mesylate (IM) binds to the BCR-ABL protein, inhibiting its kinase activity and effectively controlling diseases driven by this kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "The supporting sentence from the context is:\n\n\"IM resistance has been associated with kinase mutations or increased BCR-ABL expression.\"\n\nThis sentence indicates that Imatinib's target is the BCR-ABL tyrosine kinase, and resistance can occur through mutations or increased expression of this kinase.", "retries": 1}
{"idx": 437, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, stating '1' when the gold answer is '7'. The supporting sentence does not logically support the model's answer and fails to address the correct number of TAp73 isoforms. Additionally, the provided context explicitly lists multiple isoforms, contradicting the model's claim.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is one.\n\nAnswer: 1", "model_support": "The number of TAp73 isoforms identified in humans is one. \n\n**Supporting sentence:** \"The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.\" This sentence lists TAp73 as one of the five isoforms, indicating that only one TAp73 isoform exists.", "retries": 1}
{"idx": 438, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard in meaning, though it provides additional descriptive information ('identifying acute stroke in emergency settings, helping to differentiate it from other conditions that mimic stroke symptoms') rather than simply stating 'stroke.' The supporting sentence effectively conveys the purpose of the ROSIER scale by mentioning its role in differentiating stroke from mimics, which logically supports the answer. However, it could be slightly more concise, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for identifying acute stroke in emergency settings, helping to differentiate it from other conditions that mimic stroke symptoms.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\" This sentence directly states the purpose of the ROSIER scale, which is to identify acute stroke by distinguishing it from other conditions that mimic stroke symptoms in emergency settings.", "retries": 1}
{"idx": 439, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard, as 'interleukin-5 (IL-5)' is equivalent to 'interleukin-5'. The supporting sentence provided by the model acknowledges that there is no relevant context for Mepolizumab or IL-5, which is accurate. However, it introduces slight redundancy by restating the answer in the format of a supporting sentence when no supporting sentence can be derived from the context. Despite this, the logic and relevance are strong.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "There has been a variable effect with the leukotriene receptor antagonist montelukast and promising early results with mepolizumab, a monoclonal antibody against interleukin-5.", "model_answer": "Mepolizumab targets interleukin-5 (IL-5).", "model_support": "The molecule targeted by the monoclonal antibody Mepolizumab is interleukin-5 (IL-5). However, the provided context does not mention Mepolizumab or IL-5, so there is no supporting sentence from the context.\n\n**Answer:** Mepolizumab targets interleukin-5 (IL-5). However, the context does not provide supporting information for this answer.", "retries": 1}
{"idx": 440, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions specific hormone abnormalities (reduced T4 and T3), which are not explicitly stated in the gold answer ('thyroid'). While these abnormalities are indirectly related to thyroid dysfunction, they do not directly match the gold standard. The supporting sentence provided by the model repeats the answer verbatim, which is redundant and lacks concise logical support for the gold answer. The correct supporting sentence from the context would have been more general about thyroid-related issues rather than focusing on the detailed mechanism of iodide organification.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is an autosomal recessive disorder characterized by sensorineural deafness, goiter and a partial defect in iodide organification.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are reduced levels of thyroxine (T4) and triiodothyronine (T3) due to impaired iodide organification.", "model_support": "The characteristic hormone abnormalities in Pendred syndrome are reduced levels of thyroxine (T4) and triiodothyronine (T3) due to impaired iodide organification.\n\n**Supporting sentence:**  \nLoss-of-function mutations in the SLC26A4 gene are associated with a partial iodide organification defect, presumably because of a reduced iodide efflux into the follicular lumen.", "retries": 1}
{"idx": 441, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('Factor Xa' corresponds to 'xa'). The supporting sentence provided by the model correctly identifies that the context does not explicitly mention betrixaban but aligns with the gold supporting sentence, which lists betrixaban as an example of a direct factor Xa inhibitor. The logic is clear and concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa.", "model_support": "The context does not mention betrixaban, so there is no supporting sentence to confirm that betrixaban inhibits factor Xa. Therefore, the answer cannot be supported by the given context.", "retries": 1}
{"idx": 442, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the listed features are correct and present in the context, they do not directly identify the core characteristic feature of Dyke-Davidoff-Masson syndrome, which is 'cerebral hemiatrophy.' The supporting sentence is relevant but focuses on clinical symptoms rather than the defining feature, failing to cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "cerebral hemiatrophy", "gold_support": "The so-called Dyke-Davidoff-Masson syndrome (DDMS) is a rare disorder of cerebral hemiatrophy.", "model_answer": "The characteristic features of Dyke-Davidoff-Masson syndrome (DDMS) include facial asymmetry, contralateral atrophy, hemiparesis, speech difficulties, mental retardation, and epilepsy.", "model_support": "Supporting sentence: The clinical presentation may consist of facial asymmetry, contralateral atrophy (including the trunk, and the extremities) and hemiparesis, speech difficulties, mental retardation, and epilepsy.", "retries": 1}
{"idx": 443, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying BCR-ABL as the target of Imatinib. The supporting sentence is relevant and supports the answer by referencing the effect of STI571 on BCR-ABL positive cells, but it includes slight redundancy by mentioning specific cell lines (KBM5 and KBM7) which are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND: Chronic myelogenous leukemia (CML) is characterized by a molecular aberration, a fusion BCR-ABL gene encoding for aberrant tyrosine kinase activity, which is crucial in the pathogenesis of CML.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase.", "model_support": "The supporting sentence from the context that indicates BCR-ABL as the target of Imatinib (Gleevec) is:\n\n\"The single agents and their combinations were studied for in vitro effect on proliferation of BCR-ABL positive cell lines KBM5 and KBM7...\"\n\nThis sentence implies that the study focuses on the effect of STI571 (Imatinib) on cells expressing the BCR-ABL fusion protein, thereby indicating BCR-ABL as the target.", "retries": 1}
{"idx": 444, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'AIP,' is correct and matches the gold standard conceptually. However, it does not fully match the gold answer verbatim ('Aryl hydrocarbon receptor interacting protein'). The supporting sentence provided by the model is relevant and supports the answer logically, but it contains slight redundancy by discussing the range of symptoms in AIP-mutated patients, which is not directly necessary to confirm the gene implicated. This makes the reasoning slightly less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Aryl hydrocarbon receptor interacting protein", "gold_support": "The identification of mutations in the Aryl hydrocarbon receptor interacting protein (AIP) gene in a subset of familial isolated pituitary adenoma (FIPA) cases has recently expanded our understanding of the pathophysiology of inherited pituitary adenoma disorders.", "model_answer": "The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is AIP.", "model_support": "The supporting sentence from the context that identifies the gene mutation implicated in familial isolated pituitary adenoma (FIPA) is:\n\n\"Several studies and reviews have assessed the genetic and clinical features of AIP-mutated FIPA patients, which range from a complete lack of symptoms in adult/elderly individuals to large, aggressive early-onset pituitary tumors.\"\n\nAnswer: The gene mutation implicated in familial isolated pituitary adenoma (FIPA) is AIP.", "retries": 1}
{"idx": 445, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('three'). The supporting sentence is concise, directly relevant, and logically covers the answer by explicitly stating the three genera in the Flaviviridae family. No unnecessary information is included.\", \"match\": true}", "gold_answer": "three", "gold_support": "The family Flaviviridae contains three genera of positive-strand RNA viruses, namely, Flavivirus, Hepacivirus (e.g., hepatitis C virus [HCV]), and Pestivirus.", "model_answer": "The Flaviviridae family comprises three genera: Flavivirus, Pestivirus, and Hepacivirus. \n\nAnswer: 3", "model_support": "The Flaviviridae family comprises three genera: Flavivirus, Pestivirus, and Hepacivirus. \n\nAnswer: 3\n\nSupporting Sentence: The context does not explicitly state the number of genera in the Flaviviridae family. However, based on general knowledge, the family includes three genera.", "retries": 1}
{"idx": 446, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, PTEN is mentioned in the context as a 'new guardian of the genome,' making it relevant but incorrect in this case. The supporting sentence is relevant to the model's answer but does not cover the gold answer, which refers to p53 and its role in mediating cellular responses to stress.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "PTEN is referred to as \"the guardian of the genome\" in the provided context.\n\nAnswer: PTEN", "model_support": "Supporting sentence: \"Thus, we propose that PTEN is a new guardian of the genome.\"", "retries": 1}
{"idx": 447, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer 'Iron deficiency' is very close to the gold standard 'Iron', with only minor differences in wording. However, the supporting sentence provided by the model discusses iron deficiency causing anaemia and haemochromatosis, which does not directly relate to restless leg syndrome as described in the gold supporting sentence. The correct supporting information should emphasize the role of iron deficiency in the central nervous system and its suggested link to restless leg syndrome. Thus, while the answer is mostly correct, the supporting sentence mixes relevant and irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "Iron", "gold_support": "Iron deficiency in the central nervous system is known to cause motor impairment and cognitive deficits; more recently, it has been suggested that it may play a role in the pathophysiology of the restless leg syndrome.", "model_answer": "The deficiency that causes restless leg syndrome is iron deficiency. \n\nAnswer: Iron deficiency", "model_support": "Supporting sentence: Iron deficiency has been long been known to cause anaemia, iron excess to cause haemochromatosis.", "retries": 1}
{"idx": 448, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides some context about p53 being a tumor suppressor, but it does not explicitly mention 'the guardian of the genome' or fully capture the detailed reasoning provided in the gold supporting sentence. It contains slight redundancy by mentioning microRNAs, which is not necessary to justify the answer.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53, encoded by the TP53 gene, is recognized as the guardian of the human genome because it regulates many downstream genes to exercise its function in cell cycle and cell death.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The context does not explicitly mention the nickname \"the guardian of the genome\" for p53. However, it refers to p53 as a tumor suppressor, which is related to its role as the guardian of the genome.\n\n**Supporting sentence:**  \n\"The tumor suppressor p53 gene is negatively regulated by microRNAs.\"", "retries": 1}
{"idx": 449, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but focuses specifically on subclinical hypothyroidism rather than broadly mentioning 'thyroid' abnormalities as the gold answer does. The supporting sentence provides relevant information but is somewhat specific and could be seen as slightly narrow in scope compared to the broader context of the gold supporting sentence. Logic is reasonable but could be more concise and inclusive.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid morphology and subclinical hypothyroidism in children and adolescents with Williams syndrome.", "model_answer": "The common hormone abnormality in Williams syndrome is subclinical hypothyroidism, particularly in younger patients.", "model_support": "The supporting sentence is found in the Results section, which states: \"The prevalence of patients with subclinical hypothyroidism was significantly higher in the younger patients.\" This directly supports the answer regarding the common hormone abnormality in Williams syndrome, particularly in younger individuals.\n\n**Supporting sentence:** The prevalence of patients with subclinical hypothyroidism was significantly higher in the younger patients.", "retries": 1}
{"idx": 450, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('congenital hypothyroidism') does not match the gold standard ('thyroid'), but it is present in the context as a related concept. The supporting sentence focuses on iodothyronine transporter defects, which are relevant to congenital hypothyroidism but do not directly support the gold answer ('thyroid'). The supporting sentence is somewhat relevant but fails to cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Among those causing dyshormonogenesis, the thyroid peroxidase and thyroglobulin genes were initially described, and more recently PDS (Pendred syndrome), NIS (sodium iodide symporter), and THOX2 (thyroid oxidase 2) gene defects.", "model_answer": "The characteristic hormone abnormality in Pendred syndrome is congenital hypothyroidism, resulting from defects in the iodothyronine transporter, particularly affecting iodide uptake and thyroid hormone synthesis.", "model_support": "The characteristic hormone abnormality in Pendred syndrome is congenital hypothyroidism, resulting from defects in the iodothyronine transporter, particularly affecting iodide uptake and thyroid hormone synthesis.\n\n**Supporting sentence:**  \n\"There is also early evidence for a third group of congenital hypothyroid conditions associated with iodothyronine transporter defects associated with severe neurological sequelae.\"", "retries": 1}
{"idx": 451, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('ret') in meaning, though it uses the full form 'RET gene' instead of just 'ret'. The supporting sentence is relevant and provides context for the answer, but it includes some extra information (mentioning GDNF) that slightly increases verbosity without being directly necessary. The logic connecting the RET gene mutation to both diseases is strong, but a more concise sentence could have been used.\",\n  \"match\": true\n}", "gold_answer": "ret", "gold_support": "Germline mutations of the ret protooncogene are the underlying cause of the MEN2 syndromes and a proportion of cases of HSCR.", "model_answer": "The gene frequently mutated in both Multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung disease is the RET gene.", "model_support": "The supporting sentence from the context is:\n\n**\"Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.\"**\n\nThis sentence indicates that the study examined both the RET and GDNF genes in a family affected by MEN2A and Hirschsprung disease. The context further explains that a silent mutation in the RET gene (A45A) was found in the patient with both conditions, while no mutations were found in the GDNF gene. This supports the conclusion that the RET gene is frequently mutated in both MEN2 and Hirschsprung disease.", "retries": 1}
{"idx": 452, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('7') but is present in the context of p73 isoforms. The supporting sentence acknowledges that the context does not explicitly state the number of TAp73 isoforms and hints at reliance on external knowledge. However, it fails to cover the gold answer adequately, as no reasoning or evidence is provided to support 'seven' as the correct number.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is three: TAp73α, TAp73β, and TAp73γ. These isoforms result from alternative splicing of the p73 gene, each starting with a different first exon (1a, 1b, or 1c). \n\nAnswer: Three.", "model_support": "The context provided discusses the existence of TAp73 isoforms but does not explicitly state the number of TAp73 isoforms identified in humans. It mentions that transcription from two different promoters results in TAp73 and DeltaNp73 isoforms, but it does not specify the exact number of TAp73 isoforms. Therefore, the answer provided, which states there are three TAp73 isoforms, is not directly supported by the context given. It may rely on external knowledge about p73 isoforms rather than the information provided in the context.\n\n**Answer:** The context does not explicitly state the number of TAp73 isoforms identified in humans. It only mentions the existence of TAp73 isoforms without specifying their exact count.", "retries": 1}
{"idx": 453, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "Species identification by analysis of bone collagen using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.", "model_answer": "The bone protein used in archaeology for dating and species identification is collagen.", "model_support": "The bone protein used in archaeology for dating and species identification is collagen.\n\nSupporting sentence: \"Analysis of the collagen from 32 different mammal species identified a total of 92 peptide markers that could be used for species identification, for example, in processed food and animal feed.\"", "retries": 1}
{"idx": 454, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, but it focuses on point mutations rather than the expression pattern that correlates with the phenotype, introducing slight redundancy. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "XK", "gold_support": "The mRNA expression pattern of one of them, designated as XK, correlates closely to the McLeod phenotype.", "model_answer": "The gene associated with McLeod syndrome when mutated is XK.\n\nAnswer: XK", "model_support": "Supporting sentence: Nucleotide sequence analysis of XK from two unrelated McLeod patients has identified point mutations at conserved splice donor and acceptor sites.", "retries": 1}
{"idx": 455, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('PARP'), though it includes a more elaborate version 'Poly (ADP-ribose) polymerase (PARP)', which is technically correct but not as concise as the gold answer. The supporting sentence provided by the model is relevant and covers the answer, but it repeats the model's answer verbatim, introducing some redundancy. A more direct extraction from the context would have been preferable for conciseness.\",\n  \"match\": true\n}", "gold_answer": "PARP", "gold_support": "We used two PARP inhibitors in clinical development, olaparib and rucaparib, as well as genetic downmodulation of PARP-1 for in vitro studies.", "model_answer": "The target of the drug Olaparib is Poly (ADP-ribose) polymerase (PARP). \n\nAnswer: Poly (ADP-ribose) polymerase (PARP)", "model_support": "The target of the drug Olaparib is Poly (ADP-ribose) polymerase (PARP). \n\nSupporting sentence: \"We tested PARP inhibition, alone or combined with the anti-HER2 antibody trastuzumab on HER2+ breast cancer.\"\n\nAnother supporting sentence: \"Results: In a panel of four HER2 overexpressing breast cancer cell lines, both olaparib and rucaparib significantly decreased cell growth and enhanced anti-tumour effects of trastuzumab.\"", "retries": 1}
{"idx": 456, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer '5-HT2A receptors' matches the gold standard '5-HT2A' exactly, with only a minor addition of the word 'receptors,' which does not detract from the correctness. The supporting sentence is concise, directly relevant, and logically supports the answer by confirming that [18F]altanserin PET quantifies 5-HT2A receptor availability. The logic is clear and aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "5-HT2A receptors.", "model_support": "The supporting sentence is found in the Conclusion section:\n\n\"CONCLUSION: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2A receptor availability in albino rats.\"\n\nThis sentence confirms that [18F]altanserin is used to evaluate 5-HT2A receptors.", "retries": 1}
{"idx": 457, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer correctly identifies BACH1 as a repressor, matching the gold standard. The supporting sentence provides relevant information about BACH1 acting as a feedback inhibitor, which aligns with the gold supporting sentence. However, it includes extra details about Nrf2 dependency and feedback inhibition that are not directly necessary to support the answer, making it slightly redundant.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "BACH1 is a transcriptional repressor. It is induced by Nrf2 and acts as a feedback inhibitor to down-regulate antioxidant-response-element-mediated gene expression.", "model_support": "The supporting sentence is: \"We conclude that BACH1 is a bona fide Nrf2 target gene and that induction of BACH1 by Nrf2 may serve as a feedback-inhibitory mechanism for ARE-mediated gene regulation.\" This sentence indicates that BACH1 acts as a transcriptional repressor by down-regulating ARE-mediated gene expression through a feedback mechanism.", "retries": 1}
{"idx": 458, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer mentions hypercalcemia, which is correct and present in the context, but it incorrectly states that hypercalcemia is associated with elevated parathyroid hormone (PTH) levels, which is not supported by the context. The gold answer refers to hypothyroidism, which is also an endocrine abnormality in Williams syndrome but is missing from the model's response. The supporting sentence discusses treatment for hypercalcemia, which is relevant but does not directly support or clarify the specific hormonal abnormalities in Williams syndrome. Therefore, while partially correct, the answer does not fully match the gold standard and contains inaccuracies.\",\n  \"match\": false\n}", "gold_answer": "yroidis", "gold_support": "Williams syndrome (WS) is characterized by cardiovascular disease (elastin arteriopathy, peripheral pulmonary stenosis, supravalvar aortic stenosis, hypertension), distinctive facies, connective tissue abnormalities, intellectual disability (usually mild), a specific cognitive profile, unique personality characteristics, growth abnormalities, and endocrine abnormalities (hypercalcemia, hypercalciuria, hypothyroidism, and early puberty).", "model_answer": "The common hormonal abnormality in Williams syndrome is hypercalcemia, which is associated with elevated parathyroid hormone (PTH) levels.", "model_support": "The common hormonal abnormality in Williams syndrome is hypercalcemia, which is associated with elevated parathyroid hormone (PTH) levels.\n\n**Supporting Sentence:**\n\"Treatment of hypercalcemia may include diet modification, oral corticosteroids, and/or intravenous pamidronate.\"", "retries": 1}
{"idx": 459, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and highlights the importance of collagen analysis in various fields including archaeology, but it contains slight redundancy by mentioning multiple fields (medical sciences, biology, forensic, anthropology) instead of focusing solely on archaeology as the gold supporting sentence does. Overall, the logic is sound, but the extra details make it less concise than ideal.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "The developed strategy permitted unprecedented biochemical analyses of bone-matrix proteins, including collagen modifications, using nearly nanoscale amounts of exceptionally homogenous bone tissue.", "model_answer": "Collagen is the bone protein used in archaeology for dating and species identification.", "model_support": "The supporting sentence is:\n\n\"Our strategy allows in-depth analysis of very limited amounts of bone material, and thus, can be important to medical sciences, biology, forensic, anthropology, and archaeology.\"\n\nThis sentence implies that collagen, as part of the bone material analyzed, is used in archaeology for dating and species identification.", "retries": 1}
{"idx": 460, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Tumor suppressor p53 functions as a 'guardian of the genome' to prevent cells from transformation.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\n**Supporting sentence:** Tumor suppressor p53 functions as a \"guardian of the genome\" to prevent cells from transformation.", "retries": 1}
{"idx": 461, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying LEKTI as the protein causing Netherton syndrome. The supporting sentence is relevant but includes slight redundancy by mentioning external knowledge and the SPINK5 gene, which is not necessary given the direct mention of LEKTI in the context. The logic is sound, but the sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome and its multifaceted defective protein LEKTI.", "model_answer": "The protein causing Netherton syndrome is LEKTI, which is encoded by the SPINK5 gene.", "model_support": "The context provided does not explicitly mention the protein causing Netherton syndrome. However, based on general medical knowledge, the protein responsible is LEKTI, encoded by the SPINK5 gene. \n\n**Answer:** The protein causing Netherton syndrome is LEKTI, encoded by the SPINK5 gene.\n\n**Supporting Sentence:** The context does not directly name the protein, but it mentions that specific diagnostic tools were developed after identifying the causative gene and protein, which is known from external knowledge to be LEKTI (SPINK5).", "retries": 1}
{"idx": 462, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'epidermal growth factor receptor (EGFR),' does not match the gold standard 'EGFRvIII.' However, EGFR is mentioned in the context and is related. The supporting sentence is relevant but does not directly cover the gold answer, as it mentions EGFRvIII without specifying that rindopepimut is an analog of EGFRvIII.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Rindopepimut is an analog of the epidermal growth factor receptor (EGFR).", "model_support": "Supporting sentence: Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.", "retries": 1}
{"idx": 463, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer is correct and matches the gold standard ('xa' referring to factor Xa). However, the supporting sentence is somewhat misleading as it mentions indirect factor Xa inhibitors (e.g., fondaparinux), while betrixaban is actually a direct factor Xa inhibitor according to the gold supporting sentence. The logic connecting the model's supporting sentence to the answer could be more precise, though the general idea of factor Xa inhibition is present.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. It is an indirect factor Xa inhibitor, working through antithrombin to prevent clot formation.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux.\"\n\nThis sentence establishes that betrixaban, as an indirect factor Xa inhibitor, inhibits factor Xa, even though it isn't explicitly named in the context.", "retries": 1}
{"idx": 464, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in essence, though it is slightly more verbose by specifying 'factor Xa' instead of just 'xa'. The supporting sentence introduces the class of drugs that includes betrixaban and correctly indicates they target factor Xa, but it is somewhat indirect and lacks the specificity of the gold supporting sentence. It could be more concise and directly tied to the mechanism of action like the gold sentence. Overall, the logic is sound, but there is minor redundancy.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is: \"Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation.\" This sentence introduces the class of drugs that includes betrixaban, indicating they target factor Xa.", "retries": 1}
{"idx": 465, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. While 'Epidermal Growth Factor (EGF)' is related to EGFRvIII, it is not the correct analog as specified in the context. The supporting sentence is relevant but does not directly cover the gold answer, focusing instead on EGFRvIII being targeted without clarifying that Rindopepimut is an analog of EGFRvIII itself.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Rindopepimut is an analog of Epidermal Growth Factor (EGF).", "model_support": "The supporting sentence is: \"Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.\" This sentence indicates that Rindopepimut targets EGFRvIII, which is a variant of the Epidermal Growth Factor Receptor (EGFR), making Rindopepimut an analog of Epidermal Growth Factor (EGF).", "retries": 1}
{"idx": 466, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('xa' refers to Factor Xa), and the supporting sentence is relevant but contains some redundancy. The model supporting sentence mentions 'Direct thrombin inhibitors and Factor X inhibitors,' which includes betrixaban but also adds unnecessary information about thrombin inhibitors, making it slightly verbose compared to the gold supporting sentence that directly lists betrixaban under Factor X inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Betrixaban inhibits Factor Xa.", "model_support": "Supporting sentence: Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced.", "retries": 1}
{"idx": 467, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains why the answer is correct by citing the conclusion of the study which explicitly mentions Huntington disease. There is no unnecessary verbosity or irrelevant information.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "One-year safety and tolerability profile of pridopidine in patients with Huntington disease.", "model_answer": "Huntington disease", "model_support": "The supporting sentence from the context that indicates Pridopidine has been tested for the treatment of Huntington disease is:\n\n\"CONCLUSION: Pridopidine ( < 90 mg/day) has an acceptable safety profile and is well-tolerated for 1 year. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that pridopidine ( < 90 mg/day) is generally safe and well-tolerated in patients with Huntington disease for up to 1 year.\"\n\nThis sentence explicitly states that the study involved patients with Huntington disease, confirming that Pridopidine was tested for this disorder.", "retries": 1}
{"idx": 468, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is redundant as it repeats the answer without offering additional context or reasoning. The gold supporting sentence is more concise and directly explains the role of Xist in silencing one X chromosome during XCI. While the model's supporting sentence is relevant, it lacks the clarity and conciseness of the gold standard.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "During XCI, one X is randomly silenced by Xist.", "model_answer": "The transcript responsible for X-chromosome inactivation is **Xist**.", "model_support": "The transcript responsible for X-chromosome inactivation is **Xist**.\n\n**Supporting sentence:** \"X chromosome choice is determined by asymmetric expression of Tsix whose antisense action represses Xist.\"", "retries": 1}
{"idx": 469, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to extract the key information about ZEB2 being the gene responsible for Mowat-Wilson syndrome.\", \"match\": false}", "gold_answer": "ZEB2", "gold_support": "A similar issue of differential diagnosis was raised by a large 4.3 Mb 2q22.3q23.1 deletion encompassing ZEB2, the gene responsible for the Mowat-Wilson syndrome, whose signs may overlap with RSTS.", "model_answer": "The question regarding the gene responsible for Mowat-Wilson syndrome cannot be answered based on the provided context, as it does not mention Mowat-Wilson syndrome or its associated gene, ZEB2. \n\nAnswer: The context does not provide information about the gene responsible for Mowat-Wilson syndrome.", "model_support": "The context does not provide information about the gene responsible for Mowat-Wilson syndrome. \n\n**Answer:** The context does not mention Mowat-Wilson syndrome or its associated gene, ZEB2.", "retries": 1}
{"idx": 470, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking the NF1 gene to a mutation causing neurofibromatosis type 1, but it includes slightly more detail than necessary, introducing minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "NF1", "gold_support": "Neurofibromatosis type 1 (NF1) is a common genetic disease caused by haploinsufficiency of the NF1 tumor-suppressor gene.", "model_answer": "The gene mutated in type 1 neurofibromatosis is **NF1**.", "model_support": "The supporting sentence from the context that identifies the gene mutated in type 1 neurofibromatosis is:\n\n\"Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele.\"\n\nThis sentence directly links the NF1 gene to a multiexonic deletion, which is a mutation causing neurofibromatosis type 1.", "retries": 1}
{"idx": 471, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with a slight additional detail (the '1,4-' prefix), which is acceptable as it doesn't alter the core meaning. The supporting sentence provides relevant information and directly ties JTV519 to being a benzothiazepine derivative, but it unnecessarily mentions that this isn't explicitly stated in the context, introducing slight redundancy. Overall, the logic is strong, and the supporting sentence is mostly concise.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. This information is not explicitly supported by the provided context, as JTV519 is not mentioned there. However, based on prior knowledge and examples, JTV519, also known as K201, is identified as a 1,4-benzothiazepine derivative.\n\n**Answer:** 1,4-benzothiazepine", "retries": 1}
{"idx": 472, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('Xa') in essence, though it includes the word 'Factor,' which is not strictly necessary but still correct. The supporting sentence is relevant and supports the answer by identifying betrixaban as a direct Xa inhibitor, but it contains slight redundancy by introducing broader categories of antithrombotic agents rather than directly focusing on betrixaban's role as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Direct factor Xa inhibitors include rivaroxiban, which has shown promising results for VTE prophylaxis and is being studied for VTE treatment, as well as apixaban and betrixaban, which are at earlier stages of clinical validation.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is: \"New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.\" This indicates that betrixaban, being a direct Xa inhibitor, targets Factor Xa.", "retries": 1}
{"idx": 473, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes extra details such as 'subclinical hypothyroidism' and 'reduced TSH bioactivity to immunoreactivity ratio,' which, although relevant, make it more specific than the broader 'thyroid' abnormality indicated by the gold answer. The supporting sentence is somewhat detailed but does logically support the idea of thyroid-related hormone abnormalities in Williams syndrome. However, it focuses on subclinical hypothyroidism rather than aligning closely with the simpler gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "The common hormone abnormality in Williams syndrome is subclinical hypothyroidism, characterized by elevated Thyroid-Stimulating Hormone (TSH) levels and a reduced TSH bioactivity to immunoreactivity ratio. This condition is linked to genetic factors affecting thyroid development.", "model_support": "Supporting sentence: \"TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism.\"", "retries": 1}
{"idx": 474, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it incorrectly states there are three TAp73 isoforms instead of seven. The supporting sentence acknowledges that the context does not provide the necessary information to support the model's answer, but it fails to address the gold answer or provide relevant reasoning for the correct number of isoforms. While the supporting sentence is relevant in pointing out the lack of context, it does not directly help clarify or support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "Three TAp73 isoforms have been identified in humans: TAp73α, TAp73β, and TAp73γ.", "model_support": "The context does not explicitly state the number of TAp73 isoforms identified in humans. It mentions TAp73 in general but does not list specific isoforms like α, β, or γ. Therefore, the supporting sentence for the answer provided is not found in the given context.\n\n**Answer:** The context does not provide information on the number of TAp73 isoforms identified in humans.", "retries": 1}
{"idx": 475, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly redundant as it only introduces BCR-ABL inhibitors without directly explaining the role of BCR-ABL or its connection to Imatinib in CML. The gold supporting sentence provides more specific details about BCR-ABL-mediated signaling and how it is targeted by Imatinib. Despite this, the logic is still sound and relevant.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "In chronic myeloid leukemia (CML), BCR-ABL-mediated oncogenic signaling can be successfully targeted with the BCRABL- inhibitors imatinib, nilotinib, and dasatinib leading to complete cytogenetic (Philadelphia chromosome not detectable upon cytogenetic testing of bone marrow) and even complete molecular (BCR-ABL not detectable by PCR in peripheral blood) responses.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia (CML) is BCR-ABL.", "model_support": "The supporting sentence from the context is:\n\n\"Effects of BCR-ABL inhibitors on anti-tumor immunity.\"\n\nThis sentence introduces BCR-ABL inhibitors, including Imatinib, which target the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 476, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying 'I-1 (phosphatase inhibitor-1)' as the main inhibitor of PP1. The supporting sentence is concise, directly relevant, and logically explains that phosphorylated I-1 at Thr35 is a potent PP1 inhibitor, which aligns with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Inhibitor 1", "gold_support": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.", "model_answer": "The main inhibitor of protein phosphatase 1 (PP1) is I-1 (phosphatase inhibitor-1), specifically when it is phosphorylated at Thr35. \n\nAnswer: I-1 (phosphatase inhibitor-1)", "model_support": "The supporting sentence from the context is:\n\n\"Non-phosphorylated I-1 is inactive, whereas I-1 phosphorylated by protein kinase A (PKA) at Thr35 is a potent PP1 inhibitor.\"\n\nThis sentence explains that I-1, when phosphorylated at Thr35, functions as a potent inhibitor of PP1.", "retries": 1}
{"idx": 477, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'), and the supporting sentence provides relevant information that logically connects JNK to the phosphorylation of c-Jun. However, the supporting sentence includes additional details (e.g., 'lipopolysaccharide/interferon-γ-stimulated glial cultures') that, while correct, are not necessary for directly supporting the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "In parallel with these immunosuppressive phenomena, DHA attenuated post-stroke oxidative stress, c-Jun N-terminal kinase (JNK) phosphorylation, c-Jun phosphorylation and activating protein-1 (AP-1) activation but further elevated ischemia-induced NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 (HO-1) expression.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal Kinase).", "model_support": "The supporting sentence is:\n\n\"DHA treatment also had an immunosuppressive effect in lipopolysaccharide/interferon-γ-stimulated glial cultures by attenuating JNK phosphorylation, c-Jun phosphorylation and AP-1 activation...\"\n\nThis sentence indicates that JNK phosphorylation is associated with c-Jun phosphorylation, confirming that JNK is the MAP kinase involved in phosphorylating c-jun.", "retries": 1}
{"idx": 478, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX') conceptually, as NCX1 is a specific isoform of the Na+/Ca2+ exchanger (NCX). However, the model's answer specifies 'NCX1' rather than the broader term 'NCX', which makes it slightly less aligned with the gold answer. The supporting sentence provided by the model is relevant and supports the idea that SEA0400 reduces damage associated with NCX1 inhibition, but it does not explicitly mention that SEA0400 is an NCX inhibitor, leading to minor redundancy in connecting the logic. The gold supporting sentence more directly highlights the role of SEA0400 as a selective NCX inhibitor.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "We investigated the expression of Na(+)/Ca(2+) exchanger (NCX) and the functional role of NCX in retinal damage by using NCX1-heterozygous deficient mice (NCX1(+/-)) and SEA0400 (2-[4-[(2,5-difluorophenyl)methoxy] phenoxy]-5-ethoxyaniline), a selective NCX inhibitor in vivo.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca2+ exchanger NCX1.", "model_support": "The supporting sentence from the context is:\n\n\"SEA0400 at 3 and 10 mg/kg significantly reduced NMDA- or high intraocular pressure-induced retinal cell damage in mice.\"\n\nThis sentence suggests that SEA0400 reduces cell damage, which is consistent with it being an inhibitor of NCX1, the Na+/Ca²+ exchanger involved in the cell death process.", "retries": 1}
{"idx": 479, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and logically covers the answer by affirming that alpha-synuclein is the main component of Lewy bodies. Although an additional supporting sentence is provided in the evaluation context, the chosen sentence aligns well with the gold standard reasoning without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\n**Supporting sentence:** \"The fact that alpha-synuclein interacts with synphilin-1A, and is recruited to synphilin-1A inclusion bodies in neurons together with synphilin-1, further indicates that synphilin-1A cell model is relevant for research on Parkinson's disease.\"", "retries": 1}
{"idx": 480, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it introduces slight redundancy by repeating the answer itself instead of offering additional context or explanation. While logical, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "The database of molecular recognition features in membrane proteins is mpMoRFsDB.", "model_support": "The database of molecular recognition features in membrane proteins is mpMoRFsDB.\n\n**Supporting sentence:**  \n\"All information was stored in a publicly available mySQL database with a user-friendly web interface.\"", "retries": 1}
{"idx": 481, "gptscore_json": "{\"score\": 5, \"reason\": \"The model answer matches the gold standard exactly by identifying 'Phospholamban (PLN)' as the main regulatory molecule. The supporting sentence is concise, directly relevant, and logically explains the relationship between PLN and SERCA2a regulation, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is Phospholamban (PLN).", "model_support": "The supporting sentence from the context is: \"Dephosphorylated PLN inhibits SERCA2a.\" This sentence directly indicates that Phospholamban (PLN) regulates the function of SERCA2a in the cardiac muscle, confirming it as the main regulatory molecule.", "retries": 1}
{"idx": 482, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and logically supports the answer by reinforcing that alpha-synuclein is the main component of Lewy bodies. Although the additional context about aggregation strategies is informative, it does not detract from the clarity and relevance of the supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein.\n\n**Supporting sentence:** \"Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation, so that antiaggregation strategies would be very useful to prevent alpha-synuclein fibril formation.\"", "retries": 1}
{"idx": 483, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to factor Xa). The supporting sentence is relevant and covers the answer, but it unnecessarily mentions that the context does not explicitly provide the information, which introduces slight redundancy. The gold supporting sentence is more concise while still being fully supportive.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence for the answer is not explicitly provided in the context. While the context mentions betrixaban as one of the new oral anticoagulants, it does not specify which clotting factor it inhibits. However, based on general knowledge, betrixaban is known to inhibit factor Xa.\n\nAnswer: Betrixaban inhibits factor Xa. \n\nSupporting sentence: The context does not explicitly provide this information, but it is a known fact that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 484, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but slightly verbose and does not directly match the concise nature of the gold supporting sentence, which explicitly names the database in its description.\", \"match\": true}", "gold_answer": "mpMoRFsDB", "gold_support": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.", "model_answer": "The database of molecular recognition features in membrane proteins is called mpMoRFsDB.", "model_support": "Supporting sentence: All information was stored in a publicly available mySQL database with a user-friendly web interface.", "retries": 1}
{"idx": 485, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The answer matches the gold standard, correctly stating the average diameter of intermediate filaments as 10 nm. However, the supporting sentence provided by the model is somewhat convoluted and includes less relevant details about the 24-25 nm periodic repeat, which does not directly support the specific fact about the 10 nm diameter. The gold supporting sentence is more concise and directly tied to the 10 nm measurement. The logic is reasonable but could be clearer and more focused.\",\n  \"match\": true\n}", "gold_answer": "10 nm", "gold_support": "Scanning tunneling microscope (STM) and transmission electron microscope (TEM) micrographs showed that acidic keratins and basic keratins can assemble into dimers and further into 10 nm filamentsin vitro.", "model_answer": "The average diameter of intermediate filaments is 10 nm.", "model_support": "The supporting sentence from the context that indicates the average diameter of intermediate filaments is:\n\n\"the 24-25 nm periodic structural repeat alone the axis of both the 10 nm filaments and protofilarnents.\"\n\nThis sentence specifies that the intermediate filaments have a diameter of 10 nm, confirming the average diameter as 10 nm.", "retries": 1}
{"idx": 486, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('zfhx1b') as 'ZEB2 (also known as zfhx1b)' is equivalent. The supporting sentence provided by the model contains relevant information but includes slight redundancy by restating the answer and adding extra details about biliary development, which was not directly needed to support the answer. The gold supporting sentence is more concise and directly tied to the causative gene without additional elaboration.\",\n  \"match\": true\n}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2 (also known as zfhx1b).", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZEB2 (also known as zfhx1b). This conclusion is supported by the context which discusses the role of zfhx1b in biliary development and its association with Mowat-Wilson syndrome.\n\n**Supporting sentence:**\n\"We identified a patient with Mowat-Wilson syndrome who also developed cholestasis and histopathologic features consistent with biliary atresia, suggesting that mutations involving zfhz1b may lead to biliary developmental anomalies or injury to the biliary tract.\"", "retries": 1}
{"idx": 487, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more verbose and includes additional details like 'maintaining pluripotency' which, while relevant, are not directly part of the gold answer. The supporting sentence is somewhat lengthy and focuses on pluripotency rather than strictly covering developmental gene regulation as the gold supporting sentence does. Logic is reasonable but could be more concise and directly aligned with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "development", "gold_support": "The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs).", "model_answer": "Conserved noncoding elements (CNEs) mostly regulate gene regulation, particularly in maintaining pluripotency and controlling developmental gene expression.", "model_support": "The supporting sentence from the context is:\n\"These results highlight the importance of DNA sequence in defining the initial epigenetic landscape and suggest a novel chromatin-based mechanism for maintaining pluripotency.\"", "retries": 1}
{"idx": 488, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NCX'), although it is slightly more verbose by specifying 'Sodium-Calcium Exchanger (NCX)'. The supporting sentence is relevant and supports the answer but lacks some detail compared to the gold supporting sentence, which explicitly mentions SEA0400 as a specific Na+/Ca2+ exchange inhibitor. Despite this, the logic is sound and directly ties SEA0400 to its inhibitory role.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Sodium-Calcium Exchanger (NCX).\n\nAnswer: Sodium-Calcium Exchanger (NCX)", "model_support": "Supporting sentence: These effects of SNP were prevented by SEA0400.", "retries": 1}
{"idx": 489, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it mentions that the context does not provide the information, which is unnecessary since the correct information is eventually provided. The reference to a 'previous example' adds slight verbosity but still supports the answer logically.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "BACKGROUND: A new 1,4-benzothiazepine derivative, JTV519, has a strong protective effect against Ca(2+) overload-induced myocardial injury.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not include information about the chemical group that JTV519 is derived from. Therefore, there is no supporting sentence in this context to answer the question. However, in a previous example, JTV519 was identified as a 1,4-benzothiazepine derivative.\n\nAnswer: The context does not provide information about the chemical group of JTV519. However, in a previous example, JTV519 was identified as a 1,4-benzothiazepine derivative.", "retries": 1}
{"idx": 490, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by affirming that [18F]altanserin PET evaluates 5-HT2AR availability. Minor redundancy in repeating the answer as the supporting sentence is acceptable since the logic remains strong.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.", "model_support": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.\n\nSupporting sentence: [18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability in albino rats.", "retries": 1}
{"idx": 491, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('AF' is an accepted abbreviation for 'atrial fibrillation'). The supporting sentence provided by the model acknowledges the lack of explicit context for global prevalence but aligns with the gold supporting sentence in spirit. The gold supporting sentence explicitly confirms atrial fibrillation as the most prevalent arrhythmia, and the model’s reasoning does not contradict this.\", \"match\": true}", "gold_answer": "AF", "gold_support": "Atrial fibrillation (AF) is associated with increased morbidity and is in addition the most prevalent cardiac arrhythmia.", "model_answer": "The most prevalent form of arrhythmia worldwide is atrial fibrillation.", "model_support": "The context does not explicitly state that atrial fibrillation is the most prevalent form of arrhythmia worldwide. It discusses the study of atrial fibrillation and its treatment but does not provide data on its prevalence compared to other arrhythmias. Therefore, there is no supporting sentence in the context to answer the question.", "retries": 1}
{"idx": 492, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('template strand') does not match the gold standard ('transcribed strand'), but it is related to the context, as both terms refer to aspects of DNA during transcription. However, the supporting sentence is relevant yet does not fully cover the gold answer. It mentions the role of Cockayne syndrome gene products in TCR and the stalling of RNA polymerase but fails to explicitly state that TCR targets the transcribed strand. This leads to a score of 2 due to the incorrect answer and partial support from the context.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The transcription-coupled repair (TCR) targets the template strand of the gene. This is because TCR specifically addresses DNA lesions that block transcription, which occurs on the template strand. The Cockayne syndrome (CS) gene products, particularly CSB protein, are crucial for recognizing and repairing these lesions to ensure transcription continues and cellular survival is maintained.", "model_support": "The supporting sentence from the context is:\n\n\"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"\n\nThis sentence indicates that TCR targets the template strand where RNA polymerase stalls during transcription, leading to the repair of DNA lesions on that strand.", "retries": 1}
{"idx": 493, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it includes the full name for clarity. The supporting sentence is relevant and explains the connection between DUX4 and FSHD logically, but it contains slight redundancy by reiterating the answer itself. The gold supporting sentence is more concise while still being directly relevant.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD). This conclusion is supported by the context, which demonstrates that misexpression of DUX4 in zebrafish leads to phenotypes resembling human FSHD and that DUX4 plays a role in the disease's pathogenesis.\n\n**Supporting Sentence:**  \n\"These results strongly support the current hypothesis for a role of DUX4 in FSHD pathogenesis.\"", "retries": 1}
{"idx": 494, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer correctly identifies IL-1β as the molecule targeted by Gevokizumab, matching the gold standard. The supporting sentence provided by the model is relevant and explains that Gevokizumab inhibits the binding of IL-1β to its receptor (IL-1RI), which aligns with the context. However, it contains slight redundancy by repeating the answer within the supporting sentence, making it less concise than ideal. The gold supporting sentence is more concise while still being accurate and relevant.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β). Specifically, Gevokizumab inhibits the binding of IL-1β to the IL-1 receptor type I (IL-1RI), thereby reducing IL-1β signaling.", "model_support": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β). Specifically, Gevokizumab inhibits the binding of IL-1β to the IL-1 receptor type I (IL-1RI), thereby reducing IL-1β signaling.\n\n**Supporting sentence:**  \n\"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"", "retries": 1}
{"idx": 495, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('the transcribed strand'). The supporting sentence provided by the model is relevant and supports the answer, but it focuses on the mechanism of RNA polymerase stalling rather than directly stating the preferential repair of the transcribed strand. While the logic is sound, the gold supporting sentence is more concise and directly addresses the preferential repair of the transcribed strand. Thus, slight redundancy and indirectness reduce the score.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "Among these is a process called transcription-coupled repair (TCR) that catalyzes the removal of DNA lesions from the transcribed strand of expressed genes, often resulting in a preferential bias of damage clearance from this strand relative to its non-transcribed counterpart.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand. This is because TCR is activated when RNA polymerase stalls due to DNA damage on the transcribed strand during transcription, leading to repair specifically of the damaged area on that strand.", "model_support": "The supporting sentence from the context is: \"It is also believed that the signal for TCR is the stalled RNA polymerase that results when DNA damage prevents its translocation during transcription elongation.\"\n\nAnswer: The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand. This is because TCR is activated when RNA polymerase stalls due to DNA damage on the transcribed strand during transcription, leading to repair specifically of the damaged area on that strand.", "retries": 1}
{"idx": 496, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'). The supporting sentence is relevant and supports the answer by referencing factor Xa in relation to betrixaban, but it includes additional information about a reversal agent (PRT4445), making it slightly verbose. The core logic, however, remains strong.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis indicates that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 497, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('factor Xa' corresponds to 'xa'). The supporting sentence provided by the model is concise, directly relevant, and explains that betrixaban inhibits factor Xa, which aligns with the gold supporting sentence. Though the model notes the context does not explicitly state this, it correctly references external knowledge to support the answer, ensuring logical reasoning.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context does not explicitly state which clotting factor betrixaban inhibits. However, based on external knowledge, betrixaban is known to inhibit factor Xa. \n\nSince the context does not provide specific information about betrixaban's mechanism of action, there is no supporting sentence in the provided text to confirm this.", "retries": 1}
{"idx": 498, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by restating the answer within the explanation. It could be more concise by removing the repetition of 'the typical rash associated with gluten exposure is dermatitis herpetiformis.'\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "There is growing evidence that dermatitis herpetiformis should be considered as the skin manifestation of gluten sensitivity developing in those patients with mild coeliac disease, who produce epidermal transglutaminase autoantibodies of high avidity and affinity.", "model_answer": "The typical rash associated with gluten exposure is dermatitis herpetiformis.", "model_support": "The typical rash associated with gluten exposure is dermatitis herpetiformis. This is supported by the context which states that dermatitis herpetiformis is associated with gluten-sensitive enteropathy (coeliac disease), indicating a direct link between gluten exposure and this skin condition.\n\n**Answer:** The typical rash associated with gluten exposure is dermatitis herpetiformis.\n\n**Supporting Sentence:** \"Dermatitis herpetiformis is associated with gluten sensitive enteropathy, coeliac disease, which is characterised by IgA type autoantibodies to a closely related enzyme, tissue transglutaminase.\"", "retries": 1}
{"idx": 499, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, although it provides the full name instead of the acronym. The supporting sentence is relevant and directly ties DUX4 production to FSHD, but it is slightly less concise than the gold supporting sentence, introducing minor redundancy by repeating the disease name.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral Disease (FSHD) is a dominantly inherited progressive myopathy associated with aberrant production of the transcription factor, Double Homeobox Protein 4 (DUX4).", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is Facioscapulohumeral muscular dystrophy (FSHD).\n\nAnswer: Facioscapulohumeral muscular dystrophy (FSHD)", "model_support": "The disease associated with the ectopic expression of the DUX4 protein is Facioscapulohumeral muscular dystrophy (FSHD). \n\n**Supporting sentence:** \"Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.\"", "retries": 1}
{"idx": 500, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly, and the supporting sentence is relevant and directly supports the answer. However, the chosen supporting sentence from the context is slightly less direct than the gold supporting sentence, as it focuses on species differences rather than explicitly stating phospholamban's regulatory role in cardiac SR Ca cycling. This makes it slightly less comprehensive but still logically sound.\",\n  \"match\": true\n}", "gold_answer": "Phospholamban", "gold_support": "Phospholamban has been suggested to be a key regulator of cardiac sarcoplasmic reticulum (SR) Ca cycling and contractility and a potential therapeutic target in restoring the depressed Ca cycling in failing hearts.", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban.", "model_support": "The supporting sentence from the context is: \"In larger mammals, a higher fraction of SERCA2a pumps are regulated by phospholamban...\" This sentence directly states that phospholamban is the main regulatory molecule of SERCA2A function in the cardiac muscle.", "retries": 1}
{"idx": 501, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides additional context but remains focused and accurate.\", \"match\": true}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "The third subunit of the TSC1-TSC2 complex upstream of mTORC1 is TBC1D7.", "model_support": "The sentence supporting the answer is:\n\n\"We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.\"\n\nThis sentence identifies TBC1D7 as the third subunit of the TSC1-TSC2 complex, which is upstream of mTORC1.", "retries": 1}
{"idx": 502, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it contains some redundancy by repeating the answer itself. Additionally, the quoted context sentence could be more direct in linking APP to alpha-synuclein as the main component of Lewy bodies. Overall, it provides logical support but with slight verbosity.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. The supporting sentence from the context is:\n\n\"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"", "retries": 1}
{"idx": 503, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is less directly relevant and slightly redundant compared to the gold supporting sentence. While it introduces medulloblastoma as the tumor being studied, it does not explicitly state that it is the most common pediatric cerebellar tumor, which is critical for fully supporting the answer. The gold supporting sentence is more precise in conveying this information.\",\n  \"match\": true\n}", "gold_answer": "medulloblastoma", "gold_support": "Mouse models have increased our understanding of the pathogenesis of medulloblastoma (MB), the most common malignant pediatric brain tumor that often forms in the cerebellum.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "The supporting sentence from the context is:\n\n\"In vivo Mn-enhanced MRI for early tumor detection and growth rate analysis in a mouse medulloblastoma model.\"\n\nThis sentence introduces medulloblastoma as the tumor model studied, supporting the answer that it is the most common type of pediatric cerebellar tumor.", "retries": 1}
{"idx": 504, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xa'). However, the supporting sentence, while relevant and logical, contains slight redundancy by mentioning PRT4445 and its role as a reversal agent, which is not directly necessary to confirm betrixaban's inhibition of Factor Xa. The gold supporting sentence is more concise and directly states betrixaban's classification as a Factor Xa inhibitor.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits **Factor Xa**.", "model_support": "The supporting sentence from the context is:\n\n\"PRT4445, a factor Xa decoy, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence indicates that betrixaban inhibits Factor Xa, as it is mentioned alongside a decoy that targets Factor Xa, suggesting betrixaban's mechanism of action involves anti-Xa activity. \n\nAnswer: Factor Xa.", "retries": 1}
{"idx": 505, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more verbose than necessary. The gold answer 'stroke' is concise and directly addresses the question, whereas the model provides additional context that, while relevant, is not required by the scoring criteria. The supporting sentence is somewhat lengthy and includes information beyond what is needed to support the answer, though it remains logically connected to the topic. A more concise supporting sentence would improve the score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the recognition and initial differentiation of acute stroke in the emergency room (ER) setting.", "model_support": "The supporting sentence is:  \n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 506, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it is slightly less direct compared to the gold supporting sentence. While it correctly identifies flumazenil as a benzodiazepine antagonist, it discusses its use in hepatic encephalopathy rather than directly mentioning its role in benzodiazepine overdose, which introduces minor redundancy.\",\n  \"match\": true\n}", "gold_answer": "Flumazenil", "gold_support": "Flumazenil is the first benzodiazepine antagonist which can be used in humans and is a well established for treatment of benzodiazepine overdose.", "model_answer": "The drug that should be used as an antidote in benzodiazepine overdose is flumazenil. \n\n**Answer:** Flumazenil.", "model_support": "The supporting sentence from the context that identifies flumazenil as the antidote for benzodiazepine overdose is:\n\n\"For the first time a causal treatment of hepatic encephalopathy may be possible by the benzodiazepine antagonist flumazenil.\"\n\nThis sentence identifies flumazenil as a benzodiazepine antagonist, which implies its role as an antidote in cases of overdose.", "retries": 1}
{"idx": 507, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more verbose and provides extra details not directly required by the question. The supporting sentence is somewhat lengthy and includes information about the scale's effectiveness in a specific population, which is not directly needed to support the answer 'Stroke'. While the logic connecting the ROSIER scale to stroke identification is reasonable, the supporting sentence could be more concise and focused on the core purpose of the scale.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used to assess and differentiate acute strokes from stroke mimics in emergency room settings, particularly to help identify true strokes among patients presenting with stroke-like symptoms.", "model_support": "The supporting sentence that answers the question about the use of the ROSIER scale is:\n\n\"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\"\n\nThis sentence indicates that the ROSIER scale is used to differentiate between acute strokes and stroke mimics, even though its effectiveness varied in this specific study.", "retries": 1}
{"idx": 508, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to Factor Xa). However, the supporting sentence provided by the model is incorrect because it states that no supporting information is present in the context, while the context explicitly mentions that betrixaban targets factor Xa. The correct supporting sentence should have been extracted from the context as given in the gold supporting sentence. Despite this issue, the answer itself is correct.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Most are small synthetic molecules that target factor IIa (e.g., dabigatran etexilate, AZD-0837) or factor Xa (e.g., rivaroxaban, apixaban, betrixaban, DU176b, idrabiotaparinux).", "model_answer": "Betrixaban inhibits Factor Xa.", "model_support": "The question asks which clotting factor is inhibited by betrixaban. The context provided discusses new anticoagulants for atrial fibrillation, including a new vitamin K antagonist (ATI-5923), but does not mention betrixaban. Therefore, the supporting sentence for the answer is not present in the context.\n\nAnswer: Betrixaban inhibits Factor Xa.  \n Supporting sentence: [Not provided in the context.]", "retries": 1}
{"idx": 509, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer, 'GBA gene', is very close to the gold standard 'glucocerebrosidase' since GBA is the gene that encodes glucocerebrosidase. However, the supporting sentence simply repeats the answer without providing additional reasoning or context from the provided information. It could be more concise and directly tie into the context about the mutation in the glucocerebrosidase gene. The logic is reasonable but lacks depth.\", \"match\": false}", "gold_answer": "glucocerebrosidase", "gold_support": "A 26-year-old Bedouin with moderate thrombocytopenia and enlarged spleen and liver was diagnosed as having type I Gaucher disease based on the presence of Gaucher cells in the bone marrow biopsy and enzymatic determination of glucocerebrosidase activity.", "model_answer": "The gene mutated in Gaucher disease is the GBA gene.", "model_support": "The gene mutated in Gaucher disease is the GBA gene.\n\nSupporting sentence: The context discusses a C to T mutation at nucleotide 259 of exon 3, which is associated with Gaucher disease, implying the mutation occurs in the GBA gene.", "retries": 1}
{"idx": 510, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer specifies the 'lumbar' region and mentions the fifth lumbar vertebra (L5), which is correct but more specific than the gold answer 'lumbosacral.' The gold answer refers to the transitional area between the lumbar and sacral regions, which encompasses L5 but also includes its interaction with the sacrum. The supporting sentence provided by the model is relevant but somewhat lengthy, combining both direct evidence ('fifth lumbar vertebra') and additional details ('forming a pseudarthrosis with the infrajacent ala of the sacrum'). While it supports the answer logically, it could be more concise. Overall, the answer and reasoning are close but not an exact match to the gold standard.\",\n  \"match\": false\n}", "gold_answer": "Lumbosacral", "gold_support": "Lumbosacral transitional vertebra causing Bertolotti's syndrome: a case report and review of the literature.", "model_answer": "The abnormality in Bertolotti's syndrome occurs in the **lumbar** vertebral region, specifically at the fifth lumbar vertebra (L5).", "model_support": "The supporting sentence that identifies the specific vertebral region involved in Bertolotti's syndrome is:\n\n**\"Radiographic investigation revealed an anomalous enlargement of the left transverse process of the fifth lumbar vertebra forming a pseudarthrosis with the infrajacent ala of the sacrum.\"**\n\nThis sentence clearly states that the abnormality occurs in the fifth lumbar vertebra (L5), confirming the answer.", "retries": 1}
{"idx": 511, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence is relevant and supports the answer by referencing the formation of antiparallel dimers, but it introduces slight redundancy by discussing alpha-actinin and evolutionary aspects, which are not necessary to directly support the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "Spectrins comprise α- and β-subunits made up predominantly of a series of homologous repeating units of about 106 amino acids; the α- and β-chains form antiparallel dimers by lateral association, and tetramers through head-to-head contacts between the dimers.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The supporting sentence is in point (6) of the context, which states:\n\n\"an analysis of the sequences of the strongly interacting repeats, βIR1, βIIR1, αIR21 and αIIR20 and repeats in α-actinin, which also interact very strongly in forming an antiparallel dimer, affords a possible explanation for the different properties of the two spectrin isoforms in respect of the stability of the inter-chain interactions, and also suggests the evolutionary path by which the erythroid and non-erythroid sequences diverged.\"\n\nThis sentence supports the conclusion that alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers by comparing their interaction to that of alpha-actinin, which forms antiparallel dimers.", "retries": 1}
{"idx": 512, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer. It mentions the presence of TAp73 isoforms without specifying the number, which leads to a lower score.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context does not specify the exact number of TAp73 isoforms identified in humans.", "model_support": "The context does not specify the exact number of TAp73 isoforms identified in humans. \n\nSupporting sentence: \"Mice with a complete deficiency of p73 have severe neurological and immunological defects due to the absence of all TAp73 and DeltaNp73 isoforms.\"\n\nThis sentence indicates the presence of TAp73 and DeltaNp73 isoforms but does not provide the exact number of TAp73 isoforms in humans.", "retries": 1}
{"idx": 513, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and matches the gold standard (factor Xa). The supporting sentence provides relevant information about factor Xa inhibitors, including betrixaban, and aligns with the context. However, it includes slight redundancy by mentioning other drugs like fondaparinux and rivaroxaban, which are not strictly necessary to justify the answer. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa in the coagulation cascade, preventing the conversion of prothrombin to thrombin and thus inhibiting clot formation.", "model_support": "The context discusses various anticoagulants, including factor Xa inhibitors like fondaparinux and rivaroxaban. While betrixaban isn't explicitly mentioned, it is known from general knowledge to be a factor Xa inhibitor, functioning similarly to these agents. Therefore, betrixaban inhibits factor Xa in the coagulation cascade.\n\n**Answer:** Betrixaban inhibits factor Xa in the coagulation cascade, preventing the conversion of prothrombin to thrombin and thus inhibiting clot formation.\n\n**Supporting Sentence:** The context discusses factor Xa inhibitors such as fondaparinux and rivaroxaban, suggesting betrixaban, a known factor Xa inhibitor, functions similarly.", "retries": 1}
{"idx": 514, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it contains slight redundancy by referencing the conclusion about the calsequestrin isoform in frog ventricular muscle, which is not necessary to directly support the answer. The logic is clear, but the additional detail makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin is a calcium-binding protein known to sequester calcium accumulated in the sarcoplasmic reticulum (SR) of muscle cells during relaxation.", "model_answer": "The main calcium binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The supporting sentence is: \"Thus, we conclude that this protein corresponds to the calsequestrin isoform in frog ventricular muscle.\" This sentence identifies the protein as calsequestrin, which is known to be the main calcium-binding protein in the sarcoplasmic reticulum.", "retries": 1}
{"idx": 515, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('RANKL') in identifying the ligand to which Denosumab binds. However, it includes additional explanatory details about Denosumab's function, which, while correct, are not required for the specific question asked. The supporting sentence is relevant and explains RANKL's role in osteoclast activity and its inhibition, but it indirectly supports the answer by referencing OPG rather than directly citing Denosumab’s binding to RANKL. This makes the support slightly less direct than the gold supporting sentence, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Denosumab (AMG 162), a fully human monoclonal antibody to RANKL, shares the pharmacologic attributes of OPG but has a significantly longer half-life that allows less frequent administration.", "model_answer": "Denosumab (Prolia) binds to the ligand RANKL, which is the receptor activator of nuclear factor kappa-B ligand. By binding to RANKL, Denosumab inhibits its interaction with the RANK receptor, thereby reducing osteoclast activity and bone resorption.", "model_support": "The supporting sentence from the context is: \"RANKL stimulates osteoclast formation, function and survival, and each of these effects is inhibited by OPG.\" This sentence explains the role of RANKL in osteoclast activity and how it is inhibited, which aligns with Denosumab's mechanism of binding to RANKL to prevent its interaction with RANK, thereby reducing osteoclast activity and bone resorption.", "retries": 1}
{"idx": 516, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying 'AIP' as the gene implicated in FIPA. However, the supporting sentence is slightly redundant and does not provide the detailed reasoning present in the gold supporting sentence. The gold supporting sentence explains the discovery of AIP mutations and their prevalence in FIPA families, offering richer context. The model's supporting sentence ('The exact mechanism by which the lack of AIP leads to pituitary adenomas is not clear') is relevant but lacks this depth and specificity.\",\n  \"match\": true\n}", "gold_answer": "aryl hydrocarbon receptor interacting protein", "gold_support": "The discovery of heterozygous, loss-of-function germline mutations in the gene encoding the aryl hydrocarbon receptor interacting protein (AIP) in 2006 has subsequently enabled the identification of a mutation in this gene in 20% of FIPA families and 20% of childhood-onset simplex soma- totroph adenomas.", "model_answer": "The gene implicated in familial isolated pituitary adenoma (FIPA) is **AIP** (Aryl Hydrocarbon Receptor-Interacting Protein).", "model_support": "The gene implicated in Familial Isolated Pituitary Adenoma (FIPA) is **AIP** (Aryl Hydrocarbon Receptor-Interacting Protein).\n\n**Supporting Sentence:**  \n\"The exact mechanism by which the lack of AIP leads to pituitary adenomas is not clear.\"", "retries": 1}
{"idx": 517, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and aligns with the gold standard, though it is less specific by omitting 'epidermal growth factor receptor (EGFR) gene' and using just 'EGFR gene.' The supporting sentence chosen by the model does not directly support the answer as effectively as the gold supporting sentence. It discusses the method's sensitivity for detecting mutations but does not explicitly link EGFR mutations to the response to erlotinib and gefitinib. The logic is reasonable but could be more precise.\", \"match\": true}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with the responses to the tyrosine kinase inhibitors gefitinib and erlotinib in patients with non-small-cell lung cancer (NSCLC).", "model_answer": "The mutations in the EGFR gene determine the response to both erlotinib and gefitinib.", "model_support": "The supporting sentence from the context is:\n\n\"The present method is sensitive and specific for the detection of deletions and mutations in the EGFR gene and is thus suitable for use in laboratory tests.\"\n\nThis sentence indicates that the EGFR gene mutations are being targeted for detection, which aligns with the understanding that mutations in this gene influence the response to erlotinib and gefitinib.", "retries": 1}
{"idx": 518, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by explicitly stating that Bach1 is a transcriptional repressor.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene (Hmox-1).", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The supporting sentence is:\n\n\"Genetic ablation of transcription repressor Bach1 reduces neural tissue damage and improves locomotor function after spinal cord injury in mice.\"\n\nThis sentence explicitly states that Bach1 is a transcriptional repressor.", "retries": 1}
{"idx": 519, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence discusses the change in diameter with temperature, which is relevant but does not directly support or provide the specific measurement of 10 nm as the average diameter. It fails to extract the key detail from the gold supporting sentence.\", \"match\": false}", "gold_answer": "10 nm", "gold_support": "Negative staining showed that supernatants from the centrifugation assays contained protofilaments, protofibrils and short particles (less than 300 nm), but pellets contained long filaments (greater than 1 micron) with an average diameter of 10 nm.", "model_answer": "The average diameter of intermediate filaments is not specified in the provided context.", "model_support": "The average diameter of intermediate filaments is not specified in the provided context. The supporting sentence is: \"As the temperature increased, both the average diameter and average length of particles in the supernatant increased.\" This indicates that diameter changes with temperature but does not provide specific measurements.", "retries": 1}
{"idx": 520, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard ('af' is an accepted abbreviation for atrial fibrillation). The gold supporting sentence is concise, directly relevant, and provides clear reasoning for why atrial fibrillation is considered the most prevalent arrhythmia. Although the model notes no explicit supporting sentence in the context provided, this does not detract from the accuracy of the answer or the alignment with the gold standard.\", \"match\": true}", "gold_answer": "af", "gold_support": "Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting up to 1-1.5% of the population.", "model_answer": "The most prevalent form of arrhythmia worldwide is atrial fibrillation. \n\nAnswer: Atrial fibrillation", "model_support": "The context does not provide a direct statement supporting that atrial fibrillation is the most prevalent form of arrhythmia worldwide. The information given focuses on atrial fibrillation in athletes and does not explicitly address its prevalence globally.\n\nAnswer: The context does not contain a supporting sentence for the claim that atrial fibrillation is the most prevalent form of arrhythmia worldwide.", "retries": 1}
{"idx": 521, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model initially questions the context, the final answer and supporting sentence align perfectly with the gold standard.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not include any information about the chemical group that JTV519 is derived from. Therefore, there is no supporting sentence within this context that states JTV519 is a 1,4-benzothiazepine derivative. \n\nAnswer: The context does not provide information about the chemical group JTV519 is derived from.", "retries": 1}
{"idx": 522, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is incorrect because it states that the context does not mention tofacitinib, while the gold supporting sentence shows that tofacitinib (Xeljanz) is indeed explicitly mentioned in the context as the approved JAK inhibitor for rheumatoid arthritis. The correct supporting sentence should have been directly taken from the context, which clearly includes this information. Thus, while the answer is correct, the reasoning about the supporting sentence reduces the score.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "After two decades of research and development activity focussed on orally active kinase inhibitors, the first such drug (the JAK inhibitor Xeljanz, tofacitinib) was approved by the FDA in November 2012 for the treatment of rheumatoid arthritis (RA).", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is tofacitinib (Xeljanz).", "model_support": "The context provided does not explicitly mention tofacitinib (Xeljanz) as the approved JAK inhibitor for rheumatoid arthritis. It discusses fostamatinib, a Syk inhibitor, and the progress of kinase inhibitors in general, but does not name any specific JAK inhibitors approved for RA. Therefore, while tofacitinib is indeed an approved treatment, the context does not provide a supporting sentence for this answer.\n\n**Answer:**  \nThe context does not explicitly mention tofacitinib (Xeljanz) as the approved JAK inhibitor for rheumatoid arthritis. It discusses fostamatinib, a Syk inhibitor, and the progress of kinase inhibitors in general, but does not name any specific JAK inhibitors approved for RA. Thus, the supporting sentence is not present in the provided context.", "retries": 1}
{"idx": 523, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\n**Supporting sentence:**  \n\"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"", "retries": 1}
{"idx": 524, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in essence by specifying 'factor Xa,' though it includes the word 'inhibits,' which is implied in the gold answer. The supporting sentence provides relevant information and logical reasoning but is more verbose than necessary, as it draws a broader inference from the context rather than directly quoting the explicit statement from the text. Slight redundancy is present, but the logic is still sound.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context indicates that betrixaban is a new oral anticoagulant, part of a class that includes drugs like rivaroxaban and apixaban, which are known to inhibit factor Xa. Although the context doesn't explicitly mention the specific clotting factor, the classification of betrixaban as an oral anticoagulant and its use in preventing clotting-related conditions support the conclusion that it inhibits factor Xa.\n\nAnswer: Betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 525, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect, as it states there are two TAp73 isoforms when the gold answer specifies seven. The supporting sentence does not logically support the gold answer and introduces confusion by discussing only two main isoforms (TAp73 and ΔNp73), which misrepresents the question. The correct number of TAp73 isoforms is not mentioned or implied.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The p73 gene has two main isoforms: TAp73 and ΔNp73. Therefore, two TAp73 isoforms have been identified in humans.\n\nAnswer: Two.", "model_support": "The p73 gene is expressed as two main isoforms: TAp73 and ΔNp73. Therefore, two TAp73 isoforms have been identified in humans.\n\n**Supporting sentence:** \"The p73 gene, a homologue of the p53 tumor suppressor, is expressed as TA and ΔN isoforms.\"", "retries": 1}
{"idx": 526, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**. \n\n**Supporting Sentence:**  \n\"The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.\"", "retries": 1}
{"idx": 527, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and covers the answer, but contains slight redundancy by emphasizing specificity compared to ubiquitin. The core logic aligns well but could be more concise.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein is a presynaptic protein recently identified as a specific component of Lewy bodies (LB) and Lewy neurites.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: alpha-synuclein", "model_support": "Supporting sentence: \"alpha-Synuclein immunostaining was more specific than ubiquitin immunostaining in that it differentiated LB from globose tangles.\"", "retries": 1}
{"idx": 528, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it references general medical knowledge instead of directly citing the context provided, which explicitly states that hypertrophic cardiomyopathy is the most common cause of death at 30%. The logic is sound but could be more concise by using the specific information from the context.\", \"match\": true}", "gold_answer": "hypertrophic cardiomyopathy", "gold_support": "The most common cause of death was hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).", "model_answer": "The most common cause of sudden cardiac death in young athletes is hypertrophic cardiomyopathy (HCM).", "model_support": "The context provided does not explicitly mention the most common cause of sudden cardiac death in young athletes. However, based on general medical knowledge, hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death in young athletes. The context does not provide a specific supporting sentence for this answer.", "retries": 1}
{"idx": 529, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('calcineurin'). The supporting sentence provided by the model is relevant and supports the answer, but it contains additional information about SCID syndrome and other details that are not strictly necessary to explain the role of calcineurin in NFAT activation. While the logic is strong, the extra content makes it slightly verbose compared to the gold supporting sentence, which directly explains how calcineurin dephosphorylates NFAT, leading to its activation.\",\n  \"match\": true\n}", "gold_answer": "calcineurin", "gold_support": "Transcription downstream of Ca(2+) influx is in large part funneled through the transcription factor nuclear factor of activated T cells (NFAT), a heavily phosphorylated protein that is cytoplasmic in resting cells, but that enters the nucleus when dephosphorylated by the calmodulin-dependent serine/threonine phosphatase calcineurin.", "model_answer": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors is **Calcineurin**.", "model_support": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors is **Calcineurin**.\n\n**Supporting sentence:**  \n\"The importance of the Ca(2+)/calcineurin/NFAT signalling pathway for lymphocyte activation is underscored by the finding that the underlying defect in a family with a hereditary severe combined immune deficiency (SCID) syndrome is a defect in CRAC channel function, store-operated Ca(2+) entry, NFAT activation and transcription of cytokines, chemokines and many other NFAT target genes whose transcription is essential for productive immune defence.\"", "retries": 1}
{"idx": 530, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, specifying the 5-HT2A receptor. However, the supporting sentence is slightly redundant as it repeats part of the context without adding significant logical reasoning or clarity beyond what is already implied. It could be more concise while still supporting the answer effectively.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "The [18F]altanserin can be used to evaluate the 5-HT₂A receptor.", "model_support": "Supporting sentence: Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.", "retries": 1}
{"idx": 531, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('repressor'). The supporting sentence is relevant and provides a clear explanation of BACH1's repressive function, supported by the experimental evidence involving heme and alpha-globin gene expression. However, it includes slightly more detail than necessary, making it somewhat verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The transcriptional factor Bach1 forms a heterodimer with small Maf family, and functions as a repressor of the Maf recognition element (MARE) in vivo.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 functions as a repressor. This conclusion is supported by the observation that BACH1 inhibits the expression of the alpha-globin gene when heme levels are low, and its repressive effect is alleviated by the presence of heme, which promotes its nuclear export. \n\n**Supporting Sentence:** \"The heme-dependent expression of alpha-globin occurred at the transcriptional level since the expression of human alpha-globin gene promoter-reporter gene containing hypersensitive site-40 (HS-40) was decreased when K562 cells were cultured with SA.\" This indicates that Bach1 acts as a repressor by reducing the activity of the alpha-globin gene promoter under heme-deficient conditions.", "retries": 1}
{"idx": 532, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('alpha-synuclein'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by referencing the abnormal deposition of alpha-synuclein, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein.\n\n**Supporting sentence:** \"The term alpha-synucleinopathy is used to name a group of disorders having in common the abnormal deposition of alpha-synuclein in the cytoplasm of neurons or glial cells, as well as in extracellular deposits of amyloid.\"", "retries": 1}
{"idx": 533, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('beta-Trcp'), but the supporting sentence is slightly less precise compared to the gold supporting sentence. While the model's supporting sentence correctly identifies beta-TrCP as the responsible E3 ubiquitin ligase, it lacks the detailed context provided in the gold supporting sentence regarding the specific mechanism (e.g., 'SCFbeta-Trcp', 'phosphorylation-dependent manner'). This results in a minor loss of richness in explanation, warranting a score of 4.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is beta-TrCP.\n\nAnswer: beta-TrCP", "model_support": "The E3 ubiquitin ligase responsible for the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is beta-TrCP. \n\n**Supporting Sentence:**\n\"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"", "retries": 1}
{"idx": 534, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is a fully humanized monoclonal antibody (IgG1/κ) targeting human interleukin-5 (IL-5), a key haematopoietin needed for eosinophil development and function.", "model_answer": "Interleukin-5 (IL-5).", "model_support": "The supporting sentence is:\n\n\"Mepolizumab blocks human IL-5 from binding to the α-chain of the IL-5 receptor complex on the eosinophil cell surface, thereby inhibiting IL-5 signalling.\"", "retries": 1}
{"idx": 535, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\n**Supporting sentence:** The context discusses the regulatory domain (RD) of p53 and its functions, including stabilizing the tetramer and enhancing transcriptional activity, which are characteristic roles of p53 as the guardian of the genome.", "retries": 1}
{"idx": 536, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions goiter but does not directly match the gold answer ('Thyroid'), which is more concise and accurate for hormone-related abnormalities. The supporting sentence provides relevant context about normal hormone levels and the perchlorate test, but it does not directly support the gold answer regarding the presence of thyroid goiter. The logic is somewhat convoluted as it emphasizes normal hormone levels rather than the characteristic thyroid abnormality.\", \"match\": false}", "gold_answer": "Thyroid", "gold_support": "Thyroid goiter was found in 46.5% of cases.", "model_answer": "The characteristic feature related to Pendred syndrome is goiter, an enlargement of the thyroid gland, even though in this study, thyroid hormone levels were normal.", "model_support": "The supporting sentence that indicates the characteristic hormone abnormalities in Pendred syndrome, despite normal hormone levels in the study, is:\n\n\"Hormone analysis was normal and perchlorate test negative in all cases.\"\n\nThis sentence shows that while Pendred syndrome is typically associated with goiter, in this study, the hormone levels were normal.", "retries": 1}
{"idx": 537, "gptscore_json": "{\"score\": 3, \"reason\": \"The model answer is correct and aligns with the gold standard ('L-dopa'), though it includes additional details about Madopar, which are not necessary for answering the question. The supporting sentence chosen by the model does not directly mention the co-administration of benserazide with L-dopa but instead discusses a more general point about combination therapy's efficacy. While this is related, it is less relevant compared to the gold supporting sentence, which explicitly mentions the combination of L-dopa and benserazide. The model's supporting sentence could be more focused and concise.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "In a cross-sectional study blood was obtained, 2 h after dosing, from 104 patients with idiopathic parkinsonism, divided into four groups: no L-dopa treatment (group 1), L-dopa alone (group 2), L-dopa + benserazide (Madopar) (group 3) and L-dopa + carbidopa (Sinemet) (group 4).", "model_answer": "Benserazide is usually co-administered with levodopa. Together, they form the combination drug Madopar, which is used to treat Parkinson's disease by enhancing levodopa's effectiveness.", "model_support": "The supporting sentence from the context is:\n\n\"Further detailed pharmacokinetic studies in plasma and cerebrospinal fluid are required in order to elucidate whether the ALAAD induction by PDI may be related to the loss of clinical efficacy of combination therapy in some patients and how it is related to end-of-dose deterioration and on-off phenomena.\"\n\nThis sentence implies that the combination therapy (Madopar) involves the co-administration of levodopa and benserazide, as Madopar is the combination drug containing both.", "retries": 1}
{"idx": 538, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly redundant as it repeats the answer verbatim. The logic is sound and directly supports the answer, though a more concise phrasing would improve it.\", \"match\": true}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.\n\nAnswer: XK", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene. \n\n**Supporting sentence:** \"This confirms that the patient's 7-year-old grandson, who is currently asymptomatic, also has the XK0 allele and is therefore likely to develop MLS.\"", "retries": 1}
{"idx": 539, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Ser129' is equivalent to 'serine 129'). The supporting sentence provided by the model is concise, directly relevant, and covers the answer logically by referencing the mutation of Ser129 and its functional impact. Although it doesn't explicitly mention Lewy bodies, it strongly supports the role of Ser129 phosphorylation in alpha-synuclein neurotoxicity, which aligns with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "serine 129", "gold_support": "Alpha-synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies.", "model_answer": "The phosphorylated residue of alpha-synuclein found in Lewy bodies is Ser129.\n\nAnswer: Ser129", "model_support": "The phosphorylated residue of alpha-synuclein found in Lewy bodies is Ser129. \n\n**Supporting sentence:** \"Mutation of Ser129 to alanine to prevent phosphorylation completely suppresses dopaminergic neuronal loss produced by expression of human alpha-synuclein.\"", "retries": 1}
{"idx": 540, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'Factor Xa'). The supporting sentence is relevant and covers the answer, but it introduces slight redundancy by restating 'The answer is that betrixaban inhibits factor Xa,' which adds unnecessary verbosity. The logic is clear and accurate, but a more concise explanation would improve the score.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Answer: Factor Xa", "model_support": "The answer is that betrixaban inhibits factor Xa. \n\n**Supporting Sentence:** The context discusses oral direct factor Xa inhibitors, including apixaban and rivaroxaban, which are known to inhibit factor Xa. Although betrixaban is not explicitly mentioned, it is a known direct factor Xa inhibitor, similar to the ones discussed.", "retries": 1}
{"idx": 541, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and explains the role of p53 in maintaining genomic stability, which aligns with the context. However, it contains slight redundancy by elaborating on p53's functions (cell cycle arrest, DNA repair, apoptosis), which makes it more verbose than necessary compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. This nickname reflects its critical role in maintaining genomic stability by regulating cell cycle arrest, DNA repair, and apoptosis, thereby preventing cancer progression.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. This nickname reflects its critical role in maintaining genomic stability by regulating cell cycle arrest, DNA repair, and apoptosis, thereby preventing cancer progression.\n\n**Supporting sentence:**  \n\"When p53 function is impaired, its ability to preserve genomic integrity is compromised.\"", "retries": 1}
{"idx": 542, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence is also flawed because it claims the context does not provide information on subcellular localization, whereas the gold supporting sentence explicitly states that APOBEC3B appeared predominantly nuclear. This indicates the model missed or misinterpreted critical information in the context.\", \"match\": false}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic.", "model_support": "The context provided does not explicitly state whether the APOBEC3B protein is predominantly cytoplasmic or nuclear. While the context discusses the function and inhibition mechanisms of APOBEC3B and APOBEC3F, it does not provide information on their subcellular localization. Therefore, the answer that APOBEC3B is predominantly cytoplasmic cannot be supported by the given context. \n\nAnswer: The context does not provide explicit information about the predominant localization of APOBEC3B protein.", "retries": 1}
{"idx": 543, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information that supports the answer by mentioning the high homology to human selenoprotein P and the presence of multiple selenocysteines. However, it contains slight redundancy in specifying '12 rather than 10 TGAs (12 rather than 10 selenocysteines),' which adds verbosity without significantly enhancing clarity.\", \"match\": true}", "gold_answer": "selenoprotein P", "gold_support": "Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression.", "model_answer": "The human selenoprotein that contains several Se-Cys residues is **selenoprotein P**.", "model_support": "The supporting sentence is:  \n\"The coding nucleotide sequence of its cDNA insert displayed high homology to rat and human selenoprotein P cDNA but contained 12 rather than 10 TGAs (12 rather than 10 selenocysteines in deduced amino acids),...\"  \n\nThis sentence indicates that the cDNA sequence has high similarity to human selenoprotein P and specifies the presence of 12 selenocysteine residues, confirming that selenoprotein P contains several Se-Cys residues.", "retries": 1}
{"idx": 544, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by specifying 'factor Xa' instead of just 'Xa'. The supporting sentence provides relevant information but includes additional details about PRT4445, which, while correct, are not necessary to support the answer. This makes the supporting sentence somewhat redundant, though it still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "**Answer:** Betrixaban inhibits factor Xa.\n\n**Supporting Sentence:** \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence indicates that betrixaban has anti-Xa activity, meaning it inhibits factor Xa.", "retries": 1}
{"idx": 545, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about BCR-ABL kinase inhibitors, but it introduces additional context about leukemia stem cells, which is not directly necessary to support the answer. This makes it slightly more verbose than the ideal supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "CML is induced by the BCR-ABL oncogene, whose gene product is a BCR-ABL tyrosine kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.", "model_support": "Supporting sentence: However, the inability of BCR-ABL kinase inhibitors to completely kill leukemia stem cells (LSCs) indicates that these kinase inhibitors are unlikely to cure CML.", "retries": 1}
{"idx": 546, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'factor Xa'). The supporting sentence provided by the model is accurate in stating that the context does not explicitly confirm betrixaban's mechanism, but this is unnecessary since the gold supporting sentence clearly identifies betrixaban as a factor Xa inhibitor. The model's supporting sentence introduces slight redundancy by emphasizing the lack of explicit information, which could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Recently developed anticoagulants include direct thrombin antagonists such as dabigatran or factor Xa inhibitors such as rivaroxaban, apixaban, betrixaban, and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The context provided does not explicitly mention betrixaban or its mechanism of action. Therefore, there is no supporting sentence within the context to confirm that betrixaban inhibits factor Xa. \n\nAnswer: The context does not provide information about betrixaban.", "retries": 1}
{"idx": 547, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and matches the gold standard ('women'), but the supporting sentence chosen is somewhat indirect and does not fully cover the key evidence provided in the gold supporting sentence. While the model's supporting sentence mentions worse outcomes for women, it does not directly state the prevalence or ratio of RA in women versus men, which is critical to supporting the answer. The logic is reasonable but could be more precise and concise.\", \"match\": true}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.", "model_support": "The supporting sentence that implies Rheumatoid Arthritis is more common in women, based on the context, is:\n\n\"CONCLUSIONS: Some of those characteristics could explain the high rates of disability and worse prognosis observed in women with RA in LAC.\"\n\nThis sentence suggests that women experience more severe outcomes, which may indicate a higher prevalence or incidence of RA in women.", "retries": 1}
{"idx": 548, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard but is slightly more verbose than necessary. The supporting sentence is somewhat relevant but does not directly cover the gold answer as it focuses on the biochemical properties of PBT2 rather than its testing in Alzheimer's disease. It mixes relevant information with less pertinent details, making it less concise and logical compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "The recent report of positive results from a Phase IIa clinical trial of PBT2, a novel drug that targets amyloid-beta-metal interactions, underscores the value of abnormal transition metal metabolism as a potential therapeutic target in Alzheimer's disease.", "model_answer": "PBT2 has been tested for Alzheimer's disease.", "model_support": "The supporting sentence is:\n\n\"PBT2 is a once per day, orally bioavailable, second generation 8-OH quinoline derivative of clioquinol.\"\n\nThis sentence is within the context of discussing the Metals Hypothesis of Alzheimer's disease, indicating that PBT2 is being tested for this disorder.", "retries": 1}
{"idx": 549, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('xa') but is present in the context. The supporting sentence mentions thrombin and other factors, which are relevant to the discussion of anticoagulants, but it does not directly support the specific role of betrixaban as an FXa inhibitor. It mixes relevant content with some irrelevant details (e.g., ASOs and aptamers), making it less focused on the gold answer.\",\n  \"match\": false\n}", "gold_answer": "xa", "gold_support": "Following the success of the direct thrombin and FXa inhibitors already in the market, new agents are being tested.", "model_answer": "Betrixaban inhibits thrombin, specifically targeting FXa (factors Xa), thereby preventing clot formation by interrupting the coagulation cascade.", "model_support": "The supporting sentence from the context is:\n\n\"Currently tested ASOs and aptamers are inhibitors of FXI, FXII, thrombin, FIXa, and platelet GPIV.\"\n\nThis sentence supports the answer because it mentions that thrombin (which is Factor Xa) is inhibited by certain agents, aligning with the fact that betrixaban inhibits thrombin (FXa).", "retries": 1}
{"idx": 550, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but adds extra details (e.g., 'forgetfulness' and 'challenges with concentration and multitasking') that are not explicitly mentioned in the gold answer. The supporting sentence references a correct but less relevant part of the context, focusing on symptom reporting rather than directly addressing memory loss as the gold supporting sentence does. While it covers the topic, it mixes relevant content with less specific information, making it somewhat less concise and precise.\",\n  \"match\": true\n}", "gold_answer": "memory loss", "gold_support": "The strongest associations were for mood swings (OR 20.9, 95%CI 16.2-27.0), memory loss/lack of concentration (OR 19.6, 95% CI 15.5-24.8), night sweats (OR 9.9, 95% CI 6.5-15.2), general fatigue (OR 9.6, 95% CI 8.3-11.1) and sexual dysfunction (OR 4.6, 95%CI 3.2-6.6).", "model_answer": "The context does not specifically address memory problems in Gulf War Syndrome. However, Gulf War Syndrome is commonly associated with cognitive difficulties, including memory loss, forgetfulness, and challenges with concentration and multitasking.", "model_support": "The supporting sentence from the context is:\n\n\"6% of GWV believed they had Gulf War syndrome (GWS), and this was associated with the highest symptom reporting.\"\n\nThis sentence indicates that Gulf War Syndrome is linked to significant health issues, which can include memory problems, although they are not explicitly mentioned in the context.", "retries": 1}
{"idx": 551, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The model answer correctly identifies Factor Xa as the clotting factor inhibited by betrixaban, matching the gold answer 'xa'. The supporting sentence provides a clear explanation of Factor Xa's role in the coagulation cascade, which logically supports why it is targeted by betrixaban. However, the supporting sentence is slightly more detailed than necessary, contributing to the score of 4 instead of 5.\", \"match\": true}", "gold_answer": "xa", "gold_support": "EXPERT OPINION: A large body of Phase II and Phase III data is now available for FXa inhibitors such as rivaroxaban, apixaban, edoxaban and betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Factor Xa (FXa) is a critical enzyme in the coagulation cascade responsible for thrombin generation, the final enzyme that leads to fibrin clot formation.\"\n\nThis sentence identifies Factor Xa as the clotting factor inhibited by drugs like betrixaban.", "retries": 1}
{"idx": 552, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard by correctly identifying 'chaperone-mediated autophagy (CMA)' as the pathway triggered by the KFERQ motif. The supporting sentence is relevant and accurate but contains slight redundancy by introducing specific components like LAMP2A and Hsc70, which are not necessary to directly support the answer. The gold supporting sentence is more concise while still being fully relevant.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.", "model_answer": "The KFERQ motif of cytosolic proteins triggers chaperone-mediated autophagy (CMA). This pathway selectively degrades proteins marked by the KFERQ motif using chaperones like Hsc70 and the LAMP2A receptor.", "model_support": "Supporting sentence: Lysosome-associated membrane protein type 2A (LAMP2A) and the heat-shock cognate protein 70 (Hsc70) constitute specific CMA components.", "retries": 1}
{"idx": 553, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'Factor Xa', matches the gold standard 'Xa'. However, the supporting sentence is incorrect. The provided sentence ('Edoxaban and betrixaban are also in development.') does not directly state that betrixaban inhibits factor Xa, which is required to logically support the answer. A more accurate supporting sentence would reference the fact that betrixaban is explicitly listed as one of the new oral inhibitors of factor Xa.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is:\n\"Edoxaban and betrixaban are also in development.\"\n\nThis sentence indicates that betrixaban is a direct inhibitor of factor Xa, alongside other mentioned drugs.", "retries": 1}
{"idx": 554, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel') in meaning, albeit with additional phrasing. The supporting sentence is relevant and provides logical support, but it includes extra details about terminal nonhomologous domains that are not strictly necessary to justify the answer. This makes it slightly more verbose than ideal, though the reasoning remains sound.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Human erythrocyte spectrin is an antiparallel heterodimer comprised of a 280 kDa alpha subunit and a 246 kDa beta subunit which further associates into tetramers in the red cell membrane cytoskeleton.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The context discusses the dimerization process of alpha-spectrin and beta-spectrin, focusing on the role of terminal nonhomologous domains. It concludes that these domains are not essential for dimer formation in physiological buffers. Based on this and general knowledge, the subunits form antiparallel heterodimers.\n\n**Answer:** Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "retries": 1}
{"idx": 555, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that the ROSIER scale is used for stroke recognition. This aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "The ROSIER scale is used for stroke. \n\n**Supporting sentence:** \"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"", "retries": 1}
{"idx": 556, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional details (e.g., specific hormones like thyroxine and triiodothyronine) that, while accurate, are not directly required by the gold answer. The supporting sentence is somewhat lengthy and mixes general recommendations with specific evidence about thyroid abnormalities, making it less concise than ideal. However, the logic connecting thyroid abnormalities to Williams syndrome is reasonable.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Hormone abnormalities common in Williams syndrome include hypothyroidism, characterized by low levels of thyroid hormones (thyroxine and triiodothyronine) and elevated thyroid-stimulating hormone (TSH).", "model_support": "The supporting sentence from the context is:\n\n\"Therefore, the possibility of congenital hypothyroidism should always be taken into consideration too and, even if congenital hypothyroidism neonatal screening is negative, thyroid (morphology and function) evaluation should be regularly assessed when the diagnosis is made and, thereafter, every year in the first years of life.\"", "retries": 1}
{"idx": 557, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and supports the answer, but it focuses on the downstream effect of LEKTI deficiency (its role in the pituitary gland and growth hormone processing), which is more specific than the gold supporting sentence. While logical, it introduces slight redundancy by not directly mentioning the mutation in SPINK5 that causes LEKTI deficiency, which is the core cause of Netherton syndrome.\",\n  \"match\": true\n}", "gold_answer": "LEKTI", "gold_support": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.", "model_answer": "The protein causing Netherton syndrome is LEKTI.\n\nAnswer: LEKTI", "model_support": "The protein causing Netherton syndrome is **LEKTI**.\n\n**Supporting sentence:**  \n\"It is proposed that a lack of inhibition of proteases due to a deficiency of LEKTI in the pituitary gland leads to the overprocessing of human GH in NS.\"", "retries": 1}
{"idx": 558, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer, it still aligns well with the gold supporting sentence in terms of relevance and conciseness.\", \"match\": true}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein.\n\n**Supporting sentence:**  \n\"Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies in the brain.\"", "retries": 1}
{"idx": 559, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and accurate, but it does not explicitly mention the 'Guardian of the Genome' phrase or provide the detailed functions that make p53 crucial, which would have offered stronger logical support as seen in the gold supporting sentence. It is slightly less informative than the gold standard but still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "Often referred to as the Guardian of the Genome, the list of known functions of p53 include regulatory roles in cell cycle arrest, apoptosis, angiogenesis, DNA repair and cell senescence.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nSupporting sentence: \"The major tumour suppressor protein, p53, is one of the most well-studied proteins in cell biology.\" \n\nAnswer: p53", "retries": 1}
{"idx": 560, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the context but does not cover the gold answer, as it discusses only two isoforms (TAp73 and DeltaNp73) without specifying the total number of TAp73 isoforms.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context identifies two isoforms of the p73 gene: TAp73 and DeltaNp73. Specifically, TAp73 is mentioned as a single isoform. Therefore, the number of TAp73 isoforms identified in humans is:\n\nAnswer: 1", "model_support": "Supporting sentence: The p73 gene is able to encode transcriptionally active TAp73, as well as a dominant-negatively acting DeltaNp73 transcript isoforms.", "retries": 1}
{"idx": 561, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('beta-TrCP'). The supporting sentence provided by the model acknowledges that the context does not directly mention beta-TrCP, but it correctly identifies beta-TrCP as the E3 ubiquitin ligase responsible for IkB degradation. However, the gold supporting sentence is more precise and directly references the context, mentioning sequence motif identity between CLU and beta-TrCP as evidence. The model's supporting explanation is relevant but lacks this direct logical connection to the context, making it slightly less ideal.\", \"match\": true}", "gold_answer": "beta-TrCP", "gold_support": "Sequence comparison analysis showed sequence motif identity between CLU and beta-transducin repeat-containing protein (beta-TrCP), a main E3 ubiquitin ligase involved in IkappaB-alpha degradation.", "model_answer": "The E3 ubiquitin ligase responsible for ubiquitinating IkB, leading to its proteasomal degradation, is beta-TrCP. This ligase is part of the SCF (Skp1-Cullin-F-box) complex and facilitates the degradation of phosphorylated IkB, enabling NF-kappaB activation.\n\nAnswer: Beta-TrCP", "model_support": "The context provided does not mention Beta-TrCP or the SCF complex. Therefore, while Beta-TrCP is indeed the E3 ubiquitin ligase responsible for ubiquitinating IkB, leading to its degradation, this information is not supported by the given context.\n\nAnswer: Beta-TrCP  \nSupporting sentence: None provided in the context.", "retries": 1}
{"idx": 562, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model acknowledges that the context does not explicitly mention the SET domain but correctly identifies it based on general knowledge. The gold supporting sentence directly confirms this information from the context, making the model's response concise and accurate.\", \"match\": true}", "gold_answer": "SET domain", "gold_support": "We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity.", "model_answer": "The characteristic domain of histone methyltransferases is the SET domain.", "model_support": "The context does not explicitly mention the characteristic domain of histone methyltransferases (e.g., the SET domain). However, the answer is based on general knowledge of histone methyltransferases, which often contain the SET domain. Unfortunately, the context provided does not include a supporting sentence for this answer.", "retries": 1}
{"idx": 563, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer 'BACH1 is a transcriptional repressor' matches the gold standard 'repressor', but the supporting sentence is somewhat lengthy and introduces unnecessary complexity by discussing dual roles of BACH1 as both an activator and repressor. While this is factually correct, it detracts from the clarity and direct relevance to the specific question about BACH1 being a repressor in the context of HO-1. The gold supporting sentence is more concise and directly addresses BACH1's role as a repressor.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "This study was undertaken to clarify the effects of HO-1 and its repressor Bach1 in osteoclastogenesis.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 exhibits both activating and repressive roles depending on the target gene. Specifically, in the context of osteoclastogenesis, BACH1 acts as an activator by promoting the expression of genes necessary for osteoclast differentiation. Conversely, in the regulation of heme oxygenase 1 (HO-1), BACH1 functions as a repressor, down-regulating its transcription. Thus, BACH1 is a transcriptional regulator with dual roles, acting as an activator in some pathways and a repressor in others.\n\n**Supporting Sentence:**  \nThe present findings demonstrate that Bach1 regulates osteoclastogenesis under inflammatory conditions, via both HO-1-dependent and HO-1-independent mechanisms. Bach1 may be worthy of consideration as a target for treatment of inflammatory bone loss in diseases including RA.", "retries": 1}
{"idx": 564, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' referring to factor Xa). The supporting sentence is relevant and supports the answer, but it contains slight redundancy by mentioning other drugs like rivaroxaban and dabigatran. While logical, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. betrixaban).\"\n\nThis sentence indicates that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 565, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by linking Nestin to the identification of neuronal precursor cells, although it introduces additional details about Prominin-1 which are not necessary for answering the question directly. This makes the supporting sentence slightly more verbose than needed.\",\n  \"match\": true\n}", "gold_answer": "Nestin", "gold_support": "A small subset of Prominin-1(+) cells coexpressed the nonspecific precursor cell marker Nestin as well as GFAP and Sox2.", "model_answer": "Nestin is the intermediate filament protein used as a non-specific marker for neuronal precursor cells in the subventricular zone.", "model_support": "The supporting sentence from the context is:\n\n\"Upon fluorescence-activated cell sorting, only Prominin-1/Nestin double-positive cells fulfilled the defining stem cell criteria of proliferation, self-renewal, and multipotentiality as assessed by a neurosphere assay.\"\n\nThis sentence indicates that Nestin is used in conjunction with Prominin-1 to identify neuronal precursor cells, establishing Nestin as an intermediate filament protein marker for these cells in the subventricular zone.", "retries": 1}
{"idx": 566, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('iron'), though it is slightly more verbose by specifying 'iron deficiency' instead of just 'iron.' The supporting sentence provided by the model restates the answer, which is relevant but not as concise or directly sourced from the context as the gold supporting sentence. The gold supporting sentence is more direct in linking iron depletion to restless leg syndrome within the study's scope. Despite this, the logic and relevance are strong.\",\n  \"match\": true\n}", "gold_answer": "iron", "gold_support": "High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron.", "model_answer": "The deficiency causing restless leg syndrome (RLS) in the context provided is iron deficiency.", "model_support": "The deficiency causing restless leg syndrome (RLS) in the context provided is iron deficiency.\n\n**Supporting sentence:**  \n\"The objective of the study was to investigate the frequency and severity of iron depletion in regular blood donors and whether IV iron is more effective than oral to avoid iron depletion and symptoms thereof, especially restless legs syndrome (RLS).\"", "retries": 1}
{"idx": 567, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('autosomal dominant'). The supporting sentence is concise, directly relevant, and provides clear reasoning by referencing the heterozygous occurrence of tumors and Knudson's two-hit hypothesis, which aligns with the gold supporting sentence. Minor extra details about the zebrafish model are acceptable as they enhance logical understanding without excessive verbosity.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Li-Fraumeni syndrome (LFS) is a highly penetrant, autosomal dominant, human familial cancer predisposition.", "model_answer": "The inheritance pattern of Li-Fraumeni syndrome is autosomal dominant.", "model_support": "The inheritance pattern of Li-Fraumeni syndrome (LFS) is autosomal dominant. This conclusion is supported by the observation that in the zebrafish model, tumors arise in heterozygotes, indicating that only one copy of the mutated gene is sufficient to cause the condition. The context also references Knudson's two-hit hypothesis, which explains that the first hit is the inherited mutation (dominant), and the second hit occurs due to loss of heterozygosity (LOH) or another mutation, leading to tumor development. \n\n**Supporting Sentence:**  \n\"Tumors arise in heterozygotes and display loss of heterozygosity (LOH).\"", "retries": 1}
{"idx": 568, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'). The supporting sentence is relevant and aligns with the context by mentioning Factor X inhibitors as a class, which includes betrixaban. However, it contains slight redundancy by discussing 'direct thrombin inhibitors' alongside Factor X inhibitors, which is not directly necessary to support the specific answer about betrixaban.\", \"match\": true}", "gold_answer": "xa", "gold_support": "These newer agents directly target specific steps in coagulation cascade and include newer low molecular weight heparins (adomiparin), ultra low molecular weight heparins (semuloparin, RO-14), inhibitors of activated factor II (dabigatran, AZD0837), X (rivaroxaban, apixaban, edoxaban, betrixaban), IX (REG1,2), XI (antisense oligonucleotides, BMS 262084, clavatadine A), VII/tissue factor (tifacogin, PCI 274836, and BMS 593214), V (recomodulin, solulin), VIII (TB402), dual thrombin/factor X inhibitors (EP21709, tanogitran), and newer vitamin K antagonists (tecarfarin).", "model_answer": "Betrixaban inhibits Factor Xa.", "model_support": "The context does not explicitly mention betrixaban, but it discusses Factor X inhibitors as a class of anticoagulants. Based on general knowledge, betrixaban is a Factor Xa inhibitor. \n\nAnswer: Betrixaban inhibits Factor Xa.\n\nSupporting sentence: Direct thrombin inhibitors and Factor X inhibitors are the most clinically advanced. \n\nNote: While the context doesn't specifically mention betrixaban, it discusses Factor X inhibitors, which aligns with betrixaban's known mechanism.", "retries": 1}
{"idx": 569, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard but is more verbose than necessary. The supporting sentence provides relevant information but is somewhat lengthy and mixes additional details like the mention of emergency physicians using the scale prospectively. While the logic is reasonable, it could be more concise to directly support the gold answer.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for identifying stroke or transient ischemic attack (TIA) in emergency settings. It serves as a diagnostic tool to help emergency physicians recognize these conditions in prehospital situations, alongside other scales like the CPSS.", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 570, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by mentioning 'late replication,' which is not directly necessary to establish the role of Xist in X-chromosome inactivation. The gold supporting sentence is more concise and directly addresses the essential role of Xist.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Expression of the X inactive-specific transcript (Xist) is thought to be essential for the initiation of X chromosome inactivation and dosage compensation during female embryo development.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.", "model_support": "Supporting sentence: These results suggest that Xist expression precedes the onset of late replication in the bovine embryo, in a pattern compatible with a possible role of bovine Xist in the initiation of X chromosome inactivation.", "retries": 1}
{"idx": 571, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning XIST's role in X chromosome inactivation, but it contains slight redundancy by discussing evolutionary studies, which is not directly necessary to confirm the function of XIST. The gold supporting sentence is more concise and directly explains why XIST is a candidate for X chromosome inactivation.\",\n  \"match\": true\n}", "gold_answer": "XIST", "gold_support": "The human XIST gene, a candidate for a role in X chromosome inactivation, has recently been cloned and sequenced, yielding a 17 kb cDNA with no apparent significant, conserved open reading frame.", "model_answer": "The transcript responsible for X-chromosome inactivation is XIST. \n\nAnswer: XIST", "model_support": "**Supporting sentence:** In the absence of a conserved open reading frame, we have turned to evolutionary studies as a first step toward elucidating a function for XIST in the process of X inactivation.", "retries": 1}
{"idx": 572, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('repressor'). The supporting sentence is concise, directly relevant, and logically explains that the absence of Bach1 leads to higher HO-1 expression, clearly indicating its role as a repressor. This aligns well with the gold supporting sentence without unnecessary verbosity.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of the HO-1 gene, and plays a critical role in tissue protection from oxidative stress by reperfusion injury of the myocardium.", "model_answer": "BACH1 is a repressor of HO-1.", "model_support": "BACH1 is a repressor of HO-1. \n\n**Supporting Sentence:** \"Bach1(-/-) mice showed significantly higher HO-1 mRNA expression levels than Bach1(+/+) mice in all brain sites studied.\"\n\nThis indicates that the absence of Bach1 leads to higher HO-1 expression, suggesting that Bach1 represses HO-1.", "retries": 1}
{"idx": 573, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor, we have carried out structure-guided design, synthesis, and characterization of orthogonal vSET methyltransferase mutant/SAM analogue pairs using a 'bump-and-hole' strategy.", "model_answer": "The methyl donor for histone methyltransferases is S-adenosyl-l-methionine (SAM).", "model_support": "The supporting sentence from the context is:\n\n\"To control the enzymatic activity of vSET in vivo with an engineered S-adenosyl-l-methionine (SAM) analogue as methyl donor cofactor...\" \n\nThis sentence identifies SAM as the methyl donor compound.", "retries": 1}
{"idx": 574, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model supporting sentence repeats the answer verbatim, it still aligns well with the gold supporting sentence in terms of relevance and clarity.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.", "model_answer": "The histone residue methylated by MLL1 is H3K4.\n\nAnswer: H3K4", "model_support": "The histone residue methylated by MLL1 is H3K4.\n\n**Supporting sentence:** Thus, we identified a molecular mechanism by which the recruitment of a H3K4 histone methyltransferase complex on the promoter of a NF-kappaB-dependent gene induces its expression and potentially the invasive potential of lymphoma cells harbouring constitutive activity of the alternative NF-kappaB-activating pathway.", "retries": 1}
{"idx": 575, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to Factor Xa). The supporting sentence is relevant and correctly identifies betrixaban as an inhibitor of Factor Xa, but it references external knowledge rather than directly citing the provided context. While the logic is correct, the ideal supporting sentence would have drawn from the given context to maintain full alignment with the source material.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits Factor Xa.", "model_support": "The context provided does not mention betrixaban. However, based on general knowledge, betrixaban is known to inhibit Factor Xa. \n\nAnswer: Betrixaban inhibits Factor Xa.  \nSupporting sentence: (Not explicitly stated in the context; based on external knowledge.)", "retries": 1}
{"idx": 576, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('non-template strand') does not match the gold standard ('the transcribed strand'), though it is related to the context of transcription and repair. The supporting sentence mentions repair of both strands but does not clearly support the model's incorrect answer or explain the targeting of the transcribed strand by TCR, as the gold supporting sentence does.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "Transcription-coupled repair (TCR) targets the non-template strand of actively transcribed genes.", "model_support": "Supporting sentence: \"Within active genes, however, both DNA strands continue to be proficiently repaired.\"", "retries": 1}
{"idx": 577, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly, correctly identifying the mode of inheritance as 'autosomal recessive.' However, the supporting sentence provided by the model incorrectly states that the context does not include a relevant supporting sentence. In fact, the context does provide a concise and relevant sentence ('Inheritance seems most likely to be autosomal recessive') that directly supports the gold answer. This misidentification of the supporting sentence results in a slight deduction, warranting a score of 4.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Inheritance seems most likely to be autosomal recessive.", "model_answer": "Wilson's disease is inherited in an autosomal recessive manner. This means that both copies of the gene responsible for the condition must be defective for the disease to manifest. Affected individuals inherit one defective gene from each parent. Carriers, who have only one defective gene, typically do not show symptoms of the disease.", "model_support": "The context provided does not include a supporting sentence about the mode of inheritance for Wilson's disease. It only mentions Wilson's disease in a list of differential diagnoses but does not discuss its inheritance pattern. Therefore, the answer cannot be supported by the given context.", "retries": 1}
{"idx": 578, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model supporting sentence repeats the answer, it aligns well with the gold supporting sentence in content and relevance.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\n**Supporting sentence:** The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.", "retries": 1}
{"idx": 579, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('EGFR' is an acceptable abbreviation of 'epidermal growth factor receptor (EGFR) gene'). The supporting sentence provides relevant information but includes additional details about patient smoking history, which are not directly necessary for explaining the role of EGFR mutations in drug response. This makes it slightly redundant compared to the gold supporting sentence, which is more concise and directly tied to the association between EGFR mutations and drug sensitivity.\",\n  \"match\": true\n}", "gold_answer": "epidermal growth factor receptor (EGFR) gene", "gold_support": "Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib (Iressa), kinase inhibitor.", "model_answer": "The gene whose mutations determine the response to both erlotinib and gefitinib is **EGFR**.", "model_support": "The supporting sentence is: \"Because most mutation-positive tumors were adenocarcinomas from patients who smoked <100 cigarettes in a lifetime (\"never smokers\"), we screened EGFR exons 2-28 in 15 adenocarcinomas resected from untreated never smokers.\" This sentence highlights the role of EGFR mutations in determining drug response, as EGFR is the gene being screened for mutations to assess tumor sensitivity to erlotinib and gefitinib.", "retries": 1}
{"idx": 580, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the mode of inheritance by referencing the type of mutations associated with JLNS, aligning well with the context provided.\", \"match\": true}", "gold_answer": "autosomal recessive", "gold_support": "Jervell and Lange-Nielsen syndrome (MIM 220400; JLNS), is a rare form of profound congenital deafness combined with syncopal attacks and sudden death due to prolonged QTc; it is an autosomal recessive trait.", "model_answer": "The mode of inheritance for Jervell and Lange-Nielsen syndrome is autosomal recessive.", "model_support": "The mode of inheritance for Jervell and Lange-Nielsen syndrome (JLNS) is autosomal recessive. This conclusion is supported by the context, which states that frameshift/stop mutations cause JLNS, typically associated with recessive inheritance.\n\n**Supporting Sentence:**  \n\"Frameshift/stop mutations cause JLNS, and missense/splice site mutations cause LQTS...\"", "retries": 1}
{"idx": 581, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and accurate, explaining the role of Clostridium botulinum in causing botulism and its association with sausage poisoning. However, it introduces slight redundancy by mentioning 'anaerobic environments' and 'improperly sealed foods,' which are not necessary to support the answer directly.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "The disease is caused by exposure to toxins produced by Clostridium botulinum and other botulinum toxin-producing clostridia.", "model_answer": "The most known bacterium responsible for botulism (sausage poisoning) is **Clostridium botulinum**.", "model_support": "The most known bacterium responsible for botulism, including sausage poisoning, is **Clostridium botulinum**. This bacterium produces a toxin that causes severe neuroparalytic symptoms, and it thrives in anaerobic environments, such as those found in improperly sealed foods like sausages.", "retries": 1}
{"idx": 582, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('PP1'), and the supporting sentence is relevant, correctly pointing to the interaction between Hsp20 and PP1. However, the model’s supporting sentence repeats the answer unnecessarily and lacks the detailed reasoning provided in the gold supporting sentence (e.g., about PP1 activity being reduced by Hsp20 overexpression). This introduces slight redundancy without adding substantial value.\",\n  \"match\": true\n}", "gold_answer": "PP1", "gold_support": "Interestingly, the activity of type 1 protein phosphatase (PP1), a known regulator of PLN signaling, was significantly reduced by Hsp20 overexpression, suggesting that the Hsp20 stimulatory effects are partially mediated through the PP1-PLN axis.", "model_answer": "The protein phosphatase that interacts with HSP20 is **protein phosphatase-1 (PP1)**.", "model_support": "The protein phosphatase that interacts with HSP20 is **protein phosphatase-1 (PP1)**. \n\n**Supporting sentence:** \"Hsp20 is a novel regulator of sarcoplasmic reticulum Ca cycling by targeting the PP1-PLN axis.\"", "retries": 1}
{"idx": 583, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details in the supporting sentence are acceptable as they provide context without being excessive.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is riociguat. \n\nAnswer: Riociguat", "model_support": "The generic name of the drug Adempas is **Riociguat**.\n\n**Supporting sentence:**  \n\"Riociguat (Adempas®), an oral first-in-class soluble guanylate cyclase (sGC) stimulator...\"", "retries": 1}
{"idx": 584, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional information ('transient ischaemic attack (TIA)') not explicitly required by the gold answer. The supporting sentence mixes relevant context with some irrelevant content (e.g., comparing scales), making it less concise than ideal, though it still logically supports the answer.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "ROSIER scale is used for evaluating patients suspected of having a stroke or transient ischaemic attack (TIA) in the emergency department.", "model_support": "The supporting sentence is:\n\n\"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"\n\nThis sentence indicates that ROSIER is used for evaluating patients suspected of having a stroke or TIA in the emergency department.", "retries": 1}
{"idx": 585, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer is correct and matches the gold standard ('l-DOPA'). The supporting sentence provided by the model is relevant and directly ties benserazide to levodopa (l-DOPA), which aligns with the gold supporting sentence. However, the model's supporting sentence could be seen as slightly redundant since it repeats the information from the answer unnecessarily. Despite this minor redundancy, the logic and relevance are strong.\", \"match\": true}", "gold_answer": "l-DOPA", "gold_support": "In experiment 1, l-DOPA-primed rats were pre-treated with Vehicle (0.9% NaCl), various doses of the partial 5-HT(1A) agonist, buspirone (0.25, 1.0 or 2.5 mg/kg, ip) or buspirone (2.5 mg/kg, ip)+the 5-HT(1A) antagonist, WAY100635 (0.5 mg/kg, ip) 5 min prior to l-DOPA (12 mg/kg+15 mg/kg benserazide, ip).", "model_answer": "Benserazide is usually co-administered with levodopa to manage Parkinson's symptoms. This combination helps enhance levodopa's effectiveness by preventing its conversion to dopamine outside the brain.", "model_support": "The drug benserazide is usually co-administered with levodopa to manage Parkinson's symptoms. \n\nSupporting sentence: Although the context does not explicitly mention benserazide, it discusses the use of l-DOPA (levodopa) in Parkinson's disease and the need for adjunct therapies. Benserazide is a known decarboxylase inhibitor commonly combined with levodopa to enhance its effectiveness.", "retries": 1}
{"idx": 586, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate and matches the gold standard (BCR-ABL), though it includes additional explanatory details that are correct but not required. The supporting sentence provided by the model is relevant and explains the context well, but it introduces general medical knowledge rather than directly quoting or closely paraphrasing the provided context. While logical and correct, this makes it slightly less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "The target of Imatinib (Gleevec) is the BCR-ABL tyrosine kinase. This drug inhibits the activity of the BCR-ABL protein, which is formed due to the Philadelphia chromosome translocation in chronic myelogenous leukemia (CML). By blocking this kinase, Imatinib helps control the progression of the disease.", "model_support": "The supporting sentence for the answer is not explicitly present in the provided context. However, based on general medical knowledge, Imatinib targets the BCR-ABL tyrosine kinase, which is formed due to the Philadelphia chromosome translocation in chronic myelogenous leukemia (CML). \n\nAnswer: The target of Imatinib (Gleevec) is the BCR-ABL tyrosine kinase. This drug inhibits the activity of the BCR-ABL protein, which is formed due to the Philadelphia chromosome translocation in chronic myelogenous leukemia (CML). By blocking this kinase, Imatinib helps control the progression of the disease.", "retries": 1}
{"idx": 587, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear reasoning by referencing the context to explain why the information cannot be derived from it. This aligns perfectly with scoring criteria.\", \"match\": true}", "gold_answer": "multiple myeloma", "gold_support": "Bortezomib, a dipeptidyl boronic acid and potent inhibitor of the 26S proteasome, is remarkably effective against multiple myeloma (MM) but not against solid tumors.", "model_answer": "Velcade (bortezomib) is mainly used for treating multiple myeloma.", "model_support": "The context provided does not explicitly mention Velcade (bortezomib) or its primary use. Therefore, while it is known that Velcade is mainly used for treating multiple myeloma, this information cannot be supported by the given context.\n\nAnswer: The context does not provide information on what disease Velcade (bortezomib) is mainly used for.", "retries": 1}
{"idx": 588, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' is equivalent to 'Factor Xa'). The supporting sentence is relevant and covers the answer, but it includes slight redundancy by mentioning both direct and indirect inhibitors while betrixaban is specifically a direct factor Xa inhibitor. Additionally, the sentence could be more concise by focusing on the specific list of direct factor Xa inhibitors from the context.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Answer: Factor Xa", "model_support": "The context provided discusses various anticoagulants, including factor Xa inhibitors and IIa (thrombin) inhibitors. While betrixaban is not explicitly mentioned, it is known from prior knowledge to be an indirect factor Xa inhibitor. Therefore, based on the context and general understanding, betrixaban inhibits **Factor Xa**.\n\n**Answer:** Factor Xa", "retries": 1}
{"idx": 589, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context provided does not specify the number of TAp73 isoforms, and the model's supporting sentence correctly identifies this gap in the information. However, the model still provides an incorrect numeric answer (three) without any basis, making both the answer and reasoning invalid. This results in a score of 1.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is three: TAp73α, TAp73β, and TAp73γ. These isoforms result from alternative splicing of the p73 gene.", "model_support": "The context does not provide specific information about the number of TAp73 isoforms identified in humans. It only mentions that TAp73 isoforms are controlled by the P1 promoter and that alternative splicing occurs, but it does not specify the exact number of isoforms. Therefore, based on the given context, the number of TAp73 isoforms cannot be determined.\n\nAnswer: The context does not specify the number of TAp73 isoforms identified in humans. It mentions that TAp73 isoforms are controlled by the P1 promoter and that alternative splicing occurs, but it does not provide the exact number.", "retries": 1}
{"idx": 590, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('JNK'). The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning both p38MAPK and JNK when only JNK is necessary for the explanation. Despite this, the logic connecting JNK to c-jun phosphorylation is clear.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "OBJECTIVE: To investigate the effects of antidepressant citalopram on the gene expressions of tumor necrosis factor-alpha (TNF-α) and interleukin 1 beta (IL-1β), and to discuss the impacts of citalopram on p38 and c-jun N-terminal kinase (JNK) of mitogen-activated protein kinase (MAPK) family in microglial cells.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "model_support": "The supporting sentence is: \"the phosphorylation of p38MAPK and JNK were observed after pretreatment for 30 min.\" This indicates that JNK is involved in phosphorylation, specifically of c-jun, as JNK is known as c-Jun N-terminal kinase.", "retries": 1}
{"idx": 591, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is very close to the gold standard ('xa' vs. 'factor Xa'), which is acceptable though not exact. However, the supporting sentence provided by the model is problematic because it incorrectly states that there is no supporting sentence in the context, while the gold supporting sentence demonstrates that relevant information about betrixaban as a factor Xa inhibitor does exist. The model's supporting sentence mixes some accurate observations (e.g., lack of explicit mention of betrixaban's function) with an incorrect conclusion, leading to a score of 3 for being somewhat misleading and lacking conciseness.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Another factor Xa inhibitor, edoxaban, is under evaluation in an ongoing phase III clinical trial and others such as AZD0837, betrixaban and darexaban are still in safety and tolerability phase II studies.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban, and therefore, there is no supporting sentence to confirm that betrixaban inhibits factor Xa. The closest related information is about other factor Xa inhibitors like rivaroxaban and apixaban.\n\n**Answer:** The context does not provide information about betrixaban, so there is no supporting sentence.", "retries": 1}
{"idx": 592, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard (SAMe is just an extended form of SAM). The supporting sentence is relevant and supports the answer by indicating that S-adenosylmethionine is involved in histone methylation, though it does not explicitly state its role as a methyl donor. There is slight redundancy since the sentence discusses inhibition rather than directly stating SAMe's role as a methyl donor, but overall, the logic is strong.\", \"match\": true}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "The methyl donor of histone methyltransferases is S-adenosylmethionine (SAMe).", "model_support": "Supporting sentence: S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation.", "retries": 1}
{"idx": 593, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'IL-1 receptor type I (IL-1RI),' does not match the gold standard, which is 'IL-1β.' However, the model's answer is present in the context as gevokizumab interacts with IL-1RI by modulating IL-1β binding. The supporting sentence provided by the model is incorrect because it repeats the answer instead of offering a relevant explanation from the context. The correct supporting sentence should focus on gevokizumab targeting IL-1β, as indicated in the gold supporting sentence.\", \"match\": false}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by Gevokizumab is the IL-1 receptor type I (IL-1RI).", "model_support": "The molecule targeted by Gevokizumab is the IL-1 receptor type I (IL-1RI).\n\n**Supporting sentence:**  \n\"gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"", "retries": 1}
{"idx": 594, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('collagen'). The supporting sentence is concise, directly relevant, and logically covers the answer by linking collagen to isotopic enrichment for dietary information, which aligns with the gold supporting sentence. Minor extra details in the supporting sentence are acceptable as they enhance clarity without detracting from the logic.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "In archaeological studies, the isotopic enrichment values of carbon and nitrogen in bone collagen give a degree of information on dietary composition.", "model_answer": "The bone protein used in archaeology for dating and species identification is collagen.\n\nAnswer: Collagen", "model_support": "Supporting sentence: The isotopic enrichments of individual amino acids from bone collagen and dietary protein have the potential to provide more precise information about the components of diet.", "retries": 1}
{"idx": 595, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('PLN') in identifying the main regulatory molecule. However, the model's supporting sentence repeats the answer without providing additional context or logical reasoning as effectively as the gold supporting sentence. While correct, it lacks the detail that 'SERCA2a activity is regulated by phosphorylation of PLN,' which better explains the regulatory role of PLN.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SERCA2a activity is regulated by phosphorylation of another SR protein: Phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban (PLN).", "model_support": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban (PLN).\n\n**Supporting sentence:** \"Dephosphorylated PLN inhibits SERCA2a.\"", "retries": 1}
{"idx": 596, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'interleukin-5' as the molecule targeted by Mepolizumab. The supporting sentence is concise, directly relevant, and clearly supports the answer with logical reasoning by referencing Mepolizumab as an anti-IL-5 monoclonal antibody. Minor additional details in the context do not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "interleukin-5", "gold_support": "Mepolizumab is an anti-interleukin-5 monoclonal antibody that is in clinical trials with GlaxoSmithKline (GSK) for the treatment of severe asthma, nasal polyposis and hypereosinophilic syndrome and eosinophilic oesophagitis.", "model_answer": "The molecule targeted by the monoclonal antibody Mepolizumab is interleukin-5 (IL-5).", "model_support": "The molecule targeted by Mepolizumab is interleukin-5 (IL-5). \n\n**Supporting sentence:** \"Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.\"", "retries": 1}
{"idx": 597, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat less detailed compared to the gold supporting sentence, as it does not explicitly mention the broader context of flumazenil's use in reversing benzodiazepine overdose. Despite this, the logic is still sound and directly relevant.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "Flumazenil is indicated for reversal of sedation from benzodiazepines administered during therapeutic or diagnostic procedures and during induction or maintenance of general anesthesia, as well as for benzodiazepine overdose.", "model_answer": "The drug used as an antidote in benzodiazepine overdose is flumazenil.", "model_support": "The supporting sentence is:\n\n\"Continuous-infusion flumazenil in the management of chlordiazepoxide toxicity.\"\n\nThis sentence directly states that flumazenil is used in the management of benzodiazepine toxicity, confirming its role as an antidote.", "retries": 1}
{"idx": 598, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('adenosylmethionine' and 'S-adenosyl methionine (SAM)' are equivalent in this context). The supporting sentence is relevant and explains the role of methionine's methyl group, indirectly pointing to SAM as the donor. However, it introduces slight redundancy by discussing cytochrome c-557 details that are not directly necessary for supporting the answer, making it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "adenosylmethionine", "gold_support": "The purified cytochrome can act as a methyl acceptor for a methyltransferase activity in the cell extract that uses S-adenosylmethionine as methyl donor.", "model_answer": "The methyl donor for histone methyltransferases is S-adenosyl methionine (SAM). \n\nAnswer: S-adenosyl methionine (SAM)", "model_support": "The supporting sentence from the context is:\n\n\"The mitochondrial cytochrome c-557 of Crithidia oncopelti contains two lysine residues and an N-terminal proline residue that are methylated in vivo by the methyl group of methionine.\"\n\nThis sentence indicates that methionine's methyl group is utilized, which is consistent with S-adenosyl methionine (SAM) being the methyl donor, as SAM is derived from methionine and is the active methyl donor in these reactions.", "retries": 1}
{"idx": 599, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SET domain') and is correct. The supporting sentence provides relevant information about the SET domain's function, but it includes extra details about specific mutations that are not directly necessary to support the answer. While logical and related, it is slightly more verbose than the gold supporting sentence, which is more concise and directly tied to the question.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Dominant alleles identify SET domain residues required for histone methyltransferase of Polycomb repressive complex 2.", "model_answer": "The characteristic domain of histone methyltransferases is the **SET domain**. This domain is essential for their catalytic activity, enabling the transfer of methyl groups to histones, which plays a key role in epigenetic regulation.", "model_support": "The supporting sentence from the context that identifies the characteristic domain of histone methyltransferases is:\n\n\"The mutations likely affect either the lysine-substrate binding pocket, the binding site for the adenosylmethionine methyl donor, or a critical tyrosine predicted to interact with the substrate lysine epsilon-amino group.\"\n\nThis sentence highlights the SET domain's critical role in the enzyme's function, confirming it as the characteristic domain for histone methyltransferases.", "retries": 1}
{"idx": 600, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer specifies '17,20-lyase, which is a component of the CYP17A1 enzyme,' while the gold answer simply states 'CYP17A1.' Although both answers are technically correct, the gold answer is more concise and directly aligns with the gold supporting sentence. The model's supporting sentence provides relevant information but is slightly redundant, repeating the term '17,20-lyase' multiple times. Despite this, it still logically supports the answer by emphasizing Orteronel's role as an inhibitor of 17,20-lyase, which is part of CYP17A1.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "An important enzyme responsible for the synthesis of extra-gonadal androgens is CYP17A1 which possesses both 17,20-lyase and 17-hydroxylase catalytic activities with the 17,20-lyase activity being key in the androgen biosynthetic process.", "model_answer": "The enzyme inhibited by Orteronel is 17,20-lyase, which is a component of the CYP17A1 enzyme.", "model_support": "The enzyme inhibited by Orteronel is 17,20-lyase, a component of the CYP17A1 enzyme. This is supported by the context, which describes Orteronel as a novel non-steroidal 17,20-lyase inhibitor and highlights its potent suppression of androgen production through targeting this enzyme. The study demonstrates that Orteronel inhibits 17,20-lyase activity more effectively than 17-hydroxylase, further confirming its role in androgen biosynthesis inhibition.\n\n**Answer:**\n\nThe enzyme inhibited by Orteronel is 17,20-lyase, which is a component of the CYP17A1 enzyme. \n\n**Supporting Sentence:**  \n\"Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.\"", "retries": 1}
{"idx": 601, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'medicarpin' is the correct response. However, the supporting sentence, while relevant and logical, does not directly quote or focus on the explicit statement from the context that identifies medicarpin as the major phytoalexin in alfalfa. Instead, it discusses the kinetics of induction, which indirectly supports the answer but lacks the precision of the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is medicarpin.", "model_support": "The supporting sentence is: \"The kinetics of induction are consistent with the appearance of IFR activity, the accumulation of medicarpin, and the observed induction of other enzymes in the pathway.\" This sentence directly connects the induction of IFR activity with the accumulation of medicarpin, confirming it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 602, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it contains slight redundancy by repeating the answer itself. The selected context sentence is accurate and provides useful additional information, though it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for identifying chorion proteins in Lepidopteran proteomes is LepChorionDB.", "model_support": "The database available for identifying chorion proteins in Lepidopteran proteomes is LepChorionDB.\n\n**Supporting sentence:**  \n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins.\"", "retries": 1}
{"idx": 603, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence, while relevant and identifying BCR-ABL as the target of Imatinib, does not directly explain the Philadelphia chromosome or the constitutively active Abl kinase, which are key details in the gold supporting sentence. The chosen supporting sentence is slightly less precise in covering the full context of the answer, though it still provides logical support.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of a constitutively active Abl kinase, which is the product of a chimeric BCR-ABL gene, caused by the genetic translocation known as the Philadelphia chromosome.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is BCR-ABL.\n\nAnswer: BCR-ABL", "model_support": "The supporting sentence from the context is:\n\n\"Although alternative Bcr-Abl tyrosine kinase inhibitors have been developed to overcome drug resistance...\"\n\nThis sentence explicitly identifies Bcr-Abl (BCR-ABL) as the target of Imatinib, confirming it as the tyrosine kinase involved in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 604, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('repressor'). The supporting sentence provided by the model is relevant and covers the gold answer logically; however, it repeats the model's answer verbatim, introducing slight redundancy. Ideally, the supporting sentence should directly reference the context without restating the answer itself.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "The transcription factor Bach1 heterodimerizes with small Maf proteins to repress MARE-dependent gene expression.", "model_answer": "The transcriptional regulator BACH1 is a repressor. It represses the expression of genes containing Maf recognition elements (MARE) by binding to these elements, thereby inhibiting transcription.", "model_support": "The transcriptional regulator BACH1 is a repressor. It represses the expression of genes containing Maf recognition elements (MARE) by binding to these elements, thereby inhibiting transcription.\n\n**Supporting sentence:**  \n\"The transcription factor Bach1 heterodimerizes with small Maf proteins to repress Maf recognition element (MARE)-dependent gene expression.\"", "retries": 1}
{"idx": 605, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model, although identical to the answer, is concise and directly relevant, covering the answer with clear and logical reasoning. While it could have included additional context for richness, it still aligns well with the gold supporting sentence in terms of relevance and conciseness.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein.\n\nSupporting sentence: In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.", "retries": 1}
{"idx": 606, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and provides clear logical reasoning by linking [18F]altanserin to its specific use in quantifying 5-HT2A receptors. Minor extra details are acceptable as the logic remains strong.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are **5-HT2A receptors**.", "model_support": "The receptors that can be evaluated with [18F]altanserin are **5-HT2A receptors**.\n\n**Supporting sentence:**  \n\"[18F]Altanserin PET is a reliable tool for in vivo quantification of 5-HT2AR availability.\"", "retries": 1}
{"idx": 607, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard ('ultrasound'), though it provides additional specificity by mentioning 'transvaginal ultrasound,' which is acceptable as it does not contradict the gold answer. The supporting sentence is relevant and logically supports the answer, but it is slightly more detailed than necessary, introducing information about diagnosing detrusor instability, which is not directly required to support the answer about how bladder wall thickness is measured.\", \"match\": true}", "gold_answer": "ultrasound", "gold_support": "OBJECTIVE: To determine whether transvaginal ultrasound measurement of bladder wall thickness can be used as a screening test for detrusor instability in women with urinary symptoms.", "model_answer": "Bladder wall thickness is measured using transvaginal ultrasound.", "model_support": "Supporting sentence: The measurement of a mean bladder wall thickness greater than 5 mm with transvaginal ultrasound is a sensitive screening method for diagnosing detrusor instability in symptomatic women without outflow obstruction.", "retries": 1}
{"idx": 608, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence provided by the model is relevant and supports the answer, but it focuses on different fragments (HEalpha1,2 and HEalpha2,3) rather than the specific fragments mentioned in the gold supporting sentence (HEalpha13,14 and HEbeta8,9). This introduces slight redundancy and a less precise alignment with the gold standard's logic, though the overall reasoning remains strong.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "Two of the less stably folded fragments, human erythroid alpha-spectrin repeats 13 and 14 (HEalpha13,14) and human erythroid beta-spectrin repeats 8 and 9 (HEbeta8,9), are located opposite each other on antiparallel spectrin dimers.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "Supporting sentence: More stably folded fragments, human erythroid alpha-spectrin repeats 1 and 2 (HEalpha1,2) and human erythroid alpha-spectrin repeats 2 and 3 (HEalpha2,3), lie nearly opposite each other on antiparallel spectrin dimers of a tetramer.", "retries": 1}
{"idx": 609, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('ZEB2') does not match the gold standard ('SIP-1'), but it is present in the context as an alternative name for the same gene. The supporting sentence provided by the model is concise and relevant, but it does not cover the gold answer ('SIP-1'). Instead, it focuses solely on ZEB2 without mentioning its alternative names, which would have aligned it more closely with the gold standard.\",\n  \"match\": false\n}", "gold_answer": "SIP-1", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZEB2.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZEB2. \n\n**Supporting sentence:**  \n\"We report on the results of comprehensive molecular testing for 27 patients testing positive for MWS. Twenty-one patients had a nonsense, frameshift, or splice site mutation identified by sequencing; 14 of which localized to exon 8 and 17 of which are novel. Six patients had deletions in the ZEB2 gene, including two novel partial gene deletions.\"", "retries": 1}
{"idx": 610, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('collagen') and provides additional relevant context about its use in dating and species identification. However, the supporting sentence includes details about the Longin procedure, which, while related to collagen extraction, is not directly necessary to support the specific answer. The gold supporting sentence is more concise and directly relevant. Thus, the model's supporting sentence contains slight redundancy.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "Collagen is the most suitable fraction and is the material normally used in radiocarbon dating.", "model_answer": "Collagen is the bone protein used in archaeology for dating and species identification. It is extracted from bones and analyzed, often through methods like radiocarbon dating, to determine the age and species of the remains.", "model_support": "The sentence that supports the answer is:\n\n\"The most widespread method for collagen extraction is based on the Longin procedure, which consists in HCl demineralization to dissolve the inorganic phase of the samples, followed by dissolution of collagen in a weak acid solution.\"\n\nThis sentence indicates that collagen extraction is a common method used in archaeology for dating, which supports the answer.", "retries": 1}
{"idx": 611, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer is correct in identifying thyroid-related abnormalities as characteristic of Pendred syndrome, but it does not match the gold standard 'thyroid' exactly. The supporting sentence chosen by the model is relevant to the context of thyroid evaluation but does not directly address or logically support the specific hormone abnormalities (hypothyroidism and goiter) mentioned in the answer. It lacks clear alignment with the gold supporting sentence, which explicitly discusses thyroid functional disorders and hypothyroidism.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "The characteristic hormone abnormalities in Pendred syndrome are related to thyroid function, specifically issues in producing thyroid hormones. This leads to conditions such as hypothyroidism and goiter.", "model_support": "The supporting sentence from the context that addresses the characteristic hormone abnormalities in Pendred syndrome is:\n\n**\"The objective is the hearing and balance system evaluation and the analysis of the inner ear structure and also the assessment of the function and structure of thyroid gland.\"**\n\nThis sentence indicates that evaluating thyroid function is part of the comprehensive assessment for Pendred syndrome, which aligns with the answer regarding thyroid-related issues such as hypothyroidism and goiter.", "retries": 1}
{"idx": 612, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' exactly in meaning, as '1,4-benzothiazepine' is a specific subclass of benzothiazepine. The supporting sentence from the external context directly and concisely confirms that JTV519 is a 1,4-benzothiazepine derivative, aligning perfectly with the gold supporting sentence. Minor extra details (e.g., 'multi-channel blocker') do not detract from the clarity or correctness of the logic.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "Reversal of cisplatin resistance by the 1,4-benzothiazepine derivative, JTV-519.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The answer to the question is that JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. However, the provided context does not contain a supporting sentence that explicitly states this information. The supporting sentence is found in a different context, which is:\n\n**Supporting sentence:** In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 613, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "Supporting sentence: It has been famously dubbed \"the guardian of the genome\" due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "retries": 1}
{"idx": 614, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard (FSHD), but it is more verbose than necessary. The supporting sentence is relevant and covers the answer, referencing the unique disease mechanism involving DUX4 in FSHD. However, it contains slight redundancy by repeating the full name of the disease instead of using the acronym FSHD consistently. Overall, the logic is clear and accurate.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD). \n\n**Supporting sentence:** FSHD is thereby the first example of a human disease caused by the inefficient repression of a retrogene in a macrosatellite repeat array.", "retries": 1}
{"idx": 615, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('alpha-Synuclein'). The supporting sentence is concise, directly relevant, and covers the answer logically by clearly stating that alpha-synuclein is the main component of Lewy bodies. There is no excessive verbosity or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "alpha-Synuclein", "gold_support": "alpha-Synuclein, the main component of LBs, is expressed as two main isoforms (112 and 140), but little is known about their differential expression in the brain.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\nSupporting sentence: \"Dementia with Lewy bodies (DLB) is characterized by the widespread presence of Lewy bodies (LBs) in the brain.\"", "retries": 1}
{"idx": 616, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that benserazide is co-administered with L-Dopa. The logic is strong and straightforward without unnecessary details.\", \"match\": true}", "gold_answer": "L-Dopa", "gold_support": "They were injected subcutaneously (s.c.) with L-Dopa methyl ester (125 mg per animal) plus benserazide (50 mg per animal; L-Dopa/benserazide) alone or in combination with JL-18 (at the doses of 0.1, 0.3, or 0.9 mg/kg, s.c.).", "model_answer": "Benserazide is usually co-administered with L-Dopa.\n\nAnswer: L-Dopa", "model_support": "The drug benserazide is usually co-administered with L-Dopa.\n\n**Supporting sentence:**  \n\"L-Dopa/benserazide increased locomotion and improved parkinsonism but also induced dyskinesias.\"", "retries": 1}
{"idx": 617, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by explaining how RNA polymerase plays a role in TCR specifically targeting the transcribed strand. Minor extra details are acceptable as they strengthen the logic without being excessive.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "The supporting sentence that indicates transcription-coupled repair (TCR) targets the transcribed strand is:\n\n**\"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage.\"**\n\nThis sentence highlights that TCR is specifically involved in addressing damage on the transcribed strand, as evidenced by the role of the stalled RNA polymerase complex in recruiting repair proteins.", "retries": 1}
{"idx": 618, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('autosomal dominant') and provides additional correct information about the genetic cause (CTG triplet repeat expansion in the DMPK gene). However, the supporting sentence is somewhat redundant, as it includes details not directly necessary to support the answer, such as the specific genetic mutation. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Dystrophic myotonia is a sufficiently rare disease inherited mainly by the autosomal dominant type.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner, caused by a CTG triplet repeat expansion in the DMPK gene located on chromosome 19.", "model_support": "The context provided does not explicitly mention the inheritance pattern of myotonic dystrophy. However, based on general medical knowledge, myotonic dystrophy is typically inherited in an autosomal dominant manner, caused by a CTG triplet repeat expansion in the DMPK gene located on chromosome 19. \n\n**Supporting Sentence:** The context does not provide a specific sentence about the inheritance pattern of myotonic dystrophy.", "retries": 1}
{"idx": 619, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as it identifies specific thyroid-related abnormalities (subclinical and overt hypothyroidism) rather than just stating 'thyroid.' However, the gold answer is more general, focusing on the thyroid as a whole. The supporting sentence provided by the model is somewhat lengthy and mixes structural details (thyroid hypoplasia) with functional abnormalities, which adds unnecessary complexity when the focus should be on the hormone abnormalities alone. A more concise explanation would better match the gold standard.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid function and morphology in patients affected by Williams syndrome.", "model_answer": "The common hormone abnormalities in Williams syndrome are subclinical hypothyroidism and overt hypothyroidism. These conditions are associated with structural issues such as thyroid hypoplasia, which impairs thyroid function.", "model_support": "The common hormone abnormalities in Williams syndrome are subclinical hypothyroidism and overt hypothyroidism. These conditions are associated with structural issues such as thyroid hypoplasia, which impairs thyroid function.\n\n**Supporting sentence:**  \n\"Three cases (15%) of subclinical hypothyroidism were identified. Overt hypothyroidism was diagnosed in two cases (10%).\"", "retries": 1}
{"idx": 620, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer 'Zfhx1b' matches the gold standard 'ZFHX1B' in substance, differing only in formatting (case sensitivity). The supporting sentence is relevant and provides information about the Zfhx1b gene's role using a mouse model; however, it contains redundancy and does not directly quote the key details from the context that mutations in ZFHX1B cause the syndrome. It could be more concise while still covering the gold answer.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome is a recently delineated autosomal dominant developmental anomaly, whereby heterozygous mutations in the ZFHX1B gene cause mental retardation, delayed motor development, epilepsy and a wide spectrum of clinically heterogeneous features, suggestive of neurocristopathies at the cephalic, cardiac and vagal levels.", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is Zfhx1b.", "model_support": "Supporting sentence: \"However, our understanding of the etiology of this condition at the cellular level remains vague. This study presents the Zfhx1b protein expression domain in mouse embryos and correlates this with a novel mouse model involving a conditional mutation in the Zfhx1b gene in neural crest precursor cells.\"", "retries": 1}
{"idx": 621, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'calcineurin,' is correct and matches the gold standard 'phosphatase 2B' as calcineurin is also known as protein phosphatase 2B. The supporting sentence provided by the model is relevant and directly supports the answer, but it contains slight redundancy by repeating the term 'calcium/calmodulin-dependent protein phosphatase,' which makes it less concise than the gold supporting sentence. Overall, the logic is strong, but minor verbosity reduces the score.\",\n  \"match\": true\n}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Calcineurin is the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors.", "model_support": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors is calcineurin. \n\nSupporting sentence: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 622, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by emphasizing the predominance of medicarpin synthesis during elicitation, which aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence from the context is:\n\n\"During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.\"\n\nThis sentence indicates that medicarpin is the major phytoalexin in alfalfa, as it is predominantly synthesized during elicitation, a process often associated with stress responses and phytoalexin production.", "retries": 1}
{"idx": 623, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and aligns with the gold standard ('cerebral hemiatrophy'), but it is more verbose than necessary. The supporting sentence provides relevant context by listing symptoms of the syndrome, but it does not directly mention the key diagnostic feature revealed by the CT scan (i.e., cerebral hemiatrophy). While the logic connecting the symptoms to the condition is reasonable, the supporting sentence could be more concise and directly tied to the gold answer.\", \"match\": true}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is brain hemiatrophy, which involves atrophy of one side of the brain, typically the cortex, leading to the observed neurological symptoms such as seizures, spastic hemiplegia, microcephaly, and developmental delays.", "model_support": "Supporting sentence: A 14-month-old male child presented with recurrent generalized seizures, spastic hemiplegia, microcephaly and had developmental delay in motor and speech domains.", "retries": 1}
{"idx": 624, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'the template strand,' does not match the gold standard, 'the transcribed strand.' However, the concept is present in the context, as TCR specifically targets the transcribed strand of active genes. The supporting sentence provided by the model repeats the incorrect answer and does not logically support the gold answer. The correct supporting sentence from the context clearly identifies that TCR repairs the transcribed strand of active genes.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "These results suggest that UV treatment results in an induced repair of UV-damaged DNA in the transcribed strand of an active gene in XP-C and normal cells through an enhancement of TCR or a mechanism which involves the TCR pathway.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the template strand.", "model_support": "The gene strand targeted by transcription-coupled repair (TCR) is the template strand. \n\n**Supporting sentence:**  \n\"CS fibroblasts retain proficient nucleotide excision repair (NER) of inactive (or bulk) DNA, but are deficient in the transcription-coupled repair (TCR) of active genes.\"", "retries": 1}
{"idx": 625, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant because it includes an unnecessary disclaimer about the context not providing the information, which detracts from conciseness. The logic is still strong as it correctly references external knowledge that aligns with the gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "BACKGROUND: Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner.", "model_support": "The context does not provide information on the inheritance pattern of myotonic dystrophy. Therefore, the supporting sentence cannot be quoted from the given text. However, based on external knowledge, myotonic dystrophy is typically inherited in an autosomal dominant manner.", "retries": 1}
{"idx": 626, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but focuses on subclinical hypothyroidism rather than broadly mentioning 'thyroid' abnormalities, which is more aligned with the gold answer. The supporting sentence is somewhat lengthy and includes both relevant details (e.g., exaggerated TSH response) and less critical specifics (e.g., bioactivity ratio values), mixing concise relevance with additional information. Logic is reasonable but could be more focused.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hemiagenesis and elevated thyrotropin levels in a child with Williams syndrome.", "model_answer": "The common hormone abnormality in Williams syndrome is subclinical hypothyroidism, characterized by exaggerated TSH response and slightly reduced TSH bioactivity.", "model_support": "The common hormone abnormality in Williams syndrome is subclinical hypothyroidism, characterized by exaggerated TSH response and slightly reduced TSH bioactivity.\n\n**Supporting sentence:** \"TSH response to thyrotropin-releasing hormone (TRH) injection (200 microg/mq, i.v.) was exaggerated and prolonged, suggesting subclinical hypothyroidism. The biological activity of circulating TSH was slightly below the normal range [TSH bioactivity (B) to immunoreactivity (I) ratio (TSH B/I) = 0.4, normal: 0.6-2.2].\"", "retries": 1}
{"idx": 627, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear and logical reasoning by linking tofacitinib with its role in rheumatoid arthritis treatment. Minor additional context from the model supporting sentence is acceptable as it does not detract from the clarity or correctness.\", \"match\": true}", "gold_answer": "tofacitinib", "gold_support": "Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis.", "model_answer": "Tofacitinib is the JAK inhibitor approved for the treatment of rheumatoid arthritis.\n\nAnswer: Tofacitinib", "model_support": "The supporting sentence from the context is:  \n\"Tofacitinib, an oral Janus kinase (JAK) inhibitor, in a mouse collagen-induced arthritis (mCIA) model was compared with clinical PK/PD data from patients with rheumatoid arthritis (RA).\"", "retries": 1}
{"idx": 628, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the answer with clear reasoning, but it includes slight redundancy by providing additional background information about betrixaban's function and use cases. This makes it somewhat more verbose than necessary, though the logic is strong.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Factor Xa.", "model_support": "The clotting factor inhibited by betrixaban is Factor Xa. Although the context does not explicitly state this, it is known from prior knowledge that betrixaban functions by inhibiting Factor Xa, a key component in the blood clotting process. This mechanism helps prevent blood clots, which is why it is used in conditions such as atrial fibrillation and venous thromboembolism.\n\nAnswer: Factor Xa.", "retries": 1}
{"idx": 629, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\n**Supporting sentence:** The p53 tumor suppressor protein is often referred to as the \"guardian of the genome\" since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "retries": 1}
{"idx": 630, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('SET domain'). The supporting sentence is relevant and supports the answer by mentioning both the chromodomain and SET domain, but it contains slight redundancy since the chromodomain is not the focus of the question. The logic is sound, though it could be more concise by focusing solely on the SET domain.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "Deletion of the chromodomain or point mutation of the conserved amino acids, W64A or W67A, of SUV39H1 impaired enzyme activity despite the presence of an intact catalytic SET domain.", "model_answer": "The characteristic domain of histone methyltransferases is the SET domain.", "model_support": "Supporting sentence: Thus, SUV39H1 utilizes both the chromodomain and the SET domain for catalysis.", "retries": 1}
{"idx": 631, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The context explicitly mentions 'growth hormone deficiency' in patients with HRAS mutations linked to Costello syndrome, which directly implies growth hormone as the correct answer. The supporting sentence provided by the model incorrectly states that there is no information about hormone deficiencies, despite the context clearly discussing growth hormone deficiency. This results in an irrelevant and incorrect response.\", \"match\": false}", "gold_answer": "growth hormone", "gold_support": "Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients.", "model_answer": "The context does not provide information about a specific hormone deficiency implicated in Costello syndrome. It focuses on genetic mutations and their effects on the MAP kinase pathway, without mentioning hormone deficiencies. Therefore, based solely on the provided context, the answer cannot be determined.", "model_support": "The context does not provide information about a specific hormone deficiency implicated in Costello syndrome. It focuses on genetic mutations and their effects on the MAP kinase pathway, without mentioning hormone deficiencies. Therefore, based solely on the provided context, the answer cannot be determined.\n\n**Supporting Statement:**  \nThe context does not provide information about a specific hormone deficiency implicated in Costello syndrome. It focuses on genetic mutations and their effects on the MAP kinase pathway, without mentioning hormone deficiencies. Therefore, based solely on the provided context, the answer cannot be determined.", "retries": 1}
{"idx": 632, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor additional detail about p53 being a central factor in protecting against cancer does not detract from the clarity or accuracy of the response.\", \"match\": true}", "gold_answer": "p53", "gold_support": "It has been famously dubbed 'the guardian of the genome' due to its ability to respond to genotoxic stress, such as DNA damage and other stress signals, and to protect the genome by inducing a variety of biological responses including DNA repair, cell cycle arrest, and apoptosis.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "Supporting sentence: \"The p53 tumor suppressor protein has long been recognized as the central factor protecting humans from cancer. It has been famously dubbed 'the guardian of the genome'...\"", "retries": 1}
{"idx": 633, "gptscore_json": "{\n  \"score\": 1,\n  \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence provided by the model is also incorrect and irrelevant, as it does not align with the context or the gold answer. The correct number of TAp73 isoforms is 7, as indicated in the gold answer, and the context mentions 'all 5 N-terminal isoforms,' which includes TAp73 but does not limit it to just one. The model's response lacks logical support and contains no basis in the provided context.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is one.", "model_support": "The number of TAp73 isoforms identified in humans is one.\n\nSupporting sentence: The expression of all 5 N-terminal isoforms (TAp73, DeltaNp73, DeltaN'p73, Ex2p73 and Ex2/3p73) was measured by real-time RT-PCR and p53 status was analyzed by immunohistochemistry.", "retries": 1}
{"idx": 634, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation by referencing the comparison between Mahalanobis distance and delta-distance, which indirectly highlights delta-distance as the common measure. However, it is slightly indirect and less concise compared to the gold supporting sentence, which explicitly states that delta-distance is commonly used.\", \"match\": true}", "gold_answer": "delta-distance", "gold_support": "The average absolute dinucleotide relative abundance difference, termed delta-distance, has been commonly used to measure differences in dinucleotide composition, or 'genomic signature', between bacterial chromosomes and plasmids.", "model_answer": "The most common measure of differences between dinucleotide relative abundance \"genomic signatures\" is **delta-distance**.", "model_support": "The supporting sentence from the context is:\n\n\"We demonstrate that the Mahalanobis distance is better than the delta-distance at measuring genomic signature differences between plasmids and chromosomes of potential hosts.\"\n\nThis sentence indicates that delta-distance is the existing measure, which is being compared to the newly introduced Mahalanobis distance, thereby establishing delta-distance as the most common measure.", "retries": 1}
{"idx": 635, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as both specify 'Na(+)/Ca(2+) exchanger.' However, the supporting sentence is relevant but contains slight redundancy. While it correctly indicates that SEA0400 prevents SNP effects, it lacks the specificity and clarity of the gold supporting sentence, which explicitly mentions SEA0400 as a Na(+)/Ca(2+) exchange inhibitor.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "The specific Na(+)/Ca(2+) exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells.", "model_answer": "SEA0400 is an inhibitor of the Na(+)/Ca(2+) exchanger (NCX).", "model_support": "The supporting sentence is: \"These effects of SNP were prevented by SEA0400.\"\n\n**Answer:** SEA0400 is an inhibitor of the Na(+)/Ca(2+) exchanger (NCX). \n\n**Supporting sentence:** \"These effects of SNP were prevented by SEA0400.\"", "retries": 1}
{"idx": 636, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning by highlighting the lethality of the toxin produced by Clostridium botulinum, which aligns well with the context of the disease botulism.\",\n  \"match\": true\n}", "gold_answer": "Clostridium botulinum", "gold_support": "Botulism is a disease characterized by neuromuscular paralysis and is produced from botulinum neurotoxins (BoNTs) found within the Gram positive bacterium Clostridium botulinum.", "model_answer": "The most known bacterium responsible for botulism (sausage-poisoning) is **Clostridium botulinum**.", "model_support": "The most known bacterium responsible for botulism (sausage-poisoning) is **Clostridium botulinum**.\n\n**Supporting sentence:**  \n\"This bacteria produces the most deadliest toxin known, with lethal doses as low as 1 ng/kg.\"", "retries": 1}
{"idx": 637, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'formononetin,' does not match the gold standard, 'medicarpin,' but is mentioned in the context. The supporting sentence discusses the possible role of an enzyme in formononetin synthesis, which is relevant to the context but does not cover the gold answer, 'medicarpin.' Therefore, while the answer is incorrect, there is some relevance in the supporting sentence.\", \"match\": false}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.", "model_support": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin. \n\nSupporting sentence: \"The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.\"", "retries": 1}
{"idx": 638, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard in identifying the E3 ubiquitin ligase as SCFbeta-Trcp, though it includes slightly more detail about the complex being Skp1-Cul1-F-box. The supporting sentence is relevant and supports the answer but contains some redundancy by repeating the model's answer verbatim. It could be more concise while still covering the essential information.\",\n  \"match\": true\n}", "gold_answer": "SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein)", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of IFNAR1 is the **SCF (Skp1-Cul1-F-box)** complex, specifically involving **beta-TrCP** as the substrate recognition component.", "model_support": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of IFNAR1 is the **SCF (Skp1-Cul1-F-box)** complex, specifically involving **beta-TrCP** as the substrate recognition component.\n\n**Supporting sentence:** \"the integrity of two Ser residues ... is essential for the ability of IFNAR1 to recruit beta-Trcp as well as to undergo efficient ubiquitination and degradation.\"", "retries": 1}
{"idx": 639, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence effectively ties ZFHX1B to Mowat-Wilson syndrome by referencing its role in the clinical manifestations of the condition.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "ZFHX1B mutations cause a complex developmental phenotype characterized by severe mental retardation (MR) and multiple congenital defects.", "model_answer": "The gene responsible for the development of the Mowat-Wilson syndrome is ZFHX1B.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZFHX1B, as indicated by the context. The supporting sentence is:\n\n\"Pleiotropic and diverse expression of ZFHX1B gene transcripts during mouse and human development supports the various clinical manifestations of the 'Mowat-Wilson' syndrome.\"", "retries": 1}
{"idx": 640, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('BCR-ABL') in meaning, albeit with slightly more detail by specifying 'tyrosine kinase.' The supporting sentence is relevant and explains why BCR-ABL is the target, but it indirectly references resistance rather than directly describing BCR-ABL as the primary target of Imatinib. This makes it somewhat less concise and direct compared to the gold supporting sentence, which explicitly describes the fusion protein and its role in CML.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is characterised by the occurrence of the Philadelphia (Ph) chromosome (9/22 translocation) and the formation of a fusion protein--the BCR-ABL transcript with constitutive activation of the BCR-ABL tyrosine kinase and consequent changes in the intracellular signal transduction, which is responsible for the deregulated myeloid cell proliferation.", "model_answer": "The target of Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase.", "model_support": "The supporting sentence is: \"which is explained by the development of resistance owing to reactivation of the BCR-ABL signal transduction.\" This indicates that BCR-ABL is the target of Imatinib (Gleevec) as the drug's effectiveness is compromised when this signal is reactivated.", "retries": 1}
{"idx": 641, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct but more verbose than necessary, as the gold answer simply states 'stroke'. The supporting sentence is relevant and supports the answer reasonably well, but it introduces slight redundancy by emphasizing the effectiveness of the scale rather than directly focusing on its purpose for stroke recognition. While the logic is sound, a more concise explanation would improve the clarity.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing and differentiating acute stroke from stroke mimics in the emergency room setting. It assists healthcare providers in quickly identifying stroke patients who require immediate intervention.", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 642, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('sodium glucose co-transporter 2') and is correct. The supporting sentence provided by the model is relevant and aligns with the context, but it is slightly less detailed compared to the gold supporting sentence. While it correctly identifies SGLT2 inhibition as a novel treatment for T2DM, it does not include specific effects of canagliflozin such as lowering blood glucose, blood pressure, and body weight, which are present in the gold supporting sentence. Thus, the model supporting sentence is accurate but could be more comprehensive.\",\n  \"match\": true\n}", "gold_answer": "sodium glucose co-transporter 2", "gold_support": "The sodium glucose co-transporter 2 inhibitor canagliflozin lowered blood glucose, blood pressure, and body weight, with increased risk of urogenital infections in Phase 2 studies.", "model_answer": "The mechanism of action of Canagliflozin is the inhibition of the sodium glucose co-transporter 2 (SGLT2). This inhibition prevents the reabsorption of glucose in the kidneys, leading to increased glucose excretion and lower blood glucose levels in patients with type 2 diabetes mellitus.", "model_support": "Supporting sentence: Sodium glucose co-transporter 2 inhibition is a novel mode of treatment for type 2 diabetes mellitus (T2DM).", "retries": 1}
{"idx": 643, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard. Microsporidia belong to the Fungi kingdom, not Protozoa. The supporting sentence is relevant but incorrect, as it discusses Sporozoa, which is unrelated to the correct classification of Microsporidia within Fungi. The logic in the supporting sentence fails to align with the gold standard.\", \"match\": false}", "gold_answer": "Fungi", "gold_support": "The kingdom Fungi is expanded by adding Microsporidia, because of protein sequence evidence that these amitochondrial intracellular parasites are related to conventional Fungi, not Protozoa.", "model_answer": "Microsporidia belong to the Protozoa kingdom.", "model_support": "The supporting sentence from the context is:\n\n\"Haplosporidia and the (formerly microsporidian) metchnikovellids are now both placed within the phylum Sporozoa.\"\n\nThis sentence indicates that microsporidia are classified within the phylum Sporozoa, which is part of the Protozoa kingdom.", "retries": 1}
{"idx": 644, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'BCR-ABL tyrosine kinase' is effectively equivalent to 'BCR-ABL' in this context. The supporting sentence provides relevant information and directly ties Imatinib to its target, the BCR-ABL tyrosine kinase. However, it includes slight redundancy by elaborating on the Philadelphia chromosome translocation, which, while accurate, is not necessary for answering the question concisely.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "BACKGROUND/AIM: Imatinib mesylate, a tyrosine kinase inhibitor with specific activity against the breakpoint cluster region--Abelson murine leukemia (BCR-ABL) tyrosine kinase has been developed for treatment of chronic myelogenous leukemia (CML).", "model_answer": "BCR-ABL tyrosine kinase.", "model_support": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia (CML) is the BCR-ABL tyrosine kinase. This conclusion is drawn from the understanding that Imatinib is a targeted therapy designed to inhibit the BCR-ABL kinase, which is formed due to the Philadelphia chromosome translocation. Although the context provided does not explicitly state this, the drug's mechanism of action and its role in treating CML confirm the target.\n\n**Answer:** BCR-ABL tyrosine kinase.", "retries": 1}
{"idx": 645, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Jnk'), and the supporting sentence is relevant, referencing Jnk as a MAP kinase that phosphorylates c-Jun. However, the supporting sentence contains slight redundancy by repeating the model's answer verbatim, and it does not include the specific detail about Ser-63 and Ser-73 phosphorylation sites mentioned in the gold supporting sentence. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is Jnk (Jun N-terminal kinase).", "model_support": "The MAP kinase that phosphorylates the transcription factor c-jun is Jnk (Jun N-terminal kinase). \n\nSupporting sentence: \"Evidence is presented here to demonstrate that Jnk is a distant relative of the MAP kinase group that is activated by dual phosphorylation at Tyr and Thr.\"", "retries": 1}
{"idx": 646, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard conceptually, though it is slightly more verbose ('recognizing acute stroke in the emergency setting' vs. 'stroke'). The supporting sentence is relevant and supports the answer well but includes minor redundancy by specifying 'initial differentiation of acute stroke from stroke mimics,' which adds detail not strictly necessary for answering the question.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke in the emergency setting.", "model_support": "The supporting sentence is: \"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room (ER).\"", "retries": 1}
{"idx": 647, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by mentioning p53 in the context of its regulatory role, but it includes additional details about miRNAs that slightly increase verbosity without being strictly necessary.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. It is known for its critical role in maintaining genomic stability by regulating cell cycle arrest, DNA repair, and apoptosis.", "model_support": "Supporting sentence: \"In particular, p53 and TA-p73/p63 appear to upregulate the expression of (1) tumor suppressor miRNAs...\"", "retries": 1}
{"idx": 648, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying 'proprotein convertase subtilisin/kexin type 9' as the enzyme targeted by Evolocumab. The supporting sentence provided by the model correctly identifies that there is no relevant information in the context to support the answer, which aligns with the instructions since the context indeed lacks a direct supporting sentence. This approach adheres to the scoring criteria for a perfect score.\", \"match\": true}", "gold_answer": "proprotein convertase subtilisin/kexin type 9", "gold_support": "Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence.", "model_answer": "Evolocumab targets the enzyme PCSK9 (proprotein convertase subtilisin/kexin type 9).", "model_support": "The context provided does not include any information about the enzyme targeted by Evolocumab. Therefore, there is no supporting sentence in the context to answer the question.\n\nAnswer: The context does not provide information about the enzyme targeted by Evolocumab.", "retries": 1}
{"idx": 649, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate and aligns with the gold standard ('Stroke'), though it is more detailed than necessary. The supporting sentence is relevant and covers the gold answer by emphasizing the ROSIER scale's role in stroke recognition, but it includes additional details about referrals and mimics, making it slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for acute stroke recognition in the emergency room setting. It helps differentiate stroke from stroke mimics, improving timely referrals and treatment.", "model_support": "The supporting sentence from the context is:\n\n**\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER. Introduction of the instrument improved the appropriateness of referrals to the stroke team.\"**", "retries": 1}
{"idx": 650, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('c-Jun NH2-terminal kinase' vs. 'JNK (c-Jun N-terminal kinase)'). The supporting sentence is relevant and correctly connects AP-1 inhibition to c-jun phosphorylation, which is known to be mediated by JNK. However, the supporting sentence provided by the model does not directly reference JNK as stated in the gold supporting sentence, leading to slight redundancy and less precision. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "c-Jun NH2-terminal kinase", "gold_support": "E2 also attenuated the LPS activation of p38 mitogen-activated protein kinase (MAPK) but not that of extracellular-regulated protein kinase 1/2 (ERK1/2) and c-Jun NH2-terminal kinase (JNK).", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal kinase).", "model_support": "The supporting sentence in the context is:\n\n\"Moreover, E2 and E2-BSA inhibited LPS-induced activation of nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1).\"\n\nThis sentence indicates that E2 inhibits AP-1 activation, which is relevant because c-jun is a component of AP-1. While the context does not explicitly name JNK, it is known from prior knowledge that JNK phosphorylates c-jun. Therefore, the inhibition of AP-1 suggests JNK's involvement in phosphorylating c-jun.", "retries": 1}
{"idx": 651, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'acute stroke recognition,' is very close to the gold standard 'stroke' and captures the essence of the ROSIER scale's purpose. The supporting sentence is relevant and directly highlights the effectiveness of the ROSIER scale in differentiating stroke from mimics, aligning well with the gold answer. However, it contains slight redundancy by specifying 'in the ER,' which is implied in the context of the ROSIER scale. Overall, the logic is strong but could be slightly more concise.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for acute stroke recognition.", "model_support": "The supporting sentence is:  \n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 652, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'factor Xa'), and the supporting sentence is relevant, correctly identifying betrixaban as a factor Xa inhibitor. However, the chosen supporting sentence contains unnecessary information about pharmacodynamics and pharmacokinetics, making it slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors.\"\n\nThis sentence identifies betrixaban, along with rivaroxaban, apixaban, and edoxaban, as direct factor Xa inhibitors, thereby indicating that betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 653, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details are acceptable if logic is strong and no excessive content.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is:\n\n\"Betr ixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).\"\n\nThis sentence explicitly states that betrixaban is an oral factor Xa inhibitor, directly answering the question.", "retries": 1}
{"idx": 654, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model supporting sentence does not specify the exact mutation site (E327K), it still accurately reflects the context by pointing to the XK gene as the source of the mutation associated with McLeod syndrome.\", \"match\": true}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "Answer: XK", "model_support": "The mutation associated with McLeod syndrome is in the XK gene. \n\n**Supporting Sentence:** The McLeod phenotype is associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement.", "retries": 1}
{"idx": 655, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer is very close to the gold standard but uses the broader term 'interleukin-17 (IL-17)' instead of the more specific 'interleukin-17A.' The supporting sentence provides relevant information and correctly identifies Secukinumab as targeting IL-17, though it does not explicitly specify IL-17A. While the logic is strong and the information is accurate, the lack of specificity in the answer and supporting sentence slightly reduces the score.\", \"match\": false}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.", "model_answer": "Secukinumab targets interleukin-17 (IL-17).", "model_support": "The molecule targeted by the monoclonal antibody Secukinumab is interleukin-17 (IL-17). While the provided context does not explicitly state this, it is a known fact that Secukinumab specifically targets IL-17, which plays a significant role in the inflammatory processes associated with psoriasis.\n\n**Answer:**  \nSecukinumab targets interleukin-17 (IL-17).\n\n**Supporting Information:**  \nAlthough the context does not explicitly mention IL-17, it is widely recognized in medical knowledge that Secukinumab is a monoclonal antibody designed to target IL-17, making it effective in treating conditions like psoriasis by modulating the immune response.", "retries": 1}
{"idx": 656, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but includes additional details about the 'EAE+Cyclosporine' model which are not necessary to directly support the answer. The logic is sound but slightly more verbose than needed.\", \"match\": true}", "gold_answer": "Experimental Autoimmune Encephalomyelitis (EAE)", "gold_support": "The aim of our study was to characterize the sensory abnormalities and in particular the clinical signs linked to persistent pain in two models of Experimental Autoimmune Encephalomyelitis (EAE) in the rat.", "model_answer": "The most widely used model for the study of multiple sclerosis (MS) is Experimental Autoimmune Encephalomyelitis (EAE).", "model_support": "Supporting sentence: Our results suggest that the model \"EAE+Cyclosporine\" in the rat is a good model of chronic sensory abnormalities observed in MS patients both from a behavioural and pharmacological point of view.", "retries": 1}
{"idx": 657, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('mechanistic Target Of Rapamycin kinase') does not match the gold standard ('mammalian target of rapamycin'), but it is a known alternative name for mTOR and present in broader scientific contexts. The supporting sentence is relevant and explains the term, but it does not cover the gold answer directly. It introduces additional information (e.g., 'mechanistic' instead of 'mammalian') which deviates from the context provided.\",\n  \"match\": false\n}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin.", "model_answer": "mTOR stands for mechanistic Target Of Rapamycin kinase.", "model_support": "The full form of mTOR is **mechanistic Target Of Rapamycin kinase**. This designation reflects its role as a key regulator in cellular pathways influenced by rapamycin, a drug known for its inhibitory effects on mTOR activity.", "retries": 1}
{"idx": 658, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is a direct repetition of the answer and lacks the additional context provided in the gold supporting sentence. While it is relevant, it could be more informative by including reasoning about the sensitivity of the rash to gluten ingestion as seen in the gold standard.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten sensitivity is dermatitis herpetiformis.", "model_support": "The typical rash associated with gluten sensitivity is dermatitis herpetiformis.\n\n**Supporting sentence:** \"Tolerance to oats in dermatitis herpetiformis.\"", "retries": 1}
{"idx": 659, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A' and '5-HT₂A receptor' are equivalent in this context). The supporting sentence is concise, directly relevant, and logically supports the answer by clearly stating that [18F]altanserin is a PET ligand for the 5-HT₂A receptor. Minor differences in formatting (e.g., subscript vs. non-subscript) do not affect the correctness.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification of the target receptors by positron emission tomography.", "model_answer": "The [18F]altanserin is used to evaluate the 5-HT2A receptor.\n\nAnswer: 5-HT₂A receptor", "model_support": "The supporting sentence from the context is:\n\n\"Characterization of radioactive metabolites of 5-HT₂A receptor PET ligand [18F]altanserin in human and rodent.\"\n\nThis sentence directly states that [18F]altanserin is used as a PET ligand for the 5-HT₂A receptor.", "retries": 1}
{"idx": 660, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides clear context for the term mTOR by logically introducing its role in a specific biological process. Although the supporting sentence references mTORC2 specifically, it still appropriately supports the definition of mTOR.\", \"match\": true}", "gold_answer": "mammalian target of rapamycin", "gold_support": "The role of the distinct mammalian target of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation and survival in PAH and their therapeutic relevance are unknown.", "model_answer": "mTOR stands for \"mammalian target of rapamycin.\"", "model_support": "The supporting sentence is: \"Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.\"\n\nAnswer: mTOR stands for \"mammalian target of rapamycin.\"", "retries": 1}
{"idx": 661, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context, but it contains slight redundancy by repeating the question and answer within the explanation. It could be more concise by directly referencing the key information from the context without restating the entire structure.\",\n  \"match\": true\n}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "The supporting sentence is:\n\n\"Pridopidine has been tested for treatment of which disorder?\" Answer: \"Pridopidine has been tested for the treatment of Huntington disease.\"\n\nSupporting sentence: \"Regional cerebral glucose metabolism after pridopidine (ACR16) treatment in patients with Huntington disease.\"", "retries": 1}
{"idx": 662, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('nuclear'). The supporting sentence is relevant and supports the answer by referencing the active nuclear import process, which aligns with the context. However, it introduces slight redundancy by elaborating on the mechanism (e.g., 'active nuclear import process') rather than directly stating the steady-state localization as in the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "nuclear", "gold_support": "However, unlike the other proteins, A3B is the only family member with steady-state nuclear localization.", "model_answer": "The APOBEC3B protein is predominantly nuclear.", "model_support": "The APOBEC3B protein is predominantly nuclear, as evidenced by the active nuclear import process it undergoes. \n\nSupporting sentence: \"A3B nuclear import is an active process requiring at least one amino acid (Val54) within an N-terminal motif analogous to the nuclear localization determinant of the antibody gene diversification enzyme AID.\"", "retries": 1}
{"idx": 663, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides useful information about the database, but it is slightly verbose and does not directly focus on the identification aspect of chorion proteins as succinctly as the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for identifying chorion proteins in Lepidopteran proteomes is:\n\nAnswer: LepChorionDB", "model_support": "The supporting sentence is:  \n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators...\"", "retries": 1}
{"idx": 664, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model correctly identifies nestin as the intermediate filament protein used as a marker for neuronal precursor cells, and the supporting sentence logically explains its relevance based on general knowledge, aligning with the context provided.\", \"match\": true}", "gold_answer": "nestin", "gold_support": "The results indicate that administration of thyroid hormone and retinoic acid increases the expression of Ki67, a nuclear antigen associated with cell proliferation, and of nestin, a marker protein for precursor cells in the subventricular zone of adult male rats.", "model_answer": "Answer: Nestin", "model_support": "The answer is based on general knowledge rather than the specific context provided. Nestin is a well-known intermediate filament protein commonly used as a marker for neuronal precursor cells, including those in the subventricular zone. \n\n**Supporting Sentence:**  \nThe context does not explicitly mention nestin or any intermediate filament proteins. The answer is derived from external knowledge that nestin is a recognized marker for neuronal precursor cells.", "retries": 1}
{"idx": 665, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to factor Xa). The supporting sentence is relevant and correctly references external knowledge about betrixaban inhibiting factor Xa. However, it includes a disclaimer regarding the lack of context in the provided text, which introduces slight redundancy. Despite this, the logic is solid, and the sentence aligns well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban, so there is no supporting sentence within it to answer the question. However, based on external knowledge, betrixaban is known to inhibit factor Xa. For confirmation, additional sources would be necessary as the given context does not include this information. \n\nAnswer: Betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 666, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence is relevant and provides context about the XK gene, but it focuses on its interaction with the Kell glycoprotein rather than directly stating its association with McLeod syndrome. The sentence is slightly less precise compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "XK", "gold_support": "It is caused by mutations of the XK gene encoding the XK protein, a putative membrane transport protein of yet unknown function.", "model_answer": "The gene associated with McLeod syndrome is the XK gene. \n\nAnswer: XK", "model_support": "Supporting sentence: \"In erythroid tissues, XK forms a functional complex with the Kell glycoprotein.\"", "retries": 1}
{"idx": 667, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly indicating that TCR targets the transcribed strand. Minor additional context from the model's supporting sentence does not detract from the clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcribed strand of a gene is targeted by transcription-coupled repair (TCR).", "model_support": "The supporting sentence is: \"Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.\" This indicates that the transcribed strand is targeted by transcription-coupled repair (TCR).", "retries": 1}
{"idx": 668, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by highlighting the utility of LepChorionDB in identifying chorion proteins, though it includes additional details about pHMMs that are not strictly necessary for answering the question, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "LepChorionDB is the database available for identifying chorion proteins in Lepidopteran proteomes.\n\nAnswer: LepChorionDB", "model_support": "The database available for identifying chorion proteins in Lepidopteran proteomes is:\n\n**LepChorionDB**\n\n**Supporting Sentence:**\n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins.\"", "retries": 1}
{"idx": 669, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym for Lubag disease is X-linked dystonia-parkinsonism.\n\nAnswer: X-linked dystonia-parkinsonism", "model_support": "The synonym for Lubag disease is X-linked dystonia-parkinsonism. \n\n**Supporting sentence:** \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 670, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by repeating the answer within the sentence itself. The logic is sound, but the repetition reduces conciseness.\", \"match\": true}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by Gevokizumab is Interleukin-1β (IL-1β).\n\nAnswer: Interleukin-1β (IL-1β)", "model_support": "The molecule targeted by Gevokizumab is Interleukin-1β (IL-1β).\n\n**Supporting sentence:** \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"", "retries": 1}
{"idx": 671, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides logical reasoning by describing the database's construction and purpose, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for identifying chorion proteins in Lepidopteran proteomes is LepChorionDB.\n\nAnswer: LepChorionDB", "model_support": "The database available for identifying chorion proteins in Lepidopteran proteomes is **LepChorionDB**.\n\n**Supporting sentence:**  \nA database, named LepChorionDB, was constructed by searching 5 different protein databases using class A and B central domain-specific profile Hidden Markov Models (pHMMs), developed in this work.", "retries": 1}
{"idx": 672, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer specifies 'serotonin 5-HT2A receptors,' which matches the gold standard '5-HT2A' conceptually but is more verbose. The supporting sentence is relevant and supports the answer well, though it includes additional details about test-retest variability that are not strictly necessary to justify the answer. Overall, the logic is strong, but slight redundancy reduces the score.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "In summary, these results demonstrate that the test-retest variability of [18F]altanserin-specific binding is comparable to that of other PET radiotracers and that the regional specific binding of [18F]altanserin in human brain was correlated with the known regional distribution of 5-HT2A receptors.", "model_answer": "The [18F]altanserin evaluates the binding of the serotonin 5-HT2A receptors.", "model_support": "The supporting sentence from the context is:\n\n\"The regional distribution and intrasubject test-retest variability of the binding of [18F]altanserin were measured as important steps in the further development of [18F]altanserin as a radiotracer for positron emission tomography (PET) studies of the serotonin 5-HT2A receptor.\"\n\nThis sentence clearly indicates that [18F]altanserin is used to evaluate the binding of the serotonin 5-HT2A receptors.", "retries": 1}
{"idx": 673, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard, describing the inheritance as autosomal dominant. The supporting sentence provides relevant information about the CTG repeat expansion's influence on disease severity and age of onset, which supports the concept of variable expressivity in autosomal dominant diseases. However, it introduces slight redundancy by discussing sex and size dependency, which is not strictly necessary to define the mode of inheritance. Overall, the logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Myotonic dystrophy type 1 is a neuromuscular, degenerative and progressive disease, with an autosomal dominant pattern of inheritance, variable expressivity and incomplete penetrance.", "model_answer": "Myotonic dystrophy is inherited in an autosomal dominant manner. The inheritance is influenced by the size of the CTG repeat expansion, which can vary between generations, affecting the severity and age of onset of the disease.", "model_support": "The supporting sentence from the context is:\n\n\"Data analysis reveals the size of the mutation presents a positive correlation with the severity of the symptoms and a negative correlation with the age of onset. Transmission of the DM1 mutation is sex and size dependent among the Costa Rican patients.\"\n\nThis sentence indicates that the inheritance of Myotonic Dystrophy Type 1 is influenced by the size of the CTG repeat expansion, which is characteristic of autosomal dominant inheritance.", "retries": 1}
{"idx": 674, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('HEXA'). The supporting sentence is concise and directly relevant, covering the answer with clear and logical reasoning by referencing the HEXA gene mutations discussed in the context. Minor extra details about the mutations are acceptable as they support the logic.\", \"match\": true}", "gold_answer": "HEXA", "gold_support": "Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.", "model_answer": "The gene most commonly mutated in Tay-Sachs disease is the HEXA gene.", "model_support": "The supporting sentence from the context is not explicitly provided, but the information about the mutations (G749T and C1351G) and their association with Tay-Sachs disease is consistent with the known mutations in the HEXA gene, which is the gene most commonly mutated in Tay-Sachs disease.\n\nAnswer: The gene most commonly mutated in Tay-Sachs disease is the HEXA gene.\n\nThe supporting sentence is not explicitly stated in the context, but the discussion of mutations in Tay-Sachs disease is consistent with the HEXA gene being the most commonly mutated gene.", "retries": 1}
{"idx": 675, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it introduces additional context about heme regulation that is not strictly necessary to define BACH1 as a repressor. While this extra detail does not detract from the logic, it adds slight redundancy.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 is a transcriptional repressor of heme oxygenase-1 and beta-globin genes, both of which are known to be transcriptionally induced by heme.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor. \n\n**Supporting Sentence:** \"Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1.\" This indicates that Bach1's presence in the nucleus is regulated by heme levels, suggesting its role in repressing gene expression when in the nucleus.", "retries": 1}
{"idx": 676, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A' vs. '5-HT2A receptors' is a minor variation that does not affect correctness). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin evaluates 5-HT2A receptors by linking it to their visualization with age. While slightly rephrased, the logic aligns perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "The [18F]altanserin can evaluate 5-HT2A receptors.\n\nAnswer: 5-HT2A receptors", "model_support": "The [18F]altanserin can evaluate 5-HT2A receptors.\n\nSupporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 677, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, and the supporting sentence is relevant. However, the supporting sentence provided by the model ('The kingdom to which microsporidia belong, according to their current classification, is Fungi.') does not directly reference the phylogenomic evidence mentioned in the context or the gold supporting sentence ('Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi'). While correct, the model's supporting sentence lacks specific detail about the role of phylogenomics or the early divergence of microsporidia, making it slightly less informative compared to the gold standard.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "Phylogenomics supports microsporidia as the earliest diverging clade of sequenced fungi.", "model_answer": "Answer: Fungi", "model_support": "The kingdom to which microsporidia belong, according to their current classification, is Fungi.\n\n**Supporting sentence:**  \n\"However, the specific position of microsporidia within the fungal tree of life is still debated.\"", "retries": 1}
{"idx": 678, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes extra details not explicitly required by the question. The supporting sentence is relevant but somewhat lengthy and mixes additional procedural details (USG, scyntography) that are not directly necessary to support the answer. While the logic connecting the thyroid abnormalities to Pendred syndrome is reasonable, the response could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Its diagnosis requires identification of the classical triad of symptoms, including hypoacusis, thyroid goitre and iodine organification defect in the thyroid, which may lead to thyroid functional disorders of hypothyroidism.", "model_answer": "The hormone abnormality characteristic of Pendred syndrome is related to the thyroid, involving issues with iodide transport, iodine uptake, and thyroid hormone synthesis. This can lead to goiter and hypothyroidism.", "model_support": "Supporting sentence: For the whole group thyroid hormones levels and iodine organification in the thyroid identified in a test with potassium perchlorate were measured and also USG and scyntography were conducted.", "retries": 1}
{"idx": 679, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "Factor Xa.", "model_support": "The sentence that supports the answer is: \"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).\" This directly states that betrixaban inhibits Factor Xa.", "retries": 1}
{"idx": 680, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'), though it is presented as 'factor Xa' instead of just 'xa'. The supporting sentence is relevant and provides context for betrixaban being a factor Xa inhibitor, but it contains slight redundancy by discussing the broader category of anticoagulants rather than directly focusing on betrixaban alone. This makes the logic clear but slightly less concise than ideal.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is:  \n\"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\"  \n\nThis sentence indicates that betrixaban is a factor Xa inhibitor, as it falls under the category of factor Xa inhibitors mentioned in the context.", "retries": 1}
{"idx": 681, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is relevant and logically supports the answer, but it contains slight redundancy by emphasizing the reduction in binding rather than directly focusing on the visualization of 5-HT2A receptors with [18F]altanserin. This makes it less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "5-HT2A", "gold_support": "Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.", "model_support": "Supporting sentence: The reduction in cerebral 5-HT2A receptor binding thus directly reflects the loss of specific 5-HT2A receptors with age.", "retries": 1}
{"idx": 682, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about LepChorionDB, but it contains slight redundancy by including additional details about pHMMs and future applications, which are not necessary to directly support the answer.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for the identification of chorion proteins in Lepidopteran proteomes is LepChorionDB.\n\nAnswer: LepChorionDB", "model_support": "The database available for identifying chorion proteins in Lepidopteran proteomes is LepChorionDB. \n\n**Supporting sentence:**  \n\"LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins. LepChorionDB is freely available at http://bioinformatics.biol.uoa.gr/LepChorionDB.\"", "retries": 1}
{"idx": 683, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate but slightly redundant as it repeats the answer verbatim. The gold supporting sentence is more concise while maintaining all necessary information. The logic is strong, but the repetition lowers the score slightly.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "MLS is caused by hemizygosity for mutations in the XK gene.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.\n\nAnswer: XK", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene. \n\n**Supporting Sentence:**  \n\"Analysis of red blood cells by flow cytometry revealed the patient and his grandson to have reduced Kell antigen expression. The patient's daughters had two populations of red cells, consistent with them being heterozygous for an XK0 allele.\"", "retries": 1}
{"idx": 684, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK') when accounting for the full gene name provided ('XK gene'). The supporting sentence is relevant and supports the answer by correctly identifying the location of the XK gene in the Xp21 region. However, it introduces slight redundancy by specifying 'located in the Xp21 region' while this detail could be more concise given the context. Overall, the logic is clear but slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.", "model_answer": "The gene associated with McLeod syndrome is the **XK gene**. Mutations in this gene lead to the syndrome, which affects the Kell blood group system and is located in the Xp21 region of the X chromosome.", "model_support": "The gene associated with McLeod syndrome is the **XK gene**, located in the Xp21 region of the X chromosome. \n\nSupporting sentence: \"The locus for this syndrome has been mapped, by deletion analysis, to a region between the loci for Duchenne muscular dystrophy (DMD) and chronic granulomatous disease (CGD).\" This sentence indicates the region where the XK gene is found, leading to the conclusion that mutations in this gene are responsible for McLeod syndrome.", "retries": 1}
{"idx": 685, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model incorrectly states that the context does not mention the antibody, when in fact the gold supporting sentence shows that the context explicitly mentions immunohistochemistry for alpha-synuclein. Therefore, while the answer is correct, the evaluation of the supporting sentence is flawed.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Immunohistochemistry for alpha-synuclein revealed LBs in 31 of 290 PSP cases (11%).", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.", "model_support": "The context does not explicitly mention the antibody used for immunostaining of Lewy bodies or specify that it is raised against alpha-synuclein. Therefore, the supporting sentence for the answer is not present in the provided context.", "retries": 1}
{"idx": 686, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('FSHD' is the abbreviation for 'Facio-scapulo-humeral dystrophy'). The supporting sentence is relevant and provides context about the disease but contains some redundancy in mentioning dysregulation without directly linking it to DUX4 expression. It could be more concise while still covering the key information.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Facio-scapulo-humeral dystrophy (FSHD) results from deletions in the subtelomeric macrosatellite D4Z4 array on the 4q35 region.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is facio-scapulo-humeral dystrophy (FSHD).\n\nAnswer: Facio-scapulo-humeral dystrophy (FSHD)", "model_support": "Supporting sentence: Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy.", "retries": 1}
{"idx": 687, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as it specifies T3 and T4 hormones, which are thyroid hormones (TH). However, the gold answer is simply 'thyroid,' which is broader but still correct. The supporting sentence provided by the model is somewhat relevant but mixes information about normal serum T3 levels with altered brain concentrations, making it less concise than ideal. It introduces some confusion by emphasizing normal serum T3 when the focus should be on altered TH levels in general. Logic is reasonable but could be more direct.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Allan-Herndon-Dudley syndrome (AHDS), an X linked condition, is characterized by severe intellectual disability, dysarthria, athetoid movements, muscle hypoplasia and spastic paraplegia in combination with altered TH levels, in particular, high serum T3 levels.", "model_answer": "The hormones affected in Allan-Herndon-Dudley syndrome are T3 (triiodothyronine) and T4 (thyroxine). The MCT8 gene mutation disrupts their transport into the brain, leading to altered concentrations in the central nervous system despite potentially normal serum levels.", "model_support": "The hormone concentrations altered in Allan-Herndon-Dudley syndrome are T3 (triiodothyronine) and T4 (thyroxine). The supporting sentence is:\n\n\"Phenotypic variability with the presence of normal serum T3 levels.\"\n\nThis sentence indicates that while serum T3 levels are normal, the transport of T3 and T4 into the brain is disrupted, leading to altered concentrations in the central nervous system.", "retries": 1}
{"idx": 688, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by discussing calpain inhibitors, which is not necessary to establish EAE as the model for MS. The gold supporting sentence is more concise and directly states the relationship between EAE and MS.\", \"match\": true}", "gold_answer": "Experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Experimental autoimmune encephalomyelitis (EAE) is an animal model for studying multiple sclerosis (MS).", "model_answer": "The most widely used model for the study of multiple sclerosis (MS) is Experimental Autoimmune Encephalomyelitis (EAE).", "model_support": "The supporting sentence that indicates Experimental Autoimmune Encephalomyelitis (EAE) is the model used for studying multiple sclerosis (MS) is:\n\n\"Thus, treating EAE animals with calpain inhibitors may block these events and ameliorate disability.\"\n\nThis sentence demonstrates the use of EAE as a model in the study, highlighting its role in testing therapeutic interventions for MS.", "retries": 1}
{"idx": 689, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but too verbose and provides additional context that goes beyond the gold standard, which simply requires 'stroke.' The supporting sentence is relevant and captures the essence of the gold supporting sentence, but it is somewhat lengthy and could be more concise. While the logic is reasonable and the information is accurate, the extra details reduce the clarity and precision expected for a top score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the early recognition and differentiation of acute stroke from stroke mimics in the emergency room setting. It helps improve the appropriateness of referrals to the stroke team by accurately identifying stroke symptoms.", "model_support": "The ROSIER scale is used for the initial differentiation of acute stroke from stroke mimics in the emergency room (ER) setting, thereby enhancing the appropriateness of referrals to the stroke team.\n\n**Supporting sentence:**  \n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER. Introduction of the instrument improved the appropriateness of referrals to the stroke team.\"", "retries": 1}
{"idx": 690, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is slightly redundant and verbose, repeating the answer within the supporting sentence itself. While it is relevant and supports the answer logically, it could be more concise like the gold supporting sentence. The gold supporting sentence directly states the key information without additional elaboration.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein, p53, is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. This nickname reflects its critical role in maintaining genomic stability by regulating cell cycle arrest, DNA repair, and apoptosis in response to DNA damage, thereby preventing cancer progression.", "model_support": "**Answer:** The tumor suppressor referred to as \"the guardian of the genome\" is p53. This nickname reflects its critical role in maintaining genomic stability by regulating cell cycle arrest, DNA repair, and apoptosis in response to DNA damage, thereby preventing cancer progression.\n\n**Supporting sentence:** \"A role for p53 in the frequency and mechanism of mutation.\"", "retries": 1}
{"idx": 691, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context, as it acknowledges the lack of specific information regarding TAp73 isoforms. However, the supporting sentence is somewhat verbose and includes unnecessary details that do not directly contribute to supporting the answer. While the logic is reasonable, the model fails to extract the direct information provided in the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context provided does not specify the exact number of TAp73 isoforms identified in humans. It mentions that p73 is expressed as TA and ΔN isoforms but does not elaborate on the number of TAp73 variants. Therefore, based solely on the given information, the number of TAp73 isoforms is not detailed.\n\nAnswer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "The context does not specify the number of TAp73 isoforms identified in humans. It only mentions that p73 is expressed as TA and ΔN isoforms but does not provide details on the number of TAp73 variants. Therefore, based on the given information, the number of TAp73 isoforms is not detailed.\n\nSupporting sentence: p73, a p53 family tumor suppressor, is expressed as TA and ΔN isoforms.", "retries": 1}
{"idx": 692, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by linking calsequestrin to calcium signaling in the sarcoplasmic reticulum, but it contains slight redundancy and lacks the specificity of the gold supporting sentence regarding calsequestrin's high-capacity calcium-binding role.\", \"match\": true}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The supporting sentence from the context that identifies calsequestrin as the main calcium-binding protein of the sarcoplasmic reticulum is:\n\n\"Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.\"\n\nThis sentence highlights the role of calsequestrin in calcium signaling within the SR, indicating its importance as a key protein involved in calcium handling.", "retries": 1}
{"idx": 693, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by specifying that [18F]altanserin evaluates 5-HT2A receptors. There are no unnecessary details or verbosity.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "While the selective 5-hydroxytryptamine type 2a receptor (5-HT2AR) radiotracer [18F]altanserin is well established in humans, the present study evaluated its suitability for quantifying cerebral 5-HT2ARs with positron emission tomography (PET) in albino rats.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.", "model_support": "The receptors that can be evaluated with [18F]altanserin are the 5-HT2A receptors.\n\nSupporting sentence: \"PURPOSE:  PROCEDURES: Ten Sprague Dawley rats underwent 180 min PET scans with arterial blood sampling. Reference tissue methods were evaluated on the basis of invasive kinetic models with metabolite-corrected arterial input functions. In vivo 5-HT2AR quantification with PET was validated by in vitro autoradiographic saturation experiments in the same animals.\"", "retries": 1}
{"idx": 694, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' is the abbreviation for factor Xa). The supporting sentence provides relevant information but includes details about indirect inhibitors, which are not directly necessary to support the answer. This makes it slightly redundant, though the logic connecting betrixaban to factor Xa inhibition is still clear.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"The objective is to substitute these indirect inhibitors of factor Xa (heparins, low molecular weight heparins and fondaparinux) in the prevention of venous and arterial thromboembolic episodes.\"\n\nThis sentence indicates that betrixaban, along with other mentioned drugs, is a direct inhibitor of factor Xa. Therefore, the answer is:\n\n**Answer:** Betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 695, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('antiparallel'). However, the supporting sentence provided by the model is a verbatim repetition of the answer and lacks the detailed reasoning present in the gold supporting sentence. While it correctly identifies the antiparallel nature, it does not explicitly mention that the basic unit of spectrin is a heterodimer composed of two homologous chains, which would have made the support stronger and more aligned with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "antiparallel", "gold_support": "The basic unit of spectrin is an antiparallel heterodimer composed of two homologous chains, beta and alpha.", "model_answer": "The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.\n\n**Supporting sentence:**  \n\"R16 is made up of three antiparallel alpha-helices separated by two loops, and folds into a left-handed coiled-coil.\"", "retries": 1}
{"idx": 696, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'S-adenosylmethionine (SAMe),' is correct and matches the gold standard 'SAM' as SAM is simply the abbreviated form of S-adenosylmethionine. However, the supporting sentence provided by the model is relevant but contains slight redundancy. It mentions the modulation of histone methylation without directly stating that SAMe acts as a methyl donor, which is key for supporting the answer. The gold supporting sentence is more concise and directly addresses SAMe's role as a methyl donor.\",\n  \"match\": true\n}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "The methyl donor of histone methyltransferases is S-adenosylmethionine (SAMe).", "model_support": "The supporting sentence is:  \n\"S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation.\"", "retries": 1}
{"idx": 697, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('the transcribed strand'). The supporting sentence is relevant and provides logical support by mentioning TCR's role in repairing the transcribed strand via recognition of stalled RNA polymerase. However, it introduces slight redundancy by discussing Cockayne syndrome gene products, which are not essential to directly support the answer. The logic is solid but could be more concise.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The transcription-coupled repair (TCR) targets the transcribed strand of the gene.", "model_support": "The supporting sentence is:  \n\"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"  \n\nThis sentence indicates that TCR targets the transcribed strand by recognizing stalled RNA polymerase, which is crucial for repair.", "retries": 1}
{"idx": 698, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK') by identifying the correct protein affected by DUSP8 activation, though it adds extra details about specific isoforms (JNK1β and JNK2α), which are not necessary for a concise response. The supporting sentence provided by the model is relevant but repeats the answer verbatim, making it slightly redundant. The gold supporting sentence is more general and appropriately concise while still covering the key concept of DUSP8 affecting JNK.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "M3/6 (DUSP8) is a dual-specificity phosphatase implicated in the dephosphorylation and inactivation of JNK and, to a lesser extent, p38 MAPKs and is found in a complex with these kinases, along with other pathway components, held together by scaffold proteins.", "model_answer": "The protein affected by DUSP8 activation is JNK (c-Jun N-terminal kinase), particularly its isoforms JNK1β and JNK2α.", "model_support": "The protein affected by DUSP8 activation is JNK (c-Jun N-terminal kinase), particularly its isoforms JNK1β and JNK2α.\n\n**Supporting Sentence:**  \n\"M3/6 exhibited stronger binding towards JNK1β and JNK2α isoforms and this was reflected in higher enzymatic activity towards JNK2α2 when compared to JNK1α1 in vitro.\"", "retries": 1}
{"idx": 699, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'BCR-ABL tyrosine kinase,' is very close to the gold standard 'BCR-ABL,' with only slight verbosity by including 'tyrosine kinase,' which is accurate but not strictly necessary. The supporting sentence acknowledges that the context does not explicitly contain a direct supporting sentence, which is correct; however, it does not utilize the available gold supporting sentence from the text, missing an opportunity to provide concise and relevant support. Overall, the logic is strong, but the answer could be slightly more concise, and the supporting sentence could better leverage the provided context.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The discovery of targeted tyrosine kinase inhibition of BCR-ABL kinase dramatically changed the treatment of CML.", "model_answer": "The target of Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase. This enzyme is produced by the BCR-ABL fusion gene resulting from the Philadelphia chromosome translocation, and Imatinib inhibits its activity to control leukemia progression. \n\nAnswer: BCR-ABL tyrosine kinase.", "model_support": "The context provided does not contain a specific sentence that directly supports the answer regarding the target of Imatinib. The information that Imatinib targets the BCR-ABL tyrosine kinase is based on external knowledge rather than the given text.\n\nAnswer: The context does not provide a specific sentence supporting the answer.", "retries": 1}
{"idx": 700, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model correctly states that the context does not explicitly mention flumazenil as an antidote, which aligns with the instructions since the context indeed lacks such specific information. The gold supporting sentence confirms flumazenil was used but is not part of the model's input context. Thus, the model handles the task appropriately based on the given context.\", \"match\": true}", "gold_answer": "flumazenil", "gold_support": "A 54-y-old man ingested 2 g of bulk laboratory diazepam and was treated with activated charcoal, enhanced diuresis and flumazenil infusion.", "model_answer": "The drug used as an antidote in benzodiazepine overdose is flumazenil.\n\nAnswer: Flumazenil", "model_support": "The context provided does not mention flumazenil or any antidote for benzodiazepine overdose. It focuses on the effects and monitoring of diazepam poisoning. Therefore, there is no supporting sentence in the context for the answer provided.\n\nAnswer: The context does not provide information about flumazenil or any antidote for benzodiazepine overdose.", "retries": 1}
{"idx": 701, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying 'calsequestrin' as the main calcium-binding protein. The supporting sentence is relevant and supports the answer by linking calsequestrin to calcium signaling abnormalities; however, it is slightly less detailed compared to the gold supporting sentence, which specifies that calsequestrin is a high-capacity calcium-binding protein in the sarcoplasmic reticulum and directly mentions its association with ventricular arrhythmia.\",\n  \"match\": true\n}", "gold_answer": "calsequestrin", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin (CASQ).", "model_support": "The supporting sentence from the context is:\n\n\"Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.\"\n\nThis sentence indicates that calsequestrin is a critical calcium-binding protein in the sarcoplasmic reticulum, as its mutation is linked to significant calcium signaling abnormalities and cardiac issues.", "retries": 1}
{"idx": 702, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant as it repeats the answer verbatim instead of providing additional context or explanation. While it is relevant and supports the answer, it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "EWS/FLI1", "gold_support": "Herein, we show that the DNA repair protein and transcriptional cofactor, EYA3, is highly expressed in Ewing sarcoma tumor samples and cell lines compared with mesenchymal stem cells, the presumed cell-of-origin of Ewing sarcoma, and that it is regulated by the EWS/FLI1 fusion protein transcription factor.", "model_answer": "The fusion protein involved in the development of Ewing sarcoma is EWS/FLI1.", "model_support": "The fusion protein involved in the development of Ewing sarcoma is EWS/FLI1. \n\nSupporting sentence: EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.", "retries": 1}
{"idx": 703, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard with a minor difference in formatting (parentheses around 'Syk'). The supporting sentence is relevant and covers the answer, but it repeats the answer verbatim, introducing slight redundancy. Despite this, the logic is clear and directly supports the answer.\",\n  \"match\": true\n}", "gold_answer": "spleen tyrosine kinase", "gold_support": "OBJECTIVE: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biologic therapies.", "model_answer": "The enzyme inhibited by fostamatinib is spleen tyrosine kinase (Syk).\n\nAnswer: spleen tyrosine kinase (Syk)", "model_support": "The enzyme inhibited by fostamatinib is spleen tyrosine kinase (Syk). \n\n**Supporting sentence:**  \n\"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.\"", "retries": 1}
{"idx": 704, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('small cell lung cancer') does not match the gold standard ('squamous cell carcinoma'), but it is a type of lung cancer mentioned in the broader context of lung cancer. The supporting sentence acknowledges that the context does not explicitly mention the origin of the NCI-H520 cell line, which is accurate. However, the supporting sentence fails to directly reference the correct information from the gold supporting sentence, missing the key detail about NCI-H520 being derived from squamous cell carcinoma.\",\n  \"match\": false\n}", "gold_answer": "squamous cell carcinoma", "gold_support": "Functional studies in A549 bronchioalveolar carcinoma and NCI-H520 squamous cell carcinoma cells revealed that Msi1 was enriched in spheroid cultures of tumor cells and in the CD133+ cell population.", "model_answer": "The NCI-H520 cell line was derived from small cell lung cancer.", "model_support": "The NCI-H520 cell line is derived from small cell lung cancer. However, this information is not explicitly mentioned in the provided context. The context discusses Musashi1 expression in various lung cancer subtypes but does not reference specific cell lines like NCI-H520.\n\n**Answer:** The NCI-H520 cell line was derived from small cell lung cancer. (This conclusion is based on general knowledge, not the provided context.)\n\n**Supporting Sentence:** The context does not provide specific information about the NCI-H520 cell line.", "retries": 1}
{"idx": 705, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'calsequestrin,' is correct and matches the gold standard conceptually, though it does not use the exact abbreviation 'CASQ.' The supporting sentence is relevant but slightly less precise compared to the gold supporting sentence, as it mentions 'abnormal calcium signaling' without directly stating that calsequestrin is a high-capacity calcium-binding protein in the sarcoplasmic reticulum. It contains minor redundancy but still supports the answer logically.\", \"match\": true}", "gold_answer": "CASQ", "gold_support": "Mutations in human cardiac calsequestrin (CASQ2), a high-capacity calcium-binding protein located in the sarcoplasmic reticulum (SR), have recently been linked to effort-induced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "Supporting sentence: \"Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.\"", "retries": 1}
{"idx": 706, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but repeats the answer verbatim, introducing slight redundancy. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas(\\u00ae)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator, is under global development by Bayer Healthcare Pharmaceuticals Inc.", "model_answer": "The generic name of the drug Adempas is Riociguat.", "model_support": "The generic name of the drug Adempas is Riociguat.\n\nSupporting sentence: \"Riociguat (Adempas(®)), an oral first-in-class soluble guanylate cyclase (sGC) stimulator...\"", "retries": 1}
{"idx": 707, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Minor extra details about p53's function are acceptable as they logically support its role as the 'guardian of the genome'.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the \"guardian of the genome\".", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\n**Supporting sentence:** \"p53 causes cell cycle arrest to allow time for genomic damage to be repaired before cell division or induces apoptosis to eliminate irreparably damaged cells.\" \n\nThis sentence highlights p53's role in maintaining genomic integrity, which is why it is known as the guardian of the genome.", "retries": 1}
{"idx": 708, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('unilateral enlargement of the Sylvian fissure') does not match the gold standard ('cerebral hemiatrophy'), but it is related to the condition as described in broader medical knowledge. The supporting sentence acknowledges that the context does not explicitly mention the characteristic feature and attempts to rely on general knowledge instead. However, this approach leads to a mismatch with the gold answer. The supporting sentence itself is relevant but fails to cover the gold answer directly.\", \"match\": false}", "gold_answer": "cerebral hemiatrophy", "gold_support": "CT of the brain revealed characteristic features diagnostic of infantile type of cerebral hemiatrophy or Dyke-Davidoff-Masson syndrome.", "model_answer": "The characteristic feature of Dyke-Davidoff-Masson syndrome is unilateral enlargement of the Sylvian fissure.", "model_support": "The context provided does not explicitly mention the characteristic feature of Dyke-Davidoff-Masson syndrome. Therefore, I cannot quote a supporting sentence from the given context. However, based on general medical knowledge, the characteristic feature of Dyke-Davidoff-Masson syndrome is unilateral enlargement of the Sylvian fissure (also known as the lateral fissure).", "retries": 1}
{"idx": 709, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('coding strand') does not match the gold standard ('transcribed strand'), but it is related to the context of DNA strands. The supporting sentence is relevant in discussing TCR but does not logically support the incorrect answer, as it mentions global genome repair rather than focusing on the transcribed strand. The logic connecting the supporting sentence to the answer is weak.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the coding strand.", "model_support": "The supporting sentence from the context is:\n\n\"Downregulation of selected NER genes with small interfering RNA has confirmed that DAR relies upon the same genes as global genome repair, rather than upon TCR-specific genes.\"\n\nThis sentence suggests that TCR is superimposed upon the global pathway of NER and that the coding strand is targeted for repair during transcription-coupled repair.", "retries": 1}
{"idx": 710, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while acknowledging that the context doesn't explicitly state the fact, correctly identifies alpha-synuclein as the main component of Lewy bodies and aligns with the gold supporting sentence in logic and relevance. The reasoning is clear and concise.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein, although the supporting sentence for this is not explicitly present in the provided context. The context discusses the role of amyloid precursor protein (APP) isoforms in dementia with Lewy bodies (DLB) and mentions alpha-synuclein deposition. However, it does not explicitly state that alpha-synuclein is the main component. This information is typically known from other sources, which is why the answer is provided as such.\n\n**Answer:** The main component of Lewy bodies is alpha-synuclein. \n\n**Supporting Sentence:** While the provided context does not explicitly state this, it is a widely recognized fact in neurobiology that Lewy bodies primarily consist of alpha-synuclein.", "retries": 1}
{"idx": 711, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (p16Ink4a). The supporting sentence provided by the model is relevant and directly references p16Ink4a, but it repeats the answer verbatim and lacks additional explanatory context. The gold supporting sentence provides more detail about the upregulation of p16Ink4a and its effect on proliferation, making the model's supporting sentence slightly less informative but still logically consistent.\", \"match\": true}", "gold_answer": "p16Ink4", "gold_support": "In the absence of Bmi-1, the cyclin-dependent kinase inhibitor gene p16Ink4a is upregulated in neural stem cells, reducing the rate of proliferation.", "model_answer": "The cyclin-dependent kinase inhibitor regulated by Bmi-1 is p16Ink4a.", "model_support": "The cyclin-dependent kinase inhibitor regulated by Bmi-1 is p16Ink4a. \n\n**Supporting Sentence:**  \n\"p16Ink4a deficiency partially reverses the self-renewal defect in Bmi-1-/- neural stem cells. This conserved requirement for Bmi-1 to promote self-renewal and to repress p16Ink4a expression...\"", "retries": 1}
{"idx": 712, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying LHCII (Light-Harvesting Complex II) as the most abundant membrane protein on Earth. However, the supporting sentence provided by the model is incorrect, stating there is no explicit supporting sentence in the context, while the gold supporting sentence clearly exists and provides direct evidence from the context. Despite this, the model's answer itself is correct, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "Light-harvesting pigment-protein complex of Photosystem II", "gold_support": "Light-harvesting pigment-protein complex of Photosystem II (LHCII) is the largest photosynthetic antenna complex of plants and the most abundant membrane protein in the biosphere.", "model_answer": "The most abundant membrane protein on Earth is **LHCII (Light-Harvesting Complex II)**.", "model_support": "The context provided does not explicitly state that LHCII is the most abundant membrane protein on Earth. While LHCII is discussed in the context of its role in photoprotection and energy quenching, there is no sentence that directly supports the claim of its abundance. Therefore, based solely on the given context, there is no explicit supporting sentence for the statement that LHCII is the most abundant membrane protein.\n\nAnswer: There is no explicit supporting sentence in the provided context that states LHCII is the most abundant membrane protein on Earth.", "retries": 1}
{"idx": 713, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the role of TBC1D7 within the TSC1-TSC2 complex, aligning well with the gold supporting sentence while providing additional context that does not detract from clarity or correctness.\",\n  \"match\": true\n}", "gold_answer": "TBC1D7", "gold_support": "TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.", "model_answer": "The third subunit of the TSC1-TSC2 complex upstream of mTORC1 is TBC1D7.\n\nAnswer: TBC1D7", "model_support": "Supporting sentence: We demonstrate that the TSC1-TSC2-TBC1D7 (TSC-TBC) complex is the functional complex that senses specific cellular growth conditions and possesses Rheb-GAP activity.", "retries": 1}
{"idx": 714, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa'). The supporting sentence is relevant and supports the answer by confirming betrixaban as a factor Xa inhibitor, but it contains redundancy by including information about other drugs (rivaroxaban, apixaban) and their uses, which is not directly necessary to justify the specific answer. The gold supporting sentence is more concise while still providing sufficient evidence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits clotting factor Xa. \n\nAnswer: Factor Xa.", "model_support": "The supporting sentence from the context that betrixaban inhibits factor Xa is:\n\n\"Rivaroxaban and apixaban are efficacious and safe in the prevention of cerebral infarcts in patients with non-valvular fibrillation. Apixaban is another direct inhibitor of factor Xa used orally which is developed in the same indications as rivaroxaban. Edoxaban and betrixaban are also in development.\"\n\nThis sentence lists betrixaban as one of the direct factor Xa inhibitors, confirming that it inhibits factor Xa.", "retries": 1}
{"idx": 715, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that pridopidine was tested in the context of Huntington disease by referencing the study's objective to investigate metabolic changes before and after treatment.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "The supporting sentence is:\n\n\"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"\n\nThis sentence clearly states that pridopidine was tested on patients with Huntington disease, confirming its use in treating the disorder.", "retries": 1}
{"idx": 716, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by describing part of the biosynthesis of medicarpin, though it focuses more on a specific detail (methylation) rather than directly stating it as the major phytoalexin, making it slightly less concise compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence from the context that identifies medicarpin as the major phytoalexin in alfalfa is:\n\n\"The methyl group at the 9 position of medicarpin is generally accepted to arise via the methylation of the 4' position (B-ring) of daidzein.\"\n\nThis sentence highlights the biosynthesis pathway of medicarpin, indicating its role as a significant phytoalexin in alfalfa.", "retries": 1}
{"idx": 717, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer is correct and matches the gold standard. However, the supporting sentence provided by the model is not optimal. While it implies that betrixaban is a direct inhibitor of factor Xa by grouping it with other inhibitors, it does not explicitly state that betrixaban inhibits factor Xa. The gold supporting sentence is more direct and explicitly mentions that betrixaban is one of the inhibitors of factor Xa. Therefore, the model's supporting sentence could be more precise and relevant.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Edoxaban and betrixaban are also in development.\"\n\nThis sentence indicates that betrixaban is one of the direct inhibitors of factor Xa, confirming that it inhibits factor Xa.", "retries": 1}
{"idx": 718, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Betrixaban inhibits factor Xa' matches the gold standard 'xa'. However, the supporting sentence provided by the model is somewhat redundant and not as concise as it could be. While it does mention that betrixaban is a factor Xa inhibitor, it includes additional information about pharmacokinetic characteristics that is not directly necessary to support the answer. The gold supporting sentence is more direct and clearly identifies betrixaban as a factor Xa inhibitor without extra details.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is: \"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life.\" However, the context also mentions that betrixaban is part of the factor Xa inhibitors class, which directly supports the answer. \n\n**Supporting sentence:** \"The emergence of two new classes of orally administered anticoagulants, direct thrombin and factor Xa inhibitors have drastically changed the landscape in the management of these disease states.\" This indicates that betrixaban is a factor Xa inhibitor.", "retries": 1}
{"idx": 719, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer is correct and matches the gold standard ('upregulated'). However, the supporting sentence chosen by the model does not directly support the answer. The selected sentence discusses the unknown contributions of MALAT-1 to metastasis, which indirectly implies its involvement but does not explicitly state that MALAT-1 is upregulated. A more appropriate supporting sentence would have been the one indicating that 'Upregulated MALAT-1 contributes to bladder cancer cell migration.' The reasoning provided by the model is reasonable but could be more concise and directly tied to the evidence.\", \"match\": true}", "gold_answer": "upregulated", "gold_support": "Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.", "model_answer": "MALAT-1 is upregulated in cancer.", "model_support": "The supporting sentence from the context that indicates MALAT-1 is upregulated in cancer is:\n\n\"However, the contributions of MALAT-1 to bladder cancer metastasis remain largely unknown.\"\n\nThis implies that MALAT-1 plays a role in cancer metastasis, suggesting it is upregulated in cancer cells.", "retries": 1}
{"idx": 720, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and directly mentions DNMT1, but it is slightly less detailed compared to the gold supporting sentence, which explains the role of DMAP1 in activating DNMT1. The logic is sound, but there is minor redundancy in repeating the model's answer within its own supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "DNMT1", "gold_support": "DMAP1 is a potent activator of DNMT1 methylation in vitro, suggesting that DMAP1 is a co-repressor that supports the maintenance and de novo action of DNMT1.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1).", "model_support": "The enzyme involved in maintaining DNA (cytosine-5-)-methylation is DNA methyltransferase 1 (DNMT1). \n\n**Supporting Sentence:**  \n\"DMAP1, a DNMT1 interacting protein, was identified as a mediator of this process.\"", "retries": 1}
{"idx": 721, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model's supporting sentence mentions that the context does not explicitly mention p53, this is accurate because the context indeed lacks a direct statement. However, the gold supporting sentence provides the necessary information from the context that directly supports the answer. Given the instructions, the model answer and its logical correctness align perfectly with the gold standard.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The oncogenic potential of iPSCs is further underscored by the findings that the critical tumor suppressor p53, known as the guardian of the genome, suppresses induced pluripotency.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. However, the provided context does not mention p53 or any tumor suppressor by name. The answer is based on general knowledge that p53 is commonly known as \"the guardian of the genome\" due to its role in maintaining genomic stability and preventing cancer.\n\n**Answer:** The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\n**Supporting Sentence:** (The context does not provide a supporting sentence for this answer.)", "retries": 1}
{"idx": 722, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer, SOCS-1, is incorrect and does not match the gold standard, which is beta-TrCP. The supporting sentence provided by the model acknowledges that the context does not mention SOCS-1, making the answer unsupported and irrelevant. Additionally, the correct E3 ubiquitin ligase, beta-TrCP2, is clearly stated in the gold supporting sentence, which the model failed to identify. The supporting sentence is overly verbose and does not logically support the incorrect answer.\", \"match\": false}", "gold_answer": "beta-TrCP", "gold_support": "IFNalpha promotes the phosphorylation of IFNAR1 on Ser535, followed by recruitment of the E3 ubiquitin ligase, beta-TrCP2 (beta-transducin repeats-containing protein 2), ubiquitination of IFNAR1 and proteolysis.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is SOCS-1.", "model_support": "The context does not explicitly mention SOCS-1 as the E3 ubiquitin ligase involved in the ubiquitination and degradation of IFNAR1. It discusses the role of Tyk2 in promoting ligand-induced IFNAR1 proteolysis, including phosphorylation and ubiquitination, but does not specify the E3 ligase responsible. Therefore, the answer provided, which identifies SOCS-1, is not directly supported by the given context.\n\n**Supporting Sentence:**  \nThe context does not provide a supporting sentence for the identification of SOCS-1 as the E3 ubiquitin ligase involved in IFNAR1 degradation.", "retries": 1}
{"idx": 723, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is redundant because it repeats the answer rather than offering additional explanatory context. The gold supporting sentence provides more relevant and detailed information about PD-1 blockade and its effect on T-cell responses, making it more informative. Despite this, the model's supporting sentence still relates to the topic and is not incorrect, hence a score of 4.\",\n  \"match\": true\n}", "gold_answer": "PD-1", "gold_support": "PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine.", "model_answer": "The antibodies MK-3475 and CT-011 target the **PD-1 (programmed cell death protein 1)** protein.", "model_support": "The antibodies MK-3475 and CT-011 target the **PD-1 (programmed cell death protein 1)** protein.\n\n**Supporting sentence:** The PD1/PDL1 pathway is an important element contributing to tumor-mediated immune suppression.", "retries": 1}
{"idx": 724, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('template strand') does not match the gold standard ('transcribed strand'). While both terms relate to transcription, they are distinct: the template strand is the DNA strand used as a template for RNA synthesis, whereas the transcribed strand refers to the strand that has the same sequence as the produced RNA. The supporting sentence mentions repair of both strands but does not directly clarify or logically support the targeting of the transcribed strand by TCR. Although the context discusses repair in active genes, it does not specifically address the distinction between the transcribed and nontranscribed strands as the gold supporting sentence does.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "The proficient repair of the nontranscribed strand cannot be explained by the dedicated subpathway of transcription-coupled repair (TCR), which is targeted to the transcribed strand in expressed genes.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the template strand of actively transcribed genes. TCR focuses on this strand because it is the one being used by RNA polymerase II during transcription, allowing for efficient repair of lesions encountered during the transcription process.", "model_support": "The supporting sentence from the context is: \"Within active genes, however, both DNA strands continue to be proficiently repaired.\"\n\nThis sentence indicates that both strands of actively transcribed genes are repaired, which aligns with the understanding that transcription-coupled repair (TCR) specifically targets the template strand. The context supports the idea that efficient repair occurs in transcriptionally active regions, consistent with TCR's role in repairing lesions on the template strand during transcription.", "retries": 1}
{"idx": 725, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('RET') in essence, though it includes 'gene' which is not strictly necessary. The supporting sentence provided by the model repeats the answer rather than offering a concise and direct explanation as instructed. However, the context-provided supporting sentence correctly identifies the RET gene’s role in MEN2, aligning with the gold supporting sentence. Slight redundancy exists in the model's approach but overall logic and relevance are maintained.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "The susceptibility gene for MEN 2 is the RET proto-oncogene.", "model_answer": "The gene frequently mutated in Multiple Endocrine Neoplasia 2 (MEN2) and Hirschsprung disease is the **RET gene**.", "model_support": "The gene frequently mutated in Multiple Endocrine Neoplasia 2 (MEN2) and Hirschsprung disease is the **RET gene**.\n\n**Supporting sentence:**  \n\"In this series, there was one proven case of germline mutation in RET codon 620, which previously has been shown to be responsible for MEN 2, thus indicating heritable disease.\"", "retries": 1}
{"idx": 726, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('three') but is present in the broader context of virology knowledge. The supporting sentence provided by the model acknowledges that the context does not explicitly state the number of genera, which is accurate, but it fails to extract the relevant information from the gold supporting sentence that mentions 'two of the three genera.' Therefore, while the supporting sentence is relevant, it does not cover the gold answer.\", \"match\": false}", "gold_answer": "three", "gold_support": "Compounds were tested in cell-based assays against viruses representative of: i) two of the three genera of the Flaviviridae family, i.e.", "model_answer": "The Flaviviridae family comprises four genera: Flavivirus, Pestivirus, Hepacivirus, and Pegivirus. \n\nAnswer: Four.", "model_support": "The context does not explicitly state the number of genera within the Flaviviridae family. It only mentions Flavivirus as a genus within Flaviviridae, specifically referring to Yellow Fever Virus. Therefore, the supporting sentence provided does not answer the question, and the context does not contain enough information to determine the number of genera in the Flaviviridae family.", "retries": 1}
{"idx": 727, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer correctly identifies SERCA as the main calcium pump and specifies SERCA2a as the primary isoform in the heart, which is accurate but slightly more detailed than the gold answer. The supporting sentence is relevant and supports the answer well, though it contains minor redundancy by emphasizing 'mainly represented,' which could be more concise.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA, specifically the SERCA2a isoform in the heart.", "model_support": "The supporting sentence from the context that identifies the main calcium pump of the sarcoplasmic reticulum is:\n\n**\"SERCA is mainly represented by the SERCA2a isoform in the heart.\"**\n\nThis sentence directly states that SERCA2a is the primary isoform responsible for calcium pumping in the heart's sarcoplasmic reticulum.", "retries": 1}
{"idx": 728, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Betrixaban inhibits factor Xa' is correct and aligns with the gold standard 'xa,' but it is slightly more verbose than necessary. The supporting sentence discusses pharmacokinetic characteristics of betrixaban rather than directly stating that it is a factor Xa inhibitor, which makes it somewhat indirect and mixes relevant with less relevant content. While the logic connecting the model's supporting sentence to the answer is reasonable, it could be more concise and directly focused on the role of betrixaban as a factor Xa inhibitor.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life.\"\n\nThis sentence indicates that betrixaban is a factor Xa inhibitor, which is the clotting factor it inhibits.", "retries": 1}
{"idx": 729, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it provides the full name instead of the abbreviation. The supporting sentence is relevant and covers the correct disease but lacks depth compared to the gold supporting sentence. It does not mention the link to D4Z4 contractions, which offers a more complete explanation. The model's supporting sentence is slightly less informative but still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).\n\nSupporting sentence: \"DUX4c is up-regulated in FSHD.\"", "retries": 1}
{"idx": 730, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly ('naloxone'). The supporting sentence is relevant and supports the answer by referencing the recommendation for naloxone use in overdose situations. However, it contains slight redundancy by discussing peer administration, which is not central to the core reasoning behind why naloxone is used. The gold supporting sentence is more concise and directly explains naloxone's pharmacological action.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Naloxone hydrochloride, an injectable opioid antagonist which reverses the respiratory depression, sedation and hypotension associated with opioids, has long been used to treat opioid overdose.", "model_answer": "The medication that should be administered when managing patients with suspected acute opioid overdose is naloxone. Naloxone is an opioid antagonist that effectively reverses the effects of opioids, making it the standard treatment for acute overdose. It is particularly useful in emergency situations, including when administered by peers in the context of heroin use.", "model_support": "The supporting sentence from the context is:\n\n\"Experts have suggested that, as part of a comprehensive overdose prevention strategy, naloxone should be provided to heroin users for peer administration after an overdose.\"\n\nThis sentence directly supports the answer by explicitly stating that naloxone is recommended for peer administration to manage heroin overdoses.", "retries": 1}
{"idx": 731, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'epidermal growth factor (EGF)', does not match the gold standard 'EGFRvIII'. However, the answer is present in the context as EGF is related to EGFR. The supporting sentence mentions Rindopepimut targeting EGFRvIII but incorrectly infers that it is an analog of EGF rather than directly addressing EGFRvIII. The logic connecting the supporting sentence to the gold answer is weak, and the focus on EGF introduces some confusion.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "The epidermal growth factor receptor variant III (EGFRvIII) is a naturally occurring mutant of EGFR and is expressed on approximately 20% to 30% of GBMs.", "model_answer": "Rindopepimut is an analog of the epidermal growth factor (EGF).", "model_support": "The supporting sentence for the answer that Rindopepimut is an analog of the epidermal growth factor (EGF) can be inferred from the context as follows:\n\n\"Rindopepimut is an immunotherapeutic vaccine that targets the EGFRvIII receptor, which is a variant of the EGF receptor. Since EGF binds to the EGFR, Rindopepimut may act as an EGF analog to target this receptor.\"\n\nHowever, the context provided does not explicitly state this. The answer is based on the understanding that Rindopepimut targets the EGFRvIII receptor, which is related to the EGF receptor, suggesting a connection to EGF.", "retries": 1}
{"idx": 732, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although it refers to a broader meta-analysis, it still logically supports the specific focus on acute ischemic stroke as investigated in MR CLEAN.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The MR CLEAN study investigated the treatment of acute ischemic stroke.", "model_support": "The supporting sentence from the context is:\n\n\"A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.\"\n\nThis sentence indicates that the study, which includes MR CLEAN, investigates the treatment of acute ischemic stroke.", "retries": 1}
{"idx": 733, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard in meaning, but it is slightly more verbose than necessary. The supporting sentence references the glucocerebrosidase gene and provides relevant context, though it focuses on a specific detail (haplotype analysis) rather than directly stating that mutations in this gene cause Gaucher disease. This makes it somewhat less direct than the gold supporting sentence, but it still logically supports the answer.\", \"match\": true}", "gold_answer": "glucocerebrosidase", "gold_support": "Gaucher disease results, in most patients, from mutations in the gene encoding glucocerebrosidase.", "model_answer": "The gene mutated in Gaucher disease is the glucocerebrosidase gene.", "model_support": "The supporting sentence is: \"A common origin for the Spanish D409H alleles was ruled out by haplotype analysis using an internal polymorphism of the glucocerebrosidase gene and two external microsatellite markers.\"\n\nThis sentence mentions the glucocerebrosidase gene, which is the gene mutated in Gaucher disease.", "retries": 1}
{"idx": 734, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard (IL-1β), though it includes the full name 'interleukin-1β (IL-1β)' which is acceptable. The supporting sentence provided by the model is relevant but slightly redundant as it repeats the answer verbatim. The gold supporting sentence is more concise and directly introduces gevokizumab's role as an anti-IL-1β antibody. However, the logic in the model's supporting sentence is still strong and aligns with the context.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β).", "model_support": "The molecule targeted by the drug Gevokizumab is interleukin-1β (IL-1β).\n\n**Supporting sentence:** \"Previous data indicated that gevokizumab negatively modulates IL-1β signaling through an allosteric mechanism.\"", "retries": 1}
{"idx": 735, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('PLN') by identifying phospholamban (PLN) as the main regulatory molecule. The supporting sentence is relevant and covers the answer with logical reasoning, referencing the 'PLN/SERCA interactome' and PLN's central role in regulating SERCA2A. However, it includes slight redundancy by elaborating on additional regulators like I-1, Hsp20, HAX1, and HRC, which are not necessary to support the answer directly. This makes the sentence slightly more verbose than needed.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in cardiac muscle is phospholamban (PLN).", "model_support": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban (PLN). This is evident from the context's discussion of the \"PLN/SERCA interactome,\" which highlights PLN's central role in regulating SR calcium cycling and its interactions with SERCA2A. Other proteins mentioned, such as I-1, Hsp20, HAX1, and HRC, are additional regulators but not the primary one.\n\n**Answer:**  \nThe main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban (PLN). This is supported by the context discussing the \"PLN/SERCA interactome,\" emphasizing PLN's role in regulating SERCA2A and SR calcium cycling.", "retries": 1}
{"idx": 736, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a relevant context by mentioning 'Mammalian Target of Rapamycin,' which aligns well with the gold answer.\", \"match\": true}", "gold_answer": "mammalian Target of Rapamycin", "gold_support": "One class of agents that are highly effective in the prevention of in-stent restenosis is the mammalian Target of Rapamycin (mTOR) inhibitors.", "model_answer": "mTOR stands for Mammalian Target of Rapamycin.", "model_support": "Supporting sentence: Dysregulation of the Mammalian Target of Rapamycin and p27Kip1 Promotes Intimal Hyperplasia in Diabetes Mellitus.", "retries": 1}
{"idx": 737, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (10 nm). However, the supporting sentence is somewhat redundant and verbose, as it includes a disclaimer about the context not containing the information, which is unnecessary since the question asks for general knowledge. The gold supporting sentence is more concise and directly relevant. Despite this, the model's supporting sentence still logically supports the answer with correct information.\", \"match\": true}", "gold_answer": "10 nm", "gold_support": "Ultrastructurally, rhabdoid cells showed paranuclear aggregates and whorls of intermediate filaments with a 9-10 nm diameter.", "model_answer": "The average diameter of intermediate filaments is approximately 10 nanometers.", "model_support": "The context provided does not contain any information about the average diameter of intermediate filaments. Therefore, I cannot provide a supporting sentence from the context to answer this question. \n\nIf you are asking about general knowledge, intermediate filaments typically have an average diameter of approximately 10 nanometers, but this information is not supported by the provided context.", "retries": 1}
{"idx": 738, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model does not directly address the effectiveness of GPi stimulation in treating dystonia, as it merely mentions the targeting of both nuclei without highlighting the specific benefit of GPi. The gold supporting sentence is more precise in demonstrating the therapeutic effect of GPi stimulation. The model's supporting sentence is relevant but lacks the clarity and specificity of the gold standard.\", \"match\": true}", "gold_answer": "globus pallidus internus", "gold_support": "After bilateral stimulation of the GPi, the patient showed a clear and stable improvement of the painful dystonic syndrome within hours.", "model_answer": "The globus pallidus internus (GPi) is the nucleus used for neurostimulation in the treatment of dystonia.", "model_support": "Supporting sentence: After informed consent, a bilateral stereotactic electrode placement targeting the ventral intermediate thalamic nucleus (VIM) and the globus pallidus internus (GPi) was performed.", "retries": 1}
{"idx": 739, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides correct information about Clostridium botulinum being responsible for botulism, but it includes a slight redundancy by stating 'the context does not explicitly mention...' which is unnecessary since the answer can be directly inferred from general knowledge and the context provided. Overall, the logic is sound, but it could be more concise.\", \"match\": true}", "gold_answer": "Clostridium botulinum", "gold_support": "The botulinum neurotoxins (BoNTs) produced by different strains of the bacterium Clostridium botulinum are responsible for the disease botulism and include a group of immunologically distinct serotypes (A, B, E, and F) that are considered to be the most lethal natural proteins known for humans.", "model_answer": "Clostridium botulinum.", "model_support": "The context does not explicitly mention the bacterium responsible for botulism. However, based on general knowledge, the most known bacterium responsible for botulism (sausage poisoning) is **Clostridium botulinum**.", "retries": 1}
{"idx": 740, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' is very close to the gold standard 'benzothiazepine' but includes additional specificity ('1,4-') that is not present in the gold answer. The supporting sentence is relevant and supports the answer well, though it introduces extra details like 'multi-channel blocker' and specifics about RyR2s and SR Ca²⁺ leak, which are not necessary for directly supporting the answer. This makes the supporting sentence slightly more verbose than needed.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "K201 (JTV519), a benzothiazepine derivative, has been shown to possess anti-arrhythmic and cardioprotective properties, but the mechanism of its action is both complex and controversial.", "model_answer": "The drug JTV519 is derived from the group of chemical compounds known as 1,4-benzothiazepines.\n\nAnswer: 1,4-benzothiazepine", "model_support": "Supporting sentence: In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.", "retries": 1}
{"idx": 741, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer and is overly concise without logical alignment with the broader context provided in the gold supporting sentence.\", \"match\": false}", "gold_answer": "more than 30", "gold_support": "Large genome-wide association studies (GWAS) have identified more than 30 loci involved in RA pathogenesis.", "model_answer": "The number of genes outside the MHC locus associated with Rheumatoid Arthritis through GWAS is 8.", "model_support": "The number of genes outside the MHC locus associated with Rheumatoid Arthritis through GWAS is 8.\n\nSupporting sentence: \"The most relevant non-HLA gene single nucleotide polymorphisms (SNPs) associated with RA include PTPN22, IL23R, TRAF1, CTLA4, IRF5, STAT4, CCR6, PADI4.\"", "retries": 1}
{"idx": 742, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'Facioscapulohumeral muscular dystrophy (FSHD),' matches the gold standard 'FSHD' and is correct. The supporting sentence provided by the model is relevant and directly links DUX4 to FSHD pathogenesis, which aligns with the context. However, it contains slight redundancy by mentioning 'it is unclear how,' which adds unnecessary information that does not contribute to the core explanation. Overall, the logic is strong but could be more concise.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "BACKGROUND: Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contraction of an array of tandem 3.3-kb repeats (D4Z4) at 4q35.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The supporting sentence is:\n\n\"A DUX4 transcript derived from the last repeat unit in a contracted array is associated with pathogenesis but it is unclear how.\"\n\nThis sentence directly links the DUX4 transcript to the pathogenesis of FSHD, indicating the disease's association with the ectopic expression of the DUX4 protein.", "retries": 1}
{"idx": 743, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'immunoaffinity enrichment,' is very close to the gold standard 'immunoaffinity purification,' with both referring to the same general technique using antibodies for peptide enrichment. The supporting sentence provided by the model is relevant and supports the answer, but it is slightly redundant as it repeats the answer itself rather than providing richer context like the gold supporting sentence. Minor improvements in conciseness and alignment with the gold supporting sentence's detail could have warranted a score of 5.\", \"match\": true}", "gold_answer": "immunoaffinity purification", "gold_support": "These antibodies were used to perform immunoaffinity purification of methyl peptides followed by LC-MS/MS analysis to identify and quantify arginine and lysine methylation sites in several model studies.", "model_answer": "The method used for enrichment of arginine-methylated peptides is immunoaffinity enrichment. \n\nAnswer: Immunoaffinity enrichment.", "model_support": "The method used for enrichment of arginine-methylated peptides is immunoaffinity enrichment. \n\nSupporting sentence: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.", "retries": 1}
{"idx": 744, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (beta-TrCP vs. beta-Trcp, which are equivalent notations). The supporting sentence is concise, directly relevant, and logically explains that beta-TrCP is an E3 ubiquitin ligase known for targeting phosphorylated proteins like IFNAR1, aligning with the context provided.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Both ligand-dependent and -independent pathways converge on phosphorylation of Ser(535) within the IFNAR1 degron leading to recruitment of beta-Trcp E3 ubiquitin ligase and concomitant ubiquitination and degradation.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is beta-TrCP.\n\nAnswer: beta-TrCP", "model_support": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is beta-TrCP. \n\nAnswer: beta-TrCP\n\nSupporting sentence: The context discusses the phosphorylation of IFNAR1 leading to ubiquitination and degradation, processes commonly mediated by beta-TrCP, an E3 ubiquitin ligase known for targeting phosphorylated proteins.", "retries": 1}
{"idx": 745, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'kinase enzyme,' is correct but overly general and does not match the specificity of the gold answer, 'nonreceptor tyrosine kinase.' The supporting sentence mentions ABL kinases in solid tumors but does not directly confirm or elaborate on the specific type of kinase encoded by ABL1. While relevant, it lacks the precision needed to fully support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "nonreceptor tyrosine kinase", "gold_support": "The Abelson (ABL) family of nonreceptor tyrosine kinases, ABL1 and ABL2, transduces diverse extracellular signals to protein networks that control proliferation, survival, migration and invasion.", "model_answer": "The proto-oncogene ABL1 encodes a kinase enzyme.", "model_support": "The proto-oncogene ABL1 encodes a kinase enzyme.\n\n**Supporting sentence:** \"Recent reports have uncovered roles for ABL kinases in solid tumours.\" This sentence indicates that ABL1 is associated with kinases, confirming the enzyme type it encodes.", "retries": 1}
{"idx": 746, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('NCX'). The supporting sentence is concise, directly relevant, and clearly explains that SEA0400 inhibits the NCX current, aligning perfectly with the gold supporting sentence. There is no unnecessary verbosity or irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "The effects of 2-[4-[(2,5-difluorophenyl) methoxy]phenoxy]-5-ethoxyaniline (SEA0400), a newly synthesized Na(+)-Ca(2+) exchanger (NCX) inhibitor, on the NCX current and other membrane currents were examined in isolated guinea-pig ventricular myocytes and compared with those of 2-[2-[4-(4-nitrobenzyloxy) phenyl]ethyl]isothiourea (KB-R7943).", "model_answer": "The small molecule SEA0400 is an inhibitor of the sodium-calcium exchanger (NCX).", "model_support": "The supporting sentence from the context is:\n\n\"SEA0400 concentration-dependently inhibited the NCX current with a 10 fold higher potency than that of KB-R7943; 1 microM SEA0400 and 10 microM KB-R7943 inhibited the NCX current by more than 80%.\"\n\nThis sentence clearly states that SEA0400 inhibits the sodium-calcium exchanger (NCX).", "retries": 1}
{"idx": 747, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and accurate but slightly less detailed compared to the gold supporting sentence, which explicitly mentions the immunohistochemical identification of cortical Lewy bodies with alpha-synuclein-specific antibodies. The model's supporting sentence refers to the importance of alpha-synuclein in cortical Lewy bodies but does not directly state the use of specific antibodies, making it slightly less comprehensive.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In addition, CLBs and dystrophic neurites were identified immunohistochemically with antibodies specific for alpha-synuclein and ubiquitin; plaques and tangles were identified by staining with thioflavine S.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nAnswer: Alpha-synuclein", "model_support": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein. \n\nSupporting sentence: \"Recent advances in immunostaining of alpha-synuclein have suggested the possible importance of cortical Lewy bodies (CLBs) in the brains of demented patients with PD.\"", "retries": 1}
{"idx": 748, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence repeats the answer rather than providing concise, logical reasoning from the context. The gold supporting sentence is more informative and directly explains why alpha-synuclein is relevant to Lewy bodies. The model's supporting sentence is relevant but lacks depth and originality.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The precursor of the non-Abeta component of Alzheimer's disease amyloid (NACP) (also known as alpha-synuclein) is a presynaptic terminal molecule that abnormally accumulates in the plaques of Alzheimer's disease (AD) and in the Lewy bodies (LBs) of Lewy body variant of AD, diffuse Lewy body disease, and Parkinson's disease.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.", "model_support": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.\n\nSupporting sentence: Furthermore, formic acid pretreatment revealed an extensive anti-NAC immunostaining of LBs, plaques, and glial cells.", "retries": 1}
{"idx": 749, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard (15), but the supporting sentence is somewhat flawed. It incorrectly states that the context does not provide the number of tissue kallikrein genes, when in fact the context explicitly mentions '15 genes tandemly arranged on human chromosome 19q13.4.' Despite this, the logic connecting the answer to the context is reasonable, though it could be more precise.\", \"match\": true}", "gold_answer": "15", "gold_support": "The tissue kallikrein gene family consists of 15 genes tandemly arranged on human chromosome 19q13.4.", "model_answer": "The human genome contains 15 kallikrein-related peptidase genes, with KLK1 being the tissue kallikrein. \n\nAnswer: 15", "model_support": "The context provided does not explicitly mention the number of tissue kallikrein genes in the human genome. It discusses the aberrant expression of kallikreins in cancers and their potential as biomarkers, but it does not provide the specific count of 15 kallikrein-related peptidase genes. Therefore, there is no supporting sentence within the context to confirm the number 15.\n\nAnswer: The context does not provide the number of tissue kallikrein genes in the human genome.", "retries": 1}
{"idx": 750, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, correctly identifying the Na(+)/Ca(2+) exchanger as the target of SEA0400. However, the supporting sentence is relevant but contains slight redundancy by discussing the experimental design rather than directly focusing on the inhibitory action of SEA0400 on the Na(+)/Ca(2+) exchanger. A more concise and direct supporting sentence could have been chosen.\",\n  \"match\": true\n}", "gold_answer": "Na(+)/Ca(2+) exchanger", "gold_support": "SEA0400 is a selective inhibitor of the Na(+)/Ca(2+) exchanger having equal potencies to suppress both the forward and reverse mode operation of the Na(+)/Ca(2+) exchanger.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na(+)/Ca(2+) antiporter/exchanger.", "model_support": "Supporting sentence: Present experiments were designed to study the effect of partial blockade of Na(+)/Ca(2+) exchanger on Ca(2+) handling in isolated rat ventricular myocytes.", "retries": 1}
{"idx": 751, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' is the abbreviation for 'factor Xa'). The supporting sentence is relevant and covers the answer logically by referencing that betrixaban belongs to the class of direct factor Xa inhibitors. However, it contains slight redundancy by discussing the coagulation cascade and other details not directly needed to support the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa", "model_support": "The supporting sentence from the context is:\n\n\"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\"\n\nThis sentence establishes that betrixaban, as part of the direct factor Xa inhibitors class, inhibits factor Xa.", "retries": 1}
{"idx": 752, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'XIST RNA' is equivalent to the gold answer 'Xist,' as both refer to the same transcript. However, the supporting sentence chosen by the model is less precise compared to the gold supporting sentence. The model's supporting sentence mentions the 'Xist network' but does not directly explain that XIST RNA is responsible for X-chromosome inactivation. It adds some ambiguity by referring to protein interactions without clearly linking them to XIST’s role in silencing. Despite this, the logic connecting the answer and supporting sentence is still present, just with slight redundancy.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The transcriptional silencing of one of the female X-chromosomes is a finely regulated process that requires accumulation in cis of the long non-coding RNA X-inactive-specific transcript (Xist) followed by a series of epigenetic modifications.", "model_answer": "The transcript responsible for X-chromosome inactivation is XIST RNA.", "model_support": "The supporting sentence from the context is:\n\n\"X-inactivation: quantitative predictions of protein interactions in the Xist network.\"\n\nThis sentence refers to the Xist network, which is centered around XIST RNA, the transcript responsible for X-chromosome inactivation.", "retries": 1}
{"idx": 753, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer correctly identifies BACH1 as a repressor, matching the gold standard. The supporting sentence is relevant and explains the repressive function of BACH1 with additional context about heme-induced regulation, which is logical but slightly more verbose than necessary. The gold supporting sentence is more concise while still covering the essential point.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the enhancers of heme oxygenase-1 (HO-1) gene (Hmox-1) by forming heterodimers with the small Maf proteins such as MafK.", "model_answer": "BACH1 is a transcriptional repressor. It represses the transcription of Hmox-1 until heme inhibits its binding to enhancers, leading to its nuclear export and the subsequent activation of Hmox-1 expression.", "model_support": "BACH1 is a transcriptional repressor. It represses the transcription of Hmox-1 until heme inhibits its binding to enhancers, leading to its nuclear export and the subsequent activation of Hmox-1 expression.\n\n**Supporting Sentence:**  \n\"Heme induces expression of Hmox-1 in part by inhibiting the binding of Bach1 to the enhancers and inducing the nuclear export of Bach1.\"", "retries": 1}
{"idx": 754, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly, identifying 'phospholamban (PLN)' as the correct regulatory molecule. The supporting sentence provided by the model is relevant and highlights PLN's role in regulating SERCA2A function, but it contains slight redundancy by emphasizing broader impacts such as survival and remodeling, which are not directly necessary to support the answer. The gold supporting sentence is more concise and directly tied to the regulation of SERCA2A by PLN.\",\n  \"match\": true\n}", "gold_answer": "phospholamban", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban (PLN).", "model_support": "The supporting sentence that identifies phospholamban (PLN) as the main regulatory molecule of SERCA2A function in the cardiac muscle is:\n\n\"regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.\"\n\nThis sentence highlights PLN's central role in regulating SERCA function, emphasizing its impact on critical cardiac processes.", "retries": 1}
{"idx": 755, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information and covers the answer logically, though it is slightly more verbose than necessary. It explains the class of inhibitors but does not directly quote the most concise evidence from the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "Betrixaban inhibits factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation, partly because of its location in the coagulation cascade.\" \n\nThis sentence establishes that direct factor Xa inhibitors, including betrixaban, inhibit factor Xa.", "retries": 1}
{"idx": 756, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('ABL tyrosine kinase') is related but does not exactly match the gold standard ('bcr-abl'). The supporting sentence is relevant but fails to explicitly mention the fusion gene 'bcr-abl,' which is critical to fully addressing the question. While the logic connecting imatinib to ABL kinase is present, it lacks precision in identifying the specific target as the fusion protein.\", \"match\": false}", "gold_answer": "bcr-abl", "gold_support": "Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia chromosome, which is associated with a balanced translocation involving chromosomes 9 and 22 to produce a fusion gene (bcr-abl) that gives rise to a constitutively activated Abl tyrosine kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the ABL tyrosine kinase. \n\nAnswer: ABL tyrosine kinase", "model_support": "The supporting sentence from the context is:\n\n\"This kinase led to the discovery of several small-molecule inhibitors, imatinib being the first and most successful of these.\"\n\nThis sentence indicates that imatinib is an inhibitor of the ABL kinase, which is the target in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 757, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard (5-HT(2A) receptors is equivalent to 5-HT2A). The supporting sentence is relevant and provides logical support by referencing the displacement studies specific to 5-HT(2A) receptors. However, it contains slight redundancy by elaborating on cerebellum details not critical for directly supporting the answer.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.", "model_answer": "The receptors that can be evaluated with [18F]altanserin are the 5-HT(2A) receptors.\n\nAnswer: 5-HT(2A) receptors", "model_support": "The supporting sentence that indicates [18F]altanserin evaluates 5-HT(2A) receptors is:\n\n\"To represent free and nonspecifically bound [18F]altanserin and its radiolabeled metabolites only, cerebellum must show no displacement in 5-HT(2A) displacement studies.\"\n\nThis sentence highlights the use of [18F]altanserin in evaluating 5-HT(2A) receptors through displacement studies in the cerebellum.", "retries": 1}
{"idx": 758, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly indirect and lacks explicit mention of medulloblastoma being the 'most common' pediatric cerebellar tumor, which is present in the gold supporting sentence. The chosen sentence introduces medulloblastoma but does not fully capture its prevalence as clearly as the gold supporting sentence. Minor redundancy exists in relying on general knowledge rather than precise context.\",\n  \"match\": true\n}", "gold_answer": "Medulloblastoma", "gold_support": "Medulloblastoma (MB) is the most common malignant pediatric brain tumor which is thought to originate from cerebellar granule cell precursors (CGNPs) that fail to properly exit the cell cycle and differentiate.", "model_answer": "The most common type of pediatric cerebellar tumor is medulloblastoma.", "model_support": "The supporting sentence from the context that introduces medulloblastoma as the subject, thereby implicitly acknowledging its significance as a common pediatric cerebellar tumor, is:\n\n\"The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma.\"\n\nAlthough the context does not explicitly state that medulloblastoma is the most common, the discussion centers on it, aligning with general medical knowledge that it is the most common pediatric cerebellar tumor.", "retries": 1}
{"idx": 759, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. The drug Gevokizumab targets IL-1β, not the IL-1 receptor type I (IL-1RI). However, the supporting sentence provided by the model is relevant as it explains that gevokizumab decreases the binding affinity of IL-1β for IL-1RI, which indirectly supports the mechanism of action. Despite this, the supporting sentence does not directly cover the gold answer (IL-1β), leading to a lower score.\",\n  \"match\": false\n}", "gold_answer": "IL-1β", "gold_support": "Detailed mechanistic analysis of gevokizumab, an allosteric anti-IL-1β antibody with differential receptor-modulating properties.", "model_answer": "Gevokizumab targets the IL-1 receptor type I (IL-1RI).", "model_support": "The molecule targeted by Gevokizumab is the IL-1 receptor type I (IL-1RI). \n\n**Supporting sentence:** \"Schild analysis and surface plasmon resonance studies demonstrated that gevokizumab decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor, but not the IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).\"", "retries": 1}
{"idx": 760, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it repeats the answer itself rather than providing additional context or explanation like the gold supporting sentence. While correct, it lacks the extra detail about the preferential inhibition of 17,20-lyase found in the gold supporting sentence, making it slightly less informative.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "The enzyme inhibited by Orteronel is CYP17A1.", "model_support": "The enzyme inhibited by Orteronel is CYP17A1.\n\n**Supporting sentence:**  \n\"Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity.\"", "retries": 1}
{"idx": 761, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('spleen tyrosine kinase') in meaning, though it includes the full name of the enzyme which is slightly more verbose than necessary. The supporting sentence provided by the model is relevant but contains redundancy by repeating 'the spleen tyrosine kinase (Syk) enzyme,' making it less concise than the gold supporting sentence. Overall, the logic and relevance are strong, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "spleen tyrosine kinase", "gold_support": "The spleen tyrosine kinase (Syk) inhibitor R406 is orally administered as the prodrug R788.", "model_answer": "Fostamatinib inhibits the spleen tyrosine kinase (Syk) enzyme.", "model_support": "The enzyme inhibited by fostamatinib is the spleen tyrosine kinase (Syk) enzyme.\n\n**Supporting sentence:**  \n\"The metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey.\"", "retries": 1}
{"idx": 762, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'ZEB2' is correct and matches the gold standard 'zfhx1b' as ZEB2 is another name for zfhx1b. However, the supporting sentence includes additional information ('also known as Zfhx1b') which is redundant since the question asks for the gene name and not its alternative names. The logic is clear but slightly verbose.\", \"match\": true}", "gold_answer": "zfhx1b", "gold_support": "BACKGROUND: zfhz1b is the causative gene for Mowat-Wilson syndrome, in which patients demonstrate developmental delay and Hirschsprung disease, as well as other anomalies.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZEB2, also known as Zfhx1b. \n\nSupporting sentence: We identified a patient with Mowat-Wilson syndrome who also developed cholestasis and histopathologic features consistent with biliary atresia, suggesting that mutations involving zfhz1b may lead to biliary developmental anomalies or injury to the biliary tract.", "retries": 1}
{"idx": 763, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with a minor difference in specificity that does not affect correctness. The supporting sentence is concise, directly relevant, and logically supports the answer by mentioning the stabilization of the RyR1-FKBP12 complex by the 1,4-benzothiazepine derivative S107.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "The 1,4-benzothiazepine derivative JTV519, and the more specific derivative S107 (2,3,4,5,-tetrahydro-7-methoxy-4-methyl-1,4-benzothiazepine), are thought to improve skeletal muscle function by stabilizing the RyR1-FKBP12 complex.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "Supporting sentence: \"Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.\"", "retries": 1}
{"idx": 764, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard ('xa' refers to factor Xa). The supporting sentence provides relevant information and logically supports the answer, but it includes slight redundancy by mentioning other drugs like rivaroxaban and apixaban, which are not directly necessary for the explanation. This makes the sentence slightly more verbose than needed.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "rivaroxaban, apixaban, edoxaban, betrixaban, YM150).", "model_answer": "Betrixaban inhibits factor Xa in the coagulation process.", "model_support": "The supporting sentence from the context that indicates betrixaban inhibits factor Xa is:\n\n\"Most are small synthetic molecules that target thrombin (e.g. dabigatran etexilate) or factor Xa (e.g. betrixaban).\"", "retries": 1}
{"idx": 765, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate context for tofacitinib as a JAK inhibitor studied for rheumatoid arthritis treatment, but it is slightly more verbose than necessary. While it logically supports the answer, it includes additional details that are not essential for identifying the drug.\",\n  \"match\": true\n}", "gold_answer": "tofacitinib", "gold_support": "A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis, as indicated by the study, is tofacitinib.\n\nAnswer: Tofacitinib", "model_support": "The supporting sentence from the context that identifies tofacitinib as the JAK inhibitor under study is:\n\n\"To compare the efficacy, safety, and tolerability of 6 dosages of oral tofacitinib (CP-690,550) with placebo for the treatment of active rheumatoid arthritis (RA) in patients receiving a stable background regimen of methotrexate (MTX) who have an inadequate response to MTX monotherapy.\"\n\nThis sentence introduces tofacitinib as the drug being evaluated in the study, supporting the conclusion that it is a JAK inhibitor considered for RA treatment.", "retries": 1}
{"idx": 766, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer ('S-adenosylmethionine (SAMe)') is correct and aligns with the gold standard ('SAM'), as SAMe is the full form of SAM. However, the supporting sentence provided by the model is relevant but somewhat verbose and does not directly focus on SAMe’s role as a methyl donor, which is more explicitly captured in the gold supporting sentence. The logic is sound, but the supporting sentence could be more concise.\",\n  \"match\": true\n}", "gold_answer": "SAM", "gold_support": "While SAMe is a methyl donor, MTA is an inhibitor of methylation.", "model_answer": "The methyl donor for histone methyltransferases in this context is S-adenosylmethionine (SAMe).", "model_support": "The supporting sentence from the context is:\n\n\"S-adenosylmethionine (SAMe) and its metabolite methylthioadenosine (MTA) blocked lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNFalpha) expression in RAW (murine macrophage cell line) and Kupffer cells at the transcriptional level without affecting nuclear factor kappa B nuclear binding.\"\n\nThis sentence introduces SAMe as a compound involved in modulating gene expression, supporting the conclusion that SAMe acts as a methyl donor in histone methylation processes.", "retries": 1}
{"idx": 767, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Multiple') in meaning, though it is phrased differently. The supporting sentence provides relevant information and logically supports the answer by referencing recent studies confirming multiple origins of replication. However, the supporting sentence is slightly verbose and could be more concise to directly align with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Multiple", "gold_support": "Multiple origins of replication in archaea.", "model_answer": "Archaeal genomes can contain multiple origins of replication.", "model_support": "The supporting sentence is:  \n\"Although several in silico analyses have suggested that some archaeal species might contain more than one origin, this has only been demonstrated recently.\"  \nThis sentence indicates that while initial analyses suggested the possibility, recent studies have confirmed that archaeal genomes can have multiple origins of replication.", "retries": 1}
{"idx": 768, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Epidermal Growth Factor (EGF),' does not match the gold standard, 'EGFRvIII.' However, the context mentions EGFRvIII, which is the correct target of rindopepimut. The supporting sentence provided by the model repeats the incorrect answer and does not cover the gold answer or provide relevant reasoning. While the answer is present in the context, it is incorrect, and the supporting sentence fails to support the gold answer.\", \"match\": false}", "gold_answer": "EGFRvIII", "gold_support": "Rindopepimut specifically targets a novel junctional epitope of the EGFR deletion mutant EGFRvIII, which is a constitutively active receptor that is expressed in approximately 60 to 70% of patients with GBM.", "model_answer": "Rindopepimut is an analog of Epidermal Growth Factor (EGF).", "model_support": "Rindopepimut is an analog of Epidermal Growth Factor (EGF). \n\nSupporting sentence: \"Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.\"", "retries": 1}
{"idx": 769, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa'), though it is presented as 'factor Xa' instead of just 'xa'. The supporting sentence provides relevant information and logically supports the answer by linking betrixaban to being a direct inhibitor of factor Xa. However, it includes additional details about other drugs (rivaroxaban, apixaban) that are not necessary for directly supporting the answer, making it slightly verbose.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is: \"Rivaroxaban and apixaban are efficacious and safe in the prevention of cerebral infarcts in patients with non-valvular fibrillation. Apixaban is another direct inhibitor of factor Xa used orally which is developed in the same indications as rivaroxaban. Edoxaban and betrixaban are also in development.\" This sentence implies that betrixaban, along with edoxaban, is a direct inhibitor of factor Xa, similar to rivaroxaban and apixaban.", "retries": 1}
{"idx": 770, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate information about a mutation in the XK gene associated with McLeod syndrome, but it introduces specific details (e.g., IVS1-1G>A) not present in the gold supporting sentence, adding slight redundancy. However, the logic connecting the answer to the supporting sentence remains strong.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "McLeod syndrome is caused by mutations in the XK gene whose product is expressed at the red blood cell (RBC) surface but whose function is currently unknown.", "model_answer": "The gene mutation associated with McLeod syndrome is the **XK** gene.", "model_support": "**Supporting sentence:**  \n\"A novel XK splice site mutation (IVS1-1G>A) has been identified in a McLeod patient who has developed hematologic, neuromuscular, and neurologic symptoms.\"", "retries": 1}
{"idx": 771, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and provides logical reasoning by linking experimental autoimmune encephalomyelitis (EAE) to its role as the most widely used animal model for studying multiple sclerosis (MS). Although the supporting sentence contains additional details about cyclophilin D, this does not detract from the clarity or relevance of the explanation.\", \"match\": true}", "gold_answer": "experimental autoimmune encephalomyelitis (EAE)", "gold_support": "Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.", "model_answer": "The most widely used model for the study of multiple sclerosis (MS) is experimental autoimmune encephalomyelitis (EAE).", "model_support": "Supporting sentence: In a murine disease model, experimental autoimmune encephalomyelitis (EAE) mice lacking cyclophilin D (CyPD), a key regulator of the mitochondrial permeability transition pore (PTP), developed EAE, but unlike WT mice, they partially recovered.", "retries": 1}
{"idx": 772, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('5-HT2A'). The supporting sentence is concise, directly relevant, and logically explains that [18F]altanserin is used to evaluate the 5-HT2A receptor, aligning perfectly with the context provided. Minor redundancy in reiterating the answer is acceptable given the clarity and correctness of the logic.\", \"match\": true}", "gold_answer": "5-HT2A", "gold_support": "We investigated 94 healthy individuals (60 men, mean age 47.0±18.7, range 23-86) to determine if trait aggression and trait impulsivity were related to frontal cortex 5-HT2A receptor binding (5-HT2AR) as measured with [18F]-altanserin PET imaging.", "model_answer": "The receptor that can be evaluated with [18F]altanserin is the 5-HT2A receptor.", "model_support": "The receptor that can be evaluated with [18F]altanserin is the 5-HT2A receptor.\n\n**Supporting sentence:** The study discusses the 5-HT2A receptor and its potential role in trait aggression and impulsivity, which is consistent with the known use of [18F]altanserin as a radiotracer for imaging this receptor.", "retries": 1}
{"idx": 773, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('nuclear'), but the supporting sentence is incorrect. The context does explicitly mention that 'APOBEC3B appeared predominantly nuclear,' which directly supports the gold answer. However, the model incorrectly claims that there is no supporting information in the context. The evaluation of the supporting sentence reduces the score despite the correct answer.\", \"match\": true}", "gold_answer": "nuclear", "gold_support": "The mechanism of L1 inhibition did not correlate with an obvious subcellular protein distribution as APOBEC3B appeared predominantly nuclear and APOBEC3F was mostly cytosolic.", "model_answer": "The APOBEC3B protein is predominantly nuclear.", "model_support": "The context does not explicitly provide information about the localization of APOBEC3B as predominantly cytoplasmic or nuclear. Therefore, there is no supporting sentence within the provided context to confirm the answer.", "retries": 1}
{"idx": 774, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it repeats the same information as the answer, making it slightly redundant. The logic is strong, but conciseness could be improved by avoiding repetition.\",\n  \"match\": true\n}", "gold_answer": "naloxone", "gold_support": "Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose.", "model_answer": "The medication to administer when managing patients with suspected acute opioid overdose is naloxone.", "model_support": "The medication to administer when managing patients with suspected acute opioid overdose is naloxone.\n\n**Supporting Sentence:**  \nThe study involved comparing naloxone administered intravenously (i.v.) and subcutaneously (s.q.) in patients with suspected opioid overdose, concluding no significant difference in effectiveness between the two routes.", "retries": 1}
{"idx": 775, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and logically explains that betrixaban belongs to a class of anticoagulants known to inhibit factor Xa, which aligns with the context. There are no unnecessary details or verbosity.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Apixaban, rivaroxaban, endoxaban, and betrixaban are specific direct inhibitors of factor Xa, while dabigatran inhibits factor IIa.", "model_answer": "Betrixaban inhibits **factor Xa**.", "model_support": "The answer is that betrixaban inhibits **factor Xa**. While the context doesn't explicitly state this, betrixaban is part of a class of new oral anticoagulants known to target factor Xa, making this inference reasonable.", "retries": 1}
{"idx": 776, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('thyroid'), though it provides additional details about impaired iodide transport, goiter, and potential hypothyroidism. While this does not detract from the accuracy, it adds more information than required. The supporting sentence is relevant but contains slight redundancy by mentioning the PDS gene's mapping and function rather than focusing directly on thyroid abnormalities as the gold supporting sentence does. Overall, the logic is sound, but the response could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome is a recessive inherited disorder that consists of developmental abnormalities of the cochlea, sensorineural hearing loss, and diffuse thyroid enlargement (goiter).", "model_answer": "The characteristic hormone abnormality in Pendred syndrome is related to the thyroid, specifically involving impaired iodide transport leading to goiter and potential hypothyroidism.", "model_support": "The supporting sentence in the context is:\n\n\"The disease gene (PDS) has been mapped to chromosome 7q22-q31, and encodes a chloride-iodide transport protein.\"\n\nThis sentence indicates that the PDS gene is responsible for encoding a protein involved in transporting chloride and iodide, which relates to thyroid function and abnormalities in Pendred syndrome.", "retries": 1}
{"idx": 777, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence relies on external knowledge rather than directly citing the concise and relevant information available in the context provided. While the logic is strong and accurate, it introduces unnecessary verbosity by mentioning that the context does not explicitly state the target, which slightly reduces clarity and conciseness.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "As a result of this translocation, a novel fusion gene, BCR-ABL, is created on Philadelphia (Ph) chromosome, and the constitutive activity of the BCR-ABL protein tyrosine kinase plays a critical role in the disease pathogenesis.", "model_answer": "The target of Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase.\n\nAnswer: BCR-ABL", "model_support": "The context provided does not explicitly mention that Imatinib targets the BCR-ABL tyrosine kinase. However, based on external knowledge, Imatinib is known to target the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia (CML). The context discusses the effectiveness of Imatinib in treating CML and its impact on response rates and survival but does not specify the molecular target.\n\n**Answer:** BCR-ABL\n\n**Supporting Sentence:** While the context does not explicitly state that Imatinib targets the BCR-ABL tyrosine kinase, it is a well-established fact from external knowledge that Imatinib inhibits the BCR-ABL protein, which is the product of the Philadelphia chromosome.", "retries": 1}
{"idx": 778, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer mentions specific thyroid hormones (T4 and T3), which are more detailed than the gold answer 'thyroid.' While this is not incorrect, it does not match the gold standard exactly. The supporting sentence provided by the model discusses molecular aspects of transporters but does not directly connect to the altered hormone concentrations in Allan-Herndon-Dudley syndrome. It is relevant to the context but fails to cover the gold answer clearly or concisely.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "With the discovery of monocarboxylate transporter 8 (MCT8) as a specific thyroid hormone transporter and the finding that mutations in this transporter lead to a syndrome of severe psychomotor retardation and elevated serum 3,3',5-tri-iodothyronine levels known as the Allan-Herndon-Dudley syndrome, the interest in this area of research has greatly increased.", "model_answer": "In patients with Allan-Herndon-Dudley syndrome, the concentrations of thyroxine (T4) and triiodothyronine (T3) are elevated in the serum. This occurs due to impaired transport of these hormones into the brain and other tissues by the defective MCT8 transporter, leading to their accumulation in the bloodstream.", "model_support": "The supporting sentence is: \"In this review, we will focus on the molecular aspects of thyroid hormone transporters, including MCT8, MCT10, organic anion transporting polypeptides, and the effects of genetic variation in these transporters.\"\n\nThis sentence highlights the role of MCT8 in thyroid hormone transport and the impact of genetic variations, which is central to understanding why Allan–Herndon–Dudley syndrome leads to elevated thyroid hormone levels in the serum.", "retries": 1}
{"idx": 779, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, '1,4-benzothiazepine,' is very close to the gold standard 'benzothiazepine' but includes additional specificity ('1,4-') that is not strictly necessary based on the gold answer. The supporting sentence is relevant and accurate, directly linking JTV519 to the 1,4-benzothiazepine group, though it contains slight redundancy by repeating the term 'derivative.' Overall, the logic is strong, and the information supports the answer well.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "A newly synthesized 1,4-benzothiazipine derivate, 4-[3-(4-benzylpiperidin-1-yl) propionyl]-7-methoxy-2,3,4,5-tetrahydro-1, 4-benzothiazepine monohydrochloride (JTV-519) was examined for its ability to reverse P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP1) mediated multidrug resistance (MDR) in K562/MDR and KB/MRP cells, respectively.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\n**Supporting Sentence:**  \n\"Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazepine derivative, JTV-519.\"", "retries": 1}
{"idx": 780, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**. This nickname highlights its crucial role in maintaining genomic stability by regulating cell cycle arrest, DNA repair, and apoptosis.", "model_support": "The supporting sentence is:\n\n\"The p53 tumor suppressor protein is often referred to as the 'guardian of the genome' since its response to DNA-damage or checkpoint failure gives rise to a series of anti-proliferative responses.\"", "retries": 1}
{"idx": 781, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct and matches the gold standard conceptually (factor Xa), though it uses a slightly different format ('factor Xa' vs. 'xa'). The supporting sentence provided by the model does not directly support the answer, as it focuses on pharmacokinetic properties rather than explicitly stating that betrixaban inhibits factor Xa. While the context allows for an inference, the sentence chosen lacks direct relevance and includes unnecessary details about pharmacokinetics. A more concise and relevant supporting sentence would have improved the score.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Betrixaban, the fifth novel oral anticoagulant in line for the Food and Drug Administration (FDA) approval, possesses some unique pharmacokinetic characteristics in comparison with the currently available novel anticoagulants, including limited renal excretion, minimal metabolism through the cytochrome p450 system and a long half-life.\"\n\nWhile this sentence doesn't explicitly state that betrixaban inhibits factor Xa, the context discusses the classification of anticoagulants, including factor Xa inhibitors, and later mentions that betrixaban is part of this class. Therefore, it can be inferred that betrixaban inhibits factor Xa.\n\nAnswer: Betrixaban inhibits factor Xa.", "retries": 1}
{"idx": 782, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that transcription-coupled repair targets the transcribed strand by contrasting it with the non-transcribed strand, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription coupled repair (TCR) is a nucleotide excision repair (NER) pathway that is dedicated to repair in the transcribed strand of an active gene.", "model_answer": "The transcribed strand is targeted by transcription-coupled repair (TCR).\n\nAnswer: The transcribed strand.", "model_support": "The transcribed strand is targeted by transcription-coupled repair (TCR).\n\nSupporting sentence: Cells deleted for elc1 show normal NER in the transcribed strand of an active gene but have no detectable NER in the non-transcribed strand.", "retries": 1}
{"idx": 783, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('0') but is present in the context as it correctly identifies that no specific data on off-label drug trials in neonates is provided. However, the supporting sentence, while relevant, does not directly cover the gold answer and is somewhat verbose. It explains the absence of information but does not logically lead to the conclusion that the number of cited trials is zero.\", \"match\": false}", "gold_answer": "0", "gold_support": "Decisions as issued included 15 clinical trials, with at least 1,282 children to be recruited into studies across five different products.", "model_answer": "The provided context does not contain specific data on the number of clinical trials for off-label drugs in neonates. It focuses on the submission and outcomes of Paediatric Investigation Plans (PIPs) related to pain management, indicating a lack of new drug development but not providing details on off-label trials. Therefore, the information required to answer the question is not available in the given context.\n\nAnswer: The number of clinical trials for off-label drugs in neonates cited in the literature is not provided in the context.", "model_support": "The provided context does not contain specific data on the number of clinical trials for off-label drugs in neonates. It focuses on the submission and outcomes of Paediatric Investigation Plans (PIPs) related to pain management, indicating a lack of new drug development but not providing details on off-label trials. Therefore, the information required to answer the question is not available in the given context.\n\n**Answer:** The number of clinical trials for off-label drugs in neonates cited in the literature is not provided in the context.\n\n**Supporting sentence:** The context does not contain specific data on clinical trials for off-label drugs in neonates.", "retries": 1}
{"idx": 784, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer, it still aligns well with the gold supporting sentence and provides accurate context.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Therefore, while p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\n**Supporting sentence:** \"While p53 can be rightly defined as the guardian of the genome, we could think of p73 as the 'assistant' guardian of the genome!\"", "retries": 1}
{"idx": 785, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is less direct and slightly redundant compared to the gold supporting sentence. While it correctly identifies alpha-synuclein as a key component of Lewy bodies, it introduces unnecessary uncertainty by discussing APP isoforms, which makes it less concise than the ideal support.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The supporting sentence from the context is:\n\n\"It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"\n\nThis sentence indicates that alpha-synuclein is a key component involved in the formation of Lewy bodies, thereby supporting the answer that alpha-synuclein is the main component of Lewy bodies.", "retries": 1}
{"idx": 786, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard, as it provides a range (1 in 3,000 to 1 in 6,000) instead of the precise figure '1:5000'. The supporting sentence is relevant but overly verbose and does not directly cover the gold answer. It discusses oesophageal atresia and associated anomalies without clearly stating the incidence of Edwards syndrome as 1:5000. While some connection to the context is present, the model fails to extract the exact information provided in the gold supporting sentence.\",\n  \"match\": false\n}", "gold_answer": "1:5000", "gold_support": "The incidence of Edwards syndrome is 1:5000 of live-born.", "model_answer": "The incidence of Edwards syndrome in the European population is not explicitly provided in the context. However, general knowledge suggests that it occurs approximately in 1 in 3,000 to 1 in 6,000 live births. For children with oesophageal atresia, about 50% have associated genetic disorders like Edwards syndrome, but this does not translate to the overall European incidence. Therefore, the exact incidence in Europe cannot be determined from the given context.", "model_support": "The incidence of Edwards syndrome (trisomy 18) in the European population is not explicitly provided in the context. The context mentions that oesophageal atresia has an incidence of 1:3000-3500 live-born and that about 50% of these patients have associated genetic disorders, including Edwards syndrome. However, this information does not translate to the overall European incidence of Edwards syndrome. Therefore, the exact incidence in Europe cannot be determined from the given context.\n\n**Supporting Sentence:**\n\"Associated anomalies including genetic disorders occur in 50% of patients.\"", "retries": 1}
{"idx": 787, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than necessary, providing additional details that are not directly required by the gold standard. The supporting sentence is somewhat relevant but mixes contextual information about the scale's effectiveness rather than directly focusing on its primary use for stroke identification. While the logic connecting the answer and supporting sentence is reasonable, it could be more concise and directly aligned with the gold standard.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used for evaluating and differentiating acute stroke from stroke mimics in emergency settings. It helps recognize stroke in the emergency room by assessing patients with suspected cerebrovascular events.", "model_support": "The supporting sentence is: \"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\" This sentence directly states the purpose of the ROSIER scale in the context of evaluating and differentiating acute stroke from stroke mimics.", "retries": 1}
{"idx": 788, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'BCR-ABL tyrosine kinase,' is very close to the gold standard 'Bcr-Abl' but includes additional descriptive wording ('tyrosine kinase') that is accurate but not strictly necessary. The supporting sentence is relevant and explains the context of the Philadelphia chromosome and BCR-ABL fusion gene, but it contains slight redundancy by mentioning CML's genetic basis without directly focusing on Imatinib’s targeting of Bcr-Abl. Overall, the logic is strong, but the explanation could be more concise.\",\n  \"match\": true\n}", "gold_answer": "Bcr-Abl", "gold_support": "As a consequence of this translocation, a BCR-ABL fusion gene is formed on the 22q- derivative (traditionally known as the Philadelphia chromosome) and the deregulated tyrosine kinase activity of the protein encoded by this gene has been shown to be both necessary and sufficient for initiation and maintenance of the disease.", "model_answer": "The target of Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase. \n\nAnswer: BCR-ABL tyrosine kinase", "model_support": "The drug Imatinib (Gleevec) targets the BCR-ABL tyrosine kinase in Philadelphia-chromosome positive chronic myelogenous leukemia (CML). \n\n**Supporting Sentence:**  \n\"Chronic myeloid leukemia (CML) is the first human malignancy for which the promise of targeted therapy has come true. CML is invariably associated with a specific genetic lesion--the t(9;22) chromosomal translocation.\"  \nThis sentence indicates the genetic basis of CML involving the t(9;22) translocation, which leads to the BCR-ABL fusion gene. Imatinib specifically inhibits the tyrosine kinase activity of this fusion protein.", "retries": 1}
{"idx": 789, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('fungi') in meaning, though it is presented in a complete sentence rather than as a single word. The supporting sentence provided by the model is identical to its answer, which is redundant but still relevant. A more concise and appropriate supporting sentence would have been the one from the context that discusses the close relationship of microsporidia with fungi. However, the redundancy does not detract significantly from the logical support.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the kingdom Fungi according to their current classification scheme.", "model_support": "Microsporidia belong to the kingdom Fungi according to their current classification scheme.\n\n**Supporting sentence:** Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.", "retries": 1}
{"idx": 790, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer by referencing BCR-ABL mutations during Imatinib therapy, which logically implies that BCR-ABL is the target of Imatinib. However, the supporting sentence includes slight redundancy by mentioning resistance mechanisms, which is not directly necessary to justify the answer.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Dasatinib is a dual Abl/Src tyrosine kinase inhibitor (TKI) designed as a prototypic short-acting BCR-ABL-targeted TKI that inhibits BCR-ABL with greater potency compared with imatinib, nilotinib, bosutinib, and ponatinib and has been shown to have potential immunomodulatory effects.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia (CML) is the BCR-ABL protein. This protein is formed due to the genetic abnormality involving the Philadelphia chromosome and is responsible for the uncontrolled growth of leukemia cells, which Imatinib inhibits. \n\nAnswer: BCR-ABL", "model_support": "The supporting sentence from the context is: \"Dasatinib demonstrates efficacy against most BCR-ABL mutations arising during imatinib therapy and is effective in treating patients with imatinib resistance due to other mechanisms.\"\n\nThis sentence indicates that BCR-ABL is the target of Imatinib, as it refers to mutations in BCR-ABL that occur during Imatinib treatment, leading to resistance. Thus, Imatinib targets the BCR-ABL protein.\n\n**Answer:** BCR-ABL", "retries": 1}
{"idx": 791, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'PTEN', does not match the gold standard, 'p53'. However, PTEN is mentioned in the context as a 'new guardian of the genome,' which makes it relevant but incorrect in this case. The supporting sentence is accurate for PTEN but does not cover the gold answer (p53). Therefore, while relevant, the model's response fails to address the correct tumor suppressor.\", \"match\": false}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is known as a guardian of the genome that mediates the cellular response to environmental stress, leading to cell cycle arrest or cell death.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" in the context provided is PTEN.\n\nAnswer: PTEN", "model_support": "The supporting sentence from the context is:\n\n\"Thus, we propose that PTEN is a new guardian of the genome.\"\n\nThis sentence explicitly refers to PTEN as \"the guardian of the genome,\" directly supporting the answer.", "retries": 1}
{"idx": 792, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support.\", \"match\": true}", "gold_answer": "spleen tyrosine kinase", "gold_support": "Rigel Pharmaceuticals Inc is developing fostamatinib, a prodrug of the spleen tyrosine kinase (Syk) inhibitor R-406, for the potential treatment of autoimmune diseases such as rheumatoid arthritis (RA), idiopathic thrombocytopenic purpura (ITP) and B-cell lymphomas.", "model_answer": "The enzyme inhibited by fostamatinib is spleen tyrosine kinase (Syk).", "model_support": "The enzyme inhibited by fostamatinib is spleen tyrosine kinase (Syk). \n\n**Supporting Sentence:**  \n\"Fostamatinib, a Syk inhibitor prodrug for the treatment of inflammatory diseases.\"", "retries": 1}
{"idx": 793, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Acute stroke' is very close to the gold standard 'Stroke' and is contextually accurate, though slightly more specific than necessary. The supporting sentence is relevant but does not directly state that the ROSIER scale is specifically for stroke recognition, which reduces precision. It mentions sensitivity but misses the opportunity to clearly link the ROSIER scale to stroke identification.\", \"match\": true}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "Answer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale had greater sensitivity than existing stroke recognition instruments in this population.", "retries": 1}
{"idx": 794, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer is correct as betrixaban inhibits factor Xa, which matches the gold standard. However, the supporting sentence provided by the model incorrectly states that there is no mention of betrixaban in the context, while the context does indeed mention betrixaban as an orally active direct factor Xa inhibitor. The supporting sentence should have pointed to this specific information. The evaluation is penalized for not identifying the relevant sentence but is not completely incorrect as the answer itself is right.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context does not mention betrixaban, so there is no supporting sentence to answer the question. Therefore, I cannot provide an accurate answer based on the given information.", "retries": 1}
{"idx": 795, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically supports the answer by reinforcing the importance of ZFHX1B in diagnosing Mowat-Wilson syndrome. Although the model supporting sentence repeats the answer, it still maintains clarity and relevance.\",\n  \"match\": true\n}", "gold_answer": "ZFHX1B", "gold_support": "Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly-mental retardation complex caused by mutations in the Zinc Finger Homeobox 1 B gene (ZFHX1B).", "model_answer": "The gene responsible for the development of Mowat-Wilson syndrome is ZFHX1B.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZFHX1B.\n\n**Supporting sentence:**  \n\"molecular genetic analysis of ZFHX1B is important for a definite diagnosis of MWS which has a wide phenotypic spectrum of congenital anomalies.\"", "retries": 1}
{"idx": 796, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and identifies Fanconi anemia as the disease in question, but it is slightly less detailed compared to the gold supporting sentence. It does not mention the high frequency of chromosomal aberrations or sensitivity to crosslinking agents, which are key components of the gold standard reasoning.\", \"match\": true}", "gold_answer": "Fanconi anemia", "gold_support": "Fanconi anemia (FA) is characterized at the cellular level by a high frequency of spontaneous chromosomal aberrations; crosslinking agents cause an abnormal increase in the frequency of chromosomal damage, and semiconservative DNA synthesis is severely inhibited.", "model_answer": "The disease is Fanconi anemia.", "model_support": "The supporting sentence is:\n\n\"Effect of hydroxyurea and normal plasma on DNA synthesis in lymphocytes from Fanconi anemia patients.\"\n\nThis sentence identifies Fanconi anemia as the disease being studied, which is the disease in question.", "retries": 1}
{"idx": 797, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than necessary, as the gold answer 'stroke' is concise and directly addresses the question. The supporting sentence provides relevant information about the ROSIER scale differentiating stroke from mimics, but it does not explicitly align with the gold supporting sentence's focus on risk-stratifying patients with suspected stroke. While the logic is reasonable, the model's supporting sentence could be more concise and directly tied to the gold standard context.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used to differentiate acute stroke from stroke mimics in patients with suspected stroke symptoms. It helps identify whether someone presenting with stroke-like symptoms actually has a stroke or another condition that mimics stroke.", "model_support": "The supporting sentence from the context that explains the purpose of the ROSIER scale is:\n\n\"The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.\"\n\nThis sentence directly states that the ROSIER scale is used to differentiate between acute stroke and stroke mimics, which supports the answer provided.", "retries": 1}
{"idx": 798, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard ('medicarpin'), but the supporting sentence is somewhat verbose and mixes relevant with less relevant content. It discusses IFR and genetic manipulation, which, while related to medicarpin biosynthesis, do not directly support the specific statement about medicarpin being the major phytoalexin in alfalfa. The logic is reasonable but could be more concise and focused on the key fact.\",\n  \"match\": true\n}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.\n\n**Supporting sentence:** \"IFR appears to be encoded by a single gene in alfalfa. The cloning of IFR opens up the possibility of genetic manipulation of phytoalexin biosynthesis in alfalfa by altering isoflavonoid stereochemistry.\" Additionally, the context mentions that IFR is responsible for introducing one of two chiral centers in (-)-medicarpin, indicating its role in biosynthesis.", "retries": 1}
{"idx": 799, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is somewhat redundant and not as concise as it could be. While it mentions the ZEB2 gene analysis for Mowat-Wilson syndrome, it does not directly explain that haploinsufficiency of ZEB2 causes the syndrome, which is critical to fully support the answer. The gold supporting sentence provides more direct and relevant information about the role of ZEB2 in causing the syndrome.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "All typical cases result from haploinsufficiency of the ZEB2 (also known as ZFHX1B or SIP-1) gene, with over 100 distinct mutations now described.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.\n\nAnswer: ZEB2", "model_support": "Supporting sentence: Comprehensive ZEB2 gene analysis for Mowat-Wilson syndrome in a North American cohort: a suggested approach to molecular diagnostics.", "retries": 1}
{"idx": 800, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (H3K36me3). Although the model notes that there is no supporting sentence in the provided context, the gold supporting sentence directly supports the answer with concise and relevant information about H3K36me3 being enriched at internal exons and playing a role in splicing. Thus, the model's response aligns well with the scoring criteria.\", \"match\": true}", "gold_answer": "H3K36me3", "gold_support": "Moreover, recent observations indicate that chromatin structure, transcription and splicing are functionally intertwined, and that modified nucleosomes with trimethylation of lysine 36 in histone subunit 3 (H3K36me3) are enriched at internal exons and the downstream flanking intronic regions of highly expressed genes.", "model_answer": "The histone trimethylation associated with RNA splicing is H3K36me3. This mark is found in the bodies of actively transcribed genes and plays a role in facilitating proper exon recognition and splice site selection during RNA splicing.", "model_support": "The context does not contain a supporting sentence for the answer provided. The answer about H3K36me3 is based on external knowledge, as the context discusses nucleosome positioning but does not mention histone trimethylation.\n\nAnswer: There is no supporting sentence in the context for the answer provided. The answer is based on external knowledge.", "retries": 1}
{"idx": 801, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('repressor'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by stating that BACH1 is identified as a repressor based on the context. This aligns well with the gold supporting sentence without introducing unnecessary details.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Transcription factor BACH1 [BTB (broad-complex, tramtrack and bric-a-brac) and CNC (cap'n'collar protein) homology 1] binds to ARE-like sequences, functioning as a transcriptional repressor in a subset of ARE-regulated genes, thus antagonizing the activator function of Nrf2.", "model_answer": "BACH1 is a repressor.", "model_support": "The transcriptional regulator BACH1 is identified as a repressor based on the context provided. \n\n**Supporting Sentence:**  \n\"BACH1 is a transcriptional repressor.\"", "retries": 1}
{"idx": 802, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('BCR-ABL') and is correct. The supporting sentence provided by the model is relevant and explains that imatinib affects BCR-ABL, which aligns with the context. However, it contains slight redundancy by mentioning the reduction of leukemic stem cells, which is not directly necessary to support the answer. The gold supporting sentence is more concise while still providing adequate context. Overall, the logic is strong but could be more succinct.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "PURPOSE: Imatinib induces a durable response in most patients with Philadelphia chromosome-positive chronic myeloid leukemia, but it is currently unclear whether imatinib reduces the leukemic stem cell (LSC) burden, which may be an important step toward enabling safe discontinuation of therapy.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL protein. Imatinib inhibits the kinase activity of this fusion protein, which is responsible for the uncontrolled cell growth in CML.", "model_support": "The supporting sentence from the context is:\n\n\"BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.\"\n\nThis sentence indicates that imatinib affects BCR-ABL, supporting the conclusion that Imatinib targets the BCR-ABL protein in Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 803, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard ('Factor Xa' vs. 'xa'), and the supporting sentence is relevant, but it contains slight redundancy by discussing substitution of indirect inhibitors without directly emphasizing that betrixaban belongs to the category of direct factor Xa inhibitors. The logic is strong, but the gold supporting sentence provides more concise and direct support.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"The objective is to substitute these indirect inhibitors of factor Xa (heparins, low molecular weight heparins and fondaparinux) in the prevention of venous and arterial thromboembolic episodes.\"\n\nAnswer: Factor Xa", "retries": 1}
{"idx": 804, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by discussing the physiological role and localization without directly emphasizing calsequestrin as the main calcium-binding protein in the SR. The gold supporting sentence is more concise and directly identifies calsequestrin's role.\", \"match\": true}", "gold_answer": "Calsequestrin", "gold_support": "Calsequestrin (CS) is the low-affinity, high-capacity calcium binding protein segregated to the lumen of terminal cisternae (TC) of the sarcoplasmic reticulum (SR).", "model_answer": "The main calcium-binding protein of the sarcoplasmic reticulum is calsequestrin.", "model_support": "The supporting sentence from the context is:\n\n\"The physiological role of CS in controlling calcium release from the SR depends on both its intrinsic properties and its localization.\"\n\nThis sentence identifies calsequestrin (CS) as a crucial protein involved in calcium regulation within the sarcoplasmic reticulum.", "retries": 1}
{"idx": 805, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'SECIS element', is correct and aligns with the gold standard 'SECIS'. However, it includes the word 'element', which, while accurate, is slightly more detailed than the gold answer. The supporting sentence provides relevant information about SECIS-binding protein 2 but does not directly mention the stem-loop structure in the 3' UTR RNA, which is key to supporting the gold answer. It contains useful context but is less direct compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "SECIS", "gold_support": "In mammals, this requires a dedicated machinery comprising a stem-loop structure in the 3' UTR RNA (the SECIS element) and the specific SECIS Binding Protein 2.", "model_answer": "The stem loop present in the 3' end of genes encoding for selenoproteins is called the SECIS element. This structure is crucial for the incorporation of selenocysteine at the reprogrammed UGA codon during translation.\n\nAnswer: SECIS element", "model_support": "The supporting sentence from the context is:\n\n\"SECIS-binding protein 2, a key player in selenoprotein synthesis, is an intrinsically disordered protein.\"\n\nThis sentence introduces SECIS-binding protein 2, indicating that SECIS is the structure involved, which is the stem loop at the 3' end of selenoprotein genes.", "retries": 1}
{"idx": 806, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('Factor Xa') matches the gold standard ('xa'), but the supporting sentence is incorrect. It refers to indirect factor Xa inhibitors, while betrixaban is a direct factor Xa inhibitor. The supporting sentence does not properly cover the gold answer and introduces confusion by referencing the wrong category of inhibitors.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Examples of direct factor Xa inhibitors include apixaban, rivaroxaban, otamixaban, betrixaban and edoxaban.", "model_answer": "Betrixaban inhibits factor Xa. \n\nAnswer: Factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Examples of indirect factor Xa inhibitors include fondaparinux, idraparinux and idrabiotaparinux.\"\n\nThis sentence categorizes betrixaban under indirect factor Xa inhibitors, indicating that it inhibits factor Xa.", "retries": 1}
{"idx": 807, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'ABL kinase,' does not exactly match the gold standard 'Bcr-Abl,' although it is related and present in the context. The supporting sentence refers to second-generation Abl kinase inhibitors but does not directly support the specific answer regarding Imatinib targeting Bcr-Abl. The reasoning is relevant but lacks precision and fails to cover the gold answer adequately.\",\n  \"match\": false\n}", "gold_answer": "Bcr-Abl", "gold_support": "Chronic myeloid leukemia (CML) is caused by Bcr-Abl, a constitutively active tyrosine kinase that is the result of a reciprocal translocation between chromosomes 9 and 22 and cytogenetically evident as the Philadelphia chromosome.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is ABL kinase, specifically the BCR-ABL fusion protein. \n\nAnswer: ABL kinase", "model_support": "The supporting sentence is: \"The potential of second-generation Abl kinase inhibitors in the setting of clinical resistance are considered.\" This indicates that ABL kinase is the target of Imatinib in treating Philadelphia-chromosome positive chronic myelogenous leukemia.\n\nAnswer: ABL kinase", "retries": 1}
{"idx": 808, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is accurate and matches the gold standard ('thyroid') in essence, as it specifies the thyroid hormones T4 and T3. The supporting sentence provides relevant information about the altered hormone concentrations and explains the mechanism behind the changes (impaired transport into the brain). However, it repeats the answer verbatim, which introduces slight redundancy. The gold supporting sentence is more concise and directly mentions the 'typical thyroid hormone profile,' making it slightly superior in terms of brevity and clarity.\", \"match\": true}", "gold_answer": "thyroid", "gold_support": "This syndrome is characterized by axial hypotonia, severe mental retardation, dysarthria, athetoid movements, spastic paraplegia, and a typical thyroid hormone profile.", "model_answer": "The hormone concentrations altered in Allan-Herndon-Dudley syndrome are thyroid hormones, specifically thyroxine (T4) and triiodothyronine (T3). Patients typically have elevated serum T4 levels due to impaired transport into the brain, leading to a deficiency of these hormones in the central nervous system.", "model_support": "The hormone concentrations altered in Allan-Herndon-Dudley syndrome are thyroid hormones, specifically thyroxine (T4) and triiodothyronine (T3). Patients typically have elevated serum T4 levels due to impaired transport into the brain, leading to a deficiency of these hormones in the central nervous system.\n\n**Supporting Sentence:** The context does not explicitly mention the hormones, but it discusses the role of the MCT8 gene mutation, which is known to affect the transport of thyroxine (T4) and triiodothyronine (T3) into the brain.", "retries": 1}
{"idx": 809, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the link between pridopidine and Huntington disease by referencing the study's objective to investigate metabolic changes in patients with the disorder.\", \"match\": true}", "gold_answer": "Huntington disease", "gold_support": "Pridopidine (ACR16) belongs to a novel class of central nervous system compounds in development for the treatment of Huntington disease.", "model_answer": "Pridopidine has been tested for the treatment of Huntington disease.", "model_support": "The supporting sentence is:\n\n\"The objective of the study was to investigate the metabolic changes in patients with Huntington disease before and after pridopidine treatment.\"\n\nThis sentence directly links pridopidine to the treatment of Huntington disease by stating the study's objective to examine its effects on patients with the disorder.", "retries": 1}
{"idx": 810, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('factor Xa' corresponds to 'xa'). The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that betrixaban inhibits factor Xa. There is no excessive verbosity or irrelevant content.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Apixaban, betrixaban, edoxaban, and rivaroxaban are small-molecule, selective inhibitors that directly and reversibly bind to the active site of factor Xa.", "model_answer": "betrixaban inhibits **factor Xa**.", "model_support": "The clotting factor inhibited by betrixaban is **factor Xa**.\n\n**Supporting sentence:**  \n\"Direct factor Xa inhibitors comprise the largest class of oral anticoagulants in development; the inhibition of factor Xa is recognized to be a promising target for therapeutic anticoagulation...\"", "retries": 1}
{"idx": 811, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer 'SCFβ-TrCP' matches the gold standard 'beta-Trcp' functionally, as SCFβ-TrCP is the full name of the E3 ubiquitin ligase complex that includes beta-Trcp. The supporting sentence provided by the model, however, does not directly reference the role of SCFβ-TrCP or beta-Trcp in mediating IFNAR1 degradation but instead discusses Tyk2's stabilization effect, which indirectly implies beta-Trcp involvement. While relevant, this explanation is less direct than the gold supporting sentence and introduces some redundancy. Therefore, it receives a score of 4.\", \"match\": true}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase responsible for the ubiquitination and degradation of IFNAR1 is SCFβ-TrCP. \n\nAnswer: SCFβ-TrCP", "model_support": "The E3 ubiquitin ligase responsible for the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is SCFβ-TrCP. \n\n**Supporting Sentence:** \"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\" \n\nThis sentence implies that beta-TrCP is involved in the process, pointing to SCFβ-TrCP as the E3 ligase.", "retries": 1}
{"idx": 812, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer, 'Betrixaban inhibits factor Xa,' matches the gold standard ('xa') in meaning but is slightly more verbose. The supporting sentence provides relevant context about new anticoagulants and mentions that betrixaban belongs to a class of drugs that inhibit factor Xa. However, it does not directly cite the specific sentence from the context that explicitly lists betrixaban as an orally active direct factor Xa inhibitor. The reasoning is logical but could be more concise and directly tied to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"New compounds have the potential to complement heparins and fondaparinux for short-term anticoagulation and/or to replace VKA for long-term anticoagulation in most patients. Dabigatran and rivaroxaban have been the firsts of the new oral anticoagulants to be licensed for the prevention of VTE after hip and knee replacement surgery.\"\n\nThis sentence implies that new anticoagulants, including betrixaban, target specific clotting factors. Since dabigatran inhibits thrombin and rivaroxaban inhibits factor Xa, it is inferred that betrixaban, as another new agent, likely inhibits factor Xa, consistent with other new oral anticoagulants.", "retries": 1}
{"idx": 813, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and matches the gold standard ('stroke') in meaning, though it is more detailed than necessary. The supporting sentence is relevant and covers the gold answer by emphasizing the role of the ROSIER scale in identifying stroke, but it includes additional information about differentiation from mimics, which is slightly redundant for the context of the gold answer.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for identifying and distinguishing acute stroke from other stroke mimics in the emergency room. It helps healthcare providers quickly and accurately recognize stroke patients. \n\nAnswer: The ROSIER scale is used for identifying acute stroke in the emergency room setting.", "model_support": "The supporting sentence from the context is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"\n\nThis sentence directly supports the answer by stating that the ROSIER scale is used to differentiate acute stroke from other mimics in the emergency room setting.", "retries": 1}
{"idx": 814, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the chosen supporting sentence is not directly relevant to rheumatoid arthritis, as it focuses on inflammatory bowel disease rather than the specific context of rheumatoid arthritis approval. Despite this, the sentence still logically supports the use of tofacitinib as a JAK inhibitor, making the support slightly indirect but still reasonable.\", \"match\": true}", "gold_answer": "Tofacitinib", "gold_support": "Tofacitinib is an oral janus kinase (JAK) inhibitor that inhibits JAK family kinase members, in particular JAK1 and JAK3, achieving a broad limitation of inflammation by interfering with several cytokine receptors.", "model_answer": "The JAK inhibitor approved for the treatment of rheumatoid arthritis is tofacitinib.\n\nAnswer: Tofacitinib", "model_support": "The supporting sentence from the context is:\n\n\"Janus kinase inhibition with tofacitinib: changing the face of inflammatory bowel disease treatment.\"\n\nHowever, this sentence does not support the answer regarding rheumatoid arthritis, as the context only discusses the use of tofacitinib in inflammatory bowel disease (IBD), specifically ulcerative colitis and Crohn's disease. The approval of tofacitinib for rheumatoid arthritis is not mentioned in the provided context.", "retries": 1}
{"idx": 815, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but is more verbose and explanatory rather than concise. The supporting sentence is somewhat lengthy and focuses on the scale’s effectiveness, which is not directly aligned with the gold supporting sentence that simply introduces the purpose of the ROSIER scale. While the logic in the supporting sentence is reasonable, it could be more concise and directly relevant.\",\n  \"match\": false\n}", "gold_answer": "Stroke", "gold_support": "BACKGROUND AND PURPOSE: The objective of this study was to determine the performance of the Recognition Of Stroke In the Emergency Room (ROSIER) scale in risk-stratifying Chinese patients with suspected stroke in Hong Kong.", "model_answer": "The ROSIER scale is used for assessing and diagnosing acute strokes versus stroke mimics, helping to determine whether a patient is likely experiencing a stroke or another condition.", "model_support": "Supporting sentence: The ROSIER scale was not as effective at differentiating acute stroke from stroke mimics in Chinese patients in Hong Kong as it was in the original studies, primarily due to a much lower specificity.", "retries": 1}
{"idx": 816, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and does not match the gold standard. The supporting sentence is irrelevant as it merely restates the lack of information in the context without providing any logical support or reasoning related to the gold answer.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context does not specify the exact number of TAp73 isoforms identified in humans.", "model_support": "The context does not specify the exact number of TAp73 isoforms identified in humans. \n\nSupporting sentence: The context does not provide specific information on the number of TAp73 isoforms identified in humans.", "retries": 1}
{"idx": 817, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but includes unnecessary details about specific thyroid hormones (T4 and T3), which are not explicitly required by the question or gold answer. The supporting sentence provides relevant information regarding abnormalities in thyroid function but does not directly align with the concise explanation of the gold supporting sentence. It introduces additional data (e.g., thyroid volume, thyroglobulin levels) that, while related, make it less focused. Logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "The hormone abnormalities characteristic of Pendred syndrome are related to the thyroid hormones thyroxine (T4) and triiodothyronine (T3). These hormones are crucial for metabolism and development, and their dysregulation can lead to conditions such as hypothyroidism in Pendred syndrome patients.", "model_support": "Supporting sentence: Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.", "retries": 1}
{"idx": 818, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and explains the relationship between benserazide and L-DOPA, but it contains slight redundancy by mentioning general medical knowledge and dopamine's role, which is not directly necessary for answering the question. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "L-DOPA", "gold_support": "Co-administration of benserazide (i.t.), a DOPA decarboxylase inhibitor, abolished the antinociceptive effect of L-DOPA.", "model_answer": "Answer: L-DOPA", "model_support": "The answer to the question is L-DOPA. Although the context provided does not explicitly mention benzerazide, it discusses L-DOPA and its mechanism of action. Based on general medical knowledge, benzerazide is commonly co-administered with L-DOPA to enhance its effects and reduce side effects, particularly in the treatment of Parkinson's disease.\n\nAnswer: L-DOPA\n\nSupporting sentence: The context discusses L-DOPA's antinociceptive mechanism, suggesting its role in pain relief through dopamine and D2 receptors, which aligns with its use in combination with benzerazide in medical treatments.", "retries": 1}
{"idx": 819, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by clearly stating that alpha-synuclein is the main component of Lewy bodies. Although the model supporting sentence is identical to its answer, it still aligns perfectly with the gold standard reasoning.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.\n\nAnswer: Alpha-synuclein", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\nSupporting sentence: \"whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).\"", "retries": 1}
{"idx": 820, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('RET') in essence, though it includes additional phrasing ('The gene frequently mutated in...'). The supporting sentence is relevant and captures the essence of the RET gene being implicated in both MEN2 and Hirschsprung disease. However, it contains slight redundancy by referencing 'different diseases derived from neural crest' rather than directly focusing on MEN2 and HSCR as the gold supporting sentence does. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "Activating germline RET mutations are presented in patients with familial medullary thyroid carcinoma (FMTC) and multiple endocrine neoplasia (MEN) types 2A and 2B, whereas inactivating germline mutations in patients with Hirschsprung's disease (HSCR).", "model_answer": "The gene frequently mutated in Multiple endocrine neoplasia 2 (MEN2) and Hirschsprung disease is the RET gene.", "model_support": "The supporting sentence is:\n\n\"RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.\"", "retries": 1}
{"idx": 821, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant but does not cover the gold answer, as it fails to identify 'craniosynostosis' as the specific additional feature of Goldberg-Shprintzen syndrome mentioned in the context.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "The Shprintzen-Goldberg syndrome (SGS) is a disorder of unknown cause comprising craniosynostosis, a marfanoid habitus and skeletal, neurological, cardiovascular, and connective-tissue anomalies.", "model_answer": "The context does not explicitly mention a specific additional disease included in Goldberg-Shprintzen syndrome. Instead, it describes a range of features such as facial anomalies, developmental delays, and skeletal issues. Therefore, no specific additional disease is identified in the provided information.", "model_support": "The context does not explicitly mention any specific additional disease included as a feature of Goldberg-Shprintzen syndrome. It describes various clinical features such as facial anomalies, developmental delays, and skeletal issues but does not link these to another named disease. Therefore, no specific additional disease is identified in the provided information.", "retries": 1}
{"idx": 822, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, as 'XIST RNA' is equivalent to 'XIST'. The supporting sentence is relevant and provides logical support for the answer, but it contains slight redundancy by mentioning 'chromosome painting' without directly focusing on the initiation of X-chromosome inactivation. It could be more concise.\",\n  \"match\": true\n}", "gold_answer": "XIST", "gold_support": "X chromosome inactivation begins when a novel chromosomal RNA (cRNA) from the imprinted mouse Xist or human XIST locus coats or \"paints\" one X chromosome in cis and initiates a cascade of chromosome remodeling events.", "model_answer": "The transcript responsible for X-chromosome inactivation is XIST RNA.", "model_support": "Supporting sentence: The cell biology of a novel chromosomal RNA: chromosome painting by XIST/Xist RNA initiates a remodeling cascade.", "retries": 1}
{"idx": 823, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('RANK receptors') does not match the gold standard ('RANKL'). However, the supporting sentence is relevant as it discusses RANKL and its role, which is indirectly related to the gold answer. The supporting sentence does not fully cover the gold answer since it does not explicitly state that Denosumab binds to RANKL. Therefore, while the context provided is somewhat relevant, the answer itself is incorrect.\", \"match\": false}", "gold_answer": "RANKL", "gold_support": "Whether the factor has the same role in humans is of clinical interest because an inhibitor for RANKL, denosumab, is already used for the treatment of bone disease and might benefit breast cancer patients.", "model_answer": "Denosumab (Prolia) binds to the RANK receptors by targeting their ligand, RANKL. \n\nAnswer: RANK receptors", "model_support": "The supporting sentence from the context is:\n\n\"Receptor activator of nuclear factor κB ligand (RANKL) has been identified as a pivotal paracrine mediator of progesterone function in mouse mammary gland development and mammary carcinogenesis.\"\n\nThis sentence identifies RANKL as the ligand for RANK receptors, supporting the answer that Denosumab binds to RANK receptors by targeting RANKL.", "retries": 1}
{"idx": 824, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is very close to the gold standard but slightly more specific ('congenital hypothyroidism' instead of 'thyroid'). The supporting sentence is relevant and directly connects Williams syndrome with congenital hypothyroidism, but it contains a minor amount of extra detail (mentioning thyroid hypoplasia) that, while correct, makes it slightly more verbose than necessary.\", \"match\": false}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia as a cause of congenital hypothyroidism in Williams syndrome.", "model_answer": "Hormone abnormalities common in Williams syndrome include congenital hypothyroidism.", "model_support": "The supporting sentence from the context is:\n\n\"In this report we describe an infant with WBS and congenital hypothyroidism, due to an important thyroid hypoplasia.\"\n\nThis sentence directly connects Williams syndrome (WBS) with congenital hypothyroidism, supporting the answer.", "retries": 1}
{"idx": 825, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'Marfan syndrome', does not match the gold standard 'craniosynostosis'. However, Marfan syndrome is mentioned in the context as having significant clinical overlap with Goldberg-Shprintzen syndrome. The supporting sentence is relevant to the context but does not directly cover the gold answer, as it discusses the overlap between MFS and SGS without specifically mentioning craniosynostosis.\", \"match\": false}", "gold_answer": "craniosynostosis", "gold_support": "Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome.", "model_answer": "The disease included as an additional feature in Goldberg-Shprintzen syndrome is Marfan syndrome.\n\nAnswer: Marfan syndrome", "model_support": "The supporting sentence from the context is:\n\n\"Because of the significant clinical overlap between MFS and SGS, we proposed that they may be caused by allelic mutations.\"\n\nThis sentence indicates the connection between Marfan syndrome (MFS) and Goldberg-Shprintzen syndrome (SGS), supporting the answer that MFS is an additional feature in SGS.", "retries": 1}
{"idx": 826, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('fungi'). The supporting sentence is relevant and accurate, referencing external knowledge to confirm the classification of microsporidia within the Fungi kingdom. However, it introduces slight redundancy by mentioning characteristics like chitinous cell walls and spore production, which are not necessary given the context provided. The gold supporting sentence directly references the context and is more concise.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "Microsporidia are ubiquitous fungi with genomes that have undergone a strong reduction to the extreme cases of Encephalitozoon cuniculi and Encephalitozoon intestinalis.", "model_answer": "Microsporidia belong to the kingdom Fungi.", "model_support": "The answer is based on external knowledge as the context does not provide a supporting sentence.\n\n**Answer:** Microsporidia belong to the kingdom Fungi.\n\n**Supporting Information:** While the context does not explicitly state this, microsporidia are traditionally classified within the Fungi kingdom due to their characteristics such as chitinous cell walls and spore production.", "retries": 1}
{"idx": 827, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as it specifies 'thyroxine (T4)' and 'triiodothyronine (T3)', which are thyroid hormones. However, the gold answer simply states 'thyroid', which is broader but still correct. The supporting sentence provided by the model is somewhat lengthy and indirectly explains the issue by focusing on LT4 administration and TSH suppression, rather than directly addressing how MCT8 mutations impair thyroid hormone transport. The logic is reasonable but could be more concise and directly tied to the mutation’s effect on thyroid hormones.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Recently, the monocarboxylate transporter 8 (MCT8) was identified as a thyroid hormone transporter, and MCT8 mutations have been associated with Allan-Herndon-Dudley syndrome, an X linked condition characterized by severe mental retardation, dysarthria, athetoid movements, muscle hypoplasia, and spastic paraplegia.", "model_answer": "In patients with Allan–Herndon–Dudley syndrome, the concentrations of thyroxine (T4) and triiodothyronine (T3) in the brain are altered due to impaired transport by the mutated MCT8 transporter. While blood levels of these hormones may be normal or elevated, their transport into the brain is reduced, leading to developmental issues.", "model_support": "The supporting sentence from the context is:\n\n\"While LT4 administration suppressed thyrotropin (TSH) secretion, no significant changes in thyroid hormone values or clinical symptoms were observed.\"\n\nThis indicates that while blood levels of T4 and T3 may remain normal or elevated, their transport into the brain is impaired, leading to the observed clinical issues.", "retries": 1}
{"idx": 828, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'formononetin,' does not match the gold standard, 'medicarpin.' However, formononetin is mentioned in the context as a product related to enzyme activity. The supporting sentence discusses the possible role of an enzyme in synthesizing formononetin but does not directly state it as the major phytoalexin, failing to cover the gold answer. The logic is somewhat relevant but misaligned with the gold standard.\", \"match\": false}", "gold_answer": "Medicarpin", "gold_support": "Medicarpin, the major phytoalexin in alfalfa, is synthesized via the isoflavonoid branch of phenylpropanoid metabolism.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is formononetin.", "model_support": "The supporting sentence from the context that indicates formononetin is the major phytoalexin in alfalfa is:\n\n\"The possible role of the isoflavone 7-OMT in the synthesis of formononetin in vivo is discussed.\"\n\nThis sentence suggests that formononetin is a key product of the IOMT enzyme activity, which is involved in the plant's defense mechanisms, thereby implying its role as a major phytoalexin.", "retries": 1}
{"idx": 829, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('HEXA') conceptually, though it is slightly more verbose by including 'the HEXA gene' instead of just 'HEXA.' The supporting sentence provides relevant information that connects the HEXA gene mutation to Hex A deficiency, which is characteristic of Tay-Sachs disease. However, it contains some redundancy and verbosity compared to the concise gold supporting sentence, which directly states the presence of two mutated HEXA alleles in a patient with Tay-Sachs disease.\",\n  \"match\": true\n}", "gold_answer": "HEXA", "gold_support": "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-Sachs disease.", "model_answer": "The gene most commonly mutated in Tay-Sachs disease is the HEXA gene.", "model_support": "The supporting sentence that indicates the HEXA gene is the most commonly mutated gene in Tay-Sachs disease is:\n\n\"The exon 5 mutated allele with the premature translation termination resulted in severe deficiency of Hex A.\"\n\nThis sentence directly links the mutation to Hex A deficiency, a hallmark of Tay-Sachs disease, confirming the HEXA gene's role.", "retries": 1}
{"idx": 830, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. Although the model notes there is no supporting sentence in the provided context, the gold supporting sentence directly confirms the relationship between DX-88 and Ecallantide concisely and logically.\", \"match\": true}", "gold_answer": "Ecallantide", "gold_support": "Ecallantide (known as DX-88 previously), a potent and specific inhibitor of plasma kallikrein is an innovative medicinal product.", "model_answer": "DX-88 is the investigational name for Ecallantide.\n\nAnswer: Ecallantide", "model_support": "The context does not mention DX-88, so there is no supporting sentence.\n\nAnswer: There is no supporting sentence in the context provided.", "retries": 1}
{"idx": 831, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than necessary, as the gold answer simply states 'stroke'. The supporting sentence is somewhat lengthy and mixes additional information about improving referrals, which is not directly relevant to the concise focus of the gold supporting sentence. Logic is reasonable but could be more to the point.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used to identify acute stroke in the emergency room setting by differentiating it from other stroke mimics, thereby improving the accuracy of referrals to the stroke team.", "model_support": "The supporting sentence from the context is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER. Introduction of the instrument improved the appropriateness of referrals to the stroke team.\"", "retries": 1}
{"idx": 832, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('FSHD') though it provides a more detailed version of the disease name. The supporting sentence is relevant and covers the answer with logical reasoning, but it is slightly verbose compared to the concise gold supporting sentence. The additional details in the supporting sentence are accurate but not strictly necessary for answering the question.\", \"match\": true}", "gold_answer": "FSHD", "gold_support": "Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The supporting sentence that connects the ectopic expression of DUX4 to Facioscapulohumeral muscular dystrophy (FSHD) is:\n\n\"Microinjection of small amounts of human full-length DUX4 (DUX4-fl) mRNA into fertilized zebrafish eggs caused asymmetric abnormalities such as less pigmentation of the eyes, altered morphology of ears, developmental abnormality of fin muscle, disorganization of facial musculature and/or degeneration of trunk muscle later in development.\"\n\nThis sentence demonstrates that the misexpression of DUX4 leads to FSHD-like symptoms, thereby supporting the association between DUX4 ectopic expression and FSHD.", "retries": 1}
{"idx": 833, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer ('gene expression') does not match the gold standard ('development'), but it is related and present in the context. The supporting sentence provides relevant information about gene regulation, yet it does not directly support or mention 'development,' which is the focus of the gold answer. While there is some connection between gene expression and development, the model's response misses the key emphasis on developmental regulation highlighted in the gold standard.\",\n  \"match\": false\n}", "gold_answer": "development", "gold_support": "Organization of conserved elements near key developmental regulators in vertebrate genomes.", "model_answer": "The process that conserved noncoding elements mostly regulate is **gene expression**. These elements act as regulatory sequences, influencing when and where genes are expressed by interacting with transcription factors and other regulatory proteins.", "model_support": "The process that conserved noncoding elements mostly regulate is gene expression. These elements act as regulatory sequences, influencing when and where genes are expressed by interacting with transcription factors and other regulatory proteins. \n\n**Supporting sentence**: These elements are part of the noncoding \"dark matter\" of the genome and are regulatory sequences influencing when and where genes are expressed by interacting with transcription factors and other regulatory proteins.", "retries": 1}
{"idx": 834, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model incorrectly states that the context does not include information about the gene, when in fact the context explicitly mentions a truncating mutation within exon 8 of the ZEB2 gene. Despite this error in the supporting sentence evaluation, the model answer itself is correct and concise.\", \"match\": true}", "gold_answer": "ZEB2", "gold_support": "A case of Mowat-Wilson syndrome caused by a truncating mutation within exon 8 of the ZEB2 gene.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZEB2.\n\nAnswer: ZEB2", "model_support": "The context provided does not include any information about the gene responsible for Mowat-Wilson syndrome. The answer, ZEB2, is based on external knowledge and is not supported by the given text.\n\n**Answer:** The gene responsible for Mowat-Wilson syndrome is ZEB2. However, the context does not provide a supporting sentence for this answer.", "retries": 1}
{"idx": 835, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard ('xa' refers to factor Xa). However, the supporting sentence provided by the model is based on external knowledge rather than the context. The gold supporting sentence from the context directly mentions that drugs like betrixaban belong to the class of direct factor Xa inhibitors, which provides stronger support. While the model's supporting sentence is relevant and correct, it introduces slight redundancy by referencing external pharmacological knowledge unnecessarily.\", \"match\": true}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence is not explicitly provided in the given context, as betrixaban is not mentioned. However, based on external knowledge, betrixaban is known to inhibit factor Xa. \n\nAnswer: Betrixaban inhibits factor Xa. \n\n(Supporting sentence: While not present in the context, betrixaban is recognized as a factor Xa inhibitor in pharmacology.)", "retries": 1}
{"idx": 836, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('repressor'). The supporting sentence is relevant and covers the answer, but it is slightly verbose and less direct compared to the gold supporting sentence. It introduces additional context about oxidative stress and keratinocyte differentiation, which, while correct, are not necessary for answering the specific question about BACH1 being a repressor.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 is a member of the basic leucine zipper transcription factor family, and the Bach1/small Maf heterodimer specifically represses transcriptional activity directed by the Maf recognition element (MARE).", "model_answer": "BACH1 is a repressor of HO-1 expression.", "model_support": "The transcriptional regulator BACH1 is a repressor of HO-1 expression. \n\n**Supporting sentence:**  \n\"Thus, in response to oxidative stress, Bach1 regulates the oxidation state through the negative control of HO-1 expression prior to terminal keratinocyte differentiation.\"", "retries": 1}
{"idx": 837, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'E3 ligase' is a valid shorthand for 'E3 ubiquitin ligase activity.' However, the supporting sentence repeats the answer without adding further context or logical reasoning. The gold supporting sentence provides more comprehensive and precise information about the enzymatic function and its association with tumor suppression. Despite this, the model's supporting sentence is still relevant and supports the answer adequately, albeit with less depth.\", \"match\": true}", "gold_answer": "E3 ubiquitin ligase activity", "gold_support": "The BRCA1 protein displays E3 ubiquitin ligase activity, and this enzymatic function is thought to be required for tumor suppression.", "model_answer": "The enzymatic activity of BRCA1 is that of an E3 ligase.", "model_support": "The enzymatic activity of BRCA1 is that of an E3 ligase.\n\n**Supporting sentence:** BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity.", "retries": 1}
{"idx": 838, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly verbose and includes information about the unusual association with non-small-cell lung cancer, which is not necessary to support the answer. The logic is still sound, but the extra details reduce conciseness.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "LEMS is generally associated with small cell lung cancer occurring in three percent of cases.", "model_answer": "The type of lung cancer most strongly associated with Lambert-Eaton syndrome is small cell lung cancer (SCLC).", "model_support": "The supporting sentence from the context is:\n\n\"CONCLUSION: LEMS occurs because of an immunological reaction against voltage-dependent calcium channels. However, the case that we report shows the unusual association of LEMS with non small-cell lung cancer and highlights the difficulties associated in the management of this condition.\"\n\nThis sentence indicates that the case report describes an unusual association of LEMS with non-small-cell lung cancer (NSCLC), implying that the more strongly associated type is small cell lung cancer (SCLC).", "retries": 1}
{"idx": 839, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, as it correctly identifies thyroid-related abnormalities (hypothyroidism) as common in Williams syndrome. The supporting sentence is relevant and provides clear reasoning by specifying elevated TSH and low FT4 levels, which are indicative of hypothyroidism. However, it slightly reiterates the answer in a verbose manner rather than directly referencing thyroid hypoplasia or broader thyroid dysfunction, which would make it more concise and aligned with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Thyroid hypoplasia is a frequent characteristic of WBS and abnormalities of thyroid function are common in patients with this feature.", "model_answer": "The hormone abnormalities common in Williams syndrome are related to hypothyroidism, characterized by elevated thyroid-stimulating hormone (TSH) and low free thyroxine (FT4) levels.", "model_support": "The hormone abnormalities common in Williams syndrome are characterized by elevated thyroid-stimulating hormone (TSH) and low free thyroxine (FT4) levels, indicating hypothyroidism.\n\n**Supporting Sentence:**  \n\"Thyroid function tests showed a raised TSH (42 mIU/l; normal range 0.5-4 mIU/l) with a low FT(4) concentration (10.21 pmol/l; normal range: 10.29-24.45 pmol/l).\"", "retries": 1}
{"idx": 840, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK'), but it is slightly more verbose than necessary by specifying 'The gene mutation associated with McLeod syndrome.' The supporting sentence directly references the XK gene's association with McLeod syndrome and provides relevant context, though it includes extra details about neuroacanthocytosis-related genes being involved in psychiatric disorders. While this additional information is not strictly necessary, it does not detract significantly from the logic or relevance.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "We performed a comprehensive mutation screen of VPS13A and XK, the gene responsible for ChAc and MLS, respectively, in 85 mood disorder subjects and XK in 86 schizophrenia subjects and compared the variants to 100 or more control alleles.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.", "model_support": "The mutation associated with McLeod syndrome is in the XK gene. \n\n**Supporting Sentence:** \"The presence of a pathogenic mutation or a potentially functional variant in mood disorder or schizophrenia subjects suggests that neuroacanthocytosis-related-genes might be involved in the pathogenesis of these psychiatric disorders. [...] The researchers identified one non-synonymous and one intron variant in mood disorder and schizophrenia subjects, respectively, in XK.\" \n\nThis indicates that mutations in the XK gene are linked to McLeod syndrome, as it is a neuroacanthocytosis-related gene.", "retries": 1}
{"idx": 841, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly (DNMT1). Although the context provided does not explicitly support DNMT1 as the maintenance enzyme within the text itself, the supporting sentence correctly references general biological knowledge that identifies DNMT1 as the maintenance methyltransferase. The logic is clear and aligns with established scientific understanding.\", \"match\": true}", "gold_answer": "DNMT1", "gold_support": "We present in vitro evidence that the mammalian de novo DNA methyltransferases DNMT3A and DNMT3B, but not the maintenance enzyme DNMT1, are also redox-dependent DNA dehydroxymethylases.", "model_answer": "The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.", "model_support": "The context provided does not explicitly mention DNMT1. It focuses on DNMT3A and DNMT3B, discussing their roles in de novo methylation and dehydroxymethylation. Therefore, there is no supporting sentence in the context for DNMT1 being the enzyme involved in maintenance methylation. However, based on general biological knowledge, DNMT1 is known to maintain DNA methylation patterns during replication.\n\nAnswer: The enzyme involved in the maintenance of DNA (cytosine-5-)-methylation is DNMT1.\n\nSupporting sentence: [None provided in the context, but DNMT1 is a known maintenance methyltransferase.]", "retries": 1}
{"idx": 842, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is redundant, as it repeats the answer without offering additional context or reasoning. While the second supporting sentence from the context is relevant and aligns with the gold supporting sentence, the redundancy lowers the score slightly.\",\n  \"match\": true\n}", "gold_answer": "p53", "gold_support": "The p53 gene is a tumor suppressor gene that acts as \"guardian of the genome.\"", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.\n\n**Supporting sentence:**  \n\"The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.\"\n\nThis sentence introduces p53 as the tumor suppressor under discussion, and the context elaborates on its role in maintaining genomic stability, which aligns with the title \"guardian of the genome.\"", "retries": 1}
{"idx": 843, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('7') but is present in the context, as it correctly identifies that there are multiple TAp73 isoforms. However, the supporting sentence mentions the existence of 'a wide range of isoforms' without specifying the number or clearly limiting it to TAp73, making it relevant but too vague to directly support the gold answer.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is more than two. Specifically, there are several splice variants, including TAp73α, TAp73β, and TAp73γ. These are generated through alternative splicing of the p73 gene.", "model_support": "The supporting sentence from the context is:\n\n\"The protein homologous to the tumor suppressor p53, p73, has essential roles in development and tumorigenesis. This protein exists in a wide range of isoforms with different, even antagonistic, functions.\"\n\nThis sentence supports the idea that there are multiple isoforms of p73, including TAp73, but it does not explicitly mention the specific number or types of TAp73 isoforms.", "retries": 1}
{"idx": 844, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xa'), though it is slightly more verbose by specifying 'factor Xa' instead of just 'Xa'. The supporting sentence is relevant and supports the answer, but it includes extra details about PRT4445 that are not necessary to directly answer the question. This makes the reasoning slightly less concise than ideal, though it still logically connects betrixaban to factor Xa inhibition.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The supporting sentence from the context is:\n\n\"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"\n\nThis sentence indicates that betrixaban inhibits factor Xa, as it is associated with a factor Xa decoy and anti-Xa activity.", "retries": 1}
{"idx": 845, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'Xa' exactly, and the supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The minor difference in wording ('Factor Xa' vs. 'Xa') is acceptable as it does not change the meaning.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Betrixaban is an oral direct inhibitor of factor Xa (FXa) being developed for the prevention of venous thromboembolism (VTE).", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is:\n\n\"A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).\"", "retries": 1}
{"idx": 846, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly ('CRISPR-Cas'). The supporting sentence is concise, directly relevant, and explains that the CRISPR-Cas system forms an adaptive immune system in prokaryotes, which aligns with the gold supporting sentence. It includes clear and logical reasoning without excessive content.\", \"match\": true}", "gold_answer": "CRISPR-Cas", "gold_support": "Compelling evidence indicates that the CRISPR-Cas system protects prokaryotes from viruses and other potential genome invaders.", "model_answer": "The analogous process in prokaryotic organisms is known as the CRISPR-Cas system.", "model_support": "The analogous process to RNA interference (RNAi) in eukaryotic organisms in prokaryotic organisms is the CRISPR-Cas system.\n\n**Supporting Sentence:**  \n\"This adaptive prokaryotic immune system arises from the clustered regularly interspaced short palindromic repeats (CRISPRs) found in prokaryotic genomes, which harbor short invader-derived sequences, and the CRISPR-associated (Cas) protein-coding genes.\"", "retries": 1}
{"idx": 847, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it adds 'diagnosing acute' which is implied but not explicitly required. The supporting sentence provides relevant information about the ROSIER scale being used for stroke recognition by detailing its design and purpose, but it contains slight redundancy in mentioning specific clinical signs. Overall, it logically supports the answer while being somewhat verbose.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for diagnosing acute stroke.", "model_support": "The supporting sentence from the context is:\n\n\"A seven-item (total score from -2 to +5) stroke recognition instrument was constructed on the basis of clinical history (loss of consciousness, convulsive fits) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect).\"\n\nThis sentence indicates that the instrument, referred to as the ROSIER scale, is used to recognize and diagnose acute stroke by evaluating specific clinical signs and symptoms.", "retries": 1}
{"idx": 848, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('factor Xa') is correct and matches the gold standard ('xa'), but the supporting sentence states that the context does not mention betrixaban, which is incorrect. The context explicitly mentions that betrixaban belongs to the class of direct factor Xa inhibitors. Thus, while the answer is correct, the supporting sentence fails to reference the relevant information from the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "The majority of the drugs in development belong to the class of direct factor Xa inhibitors (the -xabans).", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context provided does not mention betrixaban. Therefore, it is not possible to determine which clotting factor betrixaban inhibits based on the given information.", "retries": 1}
{"idx": 849, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the model's supporting sentence repeats the answer, it does so in a way that provides additional clarity without introducing irrelevant information.\",\n  \"match\": true\n}", "gold_answer": "15", "gold_support": "The human kallikrein gene family consists of 15 serine proteases.", "model_answer": "The human genome contains 15 tissue kallikrein (KLK) genes, numbered from KLK1 to KLK15. \n\nAnswer: 15", "model_support": "The human genome contains 15 tissue kallikrein (KLK) genes, numbered from KLK1 to KLK15. \n\nSupporting sentence: KLK1, 4, 5, 6, 7, 8, 10, 11, 13, and 14 are expressed in both cerebral cortex and hippocampus. KLK9 is expressed in cortex but not hippocampus, whereas KLK2, 3, 12, and 15 are not expressed in either tissue.", "retries": 1}
{"idx": 850, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides information about dermatitis herpetiformis, but it includes additional details about jejunal villous atrophy and gastrointestinal symptoms, which are not directly necessary to support the answer. This makes it slightly verbose compared to the gold supporting sentence, which is more concise.\", \"match\": true}", "gold_answer": "dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet.", "model_answer": "The typical rash associated with gluten is dermatitis herpetiformis.", "model_support": "The supporting sentence is:\n\n\"These results confirm that most children with dermatitis herpetiformis have jejunal villous atrophy, though they rarely have gastrointestinal symptoms.\"", "retries": 1}
{"idx": 851, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('phosphatase 2B') by identifying the correct enzyme, although it provides additional names (Calcineurin, PP2B) which are accurate but not required. The supporting sentence is relevant and supports the answer well, but contains minor redundancy when mentioning both 'Dephosphorylation of NFAT by CaN' and repeating the alternate names for calcineurin.\",\n  \"match\": true\n}", "gold_answer": "phosphatase 2B", "gold_support": "The activity of NFAT proteins is tightly regulated by the Ca(2+)/calmodulin-dependent protein phosphatase 2B/calcineurin (CaN).", "model_answer": "Calcineurin, also known as Protein Phosphatase 2B (PP2B), is the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors. It dephosphorylates NFAT, allowing it to enter the nucleus and regulate gene transcription.", "model_support": "The supporting sentence is: \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\" This indicates that Calcineurin (CaN), also known as Protein Phosphatase 2B (PP2B), is the calcium/calmodulin-dependent protein phosphatase involved in NFAT activation.\n\n**Answer:** Calcineurin, also known as Protein Phosphatase 2B (PP2B), is the calcium/calmodulin-dependent protein phosphatase involved in NFAT activation. It dephosphorylates NFAT, enabling its nuclear translocation to regulate gene transcription.\n\n**Supporting Sentence:** \"Dephosphorylation of NFAT by CaN is required for NFAT nuclear localization.\"", "retries": 1}
{"idx": 852, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it introduces slight redundancy by mentioning synphilin-1, which is not necessary to directly support the answer about alpha-synuclein being the main component of Lewy bodies. The logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease, the inclusion bodies are referred to as Lewy bodies and their main component is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is **alpha-synuclein**.", "model_support": "The main component of Lewy bodies is **alpha-synuclein**, as supported by the context which states that synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies. This indicates that alpha-synuclein is a key component of Lewy bodies.\n\n**Supporting sentence:** \"Synphilin-1 interacts with alpha-synuclein and is present in Lewy bodies.\"", "retries": 1}
{"idx": 853, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('JNK'). The supporting sentence provided by the model is relevant and directly ties DUSP8 activation to JNK, which aligns with the context. However, it repeats the answer verbatim, introducing slight redundancy. The gold supporting sentence is more detailed and explicitly mentions the down-regulation of JNK phosphatases, offering richer context. Despite this, the model's supporting sentence still logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "JNK", "gold_support": "Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate.", "model_answer": "The protein affected by DUSP8 activation is JNK.", "model_support": "The protein affected by DUSP8 activation is JNK. \n\nSupporting sentence: These results suggest that JNK activation by H₂O₂ plus PDTC resulted from the down-regulation of JNK phosphatases.\n\nNote: While the context does not explicitly mention DUSP8, it discusses the role of JNK phosphatases in regulating JNK activity, which is consistent with the known function of DUSP8 in dephosphorylating and inactivating JNK.", "retries": 1}
{"idx": 854, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Calcineurin') and is accurate. The supporting sentence provided by the model is relevant and supports the role of calcineurin in NFAT activation, but it indirectly references cardiovascular and skeletal muscle development rather than directly describing calcineurin as a calcium/calmodulin-dependent phosphatase. While logical, it contains slight redundancy compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin is a calmodulin-dependent, calcium-activated protein phosphatase composed of catalytic and regulatory subunits.", "model_answer": "Calcineurin is the calcium/calmodulin-dependent protein phosphatase involved in the activation of NFAT transcription factors. It dephosphorylates NFAT, enabling it to enter the nucleus and regulate gene expression.", "model_support": "The supporting sentence that explicitly links calcineurin to its role in activating NFAT transcription factors is:\n\n\"Recent studies have demonstrated the vital nature of calcium/calcineurin/NFAT signaling in cardiovascular and skeletal muscle development in vertebrates.\"\n\nThis sentence shows that calcineurin is part of the pathway that activates NFAT, confirming its role as the calcium/calmodulin-dependent protein phosphatase involved in NFAT activation.", "retries": 1}
{"idx": 855, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('XK'), though it is slightly more verbose by specifying 'the XK gene' instead of just 'XK'. The supporting sentence provided by the model is identical to its answer, which is redundant but still relevant and covers the gold answer. However, the gold supporting sentence is more detailed and directly tied to the hematological characteristics caused by the XK gene defects, making the model's choice less ideal but still logical.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "The McLeod phenotype is derived from various forms of XK gene defects that result in the absence of XK protein, and is defined hematologically by the absence of Kx antigen, weakening of Kell system antigens, and red cell acanthocytosis.", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene.", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene.\n\n**Supporting sentence:**  \n\"MLS is an X-linked multi-system disorder caused by absence of XK alone, or when the disorder is caused by large deletions, it may be accompanied with Duchenne muscular dystrophy (DMD), chronic granulomatous disease (CYBB), retinitis pigmentosa (RPGR), and ornithine transcarbamylase deficiency (OTC).\"", "retries": 1}
{"idx": 856, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but contains some redundancy, as it discusses uncertainty regarding APP isoforms rather than directly stating that alpha-synuclein is the main component of Lewy bodies. The gold supporting sentence is more concise and directly ties APP to alpha-synuclein as the main component.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "Amyloid precursor protein (APP) is involved in the accumulation of alpha-synuclein, the main component of Lewy bodies.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "Supporting sentence: It is currently unknown, however, whether any of the APP isoforms is instrumental in alpha-synuclein deposition in dementia with Lewy bodies (DLB).", "retries": 1}
{"idx": 857, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it states that the number of TAp73 isoforms in humans is not specified, whereas the gold answer clearly identifies it as 7. The supporting sentence is also incorrect and overly verbose, discussing irrelevant details about mice without addressing the actual question regarding humans. The model fails to provide relevant or accurate information.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The context does not provide specific information on the number of TAp73 isoforms identified in humans. It only discusses the isoforms in mice. Therefore, based on the provided context, the number of TAp73 isoforms in humans is not specified. \n\nAnswer: The context does not specify the number of TAp73 isoforms identified in humans.", "model_support": "The context does not provide specific information regarding the number of TAp73 isoforms identified in humans. It focuses on the study of p73 isoforms in mice, discussing the effects of complete p73 deficiency and selective DeltaNp73 deficiency. However, it does not mention the number of TAp73 isoforms in humans. \n\n**Answer:** The context does not specify the number of TAp73 isoforms identified in humans.", "retries": 1}
{"idx": 858, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('FSHD'). The supporting sentence is concise, directly relevant, and provides clear reasoning by summarizing how DUX4's ectopic expression is linked to FSHD through chromatin relaxation and stable expression in skeletal muscle. Although slightly more detailed than the gold supporting sentence, it remains focused and logically supports the answer without unnecessary information.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "SUMMARY: Recent studies have provided a plausible disease mechanism for FSHD in which FSHD results from inappropriate expression of the germline transcription factor DUX4.", "model_answer": "The disease associated with the ectopic expression of the DUX4 protein is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the DUX4 protein is Facioscapulohumeral muscular dystrophy (FSHD). \n\n**Supporting Sentence:** \"In the majority of cases, FSHD is caused by contraction of the D4Z4 repeat array (FSHD1). This results in local chromatin relaxation and stable expression of the DUX4 retrogene in skeletal muscle, but only when a polymorphic DUX4 polyadenylation signal is present.\" \n\nThis sentence directly links the disease FSHD to the ectopic expression of DUX4, as it explains how the contraction of the D4Z4 repeat array leads to chromatin relaxation and subsequent stable expression of DUX4 in skeletal muscle.", "retries": 1}
{"idx": 859, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('fungi') in meaning, though it is slightly more verbose by specifying 'the kingdom Fungi.' The supporting sentence is relevant and supports the answer by indicating a close evolutionary relationship with zygomycetes, which are part of the fungi. However, it does not directly reference the key idea from the gold supporting sentence that microsporidia are either within the kingdom or a sister group to it, making it slightly less comprehensive than ideal.\", \"match\": true}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the kingdom Fungi according to their current classification.", "model_support": "Supporting sentence: Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.", "retries": 1}
{"idx": 860, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Acute stroke,' is very close to the gold standard 'stroke' and captures the essential meaning. The supporting sentence is relevant and directly references the ROSIER scale's role in differentiating acute stroke, aligning well with the gold supporting sentence. However, the model supporting sentence could be slightly more concise as it introduces minor redundancy by specifying 'in the ER,' which is implied in the context.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the initial differentiation of acute stroke from stroke mimics in the emergency room (ER). It helps in recognizing acute strokes promptly, improving the appropriateness of referrals to the stroke team.\n\nAnswer: Acute stroke", "model_support": "Supporting sentence: The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.", "retries": 1}
{"idx": 861, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence provided by the model is less direct compared to the gold supporting sentence. The model's supporting sentence discusses the genetic test and DNA deletion but does not explicitly state 'autosomal dominant mode of inheritance' as the gold supporting sentence does. Despite this, the logic connecting the genetic basis to autosomal dominant inheritance is reasonable, though slightly indirect.\",\n  \"match\": true\n}", "gold_answer": "autosomal dominant", "gold_support": "Facioscapulohumeral muscular dystrophy (FSHD) is a neuromuscular disease, characterized by an autosomal dominant mode of inheritance, facial involvement, and selectivity and asymmetry of muscle involvement.", "model_answer": "The mode of inheritance for Facioscapulohumeral muscular dystrophy (FSHD) is autosomal dominant.", "model_support": "The supporting sentence that suggests the genetic basis of FSHD, leading to the inference of its mode of inheritance, is:\n\n\"The diagnosis of FSHD is based on a genetic test by which a deletion of 3.3kb DNA repeats (named D4Z4 and mapping to the subtelomeric region of chromosome 4q35) is identified.\"\n\nWhile the context does not explicitly state the mode of inheritance, the mention of a genetic test and specific DNA deletion implies a hereditary condition, commonly associated with autosomal dominant inheritance in FSHD.", "retries": 1}
{"idx": 862, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, as the ROSIER scale is indeed used for stroke recognition. However, the model's answer is slightly more verbose than necessary, providing additional details about its function in evaluating suspected stroke and improving outcomes, which are not required by the gold answer. The supporting sentence is relevant and supports the answer well, but it includes extra information about the instrument's construction that is not directly needed to justify the answer. This makes it slightly redundant, though still logically sound.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for evaluating suspected stroke in the emergency room. It helps medical staff recognize stroke symptoms accurately and promptly, improving treatment outcomes.", "model_support": "The supporting sentence from the context that aligns with the function of the ROSIER scale is:\n\n\"A seven-item (total score from -2 to +5) stroke recognition instrument was constructed on the basis of clinical history (loss of consciousness, convulsive fits) and neurological signs (face, arm, or leg weakness, speech disturbance, visual field defect).\"\n\nThis sentence describes the creation of an instrument for stroke recognition in the emergency room, which corresponds to the purpose of the ROSIER scale.", "retries": 1}
{"idx": 863, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that KN-93 inhibits CaM kinase II, aligning well with the gold supporting sentence. There is no redundancy or verbosity, and the reasoning is clear.\",\n  \"match\": true\n}", "gold_answer": "CaM kinase II", "gold_support": "CaM kinase II activation was inhibited by KN-93 pretreatment (IC(50) approximately 1 microM).", "model_answer": "CaM kinase II", "model_support": "The small molecule KN-93 inhibits CaM kinase II. \n\nSupporting sentence: \"KN-93 appears to target a step(s) essential for force maintenance in response to physiological stimuli, suggesting a role for CaM kinase II in regulating tonic contractile responses in arterial smooth muscle.\"", "retries": 1}
{"idx": 864, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence selected by the model is not ideal because it references multiple system atrophy rather than Parkinson's disease or Lewy body dementia, which are more directly relevant to the question about Lewy bodies. The provided gold supporting sentence is more precise and directly addresses the role of alpha-synuclein in Lewy bodies. Despite this, the chosen supporting sentence still contains accurate information about alpha-synuclein forming inclusions, leading to a score of 4.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "In Parkinson's disease and Lewy body dementia, alpha-synuclein is the main component of Lewy bodies and dystrophic neurites; alpha-synuclein also accumulates in the cytoplasm of glial cells.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein.\n\n**Supporting sentence:** In multiple system atrophy, alpha-synuclein conforms the cytoplasmic oligodendroglial inclusions and the neuronal inclusions which are the hallmark of this disease.", "retries": 1}
{"idx": 865, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard ('stroke') in essence, though it is more descriptive than the concise gold answer. The supporting sentence from the model is relevant and captures the correct purpose of the ROSIER scale, but it contains slight redundancy by specifying 'differentiation of stroke from other stroke mimics,' which is implied in the context. Overall, the logic is sound, but a more concise phrasing would improve the score.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute strokes in the emergency room setting, aiding in the differentiation of stroke from other stroke mimics.", "model_support": "The supporting sentence is: \n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"\n\nThis sentence directly states the purpose and setting of the ROSIER scale, confirming its use in recognizing acute strokes in the emergency room.", "retries": 1}
{"idx": 866, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but focuses on describing the rash rather than naming the condition itself. The supporting sentence is somewhat relevant and supports the description of the rash, but it does not directly name 'Dermatitis herpetiformis' as the gold supporting sentence does. The logic is reasonable but could be more precise by naming the condition explicitly.\",\n  \"match\": false\n}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is a papulovesicular rash, commonly seen in dermatitis herpetiformis.", "model_support": "Supporting sentence: It presents as a papulovesicular rash and is often associated with enteropathy.", "retries": 1}
{"idx": 867, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('xa' refers to 'factor Xa'). The supporting sentence is relevant and aligns with the gold supporting sentence, but it contains slight redundancy by mentioning other anticoagulants (rivaroxaban and apixaban) when it could directly focus on betrixaban. The logic is strong, but more concise phrasing would improve it.\",\n  \"match\": true\n}", "gold_answer": "xa", "gold_support": "Betrixaban is a new direct factor Xa inhibitor with distinct pharmacological characteristics, including a long half-life, minimal renal clearance and minimal hepatic metabolism.", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The answer is that betrixaban inhibits factor Xa. Although the context does not explicitly state this, it can be inferred from the discussion of betrixaban as an anticoagulant, similar to other factor Xa inhibitors like rivaroxaban and apixaban.\n\nSupporting sentence: Betrixaban is an oral anticoagulant, similar to other new oral anticoagulants like rivaroxaban and apixaban, which are known to inhibit factor Xa.", "retries": 1}
{"idx": 868, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard by correctly identifying 'Xist' as the transcript responsible for X-chromosome inactivation. The supporting sentence is relevant and provides a logical connection between Xist and its role in controlling Xi replication through inducible expression. However, it includes additional details about mutations, chemical inhibition, and histone hypoacetylation, which are not directly necessary to support the answer, making it slightly redundant compared to the more concise gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Ectopic expression of the X-inactive-specific transcript (Xist) gene from an autosome imposed the same synchronous replication pattern.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist (X-inactive specific transcript).", "model_support": "The supporting sentence is:  \n\"We used mutations and chemical inhibition affecting different epigenetic marks as well as inducible Xist expression and we demonstrate that histone hypoacetylation has a key role in controlling Xi replication.\"\n\nThis sentence supports the answer by mentioning the use of inducible Xist expression, directly linking Xist to the process of X-inactivation.", "retries": 1}
{"idx": 869, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa') in essence by correctly identifying factor Xa as the target of betrixaban. However, it provides additional information not required by the question, making it somewhat verbose. The supporting sentence from the model is logically sound but relies on external knowledge rather than the provided context, while the gold supporting sentence directly references the context. Slight redundancy and lack of direct context lead to a score of 4.\", \"match\": true}", "gold_answer": "xa", "gold_support": "New oral anticoagulants are directed towards a single target, essentially factor Xa (FXa) or factor IIa.", "model_answer": "Betrixaban inhibits factor Xa, a key clotting factor in the coagulation cascade. It is classified as a direct factor Xa inhibitor, along with other drugs like rivaroxaban and apixaban. By targeting factor Xa, betrixaban prevents the conversion of prothrombin to thrombin, thereby inhibiting blood clot formation. This specific mechanism makes it effective for preventing clots in conditions such as after surgery or in atrial fibrillation patients.", "model_support": "The context does not explicitly mention betrixaban, so there is no supporting sentence within the provided text. However, based on external knowledge, betrixaban is a direct factor Xa inhibitor.\n\nAnswer: Betrixaban inhibits factor Xa, a key clotting factor in the coagulation cascade. However, the context does not explicitly mention betrixaban, so there is no supporting sentence provided here.", "retries": 1}
{"idx": 870, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation by mentioning the prevalence of non-synonymous mutations in driver genes, which aligns with the context. However, it includes slight redundancy by specifying TP53 and EP300, which, while accurate, are not necessary to justify the answer. The gold supporting sentence is more concise.\",\n  \"match\": true\n}", "gold_answer": "non-synonymous", "gold_support": "We identified 101 single-nucleotide variants (SNVs) including 77 non-synonymous SNVs (67 missense and 10 nonsense mutations) and 11 INDELs causing frameshifts.", "model_answer": "Answer: Non-synonymous.", "model_support": "The answer to the question is that most driver gene mutations are non-synonymous. This conclusion is supported by the study's findings, which identified a majority of non-synonymous mutations, including missense and nonsense mutations, in key driver genes such as TP53 and EP300. These mutations are significant in driving cancer development.\n\n**Supporting Sentence:**  \n\"We verified 62 of the SNVs (51 missense, 10 nonsense and 1 splicing-site mutation) and 10 of the INDELs as somatic mutations in lung cancer tissue.\"", "retries": 1}
{"idx": 871, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Bcr-Abl tyrosine kinase,' is very close to the gold standard 'BCR-ABL' but includes additional descriptive terms ('tyrosine kinase') that are accurate but not strictly necessary. The supporting sentence is relevant and provides logical support by mentioning the re-establishment of the Bcr-Abl signaling pathway in resistance to imatinib, though it does not directly reference the enhanced tyrosine kinase activity as the principal cause of leukemia, which would have made it more concise and fully aligned with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia cells contain a BCR-ABL oncoprotein with an enhanced tyrosine kinase activity, which is considered to be the principal 'cause' of the leukemia.", "model_answer": "Answer: Bcr-Abl tyrosine kinase", "model_support": "The tyrosine kinase targeted by Imatinib is the Bcr-Abl tyrosine kinase. \n\n**Supporting sentence:** \"In patients with chronic myeloid leukaemia who develop resistance to imatinib, the Bcr-Abl signaling pathway is often re-established.\"", "retries": 1}
{"idx": 872, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('human kallikrein 5 (hK5)') does not match the gold standard ('LEKTI'). However, hK5 is mentioned in the context as a protease involved in the molecular cascades related to Netherton syndrome. The supporting sentence mentions hK5's role in initiating molecular cascades leading to the disease phenotype, which makes it relevant but does not cover the gold answer (LEKTI). Thus, while the answer is incorrect, the supporting sentence provides some relevance to the broader context of the disease.\", \"match\": false}", "gold_answer": "LEKTI", "gold_support": "Netherton syndrome is caused by loss-of-function mutations in SPINK5 encoding the Kazal-type inhibitor LEKTI-1 leading to dysregulation of proteolytic cascades involving several kallikreins.", "model_answer": "The protein causing Netherton syndrome is human kallikrein 5 (hK5).", "model_support": "The protein causing Netherton syndrome is human kallikrein 5 (hK5).\n\n**Supporting sentence:** \"human kallikrein 5 (hK5), a serine protease (trypsin-like) that plays a central role in the initiation of the molecular cascades leading to the Netherton syndrome phenotype.\"", "retries": 1}
{"idx": 873, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than the gold standard. It explains the purpose of the ROSIER scale in detail, which is not required for a direct match with the gold answer. The supporting sentence is somewhat lengthy and includes information about the method of development (logistic regression analysis), which is not directly relevant to the simple fact that the ROSIER scale is used for stroke recognition. However, it still logically supports the answer by indicating the instrument's application in stroke recognition.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing strokes in emergency room settings to facilitate timely medical intervention.", "model_support": "The supporting sentence from the context that aligns with the answer about the ROSIER scale's use is:\n\n\"We used logistic regression analysis and clinical reasoning to develop a stroke recognition instrument for application in this setting.\"\n\nThis sentence indicates the purpose of the instrument, which is to recognize strokes in the emergency room setting, consistent with the ROSIER scale's application.", "retries": 1}
{"idx": 874, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('interleukin-5'), and the supporting sentence provides relevant information that logically supports the answer. However, the supporting sentence includes additional details about IL-5's role and the mechanism of Mepolizumab, which, while accurate, are not directly necessary to support the answer. The gold supporting sentence is more concise and directly extracted from the context, making it slightly preferable.\", \"match\": true}", "gold_answer": "interleukin-5", "gold_support": "Subjects received infusions of either mepolizumab, an anti-interleukin-5 monoclonal antibody (29 subjects), or placebo (32) at monthly intervals for 1 year.", "model_answer": "Mepolizumab targets interleukin-5 (IL-5), a cytokine crucial for eosinophil survival and activity. By binding to IL-5, Mepolizumab prevents it from acting on eosinophils, reducing their levels and improving asthma symptoms in patients with refractory eosinophilic asthma. \n\nAnswer: Interleukin-5 (IL-5)", "model_support": "Answer: Interleukin-5 (IL-5)\n\nSupporting sentence: The context does not explicitly mention that Mepolizumab targets interleukin-5 (IL-5). However, based on prior knowledge, Mepolizumab is known to target IL-5, which is crucial for eosinophil survival and activity, thereby reducing eosinophil levels and improving asthma symptoms in patients with refractory eosinophilic asthma. \n\n(Note: The supporting sentence is not explicitly present in the provided context but is inferred from external knowledge about Mepolizumab.)", "retries": 1}
{"idx": 875, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but has slight redundancy by discussing therapy rather than directly stating SERCA's role as the calcium pump. It could be more concise and directly focused on defining SERCA's function.\", \"match\": true}", "gold_answer": "Sarcoplasmic reticulum Ca(2+)-ATPase", "gold_support": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is **SERCA**.", "model_support": "The supporting sentence is: \"Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.\" This sentence identifies SERCA as the main calcium pump in the sarcoplasmic reticulum. \n\n**Answer:** The main calcium pump of the sarcoplasmic reticulum is **SERCA**.  \n**Supporting sentence:** \"Modulation of SERCA activity may represent an approach to the therapy of diseases with SERCA impairment involvement.\"", "retries": 1}
{"idx": 876, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and matches the gold standard conceptually, though it includes extra details ('which is the ligand for RANK receptors') that are not strictly necessary. The supporting sentence provides relevant information about RANKL but is slightly verbose and does not directly state the action of Denosumab as clearly as the gold supporting sentence. The logic is strong, but some redundancy reduces the score.\",\n  \"match\": true\n}", "gold_answer": "RANKL", "gold_support": "Initials studies have demonstrated that targeting RANK/ RANKL signaling with the fully human monoclonal antibody denosumab prevented skeletal complications in patients with MM and other cancers with bone metastases.", "model_answer": "Denosumab (Prolia) binds to RANKL, which is the ligand for RANK receptors.", "model_support": "Supporting sentence: Recent advances in the pathobiology of MM-related bone disease and other cancer-related bone metastases have led to the identification of novel therapeutic targets, such as receptor activator of nuclear factor-kappaB (RANK); its ligand (RANKL); and a decoy receptor, osteoprotegerin, for the development of potential targeted agents.", "retries": 1}
{"idx": 877, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('stroke') in meaning, though it is slightly more verbose by saying 'recognizing stroke' instead of just 'stroke.' The supporting sentence is relevant and provides logical support for the answer, but it contains a bit more detail than necessary. It could be more concise, as the gold supporting sentence demonstrates. Overall, the logic is sound, and the information directly relates to the question.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "The ROSIER scale is used for recognizing stroke.", "model_support": "Supporting sentence: emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.", "retries": 1}
{"idx": 878, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer correctly identifies the tyrosine kinase targeted by Imatinib as 'ABL kinase, specifically the BCR-ABL fusion protein,' which matches the gold standard 'BCR-ABL.' However, it is slightly more verbose than necessary. The supporting sentence provides accurate and relevant information about the BCR-ABL fusion protein and its role in Ph+ CML, but includes extra details about the mechanism of leukemia progression that are not strictly needed to support the answer. This makes the supporting sentence somewhat redundant, though still logically sound.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is triggered by constitutively activated BCR-ABL and SRC family tyrosine kinases.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia (Ph+ CML) is the ABL kinase, specifically the BCR-ABL fusion protein. This protein drives leukemia progression through its constitutive tyrosine kinase activity, which Imatinib inhibits to halt cancer cell growth.", "model_support": "Imatinib (Gleevec) targets the ABL tyrosine kinase, specifically the BCR-ABL fusion protein, which is characteristic of Philadelphia-chromosome positive chronic myelogenous leukemia (Ph+ CML). This protein is formed due to the translocation of chromosomes 9 and 22, leading to unregulated tyrosine kinase activity that drives leukemia progression. Imatinib inhibits this activity, effectively halting cancer cell growth and survival.\n\n**Supporting Sentence:**  \n\"Imatinib has few inhibitory effects on SRC tyrosine kinase with response rate of Ph+ ALL lower and relapse more frequent and quicker compared with CML.\"\n\nThis sentence highlights that imatinib's effectiveness is lower in Ph+ ALL compared to CML, suggesting its primary target is the ABL kinase in CML.", "retries": 1}
{"idx": 879, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it contains slight redundancy by mentioning 'comparable among alternative polyadenylation sites,' which is not directly related to the gold supporting sentence's focus on differences in H3K36Me3 patterns around cleavage sites. Overall, the logic is sound but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "H3K36Me3", "gold_support": "We also observe that the histone modification mark, histone H3 lysine 36 tri-methylation (H3K36Me3), exhibits different patterns around the cleavage sites of genes using multiple polyadenylation sites from those of genes using a single polyadenylation site.", "model_answer": "The histone trimethylation associated with RNA splicing is H3K36 trimethylation (H3K36Me3).", "model_support": "The supporting sentence is: \"Surprisingly, the H3K36Me3 levels are comparable among the alternative polyadenylation sites themselves.\" This indicates that H3K36Me3 is associated with RNA splicing through its involvement in polyadenylation processes.", "retries": 1}
{"idx": 880, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that JTV519 is derived from the 1,4-benzothiazepine group, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "In this article, we synthesize derivatives of the channel activator 4-chloro-3-methyl phenol (4-CmC) and the 1,4-benzothiazepine channel inhibitor 4-[-3{1-(4-benzyl) piperidinyl}propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine (K201, JTV519) with enhanced electron donor properties.", "model_answer": "The drug JTV519 is a derivative of the chemical group 1,4-benzothiazepine.\n\nAnswer: 1,4-benzothiazepine", "model_support": "The drug JTV519 is a derivative of the chemical group 1,4-benzothiazepine.\n\nSupporting sentence: \"JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker...\"", "retries": 1}
{"idx": 881, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes extra details that, while relevant, make it less concise than ideal. The supporting sentence provides relevant information about thyroid abnormalities but is more focused on specific study findings rather than directly stating the core issue of impaired thyroid hormone synthesis as described in the gold supporting sentence. Logic is reasonable, but the response could be more succinct.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "Pendred syndrome consists in sensorineural deafness, goiter and impaired thyroid hormone synthesis while in EVA thyroid function seems to be preserved.", "model_answer": "The hormone abnormalities characteristic of Pendred syndrome are primarily related to the thyroid gland, including hypothyroidism and issues with thyroid hormone production. This condition often results in an enlarged thyroid (goiter), elevated thyroglobulin levels, and impaired iodine uptake, affecting the production of thyroxine (T4) and triiodothyronine (T3).", "model_support": "Supporting sentence: Patients with mutations in the SLC26A4 gene had larger thyroid volume (p<0.002), higher serum thyroglobulin (Tg) levels (p<0.002) and greater radioiodine discharge after perchlorate (p=0.09) than patients without mutations.", "retries": 1}
{"idx": 882, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly, identifying BACH1 as a 'repressor.' The supporting sentence is concise, directly relevant, and logically explains that the absence of Bach1 leads to high HO-1 expression, which clearly supports the conclusion that BACH1 acts as a repressor. This aligns well with the gold supporting sentence without unnecessary verbosity.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "BACH1 acts as a transcriptional repressor.", "model_support": "The transcriptional regulator BACH1 acts as a repressor. This conclusion is supported by the observation that in the absence of Bach1, the HO-1 gene is expressed at high levels under normal conditions, indicating that Bach1 normally suppresses its expression.\n\n**Supporting Sentence:**\n\"Gene targeting experiments in mice revealed that, in the absence of Bach1, ho-1 became expressed constitutively at high levels in various tissues under normal physiological conditions.\"", "retries": 1}
{"idx": 883, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer, 'recognizing acute stroke,' matches the gold standard 'stroke' conceptually and is appropriately concise. The supporting sentence directly and concisely states the purpose of the ROSIER scale in differentiating acute stroke, aligning well with the gold supporting sentence while maintaining clarity and relevance.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke.", "model_support": "The supporting sentence is:\n\n**\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**\n\nThis sentence directly states the purpose of the ROSIER scale, confirming its use in recognizing acute stroke.", "retries": 1}
{"idx": 884, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes a slight redundancy by mentioning Cockayne syndrome gene products when it wasn't necessary to justify the answer. Despite this, the logic connecting TCR to the transcribed strand is clear.\", \"match\": true}", "gold_answer": "the transcribed strand", "gold_support": "NER can operate via two subpathways: global genome repair (GGR) and a specialized pathway coupled to active transcription (transcription-coupled repair, TCR) and directed to DNA lesions in the transcribed strand of active genes.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "The supporting sentence from the context is:\n\n\"In TCR the Cockayne syndrome (CS) gene products are key players in the recognition of a stalled RNA polymerase the presumed signaling structure for repair of transcribed strands.\"\n\nThis sentence indicates that transcription-coupled repair (TCR) targets the transcribed strands of DNA.", "retries": 1}
{"idx": 885, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('fungi'). The supporting sentence provided by the model is relevant and supports the answer, but it contains slight redundancy and verbosity. While the logic is strong, a more concise explanation would improve the clarity. The chosen supporting sentence from the context is accurate but could be simplified for better alignment with the scoring criteria.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "The kingdom to which microsporidia belong, according to their current classification, is:\n\n**Fungi**", "model_support": "**Step-by-Step Explanation:**\n\n1. **Introduction of Microsporidia:** The context identifies microsporidia as eukaryotic pathogens with a broad host range, including animals and protists.\n\n2. **Phylogenetic Relationship:** Recent studies indicate a close evolutionary link between microsporidia and zygomycetes, a fungal group.\n\n3. **Shared Genomic Features:** The presence of unique gene pairs in both fungi and microsporidia supports their classification under the same kingdom.\n\n4. **Sex-Related Locus Analysis:** The discussion of shared loci and genomic structures further aligns microsporidia with fungi.\n\n5. **Conclusion:** Based on phylogenetic studies and shared genomic features, microsporidia are classified within the Fungi kingdom.\n\n**Answer:**\n\nMicrosporidia belong to the kingdom **Fungi** according to their current classification.\n\n**Supporting Sentence:**  \n\"Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.\"", "retries": 1}
{"idx": 886, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The supporting sentence from the context is:\n\n\"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"", "retries": 1}
{"idx": 887, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer 'Betrixaban inhibits factor Xa' is correct and aligns with the gold standard 'Xa'. However, the supporting sentence provided by the model is somewhat misleading. It mentions fondaparinux and discusses parenteral administration, which does not directly support the specific role of betrixaban as an orally active direct factor Xa inhibitor. The reasoning mixes relevant and less relevant content, making it less concise and clear than ideal. The gold supporting sentence more directly identifies betrixaban within the group of orally active direct factor Xa inhibitors.\", \"match\": true}", "gold_answer": "Xa", "gold_support": "Novel anticoagulants in clinical testing include orally active direct factor II inhibitors [dabigatran etexilate (BIBR 1048), AZD0837)], parenteral direct factor II inhibitors (flovagatran sodium), orally active direct factor X inhibitors [rivaroxaban (BAY 59-7939), apixaban, betrixaban, YM150, DU-176b, LY-517717, GW813893, TAK-442, PD 0348292] and new parenteral FXa inhibitors [idraparinux, idrabiotaparinux (biotinilated idraparinux; SSR 126517), ultra-low-molecular-weight heparins (ULMWH: AVE5026, RO-14)].", "model_answer": "Betrixaban inhibits factor Xa.", "model_support": "The context discusses the anticoagulant fondaparinux, which inhibits factor Xa. Although betrixaban isn't explicitly mentioned, it is inferred to inhibit the same factor based on its classification as a similar anticoagulant.\n\n**Supporting sentence:** These anticoagulants are effective, but they require parenteral administration (UFH, LMWH, fondaparinux) and/or frequent anticoagulant monitoring (intravenous UFH, oral VKA).", "retries": 1}
{"idx": 888, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein. \n\nSupporting sentence: \"Accumulating evidence suggests that its aggregation constitutes one of the first steps preceding Lewy body formation...\"", "retries": 1}
{"idx": 889, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'SERCA2a', is very close to the gold standard 'SERCA2', differing only in the specific nomenclature (full term vs. abbreviation). The supporting sentence is relevant and supports the answer by emphasizing SERCA2a's critical role in cardiac function, but it does not explicitly mention that SERCA2a is the main calcium pump of the sarcoplasmic reticulum, which results in slight ambiguity. Therefore, while the answer matches closely and the logic is strong, a minor lack of precision in the supporting sentence prevents a perfect score.\",\n  \"match\": true\n}", "gold_answer": "SERCA2", "gold_support": "The calcium pump SERCA2a (sarcoplasmic reticulum calcium ATPase 2a), which plays a central role in cardiac contraction, shows decreased expression in heart failure (HF).", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA2a.", "model_support": "The supporting sentence from the context is:\n\n\"Increasing SERCA2a expression in HF models improves cardiac function.\"\n\nThis sentence indicates that SERCA2a plays a crucial role in calcium handling within the heart, thereby confirming it as the main calcium pump of the sarcoplasmic reticulum.", "retries": 1}
{"idx": 890, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'SCF-beta-Trcp,' is technically correct but slightly more detailed than the gold answer 'beta-Trcp,' which focuses on the specific F-box protein component of the SCF complex responsible for the ubiquitination. The supporting sentence provided by the model does not directly support the answer as it discusses Tyk2's stabilization of IFNAR1 rather than beta-Trcp's role in ubiquitination. However, the model answer correctly identifies the E3 ligase, and the context logically supports the role of beta-Trcp, warranting a score of 4.\",\n  \"match\": true\n}", "gold_answer": "beta-Trcp", "gold_support": "Ubiquitination, endocytosis, and lysosomal degradation of the IFNAR1 (interferon alpha receptor 1) subunit of the type I interferon (IFN) receptor is mediated by the SCFbeta-Trcp (Skp1-Cullin1-F-box protein beta transducin repeat-containing protein) E3 ubiquitin ligase in a phosphorylation-dependent manner.", "model_answer": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is SCF-beta-Trcp.\n\nAnswer: SCF-beta-Trcp", "model_support": "The E3 ubiquitin ligase that mediates the ubiquitination and degradation of the interferon receptor type 1 (IFNAR1) is SCF-beta-Trcp.\n\n**Supporting Sentence:**\n\"Expression of Tyk2 stabilized IFNAR1 in a manner that was dependent neither on its binding to beta-Trcp nor IFNAR1 ubiquitination.\"", "retries": 1}
{"idx": 891, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('fungi'), and the supporting sentence is relevant and covers the answer. However, the supporting sentence contains slight redundancy by mentioning 'zygomycetes' specifically, which is not necessary to directly support the classification of microsporidia within the fungi kingdom. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "fungi", "gold_support": "The preponderance of evidence as to the origin of the microsporidia reveals a close relationship with the fungi, either within the kingdom or as a sister group to it.", "model_answer": "Microsporidia belong to the kingdom **Fungi** according to their current classification scheme.", "model_support": "Microsporidia belong to the kingdom **Fungi** according to their current classification scheme, as indicated by their close evolutionary relationship with zygomycetes and shared genomic features.\n\n**Supporting sentence:** \"Recent phylogenetic studies and gene order analysis suggest that microsporidia share a particularly close evolutionary relationship with the zygomycetes.\"", "retries": 1}
{"idx": 892, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer '1,4-benzothiazepine' is very close to the gold standard 'benzothiazepine', with only a minor difference in specificity. The supporting sentence provided by the model incorrectly states that there is no relevant information in the context, whereas the gold supporting sentence directly provides the necessary information from the context. Despite this, the model's answer itself is correct and closely matches the gold standard.\", \"match\": true}", "gold_answer": "benzothiazepine", "gold_support": "A derivative of 1,4-benzothiazepine (JTV519) increased the affinity of calstabin2 for RyR2, which stabilized the closed state of RyR2 and prevented the Ca2+ leak that triggers arrhythmias.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context provided does not contain any information about the drug JTV519 or its chemical derivatives. Therefore, it is not possible to identify a supporting sentence for the answer \"1,4-benzothiazepine\" from the given context.", "retries": 1}
{"idx": 893, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard. While the model correctly notes that APOBEC3B is cytoplasmic during interphase and gains nuclear access during mitosis, it fails to specify the final post-mitotic localization as explicitly 'nuclear,' which is the required gold answer. The supporting sentence provides relevant information about the breakdown of the nuclear envelope and access to the nuclear compartment but does not directly confirm the post-mitotic nuclear localization. Therefore, it lacks full coverage of the gold answer.\",\n  \"match\": false\n}", "gold_answer": "nuclear", "gold_support": "After mitosis, APOBEC3B becomes nuclear, and APOBEC3D, APOBEC3F and APOBEC3G become cytoplasmic.", "model_answer": "APOBEC3B protein is predominantly cytoplasmic during interphase but gains access to the nuclear compartment during mitosis when the nuclear envelope breaks down.", "model_support": "The APOBEC3B protein is predominantly cytoplasmic during interphase. However, during mitosis, when the nuclear envelope breaks down, it gains access to the nuclear compartment, even though it is excluded from chromatin.\n\n**Supporting Sentence:**\n\"During interphase the APOBEC3 proteins have different subcellular localizations: cell-wide, cytoplasmic or nuclear. This implies that only a subset of APOBEC3s have contact with nuclear DNA. However, during mitosis, the nuclear envelope breaks down and cytoplasmic proteins may enter what was formerly a privileged zone.\"", "retries": 1}
{"idx": 894, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'). The supporting sentence is relevant and provides a reasonable analogy to explain the antiparallel arrangement, but it contains slight redundancy by elaborating on the zipper and supercoiling concept. While logical, it is less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "The antiparallel side-to-side association of spectrin alpha and beta monomers is a two-step process which occurs in seconds even at 0 degrees C and at low concentrations.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers.", "model_support": "The alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. \n\n**Supporting Sentence:** \"Assembly of spectrin heterodimers is probably most analogous to a zipper. After initial nucleation site binding, the remainder of the subunits quickly associate along their full lengths to reconstitute a normal dimer by supercoiling around each other to form a rope-like, flexible rod.\"\n\nThis sentence suggests an antiparallel arrangement, as the zipper analogy implies that the subunits interlock in opposite directions, and the supercoiling around each other supports an antiparallel orientation.", "retries": 1}
{"idx": 895, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer does not exactly match the gold standard ('thyroid'), but it is very close, as it correctly identifies that thyroid hormone concentrations (T3 and T4) are altered in patients with Allan-Herndon-Dudley syndrome. However, the supporting sentence provided by the model is somewhat lengthy and mixes relevant facts with additional details about maternal T4 influence and local deiodination, which are not directly necessary to support the answer. While the logic is reasonable, the explanation could be more concise.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "Mct8 transports thyroid hormones (T4 and T3), and the Allan-Herndon-Dudley syndrome is likely caused by lack of T3 transport to neurons during critical periods of fetal brain development.", "model_answer": "In patients with Allan-Herndon-Dudley syndrome, the hormone concentrations are altered as follows:\n\n- Elevated levels of triiodothyronine (T3) and thyroxine (T4) in the blood.\n- Elevated levels of thyroid-stimulating hormone (TSH) due to compensatory mechanisms.\n\nThe brain, however, experiences low levels of T3 despite normal or elevated serum levels, leading to the characteristic neurological impairments.", "model_support": "In patients with Allan-Herndon-Dudley syndrome, the hormone concentrations are altered as follows:\n\n- Elevated levels of triiodothyronine (T3) and thyroxine (T4) in the blood.\n- Elevated levels of thyroid-stimulating hormone (TSH) due to compensatory mechanisms.\n\nThe brain, however, experiences low levels of T3 despite normal or elevated serum levels, leading to the characteristic neurological impairments.\n\n**Supporting Sentence:**  \n\"It is concluded that T4 from the maternal compartment influences gene expression in the fetal cerebral cortex, possibly after transport via organic anion transporter polypeptide and/or Mct8, and conversion to T3 in the astrocytes. On the other hand, T3 does not reach the target neurons despite the presence of Mct8. The data indicate that T4, through local deiodination, provides most T3 in the fetal rat brain. The role of Mct8 as a T3 transporter in the fetal rat brain is therefore uncertain.\"", "retries": 1}
{"idx": 896, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence, while slightly repetitive in structure, is concise and directly relevant, covering the answer logically by referencing the inhibition of CYP17A1 by Orteronel as stated in the context.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "The enzyme inhibited by Orteronel is CYP17A1.", "model_support": "The enzyme inhibited by Orteronel is CYP17A1.\n\n**Supporting sentence:**  \n\"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.\"", "retries": 1}
{"idx": 897, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and explains that Bach1 represses HO-1 reporter activity, which aligns with the gold supporting sentence. However, it includes additional details about IHABP's effect on repression, making it slightly more verbose than necessary, hence a score of 4 instead of 5.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a transcriptional repressor of heme oxygenase-1 (HO-1) and the beta-globin genes.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "The transcriptional regulator Bach1 is a repressor. This conclusion is supported by the context, which indicates that Bach1 represses the HO-1 reporter activity. The repression is attenuated when IHABP is co-transfected, leading to increased HO-1 expression. \n\n**Supporting sentence:**  \n\"The repression of HO-1 reporter activity by Bach1 was attenuated by co-transfecting IHABP in a dose-dependent manner.\"", "retries": 1}
{"idx": 898, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model answer matches the gold standard by identifying SERCA as the main calcium pump, and specifying SERCA2a for the heart adds precision. The supporting sentence provided by the model is relevant and covers the answer but repeats the same content as the answer, leading to slight redundancy. The gold supporting sentence is more general and introduces additional context about SERCA's role in arrhythmias, making it slightly more informative.\",\n  \"match\": true\n}", "gold_answer": "SERCA", "gold_support": "This review mainly focuses on the structure, function of the sarco(endo)plasmic reticulum calcium pump (SERCA) and its role in genesis of arrhythmias.", "model_answer": "The main calcium pump of the sarcoplasmic reticulum is SERCA, specifically the SERCA2a isoform in the heart.", "model_support": "The main calcium pump of the sarcoplasmic reticulum is SERCA, specifically the SERCA2a isoform in the heart.\n\n**Supporting Sentence:** \"SERCA is mainly represented by the SERCA2a isoform in the heart.\"", "retries": 1}
{"idx": 899, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, with only a minor difference in capitalization which does not affect meaning. However, the supporting sentence provided by the model is incorrect because it states there is no supporting sentence in the context, whereas the gold supporting sentence is present and directly relevant. Despite this, the overall logic of the answer is strong.\", \"match\": true}", "gold_answer": "mammalian target of rapamycin", "gold_support": "Beyond the JAK/signal transducer and activator of transcription network, a wide number of molecular alterations were described in MPN including the fosfatidilinositolo-3-chinasi (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway constitutive activation.", "model_answer": "mTOR stands for Mammalian Target of Rapamycin.", "model_support": "The context does not explicitly state what mTOR stands for. However, based on prior knowledge, mTOR is known to stand for Mammalian Target of Rapamycin. Since the context does not provide this information, there is no supporting sentence to quote.\n\n**Answer:**  \nThe context does not explicitly state what mTOR stands for. However, based on prior knowledge, mTOR stands for Mammalian Target of Rapamycin. There is no supporting sentence in the context for this answer.", "retries": 1}
{"idx": 900, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it includes slight redundancy by referencing amphibians and birds, which is not directly necessary for supporting the use of collagen in archaeology. However, the logical connection to collagen as a key protein is still clear.\", \"match\": true}", "gold_answer": "collagen", "gold_support": "(Reports, 13 April 2007, p.", "model_answer": "The bone protein used in archaeology for dating and species identification is collagen. Specifically, alpha1(I) collagen is a component of type I collagen found in bones, which is used for both radiocarbon dating and species identification through sequence analysis.\n\nAnswer: Collagen", "model_support": "The supporting sentence is: \"association of alpha1(I) collagen sequences with amphibians rather than birds suggest that T. rex does not.\" This indicates that collagen, specifically alpha1(I) collagen, is used for species identification in archaeological contexts.\n\nAnswer: Collagen", "retries": 1}
{"idx": 901, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information with slight redundancy but overall logical support. The model's supporting sentence reiterates the answer and adds general information about Romano-Ward syndrome being a known autosomal dominant condition, which is correct but slightly verbose compared to the concise gold supporting sentence.\", \"match\": true}", "gold_answer": "autosomal dominant", "gold_support": "Romano-Ward syndrome is a subtype of prolonged QT syndrome with autosomal dominant inheritance.", "model_answer": "The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant.", "model_support": "The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant. This is a well-established fact in medical genetics, as Romano-Ward syndrome (LQTS-1) is known to follow an autosomal dominant pattern of inheritance. \n\nHowever, the provided context does not include a sentence that directly supports this information. It focuses on the case management and successful treatment during pregnancy rather than the genetic inheritance pattern. \n\n**Answer:** The mode of inheritance of Romano-Ward long QT syndrome is autosomal dominant.", "retries": 1}
{"idx": 902, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('cysteine') and is correct. The supporting sentence provides relevant information about cysteine mutations in CADASIL syndrome, with a clear connection to the NOTCH3 protein. However, it contains slight redundancy by reiterating the answer within the explanation. The logic is strong but could be more concise.\",\n  \"match\": true\n}", "gold_answer": "cysteine", "gold_support": "Considerations on a mutation in the NOTCH3 gene sparing a cysteine residue: a rare polymorphism rather than a CADASIL variant.", "model_answer": "The amino acid residue most commonly mutated in CADASIL syndrome is cysteine, particularly within the EGF-like repeats of the NOTCH3 protein. These mutations disrupt the protein's structure and function, contributing to the disease's pathogenesis.", "model_support": "The amino acid residue most commonly mutated in CADASIL syndrome is cysteine, particularly within the EGF-like repeats of the NOTCH3 protein. These mutations disrupt the protein's structure and function, contributing to the disease's pathogenesis.\n\n**Supporting Sentence:**  \n\"We describe a 49-year-old woman with a CADASIL-like phenotype, carrying a novel cysteine-sparing mutation in exon 29 of the NOTCH3 gene...\"  \nThis indicates that cysteine mutations are significant in CADASIL, even though this particular mutation spares cysteine, highlighting the importance of cysteine in the NOTCH3 protein structure.", "retries": 1}
{"idx": 903, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "Riociguat", "gold_support": "Riociguat (Adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.", "model_answer": "The generic name of the drug Adempas is Riociguat.\n\nAnswer: Riociguat", "model_support": "The supporting sentence is: \"Riociguat (adempas): a novel agent for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.\" This sentence clearly states that the generic name of the drug Adempas is Riociguat.", "retries": 1}
{"idx": 904, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('Xist'), although it includes 'RNA,' which is slightly more specific than the gold answer but still correct. The supporting sentence from the model is relevant and supports the answer by mentioning Xist RNA, but it contains some redundancy regarding the structural details (AUCG tetraloop fold) that are not necessary to directly support the answer. The logic is strong, but the extra detail makes it less concise than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "X-chromosome inactivation (XCI) in female mammals depends on the noncoding RNA X inactivation specific transcript (Xist).", "model_answer": "The transcript responsible for X-chromosome inactivation is XIST RNA.", "model_support": "The supporting sentence from the context is:\n\n\"The Xist RNA A-repeat comprises a novel AUCG tetraloop fold and a platform for multimerization.\"\n\nThis sentence identifies Xist RNA as the transcript responsible for X-chromosome inactivation, as it discusses the structural aspects of Xist RNA involved in the process.", "retries": 1}
{"idx": 905, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and supports the answer, but it focuses on calcineurin being a drug target rather than its role in NFAT activation, which makes it slightly less direct compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "Calcineurin", "gold_support": "Calcineurin, a Ca(2+)/calmodulin-stimulated protein phosphatase, plays a key role in T-cell activation by regulating the activity of NFAT (nuclear factor of activated T cells), a family of transcription factors required for the synthesis of several cytokine genes.", "model_answer": "The calcium/calmodulin-dependent protein phosphatase involved in the activation of the NFAT transcription factors is **calcineurin**.", "model_support": "The supporting sentence from the context is:  \n\"Calcineurin is the target of the immunosuppressive drugs cyclosporin A and FK506 complexed with their cytoplasmic receptors cyclophilin and FKBP12, respectively.\"", "retries": 1}
{"idx": 906, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard, as hypothyroidism (a thyroid-related condition) is indeed associated with Williams syndrome. However, the gold answer is more concise ('thyroid') and does not delve into specifics like hormone levels, making the model's answer somewhat more detailed than necessary. The supporting sentence from the model repeats the key details of the answer but adds slight redundancy by reiterating 'normal free T3 and free T4' rather than focusing on a succinct explanation. Overall, the logic is reasonable, but it could be more concise.\",\n  \"match\": true\n}", "gold_answer": "thyroid", "gold_support": "New case of thyroid dysgenesis and clinical signs of hypothyroidism in Williams syndrome.", "model_answer": "Hormone abnormality common in Williams syndrome is hypothyroidism, characterized by elevated thyrotropin (TSH) levels with normal or low-normal free T3 (FT3) and free T4 (FT4) levels.", "model_support": "The hormone abnormality common in Williams syndrome is hypothyroidism, characterized by elevated thyrotropin (TSH) levels with normal free T3 (FT3) and free T4 (FT4) levels.\n\n**Supporting Sentence:** \"Thyrotropin level was very high (>50 microU/ml; normal value 0.2-4 microU/ml), while serum free T(3) (FT3) and free T(4) (FT4) levels were normal (FT3 3.6 pg/ml, normal value 2.8-5.6 pg/ml; FT4 11.6 pg/ml, normal value 6.6-14 pg/ml); antithyroid autoantibodies were absent.\"", "retries": 1}
{"idx": 907, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and provides additional context about the utility of LepChorionDB, including its role in functional and evolutionary studies as well as its pHMM tools for classification. However, it contains slight redundancy by elaborating on future uses and specific tools (pHMMs), which makes it less concise than the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "LepChorionDB", "gold_support": "LepChorionDB, a database of Lepidopteran chorion proteins and a set of tools useful for the identification of chorion proteins in Lepidopteran proteomes.", "model_answer": "The database available for the identification of chorion proteins in Lepidopteran proteomes is LepChorionDB.\n\nAnswer: LepChorionDB", "model_support": "Supporting sentence: LepChorionDB may provide insights in future functional and evolutionary studies of Lepidopteran chorion proteins and thus, it will be a useful tool for the Lepidopteran scientific community and Lepidopteran genome annotators, since it also provides access to the two pHMMs developed in this work, which may be used to discriminate A and B class chorion proteins.", "retries": 1}
{"idx": 908, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('FSHD') in meaning, though it provides the full name instead of the abbreviation. The supporting sentence is relevant and covers the gold answer logically, but it contains some redundancy by restating the model's answer verbatim at the beginning. The sentence could be more concise while still retaining all necessary information.\",\n  \"match\": true\n}", "gold_answer": "FSHD", "gold_support": "Facioscapulohumeral dystrophy (FSHD) is a progressive muscular dystrophy caused by decreased epigenetic repression of the D4Z4 macrosatellite repeats and ectopic expression of DUX4, a retrogene encoding a germline transcription factor encoded in each repeat.", "model_answer": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD).", "model_support": "The disease associated with the ectopic expression of the protein encoded by the gene DUX4 is Facioscapulohumeral muscular dystrophy (FSHD). This conclusion is supported by the context, which explains how the contraction of the D4Z4 repeat array leads to decreased epigenetic repression and variegated DUX4 expression in skeletal muscle, a hallmark of FSHD.\n\n**Supporting Sentence:**  \n\"the most common form of FSHD (FSHD1) is caused by a contraction of the array to fewer than 10 repeats, associated with decreased epigenetic repression and variegated expression of DUX4 in skeletal muscle.\"", "retries": 1}
{"idx": 909, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides a logical explanation by linking MCT8 to the neurological phenotype, but it doesn't fully capture the distinct phenotype described in the gold supporting sentence (severe psychomotor retardation and elevated T(3) levels). It is slightly less comprehensive but still logically supports the answer.\", \"match\": true}", "gold_answer": "MCT8", "gold_support": "Mutations of the monocarboxylate transporter 8 (MCT8) gene determine a distinct X-linked phenotype of severe psychomotor retardation and consistently elevated T(3) levels.", "model_answer": "The thyroid hormone transporter implicated in thyroid hormone resistance syndrome is MCT8.", "model_support": "Supporting sentence: Lack of MCT8 transport of T(3) in neurons could explain the neurological phenotype.", "retries": 1}
{"idx": 910, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Bcr-Abl' matches the gold standard 'BCR-ABL' in meaning, despite a minor formatting difference. The supporting sentence provided by the model is relevant but slightly indirect, discussing next-generation inhibitors rather than directly stating that BCR-ABL is the constitutively activated tyrosine kinase targeted by Imatinib. It contains some redundancy and does not align as closely with the gold supporting sentence in terms of clarity and direct relevance.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The fusion gene that results (BCR-ABL) produces a constitutively activated tyrosine kinase that exists in different isoforms depending on BCR break-points.", "model_answer": "The tyrosine kinase targeted by Imatinib in Philadelphia-chromosome positive chronic myelogenous leukemia is **Bcr-Abl**.", "model_support": "The supporting sentence is: \"This review focuses on the relevant biology of CML, imatinib mesylate resistance mechanisms, and the current status of the next generation of Bcr-Abl inhibitors.\" This sentence indicates that Bcr-Abl is the target of Imatinib.", "retries": 1}
{"idx": 911, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is slightly redundant as it includes additional information about the induction of IFR activity and its relation to medicarpin accumulation, which, while relevant, is not strictly necessary to support the answer. The logic is strong, but the extra details make it less concise than ideal.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The major phytoalexin in alfalfa is the isoflavonoid (-)-medicarpin (or 6aR, 11aR)-medicarpin.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is medicarpin.", "model_support": "The major phytoalexin in alfalfa (Medicago sativa L.) is medicarpin. This conclusion is supported by the following sentence from the context:\n\n\"The transcript (1.4 kb) is highly induced in elicited alfalfa cell cultures. The kinetics of induction are consistent with the appearance of IFR activity, the accumulation of medicarpin, and the observed induction of other enzymes in the pathway.\"\n\nThis sentence indicates that the induction of IFR activity leads to the accumulation of medicarpin, establishing it as the major phytoalexin in alfalfa.", "retries": 1}
{"idx": 912, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.", "model_support": "The supporting sentence is:\n\n\"The tumor suppressor p53 is the most frequently mutated gene in human cancer and is often referred to as the 'guardian of the genome'.\"\n\nThis sentence explicitly states that p53 is referred to as \"the guardian of the genome,\" directly supporting the answer.", "retries": 1}
{"idx": 913, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is correct but more verbose than the gold standard. It elaborates on the ROSIER scale's purpose, which is accurate but not as concise as 'stroke.' The supporting sentence from the model repeats the answer instead of directly referencing the specific evidence from the context provided. The gold supporting sentence is more focused and aligns better with the task of identifying the disorder (stroke). However, the model's response still provides reasonable and relevant reasoning.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke in the emergency room setting. It helps differentiate stroke from other conditions that mimic stroke symptoms.", "model_support": "The ROSIER scale is used for recognizing acute stroke in the emergency room setting. It helps differentiate stroke from other conditions that mimic stroke symptoms.\n\n**Supporting sentence:**  \n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 914, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is **p53**.\n\n**Supporting sentence:**  \n\"The tumor suppressor p53 is often referred to as 'the guardian of the genome' because of its central role in the cellular response to oncogenic stress and prevention of tumor development.\"", "retries": 1}
{"idx": 915, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('NF1'), and the supporting sentence is relevant and covers the answer. However, the supporting sentence provided by the model contains slight redundancy by mentioning cancer patients, which is not directly necessary for supporting the answer about neurofibromatosis type 1. The logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "NF1", "gold_support": "Lysine 1423 of neurofibromin (neurofibromatosis type I gene product [NF1]) plays a crucial role in the function of NF1.", "model_answer": "The gene mutated in type 1 neurofibromatosis is the NF1 gene.", "model_support": "The supporting sentence from the context is:\n\n\"Mutations of this lysine were detected in samples from a neurofibromatosis patient as well as from cancer patients.\"\n\nThis sentence indicates that mutations in neurofibromin, which is encoded by the NF1 gene, are associated with neurofibromatosis, specifically type 1.", "retries": 1}
{"idx": 916, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. However, the supporting sentence is relevant but does not directly provide the specific information that BACH1 is a repressor of the antioxidant response element, as clearly stated in the gold supporting sentence. The model supporting sentence is more general and lacks the precise detail found in the gold version, making it slightly less effective.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "In HaCaT cells, FB and EC (200 μM) induced nuclear translocation of NRF2 protein after 24 h and reduced nuclear protein levels of BACH1, a repressor of the antioxidant response element.", "model_answer": "BACH1 is a transcriptional repressor.", "model_support": "Supporting sentence: PPGs affect the balance of NRF2 and BACH1 transcription factors.", "retries": 1}
{"idx": 917, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning.\", \"match\": true}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Lubag disease is a genetic X-linked dystonia-parkinsonism syndrome afflicting Filipino men.", "model_answer": "The synonym of Lubag disease is X-linked dystonia-parkinsonism.", "model_support": "Supporting sentence: \"Anesthesia for deep brain stimulation in a patient with X-linked dystonia-parkinsonism/Lubag disease.\"", "retries": 1}
{"idx": 918, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns well with the gold standard, as both describe Groucho as a transcriptional repressor/corepressor in Drosophila melanogaster. However, the model answer elaborates further on the mechanism (histone deacetylation and nucleosome density), which, while correct and supported by the context, is not directly present in the gold answer. The supporting sentence provided by the model is relevant and concise but does not fully capture the specific interaction with Rpd3 mentioned in the gold supporting sentence. This makes the reasoning slightly less precise compared to the gold standard.\",\n  \"match\": true\n}", "gold_answer": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor", "gold_support": "Groucho (Gro) is a Drosophila melanogaster transcriptional corepressor that directly interacts with the histone deacetylase Rpd3.", "model_answer": "The Drosophila melanogaster Groucho protein is a transcriptional repressor that functions by promoting histone deacetylation, which increases nucleosome density and leads to transcriptional repression of target genes.", "model_support": "The supporting sentence from the context is:\n\n\"Groucho-mediated repression may result from a histone deacetylase-dependent increase in nucleosome density.\"\n\nThis sentence directly supports the answer by stating that Groucho's role as a transcriptional repressor involves histone deacetylation, which increases nucleosome density and leads to transcriptional repression of target genes.", "retries": 1}
{"idx": 919, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('IL-1β'), and the supporting sentence is relevant and provides accurate information about Gevokizumab targeting IL-1β. However, the supporting sentence repeats the answer verbatim, which introduces slight redundancy, though the logic is still strong.\",\n  \"match\": true\n}", "gold_answer": "IL-1β", "gold_support": "Canakinumab and gevokizumab are highly specific IL-1β monoclonal antibodies.", "model_answer": "The molecule targeted by Gevokizumab is interleukin-1β (IL-1β).", "model_support": "The molecule targeted by Gevokizumab is interleukin-1β (IL-1β).\n\n**Supporting Sentence:**\n\"In contrast, gevokizumab occupies an allosteric site on IL-1β and complex formation results in a minor reduction of binding affinity to IL-1RI.\"", "retries": 1}
{"idx": 920, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and directly links SCLC with LEMS, but it is slightly more detailed than necessary, as the key information about the strong association between small-cell lung cancer and Lambert-Eaton syndrome is already clear from the context. The additional detail about cytologic examination is not essential to support the answer.\", \"match\": true}", "gold_answer": "small-cell lung cancer", "gold_support": "Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure.", "model_answer": "The type of lung cancer most strongly associated with Lambert-Eaton syndrome is small cell lung cancer (SCLC).", "model_support": "The supporting sentence from the context is:\n\n\"Cytologic examination of ultrasound-guided fine needle aspiration disclosed SCLC.\"\n\nThis sentence directly links the diagnosis of Lambert-Eaton myasthenic syndrome (LEMS) with small cell lung cancer (SCLC).", "retries": 1}
{"idx": 921, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer matches the gold standard ('women'), but the supporting sentence is somewhat indirect and does not fully capture the key evidence provided in the gold supporting sentence. While the model correctly references differences in RA characteristics between men and women, it fails to explicitly mention the 'high prevalence of RA in women' or the specific ratio of 5.2 women per man, which are critical to directly supporting the answer. The logic is reasonable but could be more concise and directly aligned with the gold standard evidence.\",\n  \"match\": true\n}", "gold_answer": "women", "gold_support": "Our results show a high prevalence of RA in LAC women with a ratio of 5.2 women per man.", "model_answer": "Rheumatoid Arthritis is more common in women.\n\nAnswer: Women.", "model_support": "The answer that Rheumatoid Arthritis (RA) is more common in women is correct based on general medical knowledge, although the supporting sentence in the context provided does not explicitly state this. Instead, the context discusses that women with RA have a higher prevalence of certain characteristics, such as early age at onset, polyautoimmunity, and abdominal obesity, compared to men. While this suggests that women may experience RA differently, it does not directly assert that RA is more common in women. However, the conclusion aligns with known medical facts that RA is more prevalent in women.\n\n**Answer:**\nWomen.\n\n**Supporting Sentence:**\n\"Women with RA in LAC have a higher prevalence of certain characteristics, such as early age at onset, polyautoimmunity, and abdominal obesity, compared to men.\"", "retries": 1}
{"idx": 922, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Interleukin-17 (IL-17)' is very close to the gold standard 'interleukin-17A,' with only a minor difference in specificity. The supporting sentence is relevant and provides logical support, but it does not explicitly mention the monoclonal antibody Secukinumab targeting interleukin-17A specifically, leading to slight imprecision.\", \"match\": false}", "gold_answer": "interleukin-17A", "gold_support": "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.", "model_answer": "Secukinumab targets Interleukin-17 (IL-17), a cytokine involved in inflammatory processes, particularly in conditions like Ankylosing Spondylitis. By inhibiting IL-17, Secukinumab helps reduce inflammation and improve disease symptoms. \n\nAnswer: Interleukin-17 (IL-17)", "model_support": "Supporting sentence: Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis, the prototypical form of spondyloarthritis.", "retries": 1}
{"idx": 923, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer and supporting sentence are incorrect and do not address the gold answer. The context does mention SEA0400 as an inhibitor selective for NCX(REV), which directly provides the information needed to answer the question. The model failed to extract this relevant information, resulting in an irrelevant response.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "The context provided does not mention SEA0400, so it is not possible to determine which ion antiporter or exchanger it inhibits based on the given information.", "model_support": "The context provided does not mention SEA0400, so it is not possible to determine which ion antiporter or exchanger it inhibits based on the given information.\n\nSupporting sentence: None provided in the context.", "retries": 1}
{"idx": 924, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'JNK (c-Jun N-terminal Kinase)' matches the gold standard 'Jnk' in meaning, despite slight differences in formatting. The supporting sentence provided by the model is relevant and supports the answer by mentioning that c-Jun is a transcription factor regulated by MAP kinase phosphorylation. However, it does not explicitly mention JNK or the specific detail about Ser-63 and Ser-73 phosphorylation as the gold supporting sentence does, making it slightly less precise.\", \"match\": true}", "gold_answer": "Jnk", "gold_support": "A candidate for this extended family of MAP kinases is the c-Jun NH2-terminal kinase (Jnk), which binds to and phosphorylates the transcription factor c-Jun at the activating sites Ser-63 and Ser-73.", "model_answer": "The MAP kinase that phosphorylates the transcription factor c-jun is JNK (c-Jun N-terminal Kinase). \n\nAnswer: JNK (c-Jun N-terminal Kinase)", "model_support": "Supporting sentence: \"These substrates include transcription factors that are regulated by MAP kinase phosphorylation (e.g., Elk-1, c-Myc, c-Jun, c-Fos, and C/EBP beta).\"\n\nThe context implies that c-Jun is a transcription factor phosphorylated by MAP kinases, and based on general knowledge, JNK (c-Jun N-terminal Kinase) is the specific MAP kinase that phosphorylates c-Jun.", "retries": 1}
{"idx": 925, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard in identifying SCF(β-TrCP) as the E3 ubiquitin ligase responsible for IκB ubiquitination, though it includes additional descriptive details about the complex. The supporting sentence provided by the model is relevant and supports the answer by referencing β-TrCP's role in IκB degradation; however, it introduces slight redundancy by discussing 'in vivo ablation,' which is not directly necessary to justify the answer. The gold supporting sentence is more concise and directly mentions SCF(β-TrCP), making it slightly superior.\",\n  \"match\": true\n}", "gold_answer": "SCF(β-TrCP)", "gold_support": "IKK activation and IκB degradation involve different ubiquitination modes; the latter is mediated by a specific E3 ubiquitin ligase SCF(β-TrCP) .", "model_answer": "The E3 ubiquitin ligase responsible for ubiquitinating IκB is the SCF (Skp1-Cul1-F-box) complex, with β-TrCP acting as the F-box protein that targets IκB for degradation.\n\nAnswer: The SCF (Skp1-Cul1-F-box) E3 ubiquitin ligase, with β-TrCP as the F-box protein.", "model_support": "The E3 ubiquitin ligase responsible for ubiquitinating IκB, leading to its proteasomal degradation, is the SCF (Skp1-Cul1-F-box) complex. β-TrCP acts as the F-box protein within this complex, targeting IκB for degradation.\n\n**Supporting Sentence:** \"In vivo ablation of β-TrCP results in accumulation of all the IκBs and complete NF-κB inhibition.\" This indicates β-TrCP's role in IκB degradation, which aligns with its function as part of the SCF E3 ligase complex.", "retries": 1}
{"idx": 926, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Iron deficiency' matches the gold standard 'iron' in meaning, though it is slightly more verbose. The supporting sentence is relevant but contains redundancy by discussing PLMD and other unrelated details instead of focusing solely on RLS and iron deficiency. Despite this, the logic connecting iron deficiency to RLS is present.\", \"match\": true}", "gold_answer": "iron", "gold_support": "Restless leg syndrome (RLS), aging, pregnancy, uraemia, iron deficiency, polyneuropathy are some of the common causes of secondary PLMD.", "model_answer": "The cause of restless leg syndrome is often linked to an iron deficiency.\n\nAnswer: Iron deficiency", "model_support": "The context provided does not mention Restless Legs Syndrome (RLS) or its causes, including iron deficiency. It focuses on Periodic Limb Movement Disorder (PLMD). Therefore, there is no supporting sentence in the context regarding the cause of RLS.\n\nAnswer: There is no supporting sentence in the context for the given answer.", "retries": 1}
{"idx": 927, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains the answer by referencing the selective inhibition of CYP17A1 activity, which aligns well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "Orteronel inhibits the enzyme CYP17A1.", "model_support": "The enzyme inhibited by Orteronel is CYP17A1. This is supported by the context which explicitly states that Orteronel is an investigational CYP17A1 inhibitor and that it suppresses serum estradiol concentrations through selective inhibition of CYP17A1 activity.\n\n**Supporting Sentence:**\n\"Orteronel can suppress serum estradiol concentrations in hypophysectomized female rats and monkeys through selective inhibition of CYP17A1 activity...\"", "retries": 1}
{"idx": 928, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect and states that the context does not provide information about SEA0400, which is false. The gold supporting sentence clearly mentions that SEA0400 is selective for NCX(REV). The supporting sentence provided by the model is also incorrect as it reiterates the same mistake. Both the answer and supporting sentence fail to identify the correct ion antiporter/exchanger (NCX) and are thus irrelevant.\", \"match\": false}", "gold_answer": "NCX", "gold_support": "NCX(REV) can be inhibited by: KB-R7943 a non-specific compound that blocks voltage-dependent and store-operated Ca(2+) channels; SEA0400 that appears to be selective for NCX(REV), but difficult to obtain and SN-6, which efficacy has been shown only in cardiomyocytes.", "model_answer": "The context does not provide information about SEA0400. Therefore, based on the given information, it is not possible to determine which ion antiporter/exchanger SEA0400 inhibits.", "model_support": "The context does not provide information about SEA0400. Therefore, based on the given information, it is not possible to determine which ion antiporter/exchanger SEA0400 inhibits.\n\nSupporting sentence: None provided in the context.", "retries": 1}
{"idx": 929, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('thyroid') but is present in the context as it describes abnormalities related to thyroid hormones. The supporting sentence discusses abnormal thyroid hormone synthesis, which is relevant but does not directly cover the gold answer ('thyroid'). Additionally, the supporting sentence includes details about oxidative stress and cell destruction, which are somewhat tangential to the core issue of thyroid hormone abnormalities. The logic is reasonable but could be more concise and focused.\",\n  \"match\": false\n}", "gold_answer": "thyroid", "gold_support": "CONTEXT: Pendred syndrome is caused by mutations in the gene coding for pendrin, an apical Cl-/I- exchanger.", "model_answer": "Hormone abnormalities characteristic of Pendred syndrome include hypothyroidism, characterized by low levels of thyroid hormones (triiodothyronine, T3, and thyroxine, T4), and elevated thyroid-stimulating hormone (TSH) due to the pituitary gland's response to low thyroid hormone levels.", "model_support": "The supporting sentence from the context that addresses the hormone abnormalities in Pendred syndrome is:\n\n\"Duox and TPO are relocated in the cytosol, leading to abnormal intracellular thyroid hormone synthesis, which results in cell destruction presumably because intracellular OS cannot be buffered by antioxidant defenses.\"\n\nThis sentence supports the idea that Pendred syndrome is associated with abnormal thyroid hormone synthesis, leading to low levels of T3 and T4. However, the context does not explicitly mention elevated TSH levels, which are typically associated with hypothyroidism in Pendred syndrome. The TSH elevation is inferred from general endocrinological understanding rather than the provided context.", "retries": 1}
{"idx": 930, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and covers the answer, but it repeats the model's answer verbatim, which introduces slight redundancy. While the logic is strong, a more concise explanation or additional context from the given supporting sentence could have improved the response.\",\n  \"match\": true\n}", "gold_answer": "Chaperone-mediated autophagy (CMA)", "gold_support": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.", "model_answer": "The KFERQ motif in cytosolic proteins triggers degradation via **chaperone-mediated autophagy (CMA)**. This motif is recognized by the chaperone Hsc70, facilitating protein translocation into lysosomes for degradation.", "model_support": "The KFERQ motif in cytosolic proteins triggers degradation via **chaperone-mediated autophagy (CMA)**. This motif is recognized by the chaperone Hsc70, facilitating protein translocation into lysosomes for degradation.\n\n**Supporting sentence:**  \n\"In silico analysis also revealed that the RyR2 sequence harbours six KFERQ motifs which are required for the recognition Hsc70 and its degradation via CMA.\"", "retries": 1}
{"idx": 931, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('repressor'), but the supporting sentence is slightly redundant. While it correctly explains that BACH1 represses HO-1 expression and provides relevant details about the inverse relationship between their expressions, it could be more concise. The gold supporting sentence directly states that BACH1 functions as a hypoxia-inducible repressor, which is clearer and more to the point.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells.", "model_answer": "BACH1 is a transcriptional repressor of HO-1 expression.", "model_support": "BACH1 is a transcriptional repressor of HO-1 expression. \n\n**Supporting Sentence:**  \n\"Expression of HO-1 was also reduced in human cells when exposed to interferon-gamma or an iron chelator desferrioxamine, each of which induced Bach1 expression. In contrast, induction of HO-1 expression by CoCl(2) is associated with reduced expression of Bach1 mRNA. Thus, expression of HO-1 and Bach1 is inversely regulated. We have identified a Maf recognition element in the human HO-1 gene that is required for repression of a reporter gene by hypoxia and targeted by Bach1.\"\n\nThis sentence indicates that Bach1 represses HO-1 expression, as shown by the inverse relationship between their expressions and the presence of a Maf recognition element targeted by Bach1.", "retries": 1}
{"idx": 932, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer ('template strand, which is the non-coding strand') does not match the gold standard ('the transcribed strand'), but it is present in the context of transcription mechanisms. The supporting sentence is relevant to the idea of TCR targeting a specific strand for repair, but it incorrectly emphasizes the template (non-coding) strand instead of the transcribed strand, and thus does not cover the gold answer correctly.\", \"match\": false}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "Transcription-coupled repair (TCR) targets the template strand of DNA, which is the non-coding strand. This is because RNA polymerase reads the template strand during transcription, and any lesions on this strand would hinder the process, prompting repair.", "model_support": "The supporting sentence is:\n\n\"Transcription-coupled repair (TCR) targets the template strand of DNA, which is the non-coding strand. This is because RNA polymerase reads the template strand during transcription, and any lesions on this strand would hinder the process, prompting repair.\"\n\nHowever, this sentence is not present in the provided context. The context discusses TCR as a subpathway of NER and its involvement with RNA polymerase, but it does not explicitly state which strand TCR targets. The answer is inferred based on the understanding that RNA polymerase transcribes the template (non-coding) strand, prompting repair when damage is encountered.", "retries": 1}
{"idx": 933, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is correct and aligns with the gold standard ('stroke'), though it is slightly more verbose than necessary. The supporting sentence is relevant and provides logical backing for the answer, but it contains minor redundancy by specifying 'initial differentiation of acute stroke from stroke mimics,' which is more detailed than required. Overall, the logic is strong, but a more concise supporting sentence would improve the response.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the recognition of acute stroke in the emergency room setting.", "model_support": "The supporting sentence from the context is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the emergency room (ER).\"\n\nThis sentence directly indicates that the ROSIER scale is used for recognizing acute stroke in the ER setting.", "retries": 1}
{"idx": 934, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides context about acute ischemic stroke, but it is slightly redundant as it mentions a meta-analysis rather than directly focusing on the MR CLEAN study itself. The logic is sound, but the sentence could be more concise to directly align with the gold supporting sentence.\", \"match\": true}", "gold_answer": "Acute ischemic stroke", "gold_support": "INTRODUCTION: A recent randomized controlled trial (RCT), the Multicenter Randomized CLinical trial of Endovascular treatment for Acute ischemic stroke in the Netherlands (MR CLEAN), demonstrated better outcomes with endovascular treatment compared with medical therapy for acute ischemic stroke (AIS).", "model_answer": "The disease investigated in the MR CLEAN study is acute ischemic stroke.", "model_support": "Supporting sentence: A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.", "retries": 1}
{"idx": 935, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support, but it includes additional details about the study that are not strictly necessary to justify the answer, making it slightly verbose.\",\n  \"match\": true\n}", "gold_answer": "dermatitis herpetiformis", "gold_support": "The presence of a rash is also a sensitive indicator of gluten ingestion in dermatitis herpetiformis, and this was used to study whether patients with this disease could also tolerate oats.", "model_answer": "The typical rash associated with gluten is called dermatitis herpetiformis.", "model_support": "The typical rash associated with gluten is dermatitis herpetiformis. This conclusion is supported by the context, which discusses a study involving patients with this condition and their tolerance to oats, indicating that the rash is linked to gluten sensitivity rather than the consumption of oats.\n\n**Answer:** The typical rash associated with gluten is dermatitis herpetiformis. \n\n**Supporting Sentence:** \"Eleven patients with dermatitis herpetiformis in remission on a gluten-free diet were challenged daily with 50 g oats for six months. Clinical symptoms were recorded, serum samples taken, and skin and small bowel biopsies performed before and after the oat challenge.\"", "retries": 1}
{"idx": 936, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard conceptually, but it is more verbose than necessary. The supporting sentence is relevant and supports the answer well, though it includes minor redundancy by specifying 'effective in the initial differentiation,' which could be more concise.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for the recognition of acute stroke in the emergency room setting. It helps differentiate stroke from other conditions, improving early intervention and appropriate referrals.", "model_support": "Supporting sentence:  \n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 937, "gptscore_json": "{\"score\": 3, \"reason\": \"The model answer is very close to the gold standard but is more verbose than necessary. The gold answer 'stroke' is concise and directly answers the question, whereas the model's answer provides additional context that, while correct, is not required by the question. The supporting sentence from the model is relevant and captures the essence of the ROSIER scale's purpose, but it could be more concise. It includes relevant information but does not exactly match the brevity and directness of the gold supporting sentence.\", \"match\": true}", "gold_answer": "stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used to differentiate acute stroke from stroke mimics in the emergency room, aiding in the initial diagnosis and appropriate referral of stroke patients.", "model_support": "The supporting sentence from the context is:\n\n**\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"**\n\nThis sentence clearly states the purpose of the ROSIER scale, which is to differentiate acute stroke from stroke mimics in the emergency room setting.", "retries": 1}
{"idx": 938, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides accurate reasoning by highlighting medicarpin as the predominant compound synthesized under elicitation conditions. However, it includes slight redundancy by mentioning conjugation, which is not central to proving medicarpin as the major phytoalexin. The gold supporting sentence is more concise and directly ties the rapid accumulation of medicarpin to the elicitor treatment.\", \"match\": true}", "gold_answer": "medicarpin", "gold_support": "The phytoalexin medicarpin accumulated rapidly in suspension cultured cells treated with elicitor from Colletotrichum lindemuthianum, and this was subsequently accompanied by an increase in the levels of MGM.", "model_answer": "The major phytoalexin in alfalfa (Medicago sativa L.) is **medicarpin**.", "model_support": "The supporting sentence that identifies medicarpin as the major phytoalexin in alfalfa during elicitation is:\n\n\"During elicitation, [(14)C]phenylalanine was incorporated predominantly into medicarpin, although a significant proportion of the newly synthesized medicarpin was also conjugated.\"\n\nThis sentence indicates that medicarpin becomes the predominant compound synthesized under stress conditions, highlighting its role as the major phytoalexin.", "retries": 1}
{"idx": 939, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it repeats the answer verbatim, which introduces slight redundancy. The logic is clear, but a more concise explanation from the context would have been preferable.\", \"match\": true}", "gold_answer": "CYP17A1", "gold_support": "Orteronel (TAK-700) is an investigational, non-steroidal inhibitor of CYP17A1 with preferential inhibition of 17,20-lyase in NCI-H295 cells.", "model_answer": "The enzyme inhibited by Orteronel is CYP17A1.", "model_support": "The enzyme inhibited by Orteronel is CYP17A1. \n\n**Supporting sentence:** \"Effect of an investigational CYP17A1 inhibitor, orteronel (TAK-700), on estrogen- and corticoid-synthesis pathways in hypophysectomized female rats and on the serum estradiol levels in female cynomolgus monkeys.\"", "retries": 1}
{"idx": 940, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard ('Dermatitis herpetiformis') but is present in the context as a description of the rash. The supporting sentence is relevant but does not directly cover the gold answer, instead focusing on the rash's appearance rather than naming the condition itself.\", \"match\": false}", "gold_answer": "Dermatitis herpetiformis", "gold_support": "Dermatitis herpetiformis (DH) is an autoimmune blistering skin disorder that is associated with gluten sensitivity.", "model_answer": "The typical rash associated with gluten is a papulovesicular rash.", "model_support": "The supporting sentence is: \"It presents as a papulovesicular rash and is often associated with enteropathy.\" This sentence directly links the rash to gluten-associated conditions like dermatitis herpetiformis (DH), confirming the typical rash associated with gluten exposure.", "retries": 1}
{"idx": 941, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('repressor'). The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning by explicitly stating that Bach1 functions as a transcriptional repressor. No unnecessary details are included.\",\n  \"match\": true\n}", "gold_answer": "repressor", "gold_support": "The mammalian transcription factor Bach1 functions as a repressor of the Maf recognition element (MARE) by forming antagonizing hetero-oligomers with the small Maf family proteins.", "model_answer": "The transcriptional regulator BACH1 is a repressor.", "model_support": "The transcriptional regulator BACH1 is a repressor. \n\n**Supporting sentence:** \"Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1.\" \n\nThis sentence explicitly identifies Bach1 as a transcription repressor, indicating its role in repressing gene expression.", "retries": 1}
{"idx": 942, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly, specifying 'Ser129' as the phosphorylated residue in alpha-synuclein found in Lewy bodies. The supporting sentence is concise, directly relevant, and provides clear logical reasoning by referencing the accumulation of Ser129-phosphorylated α-synuclein leading to Lewy body formation, aligning with the context provided.\",\n  \"match\": true\n}", "gold_answer": "Parkinson", "gold_support": "Approximately 90% of α-syn deposited in Lewy bodies is phosphorylated at serine 129 (Ser129).", "model_answer": "The residue of alpha-synuclein that was found to be phosphorylated in Lewy bodies is Ser129.", "model_support": "The residue of alpha-synuclein that was found to be phosphorylated in Lewy bodies is Ser129. \n\n**Supporting sentence:** \"In contrast, only 4% or less of total α-syn is phosphorylated at this residue in the normal brain. This suggests that the accumulation of Ser129-phosphorylated α-syn leads to the formation of Lewy bodies and dopaminergic neurodegeneration in Parkinson's disease.\"", "retries": 1}
{"idx": 943, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, though it is slightly more verbose by including 'Selenocysteine Insertion Sequence' in full rather than abbreviating it as 'SECIS'. The supporting sentence provided by the model is relevant but contains additional details about the experimental approach that are not directly necessary to support the answer. This makes it less concise than the gold supporting sentence, which directly explains the role of SECIS in recoding UGA as a Sec codon.\", \"match\": true}", "gold_answer": "SECIS", "gold_support": "The machinery comprises the tRNA(Sec), a 3'-UTR mRNA stem-loop termed SElenoCysteine Insertion Sequence (SECIS), which is mandatory for recoding UGA as a Sec codon, the SECIS Binding Protein 2 (SBP2), and other proteins.", "model_answer": "The stem loop present in the 3' end of genes encoding for selenoproteins is called the Selenocysteine Insertion Sequence (SECIS).", "model_support": "Supporting sentence: Here, we developed a novel approach using instead engineered minimal selenoprotein mRNAs containing SECIS elements derivatized with photoreactive groups.", "retries": 1}
{"idx": 944, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer '1,4-benzothiazepine' matches the gold standard 'benzothiazepine' with a high degree of accuracy, as '1,4-benzothiazepine' is a specific subclass of benzothiazepine. However, the supporting sentence, while relevant and logical, contains additional information about JTV519 being a multi-channel blocker and its effects on RyR2s and SR Ca²⁺ leak, which is not directly necessary to support the answer. This makes it slightly more verbose than required.\",\n  \"match\": true\n}", "gold_answer": "benzothiazepine", "gold_support": "Protective effect of JTV519, a new 1,4-benzothiazepine derivative, on prolonged myocardial preservation.", "model_answer": "The drug JTV519 is a derivative of the 1,4-benzothiazepine group of chemical compounds. \n\nAnswer: 1,4-benzothiazepine", "model_support": "The supporting sentence is: \"In these conditions, JTV519 (K201), a 1,4-benzothiazepine derivative and multi-channel blocker, stabilizes RyR2s and decrease SR Ca²⁺ leak.\"", "retries": 1}
{"idx": 945, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'The gene associated with McLeod syndrome is the XK gene' correctly identifies the XK gene. The supporting sentence provided by the model is relevant and supports the answer, but it contains more detail than necessary, describing multiple loci deletions in patients rather than focusing solely on the defect in the XK gene. This makes it slightly verbose compared to the gold supporting sentence, which directly states that McLeod syndrome is caused by XK gene defects.\", \"match\": true}", "gold_answer": "XK", "gold_support": "It is caused by XK gene defects and may include large deletions in the Xp21 region.", "model_answer": "The gene associated with McLeod syndrome is the XK gene.", "model_support": "The supporting sentence from the context that links McLeod syndrome to the XK gene is:\n\n\"Analysis of three unrelated McLeod patients for the presence of the XK, DMD, CYBB, ETX1, RPGR and OTC loci, as well as for the DXS709 marker, revealed deletions from the 39th exon of DMD to the ETX1 locus (patient Be), from the XK to RPGR loci (patient Bi) and from the XK to CYBB loci (patient Lh).\"\n\nThis sentence indicates that deletions involving the XK locus were found in McLeod patients, supporting the association of the XK gene with the syndrome.", "retries": 1}
{"idx": 946, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically covers the answer by referencing the specific histone residue (H3K4) methylated by MLL1, aligning with the context provided. Minor extra details in the gold supporting sentence do not detract from the strong logical support in the model's sentence.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "While androgen suppresses EZH2 in CRPC cells, in LNCaP cells, physiological concentrations of androgen stimulate expression of PRC2 genes (EZH2, SUZ12, and EED), which is mediated by androgen-induced ANCCA and involves E2F and histone H3K4me3 methylase MLL1 complex.", "model_answer": "The histone residue methylated by MLL1 is H3K4. \n\nAnswer: H3K4", "model_support": "The histone residue methylated by MLL1 is H3K4. \n\nSupporting sentence: The context mentions the MLL histone methylase complex, which is known to methylate histone H3 at lysine 4 (H3K4) based on general knowledge about MLL1's function. \n\nAnswer: H3K4", "retries": 1}
{"idx": 947, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('epidural blood patch') and provides additional relevant details about the procedure, such as the volume of blood used. However, the supporting sentence, while correct and concise, does not fully capture the context provided in the gold supporting sentence, which emphasizes the timing and high-risk patient criteria for performing the epidural blood patch. The logic is strong but slightly less comprehensive than the gold standard.\",\n  \"match\": true\n}", "gold_answer": "epidural blood patch", "gold_support": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch should be performed within 24-48 h of dural puncture.", "model_answer": "The definitive treatment for low-pressure headache is the epidural blood patch (EBP), where a volume of 12-20 mL of blood is administered to the epidural space to seal the leak and alleviate symptoms.", "model_support": "Supporting sentence: The optimum volume of blood has been shown to be 12-20 mL for adult patients.", "retries": 1}
{"idx": 948, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. It effectively highlights that the ROSIER scale is used as a stroke recognition tool, aligning perfectly with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "stroke", "gold_support": "Validation of the use of the ROSIER scale in prehospital assessment of stroke.", "model_answer": "Answer: Stroke", "model_support": "The supporting sentence from the context is:\n\n\"emergency physicians prospectively used the ROSIER as a stroke recognition tool on suspected patients in the prehospital setting.\"\n\nThis sentence directly states that the ROSIER scale is used for recognizing stroke in suspected patients in a prehospital setting.", "retries": 1}
{"idx": 949, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, though it is slightly more verbose by including 'receptor' in the response. The supporting sentence repeats the answer verbatim, which is redundant but still relevant and covers the correct information. The gold supporting sentence is more detailed and provides additional context about the drug's purpose, making the model's supporting sentence less ideal but still logically valid.\",\n  \"match\": true\n}", "gold_answer": "calcitonin gene-related peptide", "gold_support": "Telcagepant is a novel, orally active, and selective calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.", "model_answer": "The receptor targeted by telcagepant is the calcitonin gene-related peptide receptor.", "model_support": "The receptor targeted by telcagepant is the calcitonin gene-related peptide receptor. \n\n**Supporting sentence:** \"Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults.\"", "retries": 1}
{"idx": 950, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provides relevant information about flumazenil being used in benzodiazepine overdose, but it is unnecessarily lengthy and includes details that are not directly required to support the answer. A more concise sentence could have been selected to align better with the scoring criteria.\",\n  \"match\": true\n}", "gold_answer": "flumazenil", "gold_support": "STUDY OBJECTIVE: To develop clinical rules for the safe and effective use of flumazenil in suspected benzodiazepine overdose.", "model_answer": "The drug used as an antidote for benzodiazepine overdose is flumazenil.", "model_support": "The supporting sentence is:\n\n\"We assembled a retrospective series of 35 consecutive comatose patients admitted between October 1992 and July 1993 to a toxicologic ICU with the presumptive diagnosis of drug overdose. These patients were divided into two groups. Group A (low-risk) patients had a clinical picture compatible with uncomplicated benzodiazepine intoxication... The safety of flumazenil was defined on the basis of the absence of seizures or death.\"\n\nThis sentence indicates that flumazenil was administered to patients with benzodiazepine intoxication, supporting its role as an antidote.", "retries": 1}
{"idx": 951, "gptscore_json": "{\"score\": 1, \"reason\": \"The model's answer is incorrect as it mentions 'Hallervorden-Spatz syndrome,' which is not related to lubag disease. The supporting sentence provided by the model also does not logically support any correct synonym and instead highlights the lack of relevance to the context. The gold answer 'X-linked dystonia-parkinsonism' is clearly mentioned in the context, but the model failed to identify it.\", \"match\": false}", "gold_answer": "X-linked dystonia-parkinsonism", "gold_support": "Regional and global metabolic rates for glucose (rCMRGlc and GMR) were estimated using [18F]fluorodeoxyglucose and positron emission tomography in 3 patients with Filipino X-linked dystonia-parkinsonism (lubag).", "model_answer": "The synonym for the lubag disease is Hallervorden-Spatz syndrome.", "model_support": "The context provided does not mention \"Hallervorden-Spatz syndrome\" as a synonym for lubag. Instead, lubag is referred to as Filipino X-linked dystonia-parkinsonism. There is no supporting sentence in the context for the synonym provided.\n\nAnswer: The context does not provide a synonym for lubag, as Hallervorden-Spatz syndrome is not mentioned. The disease is referred to as Filipino X-linked dystonia-parkinsonism.", "retries": 1}
{"idx": 952, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('NCX') in meaning, though it is slightly more verbose by specifying 'Na+/Ca2+ exchanger (NCX)'. The supporting sentence chosen by the model is relevant and supports the answer logically, but it is less concise than the gold supporting sentence. It introduces additional information about preventing arrhythmias, which, while correct, is not necessary to justify the answer.\",\n  \"match\": true\n}", "gold_answer": "NCX", "gold_support": "A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX).", "model_support": "The supporting sentence from the context is:\n\n\"It is concluded that the selective inhibition of NCX may be effective to preserve high-energy phosphates and to improve cardiac function after reperfusion, but may not be able to prevent fatal arrhythmias.\"\n\nThis sentence explicitly states that SEA0400 acts as an inhibitor of the Na+/Ca2+ exchanger (NCX).", "retries": 1}
{"idx": 953, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('RET') in meaning, though it is slightly more verbose by including 'The gene frequently mutated in Multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung disease is the RET gene' instead of just 'RET'. The supporting sentence is relevant and provides specific evidence from the context about a mutation in the RET gene. However, it contains more detail than necessary (e.g., specifying the exon and codon), which adds slight redundancy compared to the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "RET", "gold_support": "The RET proto-oncogene is involved in neural crest disorders.", "model_answer": "The gene frequently mutated in Multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung disease is the RET gene.", "model_support": "Supporting sentence: Direct fluorescent sequencing of genomic DNA revealed a heterozygous mutation in the RET proto-oncogene in exon 10 at codon C609Y in both persons tested.", "retries": 1}
{"idx": 954, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'Acute stroke,' is very close to the gold standard 'Stroke' and is correct in the context provided. The supporting sentence is relevant and supports the answer well, but it contains slight redundancy by specifying 'in the emergency room,' which is implied by ROSIER. Overall, the logic is strong, but minor verbosity reduces the score slightly.\",\n  \"match\": true\n}", "gold_answer": "Stroke", "gold_support": "The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument.", "model_answer": "The ROSIER scale is used for recognizing acute stroke in the emergency room by differentiating it from other conditions that mimic stroke symptoms.\n\nAnswer: Acute stroke", "model_support": "The supporting sentence that indicates the ROSIER scale is used for recognizing acute stroke in the emergency room is:\n\n\"The ROSIER scale was effective in the initial differentiation of acute stroke from stroke mimics in the ER.\"", "retries": 1}
{"idx": 955, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise and directly relevant, repeating the key information that p53 is referred to as 'the guardian of the genome,' which aligns perfectly with the gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The tumor suppressor protein p53 is often referred to as the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53. \n\nSupporting sentence: The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.", "retries": 1}
{"idx": 956, "gptscore_json": "{\"score\": 4, \"reason\": \"The answer matches the gold standard exactly. However, the supporting sentence provided by the model is missing, while the gold supporting sentence directly references PBT2 in the context of Alzheimer's disease. Including this sentence would have made the support more robust and aligned with the gold standard.\", \"match\": true}", "gold_answer": "Alzheimer's disease", "gold_support": "Experimental treatments potentially useful for Alzheimer's disease include dimebon, PBT2 and etanercept; the safety and efficacy of the Alzheimer's vaccine remains to be proven, and growth hormone secretagogue and tarenflurbil are likely ineffective.", "model_answer": "Answer: Alzheimer's disease", "model_support": "The context does not mention PBT2, so there is no supporting sentence provided for the answer \"Alzheimer's disease\" regarding PBT2. \n\nAnswer: The context does not provide information about PBT2, so no supporting sentence is available.", "retries": 1}
{"idx": 957, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer, 'the template strand,' does not match the gold standard, 'the transcribed strand.' However, the answer is related to the context as the template strand is involved in transcription. The supporting sentence is relevant but does not directly support the gold answer. It discusses the complexity of TCR and involvement of RNA polymerase without explicitly mentioning that TCR targets the transcribed strand, leading to a lower score.\",\n  \"match\": false\n}", "gold_answer": "the transcribed strand", "gold_support": "Transcription-coupled repair (TCR) is generally observed as more rapid or more efficient removal of certain types of DNA damage from the transcribed strands of expressed genes compared with the nontranscribed strands.", "model_answer": "The template strand is targeted by transcription-coupled repair (TCR).\n\nAnswer: The template strand.", "model_support": "The supporting sentence from the context that implies the template strand is targeted by transcription-coupled repair (TCR) is:\n\n\"Genetic and biochemical studies indicate that it is a highly complex process and requires the participation of the NER pathway, the RNA polymerase complex and additional factors.\"\n\nThis sentence suggests that TCR involves RNA polymerase, which operates on the template strand during transcription, thereby targeting that strand for repair.", "retries": 1}
{"idx": 958, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('xa' refers to Factor Xa, which is effectively the same as 'Factor X'). The supporting sentence from the gold standard directly lists betrixaban under inhibitors of Factor X, making it a concise and relevant support. However, the model's supporting sentence incorrectly states that the context does not provide information about betrixaban, which is inaccurate given the clear mention in the gold supporting sentence. This introduces slight redundancy and an incorrect claim about the context.\", \"match\": true}", "gold_answer": "xa", "gold_support": "X (rivaroxaban, apixaban, edoxaban, betrixaban)", "model_answer": "Betrixaban inhibits Factor X. \n\nAnswer: Factor X", "model_support": "The context provided does not explicitly mention betrixaban. However, based on external knowledge, betrixaban is known to inhibit Factor Xa. Since the context does not contain the specific information, there is no supporting sentence within the provided text.\n\nAnswer: The context does not provide information about betrixaban.", "retries": 1}
{"idx": 959, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context of general p73 isoforms. The supporting sentence acknowledges that the context does not explicitly state the number of TAp73 isoforms, which is accurate. However, it fails to cover the gold answer (7) and lacks concise logical support for the correct information.\", \"match\": false}", "gold_answer": "7", "gold_support": "", "model_answer": "The number of TAp73 isoforms identified in humans is three. These are TAp73α, TAp73β, and TAp73γ. \n\nAnswer: Three.", "model_support": "The context provided does not explicitly state the number of TAp73 isoforms identified in humans. While it discusses the role of TAp73 isoforms and their tumor-suppressive functions, it does not specify how many isoforms exist. Therefore, based on the given information, the exact number of TAp73 isoforms cannot be determined.\n\nAnswer: The context does not provide the exact number of TAp73 isoforms identified in humans.", "retries": 1}
{"idx": 960, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('RANKL') in meaning, though it is slightly more verbose by specifying 'the ligand RANKL.' The supporting sentence is relevant and directly references the RANKL-RANK-OPG pathway, which provides logical support for the answer. However, it is somewhat redundant compared to the gold supporting sentence, which is more concise while still clearly linking Denosumab to RANKL.\", \"match\": true}", "gold_answer": "RANKL", "gold_support": "Denosumab, an anti-RANKL monoclonal antibody with proven antiosteoclast activity, may suppress immune responses.", "model_answer": "Denosumab binds to the ligand RANKL, which interacts with the RANK receptor.", "model_support": "The supporting sentence is: \"the receptor activator of nuclear factor-κΒ ligand/receptor activator of nuclear factor-κΒ/osteoprotegerin (RANKL-RANK-OPG) pathway.\"\n\nDenosumab binds to RANKL, the ligand for the RANK receptor, as indicated by the context discussing the RANKL-RANK-OPG pathway.", "retries": 1}
{"idx": 961, "gptscore_json": "{\"score\": 2, \"reason\": \"The answer 'artificial urinary sphincter (AUS)' matches the gold standard, but the supporting sentence provided by the model does not directly support this from the context. The context does not explicitly state that AUS is the gold standard; it only mentions that BAUS compares favorably with AUS. The supporting sentence from the model discusses external knowledge rather than reasoning based on the context, making it less relevant.\", \"match\": true}", "gold_answer": "AUS", "gold_support": "It compares favourably with AUS.", "model_answer": "The gold standard treatment for iatrogenic male incontinence is the artificial urinary sphincter (AUS).", "model_support": "The gold standard treatment for iatrogenic male incontinence is the artificial urinary sphincter (AUS). However, the provided context does not explicitly mention AUS or designate it as the gold standard. The context focuses on evaluating bone-anchored sub-urethral slings (BAUS) as a treatment method, without comparing it to AUS. Therefore, while AUS is widely recognized as the gold standard based on external knowledge, the supporting sentence for this answer is not present in the given context. \n\nAnswer: The gold standard treatment for iatrogenic male incontinence is the artificial urinary sphincter (AUS). \n\nSupporting sentence: [Not explicitly provided in the context.]", "retries": 1}
{"idx": 962, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but contains slight redundancy by mentioning 'the gene mutation associated with McLeod syndrome is the XK gene' twice. While this does not detract significantly from the logic, it makes the sentence slightly verbose compared to the concise gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "XK", "gold_support": "XK gene sequence analysis revealed a missense mutation in exon 3 (E327K).", "model_answer": "The gene mutation associated with McLeod syndrome is the XK gene. Specifically, the E327K missense mutation in the XK gene is linked to the condition. \n\nAnswer: XK", "model_support": "The gene mutation associated with McLeod syndrome is the XK gene. The specific mutation mentioned is the E327K missense mutation. \n\n**Supporting Sentence:**  \n\"Although the E327K missense mutation was associated with the immunohematologic characteristics of McLeod syndrome, the mutated XK protein seemed to be largely functional.\"", "retries": 1}
{"idx": 963, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is close to the gold standard but is more detailed than necessary. The gold answer 'ultrasound' is concise and directly addresses the method of measurement, while the model's answer elaborates on both manual and automatic methods, which introduces slight verbosity. The supporting sentence is somewhat relevant but mixes information about both methods rather than focusing solely on ultrasound as the gold standard does. Logic is reasonable but could be more concise.\",\n  \"match\": false\n}", "gold_answer": "ultrasound", "gold_support": "To compare repeatability and agreement of conventional ultrasound bladder wall thickness (BWT) measurements with automatically obtained BWT measurements by the BVM 6500 device.", "model_answer": "Bladder wall thickness is measured using either manual conventional ultrasound or an automatic device (BVM 6500). Both methods were found to be repeatable and agreed with each other in the study.", "model_support": "The supporting sentence from the context is:\n\n\"Both BWT measurements are repeatable and agree with each other.\"\n\nThis sentence indicates that both manual and automatic methods (conventional ultrasound and BVM 6500 device) were used to measure bladder wall thickness and were found to be repeatable and in agreement.", "retries": 1}
{"idx": 964, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant and covers the answer logically.\", \"match\": true}", "gold_answer": "p53", "gold_support": "The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\n**Supporting sentence:**  \n\"The p53 gene is involved in genome stability and thus is referred to as 'the guardian of the genome.'\"", "retries": 1}
{"idx": 965, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer is accurate and aligns with the gold standard, clearly identifying interleukin-17A as the molecule targeted by Secukinumab. However, the supporting sentence references external knowledge rather than directly citing the provided context, which includes the concise and relevant sentence 'Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.' This makes the supporting sentence less ideal despite the correct answer.\",\n  \"match\": true\n}", "gold_answer": "interleukin-17A", "gold_support": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A monoclonal antibody.", "model_answer": "Secukinumab targets interleukin-17A (IL-17A), a cytokine involved in the inflammatory process of psoriasis. By binding to IL-17A, Secukinumab prevents it from activating immune cells, thereby reducing inflammation and alleviating psoriasis symptoms.", "model_support": "The molecule targeted by the monoclonal antibody Secukinumab is interleukin-17A (IL-17A). This information is not explicitly stated in the provided context but is known from external sources. \n\nAnswer: Secukinumab targets interleukin-17A (IL-17A), a cytokine involved in the inflammatory process of psoriasis. By binding to IL-17A, Secukinumab prevents it from activating immune cells, thereby reducing inflammation and alleviating psoriasis symptoms.\n\nSupporting Sentence: The context does not provide a direct supporting sentence for this answer. However, it is established from external medical knowledge that Secukinumab targets IL-17A.", "retries": 1}
{"idx": 966, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('Xist'), albeit with a slightly different but acceptable formatting (capitalization). The supporting sentence provided by the model is relevant and correctly references general knowledge about XIST being responsible for X-chromosome inactivation. However, it does not directly extract or reference the specific sentence from the context that supports the answer, which results in slight redundancy when compared to the gold supporting sentence. Despite this, the logic is strong and accurate.\",\n  \"match\": true\n}", "gold_answer": "Xist", "gold_support": "As deletions of the X inactivation center (XIC/Xic) and/or the X inactive specific transcript (XIST/Xist) gene result in failure of cis X-inactivation, mutations in genes from this region might lead to preferential inactivation of one X chromosome or the other.", "model_answer": "The transcript responsible for X-chromosome inactivation is XIST (X-Inactive Specific Transcript).\n\nAnswer: XIST", "model_support": "The context provided does not explicitly mention the transcript responsible for X-chromosome inactivation. Therefore, I cannot provide a supporting sentence from the context. However, based on general knowledge, the transcript responsible is XIST (X-Inactive Specific Transcript). \n\nAnswer: The transcript responsible for X-chromosome inactivation is XIST. However, the supporting sentence cannot be provided as it is not mentioned in the context.", "retries": 1}
{"idx": 967, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information about p53 and its role, but it is slightly verbose and could be more concise. The chosen supporting sentence focuses on mutations and oncogenic functions rather than directly emphasizing the 'guardian of the genome' concept, which makes it less ideal compared to the gold supporting sentence.\", \"match\": true}", "gold_answer": "p53", "gold_support": "Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.", "model_answer": "The tumor suppressor referred to as \"the guardian of the genome\" is p53.\n\nAnswer: p53", "model_support": "The supporting sentence from the context is:\n\n\"Not only do such mutations result in the abrogation of wild-type p53 activity, but the expressed p53 mutant proteins also tend to gain oncogenic functions, such as interference with wild-type p53-independent apoptosis.\"\n\nThis sentence discusses the role of p53 in apoptosis and tumor suppression, which relates to its nickname as \"the guardian of the genome.\"", "retries": 1}
{"idx": 968, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is relevant and provides logical support by referencing anti-alpha-synuclein antibodies, but it contains slight redundancy by mentioning phosphorylated alpha-synuclein, which is not central to the specific question about Lewy bodies. The gold supporting sentence is more concise and directly ties alpha-synuclein to Lewy bodies.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The substantia nigra possessed alpha-synuclein-positive LB-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining.", "model_answer": "The antibody used for immunostaining of Lewy bodies is raised against alpha-synuclein.", "model_support": "The supporting sentence from the context is:\n\n\"The central amygdaloid nucleus contained anti-alpha-synuclein- and -phosphorylated alpha-synuclein-positive dystrophic axonal terminals...\"\n\nThis sentence indicates that the antibodies used for immunostaining target alpha-synuclein, confirming that the antibody for Lewy bodies is raised against this protein.", "retries": 1}
{"idx": 969, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and logically explains that mutations in ZFHX1B are responsible for Mowat-Wilson syndrome, aligning well with the gold supporting sentence.\", \"match\": true}", "gold_answer": "ZFHX1B", "gold_support": "It is caused by de novo heterozygous mutations or deletions of the ZFHX1B gene located at 2q22.", "model_answer": "The gene responsible for Mowat-Wilson syndrome is ZFHX1B.", "model_support": "The gene responsible for Mowat-Wilson syndrome is ZFHX1B. \n\n**Supporting sentence:** Over 100 mutations have been described in patients with clinically typical MWS, who almost always have whole gene deletions or truncating mutations (nonsense or frameshift) of ZFHX1B, suggesting that haploinsufficiency is the basis of MWS pathology.", "retries": 1}
{"idx": 970, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is relevant and directly mentions the SET domain, which aligns with the gold answer. However, it is slightly redundant because it repeats the answer verbatim without adding significant context beyond what is already in the gold supporting sentence. A more concise supporting sentence would improve the score.\",\n  \"match\": true\n}", "gold_answer": "SET domain", "gold_support": "The fly complex contains a catalytic SET domain subunit, E(Z), plus three noncatalytic subunits, SU(Z)12, ESC, and NURF-55.", "model_answer": "The characteristic domain of histone methyltransferases is the **SET domain**.", "model_support": "The characteristic domain of histone methyltransferases is the **SET domain**.\n\n**Supporting sentence:** \"The E(Z) SET domain requires multiple partner inputs to produce active HMTase.\"", "retries": 1}
{"idx": 971, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information, with slight redundancy but overall logical support. The chosen supporting sentence focuses on co-localization rather than the direct association mentioned in the gold supporting sentence, which makes it slightly less precise.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1. \n\nAnswer: BRG1", "model_support": "The supporting sentence from the context that indicates the interaction between FANCA and BRG1 is:\n\n\"Finally, we demonstrated co-localization in the nucleus between transfected FANCA and BRG1.\"\n\nThis sentence supports the answer by showing that FANCA and BRG1 are found together in the nucleus, suggesting an interaction.", "retries": 1}
{"idx": 972, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard but is present in the context, as it correctly identifies that the exact number of TAp73 isoforms is not explicitly mentioned. However, the supporting sentence does not cover the gold answer (7) and is somewhat verbose while explaining the absence of specific information, which detracts from its relevance.\",\n  \"match\": false\n}", "gold_answer": "7", "gold_support": "", "model_answer": "The context does not specify the exact number of TAp73 isoforms identified in humans. It discusses the Delta Np73 isoform and its regulation but does not provide explicit information on the count of TAp73 isoforms.", "model_support": "The context does not explicitly specify the exact number of TAp73 isoforms identified in humans. It mentions that p73 has alternative splicing at the carboxyl terminus, yielding several isoforms, but does not provide a specific count or list of these isoforms. The focus is on the Delta Np73 isoform and its regulatory mechanisms rather than enumerating the TAp73 isoforms.\n\n**Answer:** The context does not provide the exact number of TAp73 isoforms identified in humans.", "retries": 1}
{"idx": 973, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard ('PLN') in meaning, though it includes an extra clarification '(PLN)' that is not required but still correct. The supporting sentence is relevant and provides logical support by emphasizing PLN's regulatory role with SERCA2A. However, it contains slight redundancy since it references a broader statement about the PLN/SERCA interactome impacting multiple aspects of cardiac function instead of directly focusing on PLN as the regulator of SERCA2A.\",\n  \"match\": true\n}", "gold_answer": "PLN", "gold_support": "SR Ca-transport is mediated by the SR Ca-ATPase (SERCA2a) and its regulatory phosphoprotein, phospholamban (PLN).", "model_answer": "The main regulatory molecule of SERCA2A function in the cardiac muscle is phospholamban (PLN).", "model_support": "The supporting sentence from the context is:\n\n\"Importantly, regulation of SR Ca-cycling by the PLN/SERCA interactome does not only impact cardiomyocyte contractility, but also survival and remodeling.\"\n\nThis sentence highlights that phospholamban (PLN) interacts with SERCA in regulating calcium cycling, confirming PLN as the main regulatory molecule of SERCA2A function in the cardiac muscle.", "retries": 1}
{"idx": 974, "gptscore_json": "{\n  \"score\": 3,\n  \"reason\": \"The model's answer is very close to the gold standard but includes additional information ('and transient ischaemic attack (TIA)') that, while related, is not explicitly mentioned in the gold answer. The supporting sentence provides relevant context about comparing diagnostic scales for stroke but does not directly or concisely support the use of the ROSIER scale for stroke alone. It introduces some unnecessary generality by discussing sensitivity and specificity without clearly linking it to the specific purpose of the ROSIER scale.\",\n  \"match\": false\n}", "gold_answer": "stroke", "gold_support": "DIAGNOSTIC SCALES: The results of an assessment with the Recognition of Stroke in the Emergency Room (ROSIER) scale, the Face Arm Speech Test (FAST) scale and the diagnosis of definite or probable stroke by an emergency department.", "model_answer": "The ROSIER scale is used for identifying stroke and transient ischaemic attack (TIA) in the emergency department.", "model_support": "The supporting sentence is: \"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\" This sentence indicates that the ROSIER scale is used for identifying stroke and TIA in the emergency department.\n\n**Supporting sentence:** \"To compare the sensitivity and specificity of bedside diagnostic stroke scales in patients with suspected stroke.\"", "retries": 1}
{"idx": 975, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. Although the context provided does not explicitly state this fact, the explanation correctly references the well-known mechanism of Imatinib targeting BCR-ABL in Philadelphia-chromosome positive CML.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "All 1,063 patients selected met the following inclusion criteria: aged 18 or older and in chronic phase at the time of diagnosis, Philadelphia chromosome and/or BCR-ABL positive, received first-line treatment with imatinib, and not enrolled in a randomized clinical trial during the period of retrospective review.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is **BCR-ABL**.", "model_support": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is **BCR-ABL**.\n\n**Supporting Explanation:**  \nWhile the provided context does not explicitly state this, it is a well-established medical fact that Imatinib targets the BCR-ABL tyrosine kinase. This kinase is formed due to the Philadelphia chromosome abnormality, which results from a translocation between chromosomes 9 and 22. The BCR-ABL protein promotes uncontrolled cell growth, and Imatinib inhibits its activity, effectively treating CML.", "retries": 1}
{"idx": 976, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the context provided.\",\n  \"match\": true\n}", "gold_answer": "Alpha-synuclein", "gold_support": "Alpha-synuclein, the main component of Lewy bodies, plays a central role in the PD pathogenesis.", "model_answer": "The main component of Lewy bodies is alpha-synuclein.", "model_support": "The main component of Lewy bodies is alpha-synuclein, as indicated by the context discussing its role in autophagy and degradation processes.\n\n**Supporting Sentence:**  \n\"Accumulating evidence indicates that macroautophagy (hereafter referred to as autophagy) is involved in alpha-synuclein degradation.\"", "retries": 1}
{"idx": 977, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is less specific than the gold supporting sentence. The model's supporting sentence mentions the upregulation of Xist but does not clarify its role as a major effector of X-chromosome inactivation or its significance in brain development, which are key details in the gold standard.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "Xist (X-inactive specific transcript) is a major effector of the X-inactivation process, and X-linked genes are highly expressed in brain tissue and consistent with a role in brain developments.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist.\n\nAnswer: Xist", "model_support": "The supporting sentence is: \"By microarray, upregulation of Xist, B-raf and Drwms2 were detected.\" This indicates that Xist is a key factor involved in X-chromosome inactivation, as its expression is being studied in that context.\n\n**Answer: Xist**  \n**Supporting sentence:** By microarray, upregulation of Xist, B-raf and Drwms2 were detected.", "retries": 1}
{"idx": 978, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard, as 'levodopa' is synonymous with 'L-dopa.' However, the supporting sentence provided by the model is based on external knowledge rather than directly citing the context. While it correctly explains the co-administration and its purpose, it does not utilize the specific sentence from the context that explicitly supports the gold answer. The gold supporting sentence directly references the administration of L-dopa with benserazide, making it more concise and contextually grounded. Thus, the model's supporting sentence contains slight redundancy and lacks direct relevance to the provided context.\", \"match\": true}", "gold_answer": "L-dopa", "gold_support": "The administration of L-dopa (20 and 60 mg/kg p.o.) + benserazide (15 mg/kg p.o.) resulted in dose-dependent increase of dialysate levels of L-dopa and 3-O-methyl-DOPA.", "model_answer": "Benserazide is usually co-administered with levodopa.", "model_support": "The context does not explicitly mention \"benserazide\" or provide a supporting sentence for the answer. However, based on general medical knowledge, benserazide is a catechol-O-methyltransferase (COMT) inhibitor that is commonly co-administered with levodopa (L-dopa) to enhance its efficacy in the treatment of Parkinson's disease. \n\nIf a supporting sentence were to be inferred, it would relate to the context's discussion of tolcapone as a COMT inhibitor and its effects on L-dopa metabolism. However, the specific mention of benserazide is not present in the provided context.", "retries": 1}
{"idx": 979, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The answer matches the gold standard exactly. The supporting sentence is relevant and covers the answer, but it is slightly redundant as it does not directly mention H3K4 or provide specific details about its methylation, unlike the gold supporting sentence which explicitly links H3K4 trimethylation to transcriptional activation.\",\n  \"match\": true\n}", "gold_answer": "H3K4", "gold_support": "Trimethylation of histone H3 Lys4 (H3K4) is associated with transcriptional activation.", "model_answer": "The histone residue methylated by MLL1 is H3K4.\n\nAnswer: H3K4", "model_support": "The histone residue methylated by MLL1 is H3K4. \n\n**Supporting Sentence:** \"MLL core components give the green light to histone methylation.\"", "retries": 1}
{"idx": 980, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer, 'BCR-ABL tyrosine kinase,' is very close to the gold standard 'BCR-ABL,' with only slight additional specification that does not detract from correctness. The supporting sentence is relevant and explains the action of imatinib on the BCR-ABL tyrosine kinase, but it is slightly indirect and less precise compared to the gold supporting sentence, which directly describes the fusion gene and its constitutive activity. The extra detail in the model's supporting sentence makes it somewhat less concise than ideal.\", \"match\": true}", "gold_answer": "BCR-ABL", "gold_support": "The Philadelphia chromosome (Ph) from a reciprocal translocation, t(9;22) (q34;q11) causes a fusion gene, BCR-ABL, that encodes a constitutively active tyrosine kinase.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL tyrosine kinase.\n\nAnswer: BCR-ABL tyrosine kinase", "model_support": "The supporting sentence from the context is:\n\n\"Treatment of CML by imatinib is effective to control the tyrosyl phosphorylation of the protein related to the cell signaling.\"\n\nThis sentence indicates that imatinib targets the BCR-ABL tyrosine kinase by controlling its tyrosyl phosphorylation, confirming its role in treating Philadelphia-chromosome positive chronic myelogenous leukemia.", "retries": 1}
{"idx": 981, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer matches the gold standard, identifying alpha-synuclein as the main component of Lewy bodies. However, it includes additional details about modified forms (phosphorylated, nitrated, monoubiquitinated states), which are accurate but not necessary to match the concise gold answer. The supporting sentence repeats the model's answer verbatim instead of directly citing the more concise and relevant evidence from the context ('Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS'). While correct, this introduces slight redundancy. Overall, the logic is strong, but the extra verbosity lowers the score.\",\n  \"match\": true\n}", "gold_answer": "alpha-synuclein", "gold_support": "The main component of Lewy bodies is alpha-synuclein (AS).", "model_answer": "The main component of Lewy bodies is α-synuclein, particularly in its modified forms such as phosphorylated, nitrated, and monoubiquitinated states.", "model_support": "The main component of Lewy bodies is α-synuclein, particularly in its modified forms such as phosphorylated, nitrated, and monoubiquitinated states. \n\n**Supporting sentence:** \"Lewy bodies contain abundant phosphorylated, nitrated, and monoubiquitinated AS.\"", "retries": 1}
{"idx": 982, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer, 'ABL tyrosine kinase,' does not match the gold standard 'BCR-ABL' exactly, but it is related and present in the context. The supporting sentence refers to imatinib as a tyrosine kinase inhibitor but does not directly mention or explain the BCR-ABL fusion gene, which is critical for fully supporting the gold answer. Thus, while relevant, the supporting sentence does not adequately cover the gold answer.\", \"match\": false}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukemia (CML) is a paradigm for neoplasias that are defined by a unique genetic aberration, the BCR-ABL1 fusion gene.", "model_answer": "Answer: ABL tyrosine kinase", "model_support": "The supporting sentence is: \"The development of protein tyrosine kinase inhibitor, imatinib, has entirely changed the strategy of therapy for CML.\" This sentence indicates that Imatinib is a tyrosine kinase inhibitor, and combined with the context mentioning the BCR-ABL fusion, it leads to the conclusion that the target is the ABL tyrosine kinase.\n\n**Answer:** ABL tyrosine kinase is the target of Imatinib. The supporting sentence is: \"The development of protein tyrosine kinase inhibitor, imatinib, has entirely changed the strategy of therapy for CML.\"", "retries": 1}
{"idx": 983, "gptscore_json": "{\n  \"score\": 2,\n  \"reason\": \"The model's answer does not match the gold standard ('SET domain') but is present in the context, as the C-terminus is discussed in relation to catalytic activity. However, the supporting sentence focuses on mutations in the C-terminus affecting catalysis, which does not cover the gold answer ('SET domain'). The model misses the key detail about the SET domain being the characteristic feature of histone methyltransferases.\",\n  \"match\": false\n}", "gold_answer": "SET domain", "gold_support": "Murine G9a is a 1263 amino acid H3-K9 methyltransferase that possesses characteristic SET domain and ANK repeats.", "model_answer": "The characteristic domain of histone methyltransferases, such as G9a, is the C-terminus, which is responsible for catalytic activity.", "model_support": "The supporting sentence from the context is:\n\n\"Furthermore, mutation of conserved amino acids R1097A, W1103A, Y1120A, Y1138A and R1162A, or the metal binding C1168A in the catalytic region, resulted in catalytically impaired enzymes, thereby confirming the involvement of the C-terminus of G9a in catalysis.\"", "retries": 1}
{"idx": 984, "gptscore_json": "{\"score\": 4, \"reason\": \"Answer matches gold standard; supporting sentence contains relevant information but is slightly less direct compared to the gold supporting sentence. The model's supporting sentence mentions the association of FANCA with the SWI/SNF complex but does not explicitly name BRG1, which is the specific subunit mentioned in the question and gold answer. This makes it slightly less precise but still logically connected.\", \"match\": true}", "gold_answer": "BRG1", "gold_support": "Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex.", "model_answer": "The SWI/SNF protein complex subunit that has been demonstrated to interact with the FANCA gene product is BRG1.\n\nAnswer: BRG1", "model_support": "The supporting sentence is: \"FANCA was demonstrated to associate with the endogenous SWI/SNF complex.\"\n\n**Answer:** BRG1", "retries": 1}
{"idx": 985, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence provided by the model is concise, directly relevant, and covers the answer with clear and logical reasoning, aligning well with the gold supporting sentence.\",\n  \"match\": true\n}", "gold_answer": "the transcribed strand", "gold_support": "In addition to the recognition and excision of DNA damage throughout the genome (GGR), there exists a mechanism, transcription-coupled nucleotide excision repair (TCR), for recognizing some types of DNA damage in the transcribed strand of genes in Escherichia coli, yeast and mammalian cells.", "model_answer": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand.", "model_support": "The gene strand targeted by transcription-coupled repair (TCR) is the transcribed strand. \n\n**Supporting sentence:** \"An obstacle in the repair of the transcribed strand of active genes is the RNA polymerase complex stalled at sites of DNA damage. The stalled RNA polymerase complex may then mediate recruitment of repair proteins to damage in the transcribed strand.\"", "retries": 1}
{"idx": 986, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and aligns with the context, but it is slightly verbose and does not directly mirror the concise clarity of the gold supporting sentence. It introduces additional details about the study's objectives, which are not necessary to justify the answer.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "The drug betrixaban is a direct inhibitor of factor Xa.\n\nAnswer: Factor Xa", "model_support": "Supporting sentence: The objective of this work is to study the pharmacodynamic, pharmacokinetic, the efficacy and safety of these four oral direct factor Xa inhibitors: rivaroxaban, apixaban, edoxaban and betrixaban.", "retries": 1}
{"idx": 987, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer does not match the gold standard but is present in the context. The supporting sentence is relevant to the question but fails to cover the gold answer (HSP70). The model incorrectly concludes that no heat shock protein is mentioned as upregulated, despite HSP70 being explicitly referenced in the context.\", \"match\": false}", "gold_answer": "HSP70", "gold_support": "Conversely, inhibition of HSP90 significantly increased the expression of both VEGF and HGF mRNA, and induced HSP70 protein in PHH cultures in vitro.", "model_answer": "The context provided does not mention any heat shock protein being upregulated during Hsp90 inhibition. The study focuses on the effects of Hsp90 inhibition on liver regeneration and repair, without referencing other heat shock proteins. \n\nAnswer: None are mentioned as being upregulated in the context.", "model_support": "The context does not explicitly mention any heat shock protein being upregulated during Hsp90 inhibition. Therefore, there is no supporting sentence in the context that answers the question. \n\nAnswer: None are mentioned as being upregulated in the context.", "retries": 1}
{"idx": 988, "gptscore_json": "{\"score\": 3, \"reason\": \"The model's answer matches the gold standard ('xa' can be interpreted as an abbreviation for 'Factor Xa'). However, the supporting sentence is somewhat indirect and includes information about a factor Xa decoy (PRT4445), which is not directly relevant to the specific question about betrixaban's target. While it mentions 'anti-Xa activity,' making the connection logical, it introduces additional content that could have been more concise. The gold supporting sentence directly states that betrixaban is a 'direct factor Xa inhibitor,' which is clearer and more to the point.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Evaluation of the oral direct factor Xa inhibitor - betrixaban.", "model_answer": "The clotting factor inhibited by betrixaban is factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence is: \"Of interest, a factor Xa decoy, PRT4445, is currently under evaluation in conjunction with betrixaban, and may be a universal reversal agent for all anticoagulants with anti-Xa activity.\"", "retries": 1}
{"idx": 989, "gptscore_json": "{\n  \"score\": 5,\n  \"reason\": \"The model's answer matches the gold standard exactly ('Xa' is equivalent to 'Factor Xa'). The supporting sentence, although brief, directly states the correct mechanism of action of betrixaban and aligns with the gold supporting sentence in meaning. It is concise and logically supports the answer.\",\n  \"match\": true\n}", "gold_answer": "Xa", "gold_support": "Betrixaban is a novel oral factor Xa inhibitor administered once daily, mostly excreted unchanged in the bile and with low (17%) renal excretion.", "model_answer": "Betrixaban inhibits Factor Xa.", "model_support": "Betrixaban inhibits Factor Xa. \n\n**Supporting Sentence:** The context does not explicitly state that betrixaban inhibits Factor Xa, but based on prior knowledge and the study's focus on preventing strokes in atrial fibrillation, it is inferred that betrixaban targets Factor Xa.", "retries": 1}
{"idx": 990, "gptscore_json": "{\"score\": 3, \"reason\": \"The answer matches the gold standard, but the supporting sentence is somewhat misleading. The model incorrectly states that there is no supporting sentence in the context, while the gold supporting sentence directly provides the necessary information. However, the logic behind the answer is still reasonable since the answer itself is correct.\", \"match\": true}", "gold_answer": "1,4-benzothiazepine", "gold_support": "We report that a new drug, the 1,4-benzothiazepine derivative JTV519, reverses this pathogenic process.", "model_answer": "Answer: 1,4-benzothiazepine", "model_support": "The context does not provide information about JTV519 being a derivative of 1,4-benzothiazepine. Therefore, there is no supporting sentence in this context to answer the question.\n\n**Answer:** The context does not contain a supporting sentence regarding JTV519 being a derivative of 1,4-benzothiazepine.", "retries": 1}
{"idx": 991, "gptscore_json": "{\"score\": 4, \"reason\": \"The model answer matches the gold standard (NCX) in meaning, though it uses a slightly expanded form ('Na+/Ca2+ exchanger (NCX)'). The supporting sentence provided by the model is relevant and explains that SEA0400 blocks Ca2+ influx, which aligns with NCX inhibition. However, it introduces additional details about nifedipine, which, while correct, are not necessary to support the specific answer. This makes the supporting sentence slightly more verbose than required.\", \"match\": true}", "gold_answer": "NCX", "gold_support": "The specific NCX inhibitor SEA0400 blocked SNP-induced phosphorylation of ERK, JNK and p38 MAPK, and decrease in cell viability.", "model_answer": "The small molecule SEA0400 is an inhibitor of the Na+/Ca2+ exchanger (NCX).", "model_support": "The sentence supporting the answer is:\n\n\"This increase in (45)Ca(2+) influx was blocked by SEA0400, but not the Ca(2+) channel blocker nifedipine.\"\n\nThis indicates that SEA0400 specifically inhibits the Na+/Ca2+ exchanger (NCX), as nifedipine, a Ca2+ channel blocker, did not have the same effect.", "retries": 1}
{"idx": 992, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer 'Factor Xa' matches the gold standard 'xa'. The supporting sentence is relevant and covers the answer by indicating that betrixaban is part of the group of Factor Xa inhibitors. However, it is slightly redundant because it mentions edoxaban's development status, which is not directly necessary to confirm betrixaban's target. Overall, the logic is sound but could be more concise.\", \"match\": true}", "gold_answer": "xa", "gold_support": "Nowadays, four new inhibitors of factor Xa are used orally (rivaroxaban, apixaban, edoxaban, betrixaban), and they are at least as efficient as heparins and vitamin K antagonists.", "model_answer": "Factor Xa.\n\nAnswer: Factor Xa", "model_support": "The supporting sentence that indicates betrixaban inhibits Factor Xa is:\n\n\"Edoxaban and betrixaban are also in development.\"\n\nThis sentence places betrixaban in the group of direct Factor Xa inhibitors discussed throughout the context.", "retries": 1}
{"idx": 993, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer is correct and matches the gold standard conceptually by identifying 'Xist RNA' as the transcript responsible for X-chromosome inactivation. However, it is slightly more verbose than the gold answer, which simply states 'Xist.' The supporting sentence provided by the model is relevant and explains Xist RNA's role in initiating silencing, aligning well with the gold supporting sentence. However, it does not directly include key details like 'binds in cis' or 'chromosome-wide silencing,' making it less comprehensive than the gold supporting sentence.\", \"match\": true}", "gold_answer": "Xist", "gold_support": "The process is mediated by the non-coding RNA X inactive specific transcript (Xist) that binds in cis and propagates along the inactive X chromosome elect, triggering chromosome-wide silencing.", "model_answer": "The transcript responsible for X-chromosome inactivation is Xist RNA.", "model_support": "The supporting sentence is: \"the mechanisms by which Xist RNA binds and spreads along the chromosome, and initiates Xist-mediated chromosome silencing remain poorly understood.\" This sentence directly links Xist RNA to the process of X-chromosome inactivation by describing its role in initiating silencing.", "retries": 1}
{"idx": 994, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer ('Insulin receptor') is very close to the gold standard ('insulin'), as it correctly identifies the hormone receptor altered in Donohue syndrome. However, the gold answer is more concise and directly references the hormone rather than the full receptor name. The supporting sentence provides relevant information but contains slight redundancy when mentioning the treatment with rhIGF-I, which is not necessary for supporting the answer. Overall, the logic is strong, but it could be more concise.\", \"match\": true}", "gold_answer": "insulin", "gold_support": "Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation.", "model_answer": "The altered hormone receptor function in Donohue syndrome is the insulin receptor. The mutation causes a severe decrease in insulin receptor autophosphorylation, impairing its function. \n\nAnswer: Insulin receptor", "model_support": "The supporting sentence is:\n\n\"Treatment with rhIGF-I partially reversed severe progressive HOCM and renal tubular dysfunction in a patient with Donohue syndrome associated with a novel p.Leu795Pro INSR gene mutation causing a severe decrease in IR autophosphorylation.\"\n\nThis sentence indicates that the INSR gene mutation leads to a severe decrease in insulin receptor autophosphorylation, which is the altered hormone receptor function in Donohue syndrome.", "retries": 1}
{"idx": 995, "gptscore_json": "{\"score\": 5, \"reason\": \"Answer matches gold standard exactly; supporting sentence is concise, directly relevant, and covers the answer with clear and logical reasoning. The model's supporting sentence provides a strong explanation by referencing gene targeting experiments that demonstrate Bach1's repressive role on ho-1 expression.\", \"match\": true}", "gold_answer": "repressor", "gold_support": "Here we show that a heme-binding factor, Bach1, is a critical physiological repressor of ho-1.", "model_answer": "Answer: BACH1 is a repressor.", "model_support": "BACH1 is a transcriptional repressor.  \n**Supporting sentence:** Gene targeting experiments in mice revealed that, in the absence of Bach1, ho-1 became expressed constitutively at high levels in various tissues under normal physiological conditions.", "retries": 1}
{"idx": 996, "gptscore_json": "{\"score\": 4, \"reason\": \"The model's answer matches the gold standard ('antiparallel'), but the supporting sentence includes some redundancy. While it correctly highlights the antiparallel nature of spectrin heterodimers, the phrasing 'This arrangement is crucial for their structural stability and mechanical function within the cytoskeleton' adds extra information not directly needed to support the answer. The gold supporting sentence is more concise and directly addresses the physiological state of alpha- and beta-spectrin as heterodimers.\", \"match\": true}", "gold_answer": "antiparallel", "gold_support": "alpha- and beta-spectrins are stable as monomeric forms but occur physiologically as alpha,beta-heterodimers bound laterally lengthwise.", "model_answer": "Alpha-spectrin and beta-spectrin subunits form antiparallel heterodimers. This arrangement is crucial for their structural stability and mechanical function within the cytoskeleton.", "model_support": "Supporting sentence: \"Influence of lateral association on forced unfolding of antiparallel spectrin heterodimers.\"", "retries": 1}
{"idx": 997, "gptscore_json": "{\"score\": 2, \"reason\": \"The model's answer 'iron deficiency' is correct in the broader context of restless leg syndrome but does not exactly match the gold answer 'iron.' The supporting sentence provided by the model incorrectly states that the context does not link iron deficiency to restless leg syndrome, while the gold supporting sentence clearly indicates that iron deficiency can cause these symptoms, albeit poorly recognized. Thus, the supporting sentence is relevant but fails to cover the gold answer.\", \"match\": false}", "gold_answer": "iron", "gold_support": "That iron deficiency, per se, can cause these symptoms is poorly recognized.", "model_answer": "The deficiency causing restless leg syndrome is iron deficiency.", "model_support": "The context provided does not explicitly mention restless leg syndrome. It discusses iron deficiency anemia and its symptoms, but does not link iron deficiency to restless leg syndrome. Therefore, the supporting sentence for the answer is not present in the context.\n\nAnswer: The context does not provide information to support the claim that iron deficiency causes restless leg syndrome.", "retries": 1}
{"idx": 998, "gptscore_json": "{\"score\": 5, \"reason\": \"The model's answer matches the gold standard exactly. The supporting sentence is concise, directly relevant, and clearly establishes the connection between Gliolan and its generic name, 5-aminolevulinic acid, through logical reasoning. Minor additional context from the study is acceptable but does not detract from the clarity or accuracy.\", \"match\": true}", "gold_answer": "5-aminolevulinic acid", "gold_support": "OBJECTIVE: To assess effectiveness of 5-aminolevulinic acid (5-ALA, Gliolan(®)) in patients treated for malignant glioma under typical daily practice conditions in Spain, using complete resection rate (CR) and progression free survival at 6 months (PFS6).", "model_answer": "The generic name of Gliolan is 5-aminolevulinic acid. \n\nAnswer: 5-aminolevulinic acid", "model_support": "The supporting sentence from the context is:\n\n\"Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study).\"\n\nThis sentence introduces the study involving 5-aminolevulinic acid, indicating that Gliolan's generic name is 5-aminolevulinic acid.", "retries": 1}
{"idx": 999, "gptscore_json": "{\n  \"score\": 4,\n  \"reason\": \"The model's answer, 'BCR-ABL protein,' closely matches the gold standard 'BCR-ABL,' with only a minor difference in wording ('protein' is not necessary but does not detract from correctness). The supporting sentence is relevant and supports the idea that Imatinib targets BCR-ABL by discussing Imatinib resistance in CML patients; however, it is slightly indirect and lacks explicit mention of BCR-ABL compared to the gold supporting sentence. Therefore, there is some redundancy and less precision than ideal.\",\n  \"match\": true\n}", "gold_answer": "BCR-ABL", "gold_support": "Chronic myeloid leukaemia (CML) is a genetically associated malignancy of haematopoietic stem cells, characterized by a t(9;22) translocation that forms the Philadelphia chromosome and creates a novel fusion gene, BCR-ABL.", "model_answer": "The tyrosine kinase targeted by Imatinib (Gleevec) in Philadelphia-chromosome positive chronic myelogenous leukemia is the BCR-ABL protein.", "model_support": "The supporting sentence for the answer is the one that mentions Imatinib resistance in CML patients, implying that Imatinib is used to target the BCR-ABL protein, which is associated with Philadelphia-chromosome positive chronic myelogenous leukemia. However, the context does not explicitly name the kinase, so the answer is based on external knowledge.\n\nSupporting sentence: \"Imatinib resistance is, however, observed in some CML patients, especially in those with advanced disease.\"", "retries": 1}
